
<html lang="en"     class="pb-page"  data-request-id="c28beb1c-d144-4be2-803c-4dcffa3e5523"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm900360d;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2009.52.issue-14"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structural Assessment and Biological Evaluation of Two N3S Bombesin Derivatives" /></meta><meta name="dc.Creator" content="Eleni  Gourni" /></meta><meta name="dc.Creator" content="Penelope  Bouziotis" /></meta><meta name="dc.Creator" content="Dimitra  Benaki" /></meta><meta name="dc.Creator" content="George  Loudos" /></meta><meta name="dc.Creator" content="Stavros  Xanthopoulos" /></meta><meta name="dc.Creator" content="Maria  Paravatou-Petsotas" /></meta><meta name="dc.Creator" content="Maria  Mavri-Vavagianni" /></meta><meta name="dc.Creator" content="Maria  Pelecanou" /></meta><meta name="dc.Creator" content="Spyros C.  Archimandritis" /></meta><meta name="dc.Creator" content="Alexandra D.  Varvarigou" /></meta><meta name="dc.Description" content="The aim of the present study is the evaluation of the 99mTc complexes of two bombesin-like peptides: Gly1′-Gly2′-Cys3′-Aca-BN[2−14] (BN-1.1) and Gly1′-Gly2′-Cys3′-Aca-BN[7−14] (BN-1.1p). The BN der..." /></meta><meta name="Description" content="The aim of the present study is the evaluation of the 99mTc complexes of two bombesin-like peptides: Gly1′-Gly2′-Cys3′-Aca-BN[2−14] (BN-1.1) and Gly1′-Gly2′-Cys3′-Aca-BN[7−14] (BN-1.1p). The BN der..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 12, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900360d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900360d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900360d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900360d" /></link>
        
    
    

<title>Structural Assessment and Biological Evaluation of Two N3S Bombesin Derivatives | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900360d" /></meta><meta property="og:title" content="Structural Assessment and Biological Evaluation of Two N3S Bombesin Derivatives" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0009.jpeg" /></meta><meta property="og:description" content="The aim of the present study is the evaluation of the 99mTc complexes of two bombesin-like peptides: Gly1′-Gly2′-Cys3′-Aca-BN[2−14] (BN-1.1) and Gly1′-Gly2′-Cys3′-Aca-BN[7−14] (BN-1.1p). The BN derivatives were synthesized according to the solid phase peptide synthesis method, and characterized by ESI-MS and NMR. 185/187Re-BN-1.1 and 185/187Re-BN-1.1p were also identified by ESI-MS and NMR. The 99mTc complexes were stable over time in human plasma, while they degraded rapidly in kidney−liver homogenates. The peptides and their 99mTc complexes showed high affinity for the human GRP receptors expressed in PC-3 cells. The rate of internalization of these radiolabeled biomolecules was found to be time-dependent. Also, it was found that there was no long-term retention of the radioactive metabolites into the cells. Tissue distribution of the radiopeptides was evaluated in normal mice and in prostate cancer experimental models. Significant uptake of radioactivity was observed in the pancreas of PC-3 tumor-bearing SCID mice. Dynamic studies of both radiopeptides showed satisfactory tumor images." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900360d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900360d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900360d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900360d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900360d&amp;href=/doi/10.1021/jm900360d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 4234-4246</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm801649y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm801570y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structural Assessment and Biological Evaluation of Two N<sub>3</sub>S Bombesin Derivatives</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eleni++Gourni">Eleni Gourni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Penelope++Bouziotis">Penelope Bouziotis</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dimitra++Benaki">Dimitra Benaki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George++Loudos">George Loudos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stavros++Xanthopoulos">Stavros Xanthopoulos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Paravatou-Petsotas">Maria Paravatou-Petsotas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Mavri-Vavagianni">Maria Mavri-Vavagianni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Pelecanou">Maria Pelecanou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Spyros+C.++Archimandritis">Spyros C. Archimandritis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandra+D.++Varvarigou">Alexandra D. Varvarigou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Medical Instruments Technology, Technological Educational Institute of Athens, Athens, Greece</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Biochemistry, University of Athens, 15771 Athens, Greece</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +30210-6503659. Fax: +30210-6522661. E-mail: <a href="/cdn-cgi/l/email-protection#b3d1dcc6c9dadcc7daf3c1c1c39dd7d6dedcd8c1dac7dcc09dd4c1"><span class="__cf_email__" data-cfemail="5b39342e2132342f321b29292b753f3e36343029322f3428753c29">[email protected]</span></a>, <a href="/cdn-cgi/l/email-protection#d7b5b8a2adbeb8a3be97b0bab6bebbf9b4b8ba"><span class="__cf_email__" data-cfemail="563439232c3f39223f16313b373f3a7835393b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900360d&amp;href=/doi/10.1021%2Fjm900360d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 4234–4246</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 12, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 December 2008</li><li><span class="item_label"><b>Published</b> online</span>12 June 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900360d" title="DOI URL">https://doi.org/10.1021/jm900360d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4234%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEleni%2BGourni%252C%2BPenelope%2BBouziotis%252C%2BDimitra%2BBenaki%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D14%26contentID%3Djm900360d%26title%3DStructural%2BAssessment%2Band%2BBiological%2BEvaluation%2Bof%2BTwo%2BN3S%2BBombesin%2BDerivatives%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4246%26publicationDate%3DJuly%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900360d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">680</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900360d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structural Assessment and Biological Evaluation of Two N3S Bombesin Derivatives&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Eleni&quot;,&quot;last_name&quot;:&quot;Gourni&quot;},{&quot;first_name&quot;:&quot;Penelope&quot;,&quot;last_name&quot;:&quot;Bouziotis&quot;},{&quot;first_name&quot;:&quot;Dimitra&quot;,&quot;last_name&quot;:&quot;Benaki&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Loudos&quot;},{&quot;first_name&quot;:&quot;Stavros&quot;,&quot;last_name&quot;:&quot;Xanthopoulos&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Paravatou-Petsotas&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Mavri-Vavagianni&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Pelecanou&quot;},{&quot;first_name&quot;:&quot;Spyros&quot;,&quot;last_name&quot;:&quot;C. Archimandritis&quot;},{&quot;first_name&quot;:&quot;Alexandra&quot;,&quot;last_name&quot;:&quot;D. Varvarigou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;4234-4246&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900360d&quot;},&quot;abstract&quot;:&quot;The aim of the present study is the evaluation of the 99mTc complexes of two bombesin-like peptides: Gly1′-Gly2′-Cys3′-Aca-BN[2−14] (BN-1.1) and Gly1′-Gly2′-Cys3′-Aca-BN[7−14] (BN-1.1p). The BN derivatives were synthesized according to the solid phase peptide synthesis method, and characterized by ESI-MS and NMR. 185/187Re-BN-1.1 and 185/187Re-BN-1.1p were also identified by ESI-MS and NMR. The 99mTc complexes were stable over time in human plasma, while they degraded rapidly in kidney−liver homogenates. The peptides and their 99mTc complexes showed high affinity for the human GRP receptors expressed in PC-3 cells. The rate of internalization of these radiolabeled biomolecules was found to be time-dependent. Also, it was found that there was no long-term retention of the radioactive metabolites into the cells. Tissue distribution of the radiopeptides was evaluated in normal mice and in prostate cancer experimental models. Significant uptake of radioactivity was observed in the pancreas of PC-3 tumor-bearing S&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900360d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900360d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900360d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900360d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900360d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900360d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900360d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900360d&amp;href=/doi/10.1021/jm900360d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900360d" /></input><a href="/doi/pdf/10.1021/jm900360d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900360d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900360d%26sid%3Dliteratum%253Aachs%26pmid%3D19522464%26genre%3Darticle%26aulast%3DGourni%26date%3D2009%26atitle%3DStructural%2BAssessment%2Band%2BBiological%2BEvaluation%2Bof%2BTwo%2BN3S%2BBombesin%2BDerivatives%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D14%26spage%3D4234%26epage%3D4246%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0009.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The aim of the present study is the evaluation of the <sup>99m</sup>Tc complexes of two bombesin-like peptides: Gly1′-Gly2′-Cys3′-Aca<b>-</b>BN[2−14] (BN-1.1) and Gly1′-Gly2′-Cys3′-Aca<b>-</b>BN[7−14] (BN-1.1p). The BN derivatives were synthesized according to the solid phase peptide synthesis method, and characterized by ESI-MS and NMR. <sup>185/187</sup>Re-BN-1.1 and <sup>185/187</sup>Re-BN-1.1p were also identified by ESI-MS and NMR. The <sup>99m</sup>Tc complexes were stable over time in human plasma, while they degraded rapidly in kidney−liver homogenates. The peptides and their <sup>99m</sup>Tc complexes showed high affinity for the human GRP receptors expressed in PC-3 cells. The rate of internalization of these radiolabeled biomolecules was found to be time-dependent. Also, it was found that there was no long-term retention of the radioactive metabolites into the cells. Tissue distribution of the radiopeptides was evaluated in normal mice and in prostate cancer experimental models. Significant uptake of radioactivity was observed in the pancreas of PC-3 tumor-bearing SCID mice. Dynamic studies of both radiopeptides showed satisfactory tumor images.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A big challenge for oncologists was and still remains the identification of tumors at an early stage. The ability to detect primary cancers is of major importance, and early diagnosis has made a significant contribution in reducing the number of deaths from cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The increasing evidence of peptide receptor overexpression in various tumors has generated interest in the development of specific radiolabeled peptides to target these kind of tumors for radiodiagnosis and/or targeted radiotherapy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> One example of this approach is the gastrin-releasing peptide receptor (GRP-R),<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ACN, acetonitrile; Aca, 6-aminohexanoic acid; AcuTect, [<sup>99m</sup>TcO]apcitide; ATCC, American Type Culture Collection; BN, bombesin; BSA, bovine serum albumin; CD, circular dichroism; cpm, counts per minute; DTPA, diethylenetriaminepentaacetic acid; DOTA, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; DVT, deep vein thrombosis; DMEM, Dulbecco’s modified Eagle medium; DSS, 3-(trimethylsilyl)propanesulfonic acid, sodium salt; EDTA, ethylenediaminetetraacetic acid; ESI-MS, electrospray ionization mass spectrometry; FBS, fetal bovine serum; FDG, fluorodeoxyglycose; Fmoc, 9-fluorenylmethoxycarbonyl; GRP, gastrin releasing peptide; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; IC<sub>50</sub>, inhibitory concentration 50%; ID, injected dose; MRI, magnetic resonance imaging; NeoTect, [<sup>99m</sup>TcO]depreotide; NMB, neuromedin; NMR, nuclear magnetic resonance; PBS, phosphate buffered saline; PET, positron emission tomography; pi, postinjection; PMSF, phenylmethanesulfonyl fluoride; RP-HPLC, reversed phase high-performance liquid chromatography; ROIs, regions of interest; SCID, severe combined immunodeficiency disease; SD, standard deviation; SPECT, single photon emission computerized tomography; SPPS, solid phase peptide synthesis; TFA, trifluoroacetic acid; TPPI, time proportional phase increments.</p></div> overexpressed in a number of human cancers including prostate, breast, and small-cell lung cancer, as well as colon carcinoma, which are currently being targeted with radiolabeled bombesin (BN) derivatives<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11">(3-11)</a> and may act as a prognostic marker for the above-mentioned types of cancer.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a></div><div class="NLM_p">The amphibian 14-amino acid peptide BN<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (pGlu1-Gln2-Arg3-Leu4-Gly5-Asn6-Gln7-Trp8-Ala9-Val10-Gly11-His12-Leu13-Met14-NH<sub>2</sub>) is a member of the superfamily of BN-like peptides that also includes the mammalian homologue gastrin releasing peptide (GRP)<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> and the related peptide neuromedin B (NMB).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> BN-like peptides have a wide range of physiological activities, including stimulation of the release of gastrointestinal hormones, stimulation of pancreatic enzyme secretion, thermoregulation, and inhibition of thyroid-stimulating hormone.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> They exert their effects on target cells by binding to surface GRP-Rs that belong to the superfamily of G-protein-coupled receptors characterized by the typical configuration of seven transmembrane domains.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> There are four known receptor subtypes for BN-like peptides, three of which are found in humans, the BB2 receptor (BB2-R or GRP-R),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> the NMB-R,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and the orphan BB3-R<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> for which a native ligand has not yet been identified.</div><div class="NLM_p">A great number of radiolabeled BN analogues have been synthesized for nuclear oncology applications. Radiolabeling requires covalent coupling of the peptide sequence to a suitable chelating agent for stable binding of the radionuclide, which is usually a metal.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> For example, BN-like peptides conjugated to DTPA (diethylenetriaminepentaacetic acid) have been synthesized in order to be labeled with <sup>111</sup>In<sup>3+</sup>.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) has been also employed for labeling with <sup>111</sup>In<sup>3+</sup> as well as <sup>64</sup>Cu<sup>2+</sup>and <sup>68</sup>Ga<sup>3+</sup> for PET imaging and <sup>177</sup>Lu<sup>3+</sup> for radiotherapy and SPECT imaging.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a><sup>18</sup>F-labeled BN analogues are also reported in the literature for PET imaging.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> However, <sup>99m</sup>Tc is still the most widely applied radionuclide for diagnostic purposes, mainly because of its favorable γ-ray emission characteristics, low cost and availability.<a onclick="showRef(event, 'ref24 ref31'); return false;" href="javascript:void(0);" class="ref ref24 ref31">(24, 31)</a> Therefore, a major goal of researchers is the development of <sup>99m</sup>Tc-labeled BN-like peptides involving a wide range of chelators. The cores of the most commonly employed chelator groups for <sup>99m</sup>Tc labeling in the literature are N<sub>2</sub>S<sub>2</sub>, N<sub>3</sub>S, P<sub>2</sub>S<sub>2</sub>, and N<sub>4</sub>, resulting in very stable complexes. The oxidation state of <sup>99m</sup>Tc in labeled BN derivatives is usually (V),<a onclick="showRef(event, 'ref14 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref14 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40">(14, 32-40)</a> even though in the past 10 years an increasing number of <sup>99m</sup>Tc-BN-like peptides with the radionuclide in  oxidation state (I) have been referred to in the literature.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44">(41-44)</a></div><div class="NLM_p">One of the cancers targeted with BN-labeled derivatives is prostate carcinoma, which overexpresses the BB2 subtype of GRP-Rs.<a onclick="showRef(event, 'ref10 ref45'); return false;" href="javascript:void(0);" class="ref ref10 ref45">(10, 45)</a> Prostate cancer is the most common solid tumor found in men and the second leading cause of cancer death in the U.S. Even though prostate cancer is one of the few slowly growing cancers that when organ-confined may never threaten the lives of some patients, it becomes potentially lethal if it metastasizes. Thus, its detection at early stages and the investigation of the extent of the disease are particularly important for effective treatment.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Functional imaging methods to detect prostate cancer are MRI, SPECT, and PET. MRI imaging is able to discriminate cancer from surrounding healthy tissue and necrosis; however, in tumors less than 1 cm, the accuracy and positive predictive value are 24.2 and 75.9%, respectively.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The most widely used PET radiotracer, <sup>18</sup>F-FDG, cannot be applied for the detection of prostate cancer probably because of the low metabolic rate of this type of cancer and the proximity of the prostate to the bladder.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Other PET tracers (<sup>11</sup>C-choline, <sup>18</sup>F-fluoroethylcholine) are reported in the literature for imaging prostate cancer,<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> but their availability is currently limited. SPECT imaging on the other hand is widely available and has significant potential for imaging with tumor-specific radiopharmaceuticals, especially with those having physical half-lives well matching the time-course of tumor uptake and background clearance of the radiolabeled molecules.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p">The aim of the present work is the synthesis and evaluation of the <sup>99m</sup>Tc complexes of two BN derivatives for prostate cancer detection with SPECT. The first derivative is Gly1′-Gly2′-Cys3′-Aca-BN[2−14] (BN-1.1), and the second derivative is the truncated peptide Gly1′-Gly2′-Cys3′-Aca-BN[7−14] (BN-1.1p, Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>A), where Aca is 6-aminohexanoic acid. Both peptides include the BN C-terminal amino acid sequence Trp8-Ala9-Val10-Gly11-His12-Leu13-Met14-CONH<sub>2</sub>, known to be critical for receptor binding affinity and biological activity of BN-like peptides. The tripeptide group Gly1′-Gly2′-Cys3′ is an amino acid sequence capable of complexing a variety of radiometals.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The Aca moiety serves as a spacer between the ligating Gly1′-Gly2′-Cys3′ sequence and the BN part, in order to minimize any possible steric hindrance introduced by the oxometal core on the interaction of the biologically active sequence with the receptor. Preliminary results on the synthesis and labeling of both peptides have already been reported.<a onclick="showRef(event, 'ref36 ref52'); return false;" href="javascript:void(0);" class="ref ref36 ref52">(36, 52)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0010.jpeg" id="_i4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of BN-1.1, BN-1.1p (A) and <sup>185/187</sup>Re-BN-1.1, <sup>185/187</sup>Re-BN-1.1p (B)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The complexes of BN-1.1 and BN-1.1p were initially synthesized with the stable <sup>185/187</sup>ReO(V)<sup>3+</sup> core (<sup>185/187</sup>Re-BN-1.1 and <sup>185/187</sup>Re-BN-1.1p, respectively; Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>B) and were fully characterized by NMR and ESI-MS analysis. Rhenium has similar physical and chemical properties as technetium, being its third row congener, and commonly replaces technetium for structural characterization.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The synthesis of the complexes was subsequently successfully transferred at tracer <sup>99m</sup>Tc level. In vitro studies followed to determine the efficiency of internalization of the <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p complexes and the degree of residualization of radioactivity into the cells as a function of time. The in vivo behavior of the <sup>99m</sup>Tc complexes was assessed in normal mice as well as in mice bearing PC-3 prostate cancer xenografts. Dynamic imaging studies were also performed for the tumor bearing mice.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis</h3><div class="NLM_p">The BN derivatives BN-1.1 and BN-1.1p (Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>A) were synthesized according to the solid phase peptide synthesis (SPPS) method. The purification of the crude peptides was performed by semipreparative RP-HPLC with a yield of 34% for BN-1.1 and 48% for BN-1.1p. The purity of the peptides was >95%. The respective <sup>185/187</sup>Re complexes <sup>185/187</sup>Re-BN-1.1 and <sup>185/187</sup>Re-BN-1.1p were synthesized via the <sup>185/187</sup>Re-gluconate precursor. The purification of the <sup>185/187</sup>Re complexes was performed as above, by semipreparative RP-HPLC with a yield of 30% for <sup>185/187</sup>Re-BN-1.1 and 35% for <sup>185/187</sup>Re-BN-1.1p. HPLC analysis showed the formation of a single complex in each case. The HPLC retention times of the two peptides and their corresponding complexes are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Analytical HPLC Retention Times (<i>t</i><sub>R</sub>) for BN-1.1 and BN-1.1p and Their Complexes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="2" align="center" char=".">HPLC <i>t</i><sub>R</sub> (min)</th></tr><tr valign="top"><th align="center">compd</th><th align="center" char=".">UV detector</th><th align="center">radioactivity detector</th></tr></thead><tbody><tr valign="top"><td align="left">BN-1.1</td><td align="char" char=".">10.5</td><td align="center"> </td></tr><tr valign="top"><td align="left">BN-1.1p</td><td align="char" char=".">12.6</td><td align="center"> </td></tr><tr valign="top"><td align="left"><sup>99m</sup>Tc-BN-1.1</td><td align="char" char="."> </td><td align="center">11.1</td></tr><tr valign="top"><td align="left"><sup>99m</sup>Tc-BN-1.1p</td><td align="char" char="."> </td><td align="center">13.3</td></tr><tr valign="top"><td align="left"><sup>185/187</sup>Re-BN-1.1</td><td align="char" char=".">10.8</td><td align="center"> </td></tr><tr valign="top"><td align="left"><sup>185/187</sup>Re-BN-1.1p</td><td align="char" char=".">13.1</td><td align="center"> </td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> ESI-MS</h3><div class="NLM_p">The ESI-MS results for BN-1.1, BN-1.1p, <sup>185/187</sup>Re-BN-1.1, and <sup>185/187</sup>Re-BN-1.1p along with the theoretically expected charged ion values are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The [M + 2H]<sup>2+</sup> and [M + H]<sup>+</sup> peaks are consistent with the presence of one <sup>185/187</sup>ReO(V)<sup>3+</sup> core and the loss of three protons from the BN-1.1 and BN-1.1p peptide sequences, in agreement with the proposed structures of Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>B.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Data for BN Peptides and Their <sup>185/187</sup>Re Complexes from MS Analysis</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd</th><th class="rowsep1" align="center" char=".">calculated MW</th><th class="rowsep1" align="center">charged ion (<i>m</i>/<i>z</i>)</th><th class="rowsep1" align="center" char=".">theoretically expected <i>m</i>/<i>z</i></th><th class="rowsep1" align="center" char=".">found <i>m</i>/<i>z</i></th></tr></thead><tbody><tr valign="top"><td align="left">BN-1.1</td><td align="char" char=".">1839.14</td><td align="char">[M + 2H]<sup>2+</sup></td><td align="char" char=".">920.6</td><td align="char" char=".">920.4</td></tr><tr valign="top"><td align="left">BN-1.1p</td><td align="char" char=".">1271.5</td><td align="char">[M + H]<sup>+</sup></td><td align="char" char=".">1272.5</td><td align="char" char=".">1270.8</td></tr><tr valign="top"><td align="left"> </td><td align="char" char="."> </td><td align="center">[M + 2H]<sup>2+</sup></td><td align="char" char=".">636.7</td><td align="char" char=".">636.0</td></tr><tr valign="top"><td align="left"><sup>185/187</sup>Re-BN-1.1</td><td align="char" char=".">2038.28</td><td align="char">[M + 2H]<sup>2+</sup></td><td align="char" char=".">1020.1</td><td align="char" char=".">1020.9</td></tr><tr valign="top"><td align="left"><sup>185/187</sup>Re-BN-1.1p</td><td align="char" char=".">1470.53</td><td align="char">[M + H]<sup>+</sup></td><td align="char" char=".">1471.5</td><td align="char" char=".">1470.6</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> NMR Spectroscopy</h3><div class="NLM_p">NMR spectra for the peptides and their complexes were recorded in 9:1 H<sub>2</sub>O/D<sub>2</sub>O at 25 °C. The pH of all samples was in the 3.3−3.8 range, and it remained uncorrected. Complete assignments of <sup>1</sup>H and <sup>13</sup>C resonances for BN-1.1, BN-1.1p, <sup>185/187</sup>Re-BN-1.1, and <sup>185/187</sup>Re-BN-1.1p are reported in Tables S1, S2, S3, and S4, respectively, of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. <sup>1</sup>H assignments were based on the combined analysis of well resolved TOCSY and ROESY spectra according to the sequential assignment method,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> while the assignment of the <sup>13</sup>C resonances was based on <sup>1</sup>H−<sup>13</sup>C single and multiple bond correlation experiments (HSQC and HMBC experiments, respectively).</div><div class="NLM_p">The Gly1′-Gly2′-Cys3′ ligand moiety of the sequence was first identified for the BN-1.1 peptide. The Gly1′ amine protons are not observed in the <sup>1</sup>H NMR spectrum because of fast exchange with the solvent. The αCH<sub>2</sub> protons of both Gly1′ and Gly2′ are equivalent, appearing at 3.92 and 4.08 ppm, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). The αCH<sub>2</sub> protons of Gly1′ overlap with the αCH<sub>2</sub> protons of Gly5 and Gly11, giving rise to a high intensity peak; they were identified by their αCH-NH(<i>i</i>,<i>i</i>+1) cross-peak with the Gly2′ amide proton in the ROESY spectrum. The <sup>3</sup><i>J</i><sub>NH-αH</sub> coupling constant for Gly2′ was the only one directly measurable in the 1D spectrum and was determined to be 5.9 Hz. The βCH<sub>2</sub> protons of Cys3′ appear as two very closely spaced doublets centered at 2.92 ppm. The αCH of Cys3′ at 4.47 ppm is not visible in the 1D spectrum, being affected by the water peak suppression procedure; however, it is clearly observed in the 2D spectra.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <sup>1</sup>H NMR spectra (5.5−2.8 ppm region) of the aqueous solution of (A) the BN-1.1 peptide and (B) the <sup>185/187</sup>Re-BN-1.1 complex presented in comparison. Lines indicate the changes in the chemical shifts of the α and β protons of the Gly1′-Gly2′-Cys3′ ligand moiety after coordination of the BN-1.1 peptide to the metal core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Upon complexation of peptide BN-1.1 to the <sup>185/187</sup>ReO(V)<sup>3+</sup> core, the amide protons of Gly2′ and Cys3′ disappear from the <sup>1</sup>H spectrum. The αCH<sub>2</sub> protons of Gly1′ and Gly2′ are shifted downfield (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) and appear as magnetically nonequivalent doublets with a geminal coupling of 17.6 and 18.7 Hz, respectively. The average downfield shift of the αCH<sub>2</sub> protons is 0.30 ppm for Gly1′ and 0.52 ppm for Gly2′. Intense changes are also noted upon complexation for the Cys3′ residue. Specifically, the αCH proton is shifted downfield by 0.78 ppm appearing as a doublet of doublets (<sup>3</sup><i>J</i> = 8.3 and 3.9 Hz), while the βCH<sub>2</sub> protons appear as two well separated peaks (<sup>2</sup><i>J</i> = 12.5 Hz) shifted downfield by an average of 0.58 ppm. Downfield shifts are expected when a ligand binds to a metal; therefore, these data are consistent with the coordination of the amine nitrogen of Gly1′, the amide nitrogen of Gly2′, and the amide nitrogen and thiol sulfur of Cys3′ to the <sup>185/187</sup>ReO(V)<sup>3+</sup> core to form a N<sub>3</sub>S complex with three chelate rings, as designed (Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>B). In agreement with the participation of the Gly1′-Gly2′-Cys3′ amino acids in the coordination sphere, downfield shifts of 8.6, 14.5, and 12.7 ppm, respectively, are noted upon complexation for their αC carbons, while the βC of Cys3′ displays a downfield shift of 20.7 ppm.</div><div class="NLM_p">The truncated BN-1.1p derivative displays, analogous to BN-1.1, spectroscopic behavior in both its free and coordinated form.</div><div class="NLM_p">One interesting feature in both <sup>185/187</sup>Re-BN-1.1 and <sup>185/187</sup>Re-BN-1.1p complexes is the approximately 0.5 ppm upfield shift of the amide proton of the Aca moiety upon complexation. This upfield shift is unique among all the protons of the complexes and can be ascribed to the magnetic anisotropy of the oxometal center and the coordination sphere that mainly affects protons in the vicinity of the complexing site.<a onclick="showRef(event, 'ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57">(55-57)</a></div><div class="NLM_p last">The complexes remained stable in solution for a period of several months, and no decomposition or conversion into isomeric forms was observed.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Radiolabeling</h3><div class="NLM_p last">Radiolabeling of the BN-1.1 and BN-1.1p peptides was achieved by ligand exchange reactions employing <sup>99m</sup>Tc-gluconate as precursor. HPLC analysis of the reaction mixture revealed a single radioactive species for both peptides, at a yield of more than 98%, which remained stable for 6 h after labeling.<a onclick="showRef(event, 'ref36 ref52'); return false;" href="javascript:void(0);" class="ref ref36 ref52">(36, 52)</a> The retention times of the <sup>99m</sup>Tc complexes are similar to those of the analogous <sup>185/187</sup>Re complexes (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), indicating that the complexes formed at tracer level have the same chemical structure as those prepared at the macroscopic level. Pertechnetate had a retention time of 3.5 min under the specific HPLC conditions. The maximum specific radioactivity was 1.84 Ci/μmol for <sup>99m</sup>Tc-BN-1.1 and 1.30 Ci/μmol for <sup>99m</sup>Tc-BN-1.1p.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Competition Binding Assays</h3><div class="NLM_p">The affinity of BN-1.1 and BN-1.1p, as well as their respective <sup>185/187</sup>Re complexes for the GRP-Rs, was determined by measuring their ability to compete with [<sup>125</sup>I-Tyr4]-BN for binding to PC-3 prostate cancer cells, known to predominately express the BB2-R subtype. All compounds were able to displace [<sup>125</sup>I-Tyr4]-BN, except the T-epitope of cholera, which was used as negative control. The displacement curves of all the above derivatives are compiled in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Binding data were analyzed and IC<sub>50</sub> values were calculated by nonlinear regression according to a one-site model, and the results are summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. The IC<sub>50</sub> values determined for <sup>185/187</sup>Re-BN-1.1 and <sup>185/187</sup>Re-BN-1.1p were slightly higher than those of the BN-1.1 and BN-1.1p, respectively. All IC<sub>50</sub> values were found to be in the low nanomolar range, indicating that the presence of the chelate group, the spacer, and the metal core do not affect the affinity of the active part of the BN derivatives for the BB2-Rs.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Displacement curves of [<sup>125</sup>I-Tyr4]-BN bound to the BB2-Rs of PC-3 cells by [Tyr4]-BN, BN-1.1, <sup>185/187</sup>Re-BN-1.1, BN-1.1p, <sup>185/187</sup>Re-BN-1.1p, and the T-epitope of cholera.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Internalization/Efflux</h3><div class="NLM_p">Internalization curves of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p in PC-3 cells during incubation at 37 °C are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. Internalization was rapid with 50% and 30% of the cell-associated radioactivity being internalized at 5 min after incubation for <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p, respectively. Maximum internalization was reached at 30 min with 75% and 65% internalized radioactivity for <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p, respectively, and it remained at these levels for 120 min. Nonspecific binding was found to be approximately 1% after incubation of the cancer cells with <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p in the presence of 1 μM [Tyr4]-BN, indicating that the complexes display high affinity and specificity for the BB2-Rs. The externalization curves of the <sup>99m</sup>Tc complexes are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. It can be seen that for both complexes approximately 50% of the internalized activity was released between 1 and 2 h and that after 5 h approximately 60% of the internalized radioactivity was released.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time course internalization of <sup>99m</sup>Tc-BN-1.1 (◆) and <sup>99m</sup>Tc-BN-1.1p (◼) in PC-3 cells at 37 °C. Nonspecific internalization (▲) was performed in the presence of 1 μM [Tyr4]-BN. Data are percentage of internalized radioactivity into the cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Efflux determination of <sup>99m</sup>Tc-BN-1.1 (◆) and <sup>99m</sup>Tc-BN-1.1p (◼) in PC-3 cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Metabolic Stability</h3><div class="NLM_p">The enzymatic degradation of the labeled peptides <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p was assessed after incubation in plasma and liver−kidney homogenates at 37 °C, followed by HPLC analysis of the metabolic mixture. The percentage of intact complexes versus time is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. <sup>99m</sup>Tc-BN-1.1 is stable with more than 80% remaining intact after 2 h of incubation in human plasma, while <sup>99m</sup>Tc-BN-1.1p seems to degrade more rapidly with approximately 35% of the complex remaining intact at the same time point. Apparently, the shorter sequence of BN-1.1p is more accessible to plasma peptidases.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Enzymatic degradation of <sup>99m</sup>Tc-labeled peptides after incubation with plasma and kidney−liver homogenates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A completely different picture was observed after incubation of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p with liver and kidney homogenates. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> rapid degradation of the radiolabeled peptides takes place. In the case of <sup>99m</sup>Tc-BN-1.1p two major metabolites were detected by HPLC analysis, while for <sup>99m</sup>Tc-BN-1.1 more than two metabolites were observed.</div><div class="NLM_p last">It is interesting to note that no peak in the HPLC chromatogram corresponds to free <sup>99m</sup>TcO<sub>4</sub><sup>−</sup> that would be present in the case of degradation of the <sup>99m</sup>Tc complex and release of the metal.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Biodistribution Studies in Normal Swiss Mouse Models</h3><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> summarizes the results of biodistribution studies of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p conjugates in normal Swiss mice. The mice were sacrificed at 0.5, 1, 2, 4, and 24 h postinjection (pi). Rapid clearance from blood was observed for both radiolabeled peptides. Statistical evaluation (<i>t</i> test) of the data sets of the two radiolabeled species at 0.5, 1, 2, 4, and 24 h demonstrated <i>P</i> < 0.02. The uptake in stomach was low, providing evidence for the conjugates’ stability in vivo. Fast intestinal uptake for <sup>99m</sup>Tc-BN-1.1p at 0.5 h (15.3 ± 2.2% ID/g) was observed, which remains relatively high at 4 h for both products (10.91 ± 1.6% ID/g for <sup>99m</sup>Tc-BN-1.1 and 11.4 ± 3.1% ID/g for <sup>99m</sup>Tc-BN-1.1p). As far as the excretion pathway of the radiolabeled products is concerned, <sup>99m</sup>Tc-BN-1.1 shows slightly pronounced kidney elimination. Liver uptake was similar and nonsignificant for all the time points of the study for both of the derivatives. Competition binding assays displayed high affinity of BN-1.1 and BN-1.1p, as well as their <sup>185/187</sup>Re complexes for GRP-Rs. These results were also confirmed from the biodistribution studies, since the two radiolabeled analogues exhibit high affinity for pancreas, an organ that overexpresses the GRP-Rs (<i>P</i> < 0.05 for all the tested time points). It is worth noting that even at 2 h pi pancreatic uptake remains relatively high (3.6 ± 1.5% ID/g for <sup>99m</sup>Tc-BN-1.1 and 5.2 ± 2.1% ID/g for <sup>99m</sup>Tc-BN-1.1p).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biodistribution of <sup>99m</sup> Tc-BN-1.1 and <sup>99m</sup> Tc-BN-1.1p in Normal Mice<a class="ref internalNav" href="#t3fn1" aria-label="α">α</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center"> </th><th class="rowsep1" colspan="5" align="center"><sup>99m</sup>Tc-BN-1.1</th><th class="rowsep1" colspan="5" align="center"><sup>99m</sup>Tc-BN-1.1p</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">organ</th><th class="rowsep1" align="center">0.5 h</th><th class="rowsep1" align="center">1 h</th><th class="rowsep1" align="center">2 h</th><th class="rowsep1" align="center">4 h</th><th class="rowsep1" align="center">24 h</th><th class="rowsep1" align="center">0.5 h</th><th class="rowsep1" align="center">1 h</th><th class="rowsep1" align="center">2 h</th><th class="rowsep1" align="center">4 h</th><th class="rowsep1" align="center">24 h</th></tr></thead><tbody><tr valign="top"><td align="left">blood</td><td align="left">1.2 ± 0.2</td><td align="left">1.1 ± 0.7</td><td align="left">0.4 ± 0.1</td><td align="left">0.3 ± 0.1</td><td align="left">0.1 ± 0.1</td><td align="left">1.9 ± 1.0</td><td align="left">0.3 ± 0.1</td><td align="left">0.6 ± 0.2</td><td align="left">0.1 ± 0.1</td><td align="left">0.0 ± 0.0</td></tr><tr valign="top"><td align="left">liver</td><td align="left">2.3 ± 0.8</td><td align="left">2.7 ± 0.8</td><td align="left">1.1 ± 0.6</td><td align="left">1.0 ± 0.5</td><td align="left">0.1 ± 0.1</td><td align="left">2.4 ± 0.6</td><td align="left">3.2 ± 1.1</td><td align="left">2.3 ± 0.4</td><td align="left">0.5 ± 0.3</td><td align="left">0.1 ± 0.0</td></tr><tr valign="top"><td align="left">heart</td><td align="left">0.6 ± 0.1</td><td align="left">0.4 ± 0.2</td><td align="left">0.2 ± 0.0</td><td align="left">0.2 ± 0.1</td><td align="left">0.6 ± 0.3</td><td align="left">0.4 ± 0.1</td><td align="left">0.1 ± 0.0</td><td align="left">0.3 ± 0.1</td><td align="left">0.1 ± 0.0</td><td align="left">0.6 ± 0.1</td></tr><tr valign="top"><td align="left">kidneys</td><td align="left">9.2 ± 2.1</td><td align="left">4.6 ± 1.6</td><td align="left">3.7 ± 0.9</td><td align="left">2.0 ± 0.3</td><td align="left">0.9 ± 0.2</td><td align="left">4.9 ± 1.4</td><td align="left">2.0 ± 0.3</td><td align="left">2.0 ± 0.9</td><td align="left">0.6 ± 0.1</td><td align="left">0.3 ± 0.0</td></tr><tr valign="top"><td align="left">stomach</td><td align="left">1.3 ± 0.9</td><td align="left">1.0 ± 0.2</td><td align="left">0.6 ± 0.1</td><td align="left">0.9 ± 0.3</td><td align="left">0.4 ± 0.1</td><td align="left">1.3 ± 0.5</td><td align="left">0.9 ± 0.4</td><td align="left">1.0 ± 0.6</td><td align="left">0.4 ± 0.2</td><td align="left">0.1 ± 0.0</td></tr><tr valign="top"><td align="left">intestines</td><td align="left">2.4 ± 0.8</td><td align="left">7.3 ± 1.1</td><td align="left">10.2 ± 0.8</td><td align="left">10.9 ± 1.6</td><td align="left">0.9 ± 0.4</td><td align="left">15.3 ± 2.2</td><td align="left">11.8 ± 1.7</td><td align="left">12.1 ± 1.4</td><td align="left">11.4 ± 3.1</td><td align="left">0.8 ± 0.3</td></tr><tr valign="top"><td align="left">spleen</td><td align="left">1.2 ± 0.7</td><td align="left">0.6 ± 0.1</td><td align="left">0.5 ± 0.3</td><td align="left">0.3 ± 0.1</td><td align="left">0.1 ± 0.0</td><td align="left">1.6 ± 0.7</td><td align="left">0.6 ± 0.2</td><td align="left">0.6 ± 0.4</td><td align="left">0.1 ± 0.0</td><td align="left">0.3 ± 0.1</td></tr><tr valign="top"><td align="left">muscles</td><td align="left">0.4 ± 0.2</td><td align="left">0.6 ± 0.1</td><td align="left">0.4 ± 0.1</td><td align="left">0.1 ± 0.1</td><td align="left">0.1 ± 0.0</td><td align="left">0.3 ± 0.1</td><td align="left">0.1 ± 0.1</td><td align="left">0.1 ± 0.0</td><td align="left">0.0 ± 0.0</td><td align="left">0.2 ± 0.1</td></tr><tr valign="top"><td align="left">lungs</td><td align="left">1.5 ± 0.2</td><td align="left">1.5 ± 0.1</td><td align="left">0.5 ± 0.1</td><td align="left">0.4 ± 0.2</td><td align="left">0.1 ± 0.0</td><td align="left">0.9 ± 0.2</td><td align="left">0.3 ± 0.1</td><td align="left">1.5 ± 0.2</td><td align="left">0.5 ± 0.3</td><td align="left">0.3 ± 0.0</td></tr><tr valign="top"><td align="left">pancreas</td><td align="left">11.3  ± 2.1</td><td align="left">5.0 ± 0.5</td><td align="left">3.6 ± 1.5</td><td align="left">1.2 ± 0.4</td><td align="left">0.2 ± 0.1</td><td align="left">10.1 ± 1.5</td><td align="left">9.8 ± 1.5</td><td align="left">5.2 ± 2.1</td><td align="left">1.1 ± 0.2</td><td align="left">0.9 ± 0.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>α</sup><p class="last">Data are expressed as % ID/g tissue and are presented as the mean ± SD (<i>n</i> = 5) at 0.5, 1, 2, 4, and 24 h pi.</p></div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biodistribution Studies in PC-3 Tumor-Bearing SCID Mice</h3><div class="NLM_p">Similar biodistribution studies were also performed in PC-3 tumor-bearing SCID mice, attention being focused on BB2-R bearing organs such as the pancreas and the experimental tumor. The results of the biodistribution of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biodistribution of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p in PC-3 Bearing-Tumor SCID Mice<a class="ref internalNav" href="#t4fn1" aria-label="α">α</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="rowsep1" colspan="5" align="center"><sup>99m</sup>Tc-BN-1.1</th><th class="rowsep1" colspan="5" align="center"><sup>99m</sup>Tc-BN-1.1p</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">organ</th><th class="rowsep1" align="center">0.5 h</th><th class="rowsep1" align="center">1 h</th><th class="rowsep1" align="center">2 h</th><th class="rowsep1" align="center">4 h</th><th class="rowsep1" align="center">24 h</th><th class="rowsep1" align="center">0.5 h</th><th class="rowsep1" align="center">1 h</th><th class="rowsep1" align="center">2 h</th><th class="rowsep1" align="center">4 h</th><th class="rowsep1" align="center">24 h</th></tr></thead><tbody><tr valign="top"><td align="left">blood</td><td align="left">1.2 ± 0.3</td><td align="left">1.4 ± 0.5</td><td align="left">0.6 ± 0.0</td><td align="left">0.2 ± 0.1</td><td align="left">0.5 ± 0.2</td><td align="left">1.8 ± 0.8</td><td align="left">0.9 ± 0.4</td><td align="left">0.4 ± 0.2</td><td align="left">0.3 ± 0.1</td><td align="left">0.1 ± 0.0</td></tr><tr valign="top"><td align="left">liver</td><td align="left">4.3 ± 1.4</td><td align="left">4.4 ± 0.9</td><td align="left">3.1 ± 1.3</td><td align="left">2.1 ± 0.6</td><td align="left">0.9 ± 0.3</td><td align="left">8.7 ± 2.5</td><td align="left">5.0 ± 1.4</td><td align="left">1.5 ± 0.5</td><td align="left">0.6 ± 0.2</td><td align="left">0.3 ± 0.1</td></tr><tr valign="top"><td align="left">liver (bl)<sup></sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td align="left"> </td><td align="left">7.5 ± 0.9</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">8.7 ± 1.1</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left">heart</td><td align="left">0.7 ± 0.3</td><td align="left">1.0 ± 0.3</td><td align="left">0.3 ± 0.1</td><td align="left">0.2 ± 0.1</td><td align="left">0.1 ± 0.0</td><td align="left">1.3 ± 0.6</td><td align="left">1.0 ± 0.5</td><td align="left">0.2 ± 0.1</td><td align="left">0.5 ± 0.2</td><td align="left">0.1 ± 0.0</td></tr><tr valign="top"><td align="left">kidneys</td><td align="left">10.8 ± 2.5</td><td align="left">7.2 ± 1.2</td><td align="left">5.9 ± 0.5</td><td align="left">6.0 ± 1.1</td><td align="left">3.1 ± 0.9</td><td align="left">8.5 ± 1.9</td><td align="left">10.0 ± 2.1</td><td align="left">2.3 ± 0.3</td><td align="left">1.9 ± 0.6</td><td align="left">1.1 ± 0.2</td></tr><tr valign="top"><td align="left">kidneys (bl) <a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td align="left"> </td><td align="left">15.5 ± 0.8</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">12.1 ± 1.3</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left">stomach</td><td align="left">1.2 ± 0.4</td><td align="left">0.9 ± 0.2</td><td align="left">0.7 ± 0.0</td><td align="left">1.0 ± 0.4</td><td align="left">0.8 ± 0.4</td><td align="left">1.2 ± 0.1</td><td align="left">1.1 ± 0.5</td><td align="left">1.5 ± 0.7</td><td align="left">1.2 ± 0.8</td><td align="left">0.3 ± 0.1</td></tr><tr valign="top"><td align="left">intestines</td><td align="left">3.1 ± 0.8</td><td align="left">6.7 ± 0.8</td><td align="left">15.7 ± 2.6</td><td align="left">16.2 ± 3.4</td><td align="left">1.2 ± 0.6</td><td align="left">10.3 ± 0.8</td><td align="left">9.4 ± 0.3</td><td align="left">19.1 ± 1.8</td><td align="left">16.1 ± 4.4</td><td align="left">1.4 ± 0.5</td></tr><tr valign="top"><td align="left">intestines (bl) <a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td align="left"> </td><td align="left">1.3 ± 0.7</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">6.1 ± 0.9</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left">spleen</td><td align="left">1.3 ± 0.9</td><td align="left">0.8 ± 0.3</td><td align="left">0.8 ± 0.6</td><td align="left">0.1 ± 0.0</td><td align="left">0.2 ± 0.0</td><td align="left">0.9 ± 0.4</td><td align="left">0.7 ± 0.3</td><td align="left">0.8 ± 0.4</td><td align="left">0.4 ± 0.1</td><td align="left">0.2 ± 0.0</td></tr><tr valign="top"><td align="left">muscles</td><td align="left">0.5 ± 0.1</td><td align="left">1.0 ± 0.2</td><td align="left">0.2 ± 0.0</td><td align="left">0.1 ± 0.0</td><td align="left">0.1 ± 0.0</td><td align="left">1.3 ± 0.8</td><td align="left">1.3 ± 1.1</td><td align="left">0.2 ± 0.1</td><td align="left">0.2 ± 0.1</td><td align="left">0.0 ± 0.0</td></tr><tr valign="top"><td align="left">lungs</td><td align="left">2.7 ± 0.9</td><td align="left">1.7 ± 0.7</td><td align="left">0.7 ± 0.0</td><td align="left">0.4 ± 0.1</td><td align="left">0.3 ± 0.1</td><td align="left">2.4 ± 1.0</td><td align="left">3.2 ± 1.5</td><td align="left">1.2 ± 0.7</td><td align="left">0.3 ± 0.2</td><td align="left">0.1 ± 0.1</td></tr><tr valign="top"><td align="left">pancreas</td><td align="left">11.5 ± 1.7</td><td align="left">7.1 ± 1.0</td><td align="left">2.8 ± 0.2</td><td align="left">0.8 ± 0.3</td><td align="left">0.4 ± 0.1</td><td align="left">14.2 ± 1.3</td><td align="left">8.8 ± 1.4</td><td align="left">10.0 ± 3.1</td><td align="left">2.8 ± 1.4</td><td align="left">1.1 ± 0.1</td></tr><tr valign="top"><td align="left">pancreas (bl) <a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td align="left"> </td><td align="left">1.6 ± 0.7</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">2.7 ± 0.9</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left">PC-3 tumor</td><td align="left">4.9 ± 0.5</td><td align="left">3.7 ± 0.8</td><td align="left">3.3 ± 0.7</td><td align="left">1.6 ± 0.7</td><td align="left">0.1 ± 0.0</td><td align="left">3.8 ± 0.8</td><td align="left">3.3 ± 0.6</td><td align="left">1.4 ± 0.7</td><td align="left">0.9 ± 0.3</td><td align="left">0.7 ± 0.2</td></tr><tr valign="top"><td align="left">PC-3 tumor (bl)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td align="left"> </td><td align="left">1.8 ± 0.4</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">1.5 ± 0.5</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>α</sup><p class="last">Data are expressed as % ID/g tissue and are presented as the mean ± SD (<i>n</i> = 5) at 0.5, 1, 2, 4, and 24 h pi.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">bl stands for blocking experiments.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Blocking was achieved by co-injection of 100 μg/mouse of native BN.</p></div></div></div><div class="NLM_p">Radioactivity cleared efficiently from the blood (<i>P</i> < 0.04). Uptake in stomach was low, suggesting that the <sup>99m</sup>Tc-labeled complexes are stable in vivo. These findings are in agreement with literature data on the in vivo behavior of related <sup>99m</sup>TcO(V)[N<sub>3</sub>S] BN complexes.<a onclick="showRef(event, 'ref32 ref36 ref39 ref52'); return false;" href="javascript:void(0);" class="ref ref32 ref36 ref39 ref52">(32, 36, 39, 52)</a> In the case of <sup>99m</sup>Tc-BN-1.1 lower liver uptake was observed, which however remains higher at the later time points, as opposed to <sup>99m</sup>Tc-BN-1.1p (<i>P</i> < 0.04), where more effective clearance was observed. Up to 2 h there is a higher intestinal retention for <sup>99m</sup>Tc-BN-1.1p, which by 4 h is similar to <sup>99m</sup>Tc-BN-1.1 values (<i>P</i> < 0.05). Apparently, the faster retention of <sup>99m</sup>Tc-BN-1.1p to the liver and the intestines compared to <sup>99m</sup>Tc-BN-1.1 is probably due to the absence of the amino acid sequence [2−6] which affects the excretion pathway of the truncated radiolabeled peptide, a fact that has been reported in the literature.<a onclick="showRef(event, 'ref24 ref39 ref42'); return false;" href="javascript:void(0);" class="ref ref24 ref39 ref42">(24, 39, 42)</a></div><div class="NLM_p">In order to investigate whether <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p exhibit in vivo selectivity, the radioactivity in pancreas, an organ overexpressing BB2-Rs, was also counted. High pancreatic uptake for both derivatives with maximum uptake of 11.5 ± 1.7% ID/g for <sup>99m</sup>Tc-BN-1.1 and 14.2 ± 1.3% ID/g for <sup>99m</sup>Tc-BN-1.1p was observed at 0.5 h pi, while at 2 h the most pronounced difference was noted, with 10.0 ± 3.1% ID/g for the <sup>99m</sup>Tc-BN-1.1p. Statistical analysis of the data of the two radiolabeled species at 0.5, 1, 2, 4, and 24 h showed <i>P</i> < 0.03. Uptake in the pancreas was shown to be specific, as demonstrated by the approximately 70% reduction (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) of the radioactivity uptake in animals co-injected with a high dose of native BN (100 μg/mouse), indicating the effective in vivo blockade of this organ (<i>P</i> < 0.04).</div><div class="NLM_p last">The two complexes show relatively comparable tumor uptake with 4.9 ± 0.5% ID/g for <sup>99m</sup>Tc-BN-1.1 and 3.8 ± 0.8% ID/g for <sup>99m</sup>Tc-BN-1.1p, 0.5 h p.i., with slightly higher values for <sup>99m</sup>Tc-BN-1.1 (<i>P</i> < 0.02). Co-injection of a big excess of native BN (100 μg/mouse) resulted in both cases in the reduction of radioactivity in the tumor site, in agreement with the in vitro blocking of cancerous cells by [Tyr4]-BN (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). For both <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p blocking led to higher kidney uptake because the BB2-R rich organs have been saturated with the native BN, resulting in higher circulation of the radiolabeled products and consequently higher kidney accumulation. In the case of <sup>99m</sup>Tc-BN-1.1 blocking resulted in a great drop in the radioactivity observed in the intestines as expected by the presence of BB2-Rs in this organ. On the contrary, no significant difference between blocked and unblocked intestine percentages is observed for <sup>99m</sup>Tc-BN-1.1p, a fact that provides further evidence for the fast elimination of this derivative through this pathway.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Dynamic Studies</h3><div class="NLM_p">In addition to biodistribution measurements, dynamic imaging studies were performed. In these studies, data were continuously recorded and images were stored every 3 min providing fast and low-cost dynamic planar view of the biodistribution of the labeled compounds in the animal. It is possible to record data in list mode format and construct images at shorter intervals. Dynamic studies of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p up to 120 min are presented in Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A. The experimental tumors were clearly delineated from the first 15 min pi in both cases. Regions of interest (ROIs) were drawn in the tumor region (right shoulder) and on background regions (left foot, right foot and up left hand). Total counts were corrected for <sup>99m</sup>Tc decay and were plotted as a function of time (Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B). It can be clearly seen that the total counts recorded in the tumor region are much higher compared to the background muscle regions.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. A 2 h dynamic study of <sup>99m</sup>Tc-BN-1.1 in PC-3 bearing-tumor SCID mice (A) and ROI analysis (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. A 2 h dynamic study of <sup>99m</sup>Tc-BN-1.1p in PC-3 bearing-tumor SCID mice (A) and ROI analysis (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this work, N<sub>3</sub>S tripeptide <sup>99m</sup>Tc complexes of two BN derivatives are synthesized and evaluated for imaging of GRP-R positive tumors. Tripeptide chelators of the N<sub>3</sub>S type are frequently employed for the synthesis of MO(V)<sup>3+</sup> (M = <sup>99m</sup>Tc, <sup>185/187</sup>Re) complexes of receptor-binding peptides.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58, 59)</a> AcuTect ([<sup>99m</sup>TcO]apcitide)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> employed for the imaging of acute deep vein thrombosis (DVT) and NeoTect ([<sup>99m</sup>TcO]depreotide)<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> for lung tumor imaging, both in clinical use today, are based on peptide targeting vectors linked to tripeptide N<sub>3</sub>S ligands. In our case, the peptide chelate sequence Gly1′-Gly2′-Cys3′ is expected<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> to lead to the formation of a neutral N<sub>3</sub>S MO(V)<sup>3+</sup> (M  = <sup>99m</sup>Tc, <sup>185/187</sup>Re) complex with the loss of three protons of the donor groups (the amide proton of Gly2′ and the amide and thiol protons of Cys3′), while the less readily ionizable primary amine of Gly1′ is expected to coordinate to the MO(V)<sup>3+</sup> core through its lone pair of electrons and form a dative bond with the metal.</div><div class="NLM_p">All the NMR and MS analysis data are consistent with this type of coordination and formation of the complexes <sup>185/187</sup>Re-BN-1.1 and <sup>185/187</sup>Re-BN-1.1p shown in Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>B. According to the literature,<a onclick="showRef(event, 'ref64 ref65 ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66 ref67 ref68">(64-68)</a> these complexes are expected to have a distorted square pyramidal structure with the <sup>185/187</sup>Re═O bond perpendicular to the plane of the N<sub>3</sub>S coordinating atoms.</div><div class="NLM_p">The presence of the chiral αC of Cys3′ in the coordination plane may lead to the formation of two diastereomeric complexes depending on the <i>syn</i> or <i>anti</i> orientation of the peptide chain on αC with respect to the oxygen of the <sup>185/187</sup>Re═O bond.<a onclick="showRef(event, 'ref64 ref65 ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66 ref67 ref68">(64-68)</a> In our case, HPLC analysis of the reaction mixture showed the preferential formation (>95%) of one isomer for both <sup>185/187</sup>Re-BN-1.1 and <sup>185/187</sup>Re-BN-1.1p, a fact that is considered advantageous since <i>syn</i> and <i>anti</i> diastereomers often exhibit different biological behavior and separate evaluation of their properties is necessary. Comparisons of our NMR data to those reported in the literature<a onclick="showRef(event, 'ref64 ref67 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref64 ref67 ref68 ref69 ref70">(64, 67-70)</a> for diastereomers of <sup>99</sup>TcO(V)/<sup>185/187</sup>ReO(V) tripeptide N<sub>3</sub>S complexes of related, but not identical, structure are not conclusive enough to allow for unambiguous assignment of the <i>syn</i> or <i>anti</i> configuration in our complexes. Furthermore, no conclusive comparisons of the circular dichroism (CD) data of our complexes (Figure S1) can be made to those reported in the literature<a onclick="showRef(event, 'ref68 ref70'); return false;" href="javascript:void(0);" class="ref ref68 ref70">(68, 70)</a> to be diagnostic for the <i>syn</i> and <i>anti</i> configuration in tripeptide N<sub>3</sub>S complexes, because of structural differences in the chelating part (e.g., the presence of one asymmetric center in the Gly1′-Gly2′-Cys3′ sequence in our case, compared to at least two asymmetric centers in the literature). However, it is noted that the upfield shift of approximately 0.5 ppm of the NH proton of the Aca moiety observed in both complexes is suggestive of the <i>syn</i> configuration because similar upfield shifts are noted in related N<sub>3</sub>S tripeptide complexes<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> when the peptide chain on αC of Cys3′ has the <i>syn</i> direction.</div><div class="NLM_p">Comparison of the chemical shifts of <sup>185/187</sup>Re-BN-1.1 and <sup>185/187</sup>Re-BN-1.1p to those of the free peptides and to those of the parent BN<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> shows that the presence of the metal core does not affect the chemical environment and conformation of the BN moiety significantly, a fact that is also reflected in the conservation of the biological action of the peptides after their complexation. Apparently the presence of the Aca chain serves its purpose as a spacer between the metal core and the biologically active part of the BN derivatives.</div><div class="NLM_p">The biological affinity and specificity for BB2-Rs of BN-1.1 and BN-1.1p and of their <sup>185/187</sup>Re complexes was determined through in vitro competitive cell binding assays on PC-3 cells against [<sup>125</sup>I-Tyr4]-BN (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Results from these cell-binding studies demonstrated that BN-1.1, BN-1.1p, <sup>185/187</sup>Re-BN-1.1, and <sup>185/187</sup>Re-BN-1.1p bind to the BB2-Rs on PC-3 cells with high affinity and specificity, with IC<sub>50</sub> < 1.88 nM. The affinity of BN-1.1 for BB2-Rs (IC<sub>50</sub> = 0.59 ± 0.04 nM) is higher than that of BN-1.1p (IC<sub>50</sub> = 1.45 ± 0.03 nM) which is nonetheless comparable to the IC<sub>50</sub> value of the control peptide [Tyr4]-BN. The IC<sub>50</sub> value of the <sup>185/187</sup>Re complexes towards PC-3 cancer cells was only slightly higher than that of the BN-1.1 and BN-1.1p peptides, indicating that the presence of the chelated metal part does not appreciably affect biological activity. On the basis of the satisfactory IC<sub>50</sub> values of the <sup>185/187</sup>Re complexes, it was expected that the corresponding <sup>99m</sup>Tc complexes will demonstrate high affinity for the BB2-Rs.<a onclick="showRef(event, 'ref39 ref41 ref73'); return false;" href="javascript:void(0);" class="ref ref39 ref41 ref73">(39, 41, 73)</a></div><div class="NLM_p">The stability studies indicated that <sup>99m</sup>Tc complexes were practically stable in human plasma; however, they degraded quickly in the presence of kidney−liver homogenates (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), giving rise to more than one radioactive species, as evidenced by HPLC. It is known from the literature that two enzymes, especially endopeptidase EC 3.4.24.11 and angiotensin-converting enzyme, are the major metabolizing enzymes of BN.<a onclick="showRef(event, 'ref42 ref74'); return false;" href="javascript:void(0);" class="ref ref42 ref74">(42, 74)</a> Apparently, the presence of the chelated metal core and the spacer Aca moiety does not inhibit the proteolytic action of kidney and liver enzymes and the rate of degradation of the complexes is comparable to that of native BN.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">In agreement with the BB2-Rs agonist behavior displayed (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) by BN-1.1, BN-1.1p, and their <sup>185/187</sup>Re complexes, <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p internalized rapidly in PC-3 cells, a finding also reported in the literature for other <sup>99m</sup>Tc-radiolabeled agonist-BN derivatives.<a onclick="showRef(event, 'ref14 ref35 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref14 ref35 ref40 ref41 ref42 ref43">(14, 35, 40-43)</a> Despite the rapid uptake and high total amount of internalized radioactivity (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), there was no long-term retention in the cells, with approximately 50% of the internalized radioactivity being released between 1.0 and 2.0 h for both radiolabeled peptides (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The rapid externalization of radioactivity does not preclude the potential application of these radiolabeled derivatives for diagnostic purposes because the remaining amount of internalized radioactivity is enough to give satisfactory images. However, their possible use as therapeutic agents, complexed to β-emitting isotopes, may be prohibitory.</div><div class="NLM_p">Biodistribution studies in normal and PC-3 tumor-bearing SCID mice showed fast clearance of both radiolabeled peptides from the blood. <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p are eliminated from both the renal−urinary and hepatobiliary systems with <sup>99m</sup>Tc-BN-1.1 showing a slightly pronounced kidney excretion. This difference is probably due to the lipophilic character of the truncated peptide. The high accumulation of radioactivity in the abdominal region such as liver and intestines as well as the urinary bladder may prevent the detection of prostate tumors. Thus, some strategies must be applied in order to minimize the amount of nondesirable radioactivity in these regions and especially in the bladder. Highlighting the prostate gland before the filling of the urinary bladder may be one option, while voiding the bladder can also be an applicable solution to this issue.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76, 77)</a></div><div class="NLM_p">In biodistribution studies in SCID mice bearing a solid PC-3 tumor,<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> high and specific uptake of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p was observed by both the tumor and the pancreas. The pancreas is the in vivo indicator of the affinity of radiolabeled BN derivatives for BN receptors because it is an organ overexpressing BB2-Rs.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The pancreatic uptake (11.3 ± 2.1% ID/g for <sup>99m</sup>Tc-BN-1.1 and 10.1 ± 1.5% ID/g for <sup>99m</sup>Tc-BN-1.1p at 30 min pi in normal mice and 11.5 ± 1.7 ID/g for <sup>99m</sup>Tc-BN-1.1 and 14.2 ± 1.3% ID/g for <sup>99m</sup>Tc-BN-1.1p at 30 min pi in PC-3 tumor-bearing SCIC mice) was comparable to that of other assessed BN derivatives.<a onclick="showRef(event, 'ref28 ref31 ref36 ref39 ref40 ref72'); return false;" href="javascript:void(0);" class="ref ref28 ref31 ref36 ref39 ref40 ref72">(28, 31, 36, 39, 40, 72)</a> Uptake in the pancreas was higher than the tumor uptake which was 4.9 ± 0.5% ID/g for <sup>99m</sup>Tc-BN-1.1 and 3.8 ± 0.8% ID/g for <sup>99m</sup>Tc-BN-1.1p at 30 min pi. High pancreatic uptake does not always mean that good tumor binding will occur.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Low accumulation of radioactivity in the tumor tissue was presumably due to poor vascularization of the tumor.<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> For both <sup>99m</sup>Tc-BN complexes, tumor uptake is considered satisfactory, since uptake values reported elsewhere for a variety of BN derivatives labeled with <sup>99m</sup>Tc range from 0.8 to 24.6% ID/g 1 h pi.<a onclick="showRef(event, 'ref14 ref40 ref41 ref42 ref43 ref44 ref79 ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref14 ref40 ref41 ref42 ref43 ref44 ref79 ref80 ref81 ref82">(14, 40-44, 79-82)</a></div><div class="NLM_p">As can be seen from the biodistribution data (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), the length of the BN moiety does not affect tumor uptake, since both <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p exhibit similar affinity for the experimental PC-3 tumors. The length of the BN sequence appears to affect the in vivo washout from pancreas that is slower for <sup>99m</sup>Tc-BN-1.1p than <sup>99m</sup>Tc-BN-1.1. This last finding is not in accordance with the in vitro results where the percentage of the externalized radioactivity from cancer cells was similar for both radiolabeled peptides. This difference in the in vitro and in vivo results may be due to the fact that the lipophilicity of the truncated compound does not affect the in vitro results. However, similar differences between in vitro and in vivo results frequently appear in the literature.<a onclick="showRef(event, 'ref14 ref32 ref34 ref40 ref41 ref42 ref43 ref44 ref80'); return false;" href="javascript:void(0);" class="ref ref14 ref32 ref34 ref40 ref41 ref42 ref43 ref44 ref80">(14, 32, 34, 40-44, 80)</a></div><div class="NLM_p">Blocking experiments were performed by co-injection of 100 μg/mouse of native BN. An approximately 45% reduction in tumor-specific accumulation of the radiolabeled products was observed. Pancreatic uptake was reduced by approximately 70%, indicating the ability of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p to target the GRP-Rs. Co-injection of a big excess of native BN resulted in reduction in the uptake of radiolabeled peptides by intestines, tumor, and pancreas, confirming the presence of GRP-Rs in these organs.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> In other organs such as liver and kidneys the concentration of radioactivity is increased after blocking experiments, possibly caused by the saturation effect of native BN in distribution and transport mechanisms.</div><div class="NLM_p">Maina et al. states that BN-like peptides may have different structure−function relationships in different species.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> In the present study some small conflicts are reported, as far as the biodistribution profile of some organs is concerned, when comparing healthy animals and PC-3 tumor models. These discrepancies should be ascribed to the different animal models used in the present study. Particularly, Swiss mice were used for biodistribution studies in normal mice, while athymic SCID mice were used for biodistribution studies in pathological models.</div><div class="NLM_p last">The in vivo planar imaging studies show that after intravenous administration, <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p are rapidly cleared from blood circulation (Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A). Most of the radioactivity is located in the abdominal region, a fact that is more noticeable in the case of <sup>99m</sup>Tc-BN-1.1p, in accordance with the faster uptake of this peptide mainly in the intestines. It is worth noting that radioactivity in the abdominal region is maintained at a high level even 2 h after the administration of the radiotracers. Despite the amount of radioactivity in the abdominal region, the experimental tumors are clearly delineated at 15 min pi and it is obvious that after a 2 h dynamic imaging the tumors are still clearly visible. These data are confirmed from the regions of interest (ROIs) graphs (Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B) where the total counts in the tumor region are higher than the background and remain high throughout the experiment. The data from the biodistribution studies showed that the tumor uptake for both radiolabeled peptides was comparable, a point that is not in accordance with the images obtained from dynamic studies. It is obvious for Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A that in the case of <sup>99m</sup>Tc-BN-1.1 better delineation of the experimental tumor was achieved because the background in the abdominal region was not so high, a fact that is probably due to the faster uptake of <sup>99m</sup>Tc-BN-1.1p to this region.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Two BN derivatives, namely BN-1.1 and BN-1.1p, containing the 2−14 and 7−14 sequence of BN, respectively, have been radiolabeled with <sup>99m</sup>Tc. The presence of the spacer successfully distanced the metal coordination sphere from the BN part, thus leading to <sup>99m</sup>Tc complexes that retain the biological activity of native BN. Both radiolabeled BN derivatives exhibit high affinity for the BB2-Rs expressed in PC-3 cancer cell cultures, as well as in experimental PC-3 tumor models. All experimental results indicate that the truncated BN sequence (7−14) can be used in place of the longer (2−14) sequence, probably with some modifications in order to improve its excretion pathway toward more favorable kidney elimination. Overall, the biological properties exhibited by <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p (high affinity for BB2-Rs, rapid internalization, fast delineation of PC-3 experimental tumors, good quality of images) compare favorably to those of other BN derivatives in the literature, indicating a successful design concept that merits further exploration.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General</h3><div class="NLM_p">All the chemicals were of reagent grade and used without further purification. BN derivatives were synthesized by the Fmoc method in the Immunopeptide Chemistry Lab of the Institute of Radioisotopes and Radiodiagnostic Products of NCSR “Demokritos”. The crude peptides BN-1.1 and BN-1.1p, as well as their <sup>185/187</sup>Re complexes, were purified by semipreparative reverse phase high-performance liquid chromatography (RP-HPLC) on a Prep Nova-Pak HR-C18 column (300 mm × 19 mm i.d.; 6 μm, Waters). The pure peptides and complexes were identified by analytical RP-HPLC (RP C18 250 mm × 4.6 mm i.d.; 5 μm particle size, Merck), and their purity was higher than 95%. Ionization mass spectroscopy (ESI-MS) analysis was performed on a Finnigan AQA Navigator, using a Harvant syringe pump. NMR spectra were collected on a Bruker Avance DRX 500 MHz spectrometer and processed using XWIN-NMR V. 2.6 software.</div><div class="NLM_p">[Tyr4]-BN was purchased from Sigma. [<sup>125</sup>I-Tyr4]-BN was purchased from Amersham (100 μL, 10 μCi, 2000 Ci/mmol). KReO<sub>4</sub> was obtained from Sigma-Aldrich (GmbH, Austria). <sup>99m</sup>Tc, in the form of Na<sup>99m</sup>TcO<sub>4</sub> in physiological saline, was eluted from a commercial <sup>99</sup>Mo−<sup>99m</sup>Tc generator (Mallinckdrodt Medical B.V.). HPLC analyses were performed on a Waters μ-Bondapack C18 (3.9 mm i.d. × 300 mm) cartridge column (Waters, Germany). The gradient systems used are given in the text. Solvents for HPLC were of analytical grade; before use they were filtered through 0.22 μm membrane filters (Millipore, Milford, MA) and degassed. Radioactivity measurements were conducted in an automated well-typed γ-counter NaI(Tl) crystal (Packard).</div><div class="NLM_p">The human prostate adenocarcinoma cell line PC-3 was obtained from the American Type Culture Collection (ATCC). For cell culturing, Dulbecco’s modified Eagle medium (DMEM), fetal bovine serum (FBS), penicillin/streptomycin, <span class="smallcaps smallerCapital">l</span>-glutamine, and trypsin/EDTA solution were purchased from PAA Laboratories (GmbH, Austria). The bovine serum albumin (BSA), GlutaMAX, HEPES, bacitracin, aprotinin, and PMSF used were obtained from Sigma-Aldrich (GmbH, Austria).</div><div class="NLM_p">Animal experiments were carried out according to European and national regulations. Female Swiss albino mice (20−25 g) were used for the metabolic studies. For experimental tumor models male SCID mice of 8 weeks on the day of inoculation were obtained from the breeding facilities of the Institute of Biology, NCSR “Demokritos”. The animals were kept under aseptic conditions until the day of the biodistribution study experiments.</div><div class="NLM_p last">The small mouse-sized camera employed in this study was manufactured by our team. The system is based on a pair of two square H8500 flat-panel PSPMT with external dimensions of 52 mm × 52 mm and 34 mm thick. The two H8500 PSPMTs are gently coupled to NaI(Tl) crystal array (Bicron-St. Gobain) with an active area of approximately 98 mm × 48 mm. The pixel dimensions are 1 mm × 1 mm × 5 mm with a pitch of 1.2 mm. The array is viewed through a 3 mm glass window, and encapsulation is completed by a 50 μm thick aluminum cover. An optical grease (RX-688 optical coupling grease, Rexon Inc., Beachwood, OH 44122) has been used for optical coupling of the PSPMTs to the scintillation array window. The camera is equipped with a parallel-hole lead collimator with hexagonal holes 1.2 mm in diameter and 0.2 mm thick septum walls (Tecomet Inc.). The collimator is 25 mm thick and has an active area of 52 mm × 105 mm. The system is enclosed in an 8 mm tungsten (W) housing box 140 mm × 82 mm × 107 mm deep. The front face entrance window is 0.5 mm thick and consists of graphite-based composite material, manufactured principally for use in medical imaging tables. Each PSPMT provides four analog signals X+, X−, Y+, and Y−. These signals are collected using two National Instruments PCI6110 ADCs with four channels each. Data acquisition, preprocessing and system calibration are carried out using custom software written in Kmax (Sparrow Corp., Port Orange, FL 32128) environment. The spatial resolution of the system is approximately 1.5 mm in 0 mm distance from collimator surface. Energy resolution is approximately 15%, and sensitivity has been found to be approximately 5000 counts min<sup>−1</sup> mCi<sup>−1</sup> cm<sup>−2</sup>. These characteristics are suitable for short dynamic studies of 2−3 min per frame.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of BN Derivatives</h3><div class="NLM_p">Synthesis of the peptide amide was carried out manually by using α-fluorenylmethoxycarbonyl (Fmoc) amino acids on Rink amide resin following the method of Fmoc solid phase peptide synthesis. Couplings were performed by using the DIPC/HOBt methology in dimethylformamide (DMF). Coupling success was checked by the established Kaiser ninhydrin test. Deprotection of the Fmoc group was achieved by repetitive treatment with 20% piperidine in DMF. The resin-bound peptide was removed from the resin, and amino acid side chains were deprotected by treatment with a cocktail of TFA/thioanisol/ethanodiol/phenol/H<sub>2</sub>O/triisopropylsilane, 81.5:5:2.5:5:5:1 (v/v/v/v/v/v) for 1 g of resin. After removal of the organic solvents, the crude product was precipitated with cold diethyl ether.</div><div class="NLM_p last">The crude peptide was dissolved in water and purified by RP-HPLC. Elution was performed by a gradient system consisting of two solvents: solvent A consisting of 0.05% TFA in H<sub>2</sub>O and solvent B consisting of 60% acetonitrile (ACN) in solvent A at an 8 mL/min flow rate. Detection of the peptide was achieved with a variable-multiwavelength detector set at 220 nm.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of <sup>185/187</sup>ReO(V) Complexes</h3><div class="NLM_p last">Synthesis was effected through ligand exchange reaction between the <sup>185/187</sup>Re(V)-gluconate precursor and the BN derivatives according to the literature.<a onclick="showRef(event, 'ref51 ref52 ref84'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref84">(51, 52, 84)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Analysis of BN-1.1, BN-1.1p, <sup>185/187</sup>Re-BN-1.1, and <sup>185/187</sup>Re-BN-1.1p. RP-HPLC Analysis</h3><div class="NLM_p last">The pure peptides BN-1.1 and BN-1.1p, as well as their complexes with <sup>185/187</sup>Re, were analyzed by RP-HPLC. Flow rate: 1 mL/min. Eluents: A = 0.05% TFA in H<sub>2</sub>O and B = 90% ACN, 10% solvent A. Linear gradient: from 10% B to 40% B for a period of 19 min. The detection of BN-1.1 and BN-1.1p was performed via a UV detector at 220 nm.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> ESI-MS</h3><div class="NLM_p last">ESI-MS mass spectral analysis of BN-1.1, BN-1.1p, <sup>185/187</sup>Re-BN-1.1, and <sup>185/187</sup>Re-BN-1.1p was performed at the “Mass Spectrometry and Dioxin Analysis Lab”, NCSR “Demokritos”. Test solution in 50% aqueous ACN was infused into an electrospray interface mass spectrometer (AQA Navigator, Finnigan) at a flow rate of 0.1 mL/min, using a Harvant syringe pump. Negative or positive ion ESI-MS spectra were acquired by adjusting the needle and cone voltages accordingly. Hot nitrogen gas (Dominic-Hunter UHPLCMS-10) was used for desolvation at 170 °C.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> NMR Spectroscopy</h3><div class="NLM_p last">Aqueous solution studies of 3−4 mg of BN-1.1 and BN-1.1p peptides and the corresponding <sup>185/187</sup>Re complexes were undertaken in 90% H<sub>2</sub>O, 10% D<sub>2</sub>O containing 60 μM NaN<sub>3</sub> to prevent microbial growth. The concentration of the NMR samples ranged from 3.2 to 5.4 mM, and the pH was 3.1−3.8 without adjustment. No deterioration of the samples was detected for several months. The 1D spectra were acquired using 32K data points and zero filled to 64K before Fourier transformation. All 2D spectra were recorded in the phase-sensitive mode using time proportional phase increments (TPPI). ROESY spectra were acquired with a mixing time of 250 ms. TOCSY spectra were obtained with a mixing time of 80 ms using the MLEV-17 spin lock sequence. Typically, homonuclear <sup>1</sup>H 2D spectra were recorded with sweep width of 12 ppm in both dimensions, 2048 data points, 400 <i>t</i><sub>1</sub> increments, and 32−64 transients. Heteronuclear (<sup>1</sup>H−<sup>13</sup>C) 2D spectra were recorded with sweep width of 250 ppm in F1 dimension, 2048 data points, 256 <i>t</i><sub>1</sub> increments, and 96 or 512 transients in the case of long-range couplings. The relaxation delay in all the experiments was fixed to 1.5 s. The excitation sculpting pulse sequence was used for water peak suppression. Proton chemical shifts were referenced to internal or external 3-(trimethylsilyl)propanesulfonic acid, sodium salt (DSS). All spectra were collected at 25 °C.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Radiolabeling</h3><div class="NLM_p last">Radiolabeling of the BN derivatives was performed according to an already published method.<a onclick="showRef(event, 'ref36 ref52'); return false;" href="javascript:void(0);" class="ref ref36 ref52">(36, 52)</a> Peptide radiolabeling with <sup>99m</sup>Tc was accomplished via the precursor <sup>99m</sup>Tc-gluconate. For the quality control of radiolabeling, 10 μL aliquots of the reaction solution were analyzed by RP-HPLC, applying a linear gradient system at a 1 mL/min flow rate from 0% B to 100% B in 20 min, where solvent A = 0.05% TFA in H<sub>2</sub>O and solvent B = 60% ACN in solvent A.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Cell Culture</h3><div class="NLM_p last">The human PC-3 adenocarcinoma cell line was maintained in Dulbecco’s DMEM-high glucose supplemented with 10% FBS, 1% <span class="smallcaps smallerCapital">l</span>-glutamine, 1% penicillin/streptomycin, 1% GlutaMAX. Cells were cultured at 37 °C in a humidified incubator under a 5% CO<sub>2</sub> atmosphere and passaged weekly using a trypsin−EDTA solution.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Competition Binding Assays</h3><div class="NLM_p last"> Competition binding experiments were performed using the PC-3 cell line. [Tyr4]-BN served as the control peptide and [<sup>125</sup>I-Tyr4]-BN as the radioligand. In brief, cells were placed at confluence in 24-well plates with 35 000 cpm [<sup>125</sup>I-Tyr4]-BN in the presence of increasing concentrations (0−1000 nM) of the BN-1.1 and BN-1.1p as well as of their respective <sup>185/187</sup>Re complexes. The T-epitope of cholera toxin served as the negative control (0−1000 nM). The total volume of the binding buffer in which the assay was performed was 500 μL (DMEM-high glucose supplemented with 1% FBS, 1% <span class="smallcaps smallerCapital">l</span>-glutamine, 1% penicillin/streptomycin, 1% GlutaMAX, 50 mM HEPES, 1 μg/mL aprotinin, 0.25 mM PMSF, and 0.125% BSA, pH 7.4). After 1 h at 37 °C, cells were washed twice with ice-cold binding buffer in order to remove the unbound radioligand. The solubilization of the cells was achieved with 1 N NaOH. The radioactivity of the surface bound radioligand was determined in a NaI γ-counter (Packard). IC<sub>50</sub> values were calculated by applying the PRISM 4 program (Graph Pad Software, San Diego, CA). All experiments were carried out two to three times in triplicate.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Internalization of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p</h3><div class="NLM_p last">Internalization experiments were performed in six-well plates and the BB2-R positive PC-3 cell line was used. Briefly, 1 million cells per well were washed with internalization medium (binding buffer-DMEM-high glucose supplemented with 1% FBS, 1% <span class="smallcaps smallerCapital">l</span>-glutamine, 1% penicillin/streptomycin, 1% GlutaMAX, 50 mM HEPES, 1 μg/mL aprotinin, 0.25 mM PMSF, and 0.125% BSA, pH 7.4). Subsequently, in each well was added 1.2 mL of binding buffer and 150 µL of a phosphate-buffered saline (PBS)/0.5% BSA solution containing 100000−300000 cpm of the radiolabeled peptide. This amount of radioactivity corresponds to 200 fmol of the total peptide (the concentration of the total peptide was kept the same for all internalization experiments). To determine nonspecific internalization, an excess of [Tyr4]-BN (150 μL of a solution PBS/0.5% BSA, final concentration of [Tyr4]-BN 1 μM) was added. The cells were incubated at 37 °C in 5% CO<sub>2</sub>. Internalization was stopped at appropriate time points (5, 15, 30, 60, and 120 min) by removal of the medium. The cells were washed twice with ice-cold PBS (pH 7.4) and then washed twice with 1 mL of glycine buffer (0.05 mM glycine solution, pH adjusted to 2.8 with 1 N HCl) for 5 min at 37 °C to distinguish between cell surface-bound (acid releasable) and internalized (acid resistant) radioligand. Finally, cells were solubilized with 1 N NaOH at 37 °C for 10 min to detach them from the plates. Surface-bound and internalized activities were measured in a γ-counter. Considering that the total activity comprises membrane-bound plus internalized activity, the percent internalized activity for the different time points was calculated with Microsoft Excel. All experiments were carried out two to three times in triplicate.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Efflux</h3><div class="NLM_p last">Confluent PC-3 cells were seeded in six-well plates (approximately 1 000 000 cells per well) 24 h before conducting the efflux experiment. On the day of the experiment, cells were washed with internalization medium. Then 1.2 mL of fresh internalization medium was added. Subsequently, an amount of 100000−300000 cpm of the radiolabeled peptide (approximately 200 fmol of total peptide in 150 μL of PBS/0.5% BSA) was added and the cells were incubated for 30 min at 37 °C to allow for maximal internalization. The supernatant was discarded, and the cells were washed twice with PBS. Cells were then incubated again at 37 °C with 1.5 mL of culture medium for 0, 0.25, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, and 5.0 h. The activity in the supernatant was measured to determine released activity from the cells. After two washing steps with PBS, surface-bound activity was removed by two steps of 5 min acid wash (50 mM glycine-HCl, 100 mM NaCl, pH 2.8) at room temperature (1 mL of acid wash per well). Finally, the amount of the remaining internalized activity was recovered by solubilizing the cells at 37 °C with 1 mL of 1 N NaOH per well. Externalized, surface-bound and internalized activities were measured in a γ-counter. Experiments were performed two to three times in triplicate.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Metabolism in Plasma</h3><div class="NLM_p last">Human blood (approximately 3 mL) was collected in heparinized polypropylene tubes and centrifuged at 5000 rpm at 4 °C for 5 min. The plasma was collected and incubated with the radiopeptides at 37 °C. Fractions withdrawn at 15 and 120 min were mixed with ethanol in a 2:1 EtOH/aliquot v/v and centrifuged at 14 000 rpm for 30 min. Supernatants were filtered through Millex GP filters (0.22 μm) and analyzed by RP-HPLC.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Metabolism in Liver and Kidneys</h3><div class="NLM_p last">Liver and kidneys were excised from ether sacrificed female Swiss albino mice and rapidly rinsed and immersed in ice-cold 50 mM TRIS/0.2 M sucrose buffer, pH 7.4. They were subsequently homogenized with a manual homogenizer for 5 min. The radiopeptides were added in fresh homogenate at 37 °C and incubated for 5, 15, and 30 min. In order to determine the enzymatic degradation of the peptides, ethanol was added and the mixture was centrifuged at 14 000 rpm for 30 min. Supernatants were filtered through Millex GP filters (0.22 μm) and analyzed by RP-HPLC for detection of metabolites or released <sup>99m</sup>TcO<sub>4</sub><sup>−</sup>. All filtered supernatants were analyzed by RP-HPLC as above, applying the same gradient system as the one used for the identification of the radiolabeled species.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Biodistribution Studies in Normal Swiss Mouse Models</h3><div class="NLM_p last">The biodistribution studies of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p were determined in normal Swiss mice. The mice were injected with 100 μL (200−300 μCi) of each radiolabeled peptide per animal via the tail vein. The animals were sacrificed 0.5, 1, 2, 4, and 24 h pi by ether anesthesia. The main organs were removed and together with samples of muscles and urine were weighed and counted in a NaI well counter, and the biodistribution data were calculated as the percent injected dose per gram (% ID/g), using an appropriate standard. Stomach and intestines were not emptied before the measurements. The % ID in whole blood was estimated assuming a whole-blood volume of 6.5% of the total body weight.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Biodistribution Studies in PC-3 Tumor Bearing SCID Mice</h3><div class="NLM_p">Athymic SCID mice (average weight of 20 g) were obtained from the breeding facilities of the Institute of Biology NCSR “Demokritos”. The animals were inoculated subcutaneously into the right front leg with PC-3 cells (10<sup>7</sup> cells/animal). Tumors were allowed to grow for 3 weeks. Tissue distribution studies of <sup>99m</sup>Tc-BN-1.1 and <sup>99m</sup>Tc-BN-1.1p were carried out after intravenous administration of 100 μL (200−300 μCi) of each radiolabeled peptide per animal via the tail vein. The animals were sacrificed 0.5, 1, 2, 4, and 24 h pi by ether anesthesia. Subsequently, the tissues and organs were weighed and counted in a NaI well counter, and the % ID/g of each organ or tissue was calculated. Stomach and intestines were not emptied before the measurements. The animals of an additional group were co-injected each with 100 μL (100 μg) of native BN (1 mg/mL) and 100 μL (200−300 μCi) of the labeled peptide. These animals were sacrificed 1 h pi.</div><div class="NLM_p last">In vivo studies were performed in compliance with European legislation. The Hellenic authorities approved all animal protocols.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Dynamic Studies in PC-3 Tumor Bearing Mice</h3><div class="NLM_p">Mice were injected intravenously into the tail vein with 100 μL (200−300 μCi) of each radiolabeled peptide per animal. An initial stock solution of the anesthetic is prepared by dissolving 1.0 g of 2,2,2-tribromomethanol in 1.0 mL of 2-methyl-2-butanol. This solution is kept in the dark at 4 °C. On the day of the experiment, an amount of 50 μL of the above solution was dissolved in 1 mL of NaCl 0.9%. The animals were subsequently anesthetized by the subcutaneous injection of this solution at a dose of 300 μL per 30 g body weight. Mice were placed right on the camera at approximately 3 min after tracer injection. This is the position for planar studies because it minimizes the distance between the mouse and the collimator and maximum resolution and sensitivity are achieved.</div><div class="NLM_p">In both cases, tracer kinetics were not fast, so data were acquired for 3 min per frame in order to improve image statistics. The images were stored in raw format and processed with ImageJ software.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p last">Regions of interest (ROIs) were drawn in the tumor region and on a background region (up left hand). The total counts were corrected for <sup>99m</sup>Tc decay, and they were plotted as a function of time (acquisition frame number). Normally ROI analysis was carried out in SPECT mode; however, in this case, the lack of other organs in the shoulder region and the symmetry of the two shoulders gave a satisfactory approximation of radiopharmaceuticals concentration as a function of time.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Statistical Analysis</h3><div class="NLM_p last">All data are expressed as the mean of values ± standard deviation (mean ± SD). Data comparison was performed by using the Student’s <i>t</i> test. <i>P</i> < 0.05 was considered significantly different.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/jm900360d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Tables of <sup>1</sup>H and <sup>13</sup>C NMR chemical shifts for BN-1.1 (Table S1), <sup>185/187</sup>Re-BN-1.1 (Table S2), BN-1.1p (Table S3), and <sup>185/187</sup>Re-BN-1.1p (Table S4) in aqueous solution H<sub>2</sub>O/D<sub>2</sub>O (9:1) at 25 °C; Figure S1 showing the CD spectra of <sup>185/187</sup>Re-BN1.1p (A) in a 5.4 mM aqueous solution in the region 190−600 nm and (B) far-UV 190−260 nm region of a 15-fold dilution of the same sample. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900360d/suppl_file/jm900360d_si_001.pdf">jm900360d_si_001.pdf (75.9 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900360d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Penelope Bouziotis</span> - <span class="hlFld-Affiliation affiliation">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9af8f5efe0f3f5eef3dae8e8eab4fefff7f5f1e8f3eef5e9b4fde8baf8f5efe0f3f5eef3dafdf7fbf3f6b4f9f5f7"><span class="__cf_email__" data-cfemail="680a071d1201071c01281a1a18460c0d0507031a011c071b460f1a">[email protected]</span> <span class="__cf_email__" data-cfemail="0a68657f7063657e634a6d676b636624696567">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eleni Gourni</span> - <span class="hlFld-Affiliation affiliation">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dimitra Benaki</span> - <span class="hlFld-Affiliation affiliation">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Loudos</span> - <span class="hlFld-Affiliation affiliation">Department of Medical Instruments Technology, Technological Educational Institute of Athens, Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stavros Xanthopoulos</span> - <span class="hlFld-Affiliation affiliation">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Paravatou-Petsotas</span> - <span class="hlFld-Affiliation affiliation">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Mavri-Vavagianni</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, University of Athens, 15771 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Pelecanou</span> - <span class="hlFld-Affiliation affiliation">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Spyros C. Archimandritis</span> - <span class="hlFld-Affiliation affiliation">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandra D. Varvarigou</span> - <span class="hlFld-Affiliation affiliation">Institutes of Radioisotopes—Radiodiagnostic Products and Biology, NCSR “Demokritos”, 15310 Athens, Greece</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74431" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74431" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Ch. Zikos (NCSR “Demokritos”) for his contribution in the synthesis of the BN derivatives and Dr. L.  Leondiadis (NCSR “Demokritos”) for mass spectrometry. The expert advice of Dr. Th. Maina (NCSR “Demokritos”) is gratefully acknowledged. The financial support of this work was from the General Secretariat of Research and Technology grant “Research in Excellence”.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 85 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Reubi, C. R.</span><span> </span><span class="NLM_article-title">Peptide receptors as molecular targets for cancer diagnosis and therapy</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1210%2Fer.2002-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12920149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=389-427&issue=4&author=C.+R.+Reubi&title=Peptide+receptors+as+molecular+targets+for+cancer+diagnosis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide receptors as molecular targets for cancer diagnosis and therapy</span></div><div class="casAuthors">Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-427</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  During the past decade, proof of the principle that peptide receptors can be used successfully for in vivo targeting of human cancers has been provided.  A review.  The mol. basis for targeting rests on the in vitro observation that peptide receptors can be expressed in large quantities in certain tumors.  The clin. impact is at the diagnostic level: in vivo receptor scintigraphy uses radiolabeled peptides for the localization of tumors and their metastases.  It is also at the therapeutic level: peptide receptor radiotherapy of tumors emerges as a serious treatment option.  Peptides linked to cytotoxic agents are also considered for therapeutic applications.  The use of nonradiolabeled, noncytotoxic peptide analogs for long-term antiproliferative treatment of tumors appears promising for only a few tumor types, whereas the symptomatic treatment of neuroendocrine tumors by somatostatin analogs is clearly successful.  The present review summarizes and critically evaluates the in vitro data on peptide and peptide receptor expression in human cancers.  These data are considered to be the mol. basis for peptide receptor targeting of tumors.  The paradigmatic peptide somatostatin and its receptors are extensively reviewed in the light of in vivo targeting of neuroendocrine tumors.  The role of the more recently described targeting peptides vasoactive intestinal peptide, gastrin-releasing peptide, and cholecystokinin/gastrin is discussed.  Other emerging and promising peptides and their resp. receptors, including neurotensin, substance P, and neuropeptide Y, are introduced.  This information relates to established and potential clin. applications in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpImMX7eTxXDbVg90H21EOLACvtfcHk0ljnO4psesKjVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlKjtbs%253D&md5=2203d38ced1a18b3998f9e284b7f2348</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fer.2002-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2002-0007%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DC.%2BR.%26atitle%3DPeptide%2520receptors%2520as%2520molecular%2520targets%2520for%2520cancer%2520diagnosis%2520and%2520therapy%26jtitle%3DEndocr.%2520Rev.%26date%3D2003%26volume%3D24%26issue%3D4%26spage%3D389%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Glunde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhujwalla, Z. M.</span><span> </span><span class="NLM_article-title">Molecular-functional imaging of cancer: to image and imagine</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=287-303&issue=7&author=K.+Glundeauthor=A.+P.+Pathakauthor=Z.+M.+Bhujwalla&title=Molecular-functional+imaging+of+cancer%3A+to+image+and+imagine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlunde%26aufirst%3DK.%26aulast%3DPathak%26aufirst%3DA.%2BP.%26aulast%3DBhujwalla%26aufirst%3DZ.%2BM.%26atitle%3DMolecular-functional%2520imaging%2520of%2520cancer%253A%2520to%2520image%2520and%2520imagine%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2007%26volume%3D13%26issue%3D7%26spage%3D287%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kiaris, H.; Schally, A. V.; Sun, B.; Armatis, P.; Groot, K.</span><span> </span><span class="NLM_article-title">Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin releasing peptide</span>.  <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7168</span>− <span class="NLM_lpage">7173</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=7168-7173&author=H.+Kiaris&author=A.+V.+Schally&author=B.+Sun&author=P.+Armatis&author=K.+Groot&title=Inhibition+of+growth+of+human+malignant+glioblastoma+in+nude+mice+by+antagonists+of+bombesin%2Fgastrin+releasing+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiaris%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520growth%2520of%2520human%2520malignant%2520glioblastoma%2520in%2520nude%2520mice%2520by%2520antagonists%2520of%2520bombesin%252Fgastrin%2520releasing%2520peptide%26jtitle%3DOncogene%26date%3D1999%26volume%3D18%26spage%3D7168%26epage%3D7173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Moody, T. W.; Desmond, N. C.; Cutitta, F.; Quattrocchi, K.; Minna, J. D.</span><span> </span><span class="NLM_article-title">High affinity receptors for bombesin GRP-like peptides for human small cell lung carcinoma</span>.  <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span>− <span class="NLM_lpage">113</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1985&pages=105-113&author=T.+W.+Moody&author=N.+C.+Desmond&author=F.+Cutitta&author=K.+Quattrocchi&author=J.+D.+Minna&title=High+affinity+receptors+for+bombesin+GRP-like+peptides+for+human+small+cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoody%26aufirst%3DT.%2BW.%26atitle%3DHigh%2520affinity%2520receptors%2520for%2520bombesin%2520GRP-like%2520peptides%2520for%2520human%2520small%2520cell%2520lung%2520carcinoma%26jtitle%3DLife%2520Sci.%26date%3D1985%26volume%3D37%26spage%3D105%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chatzistamou, I.; Schally, A. V.; Sun, B.; Armatis, P.; Szepeshazi, K.</span><span> </span><span class="NLM_article-title">Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists</span>.  <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span>− <span class="NLM_lpage">913</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1054%2Fbjoc.2000.1374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=10970693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2000&pages=906-913&author=I.+Chatzistamou&author=A.+V.+Schally&author=B.+Sun&author=P.+Armatis&author=K.+Szepeshazi&title=Inhibition+of+growth+of+OV-1063+human+epithelial+ovarian+cancers+and+c-jun+and+c-fos+oncogene+expression+by+bombesin+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists</span></div><div class="casAuthors">Chatzistamou, I.; Schally, A. V.; Sun, B.; Armatis, P.; Szepeshazi, K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">906-913</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Harcourt Publishers Ltd.</span>)
        </div><div class="casAbstract">Receptors for bombesin are present on human ovarian cancers and bombesin-like peptides could function as growth factors in this carcinoma.  Therefore, we investigated the effects of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095 on the growth of human ovarian carcinoma cell line OV-1063, xenografted into nude mice.  Treatment with RC-3940-II at doses of 10 μg and 20 μg per day s.c. decreased tumor vol. by 60.9% (P < 0.05) and 73.5% (P < 0.05) resp., after 25 days, compared to controls.  RC-3095 at a dose of 20 μg per day reduced the vol. of OV-1063 tumors by 47.7% (P = 0.15).  In comparison, LH-releasing hormone (LH-RH) antagonist Cetrorelix at a dose of 100 μg per day caused a 64.2% inhibition (P < 0.05).  RT-PCR anal. showed that OV-1063 tumors expressed mRNA for bombesin receptor subtypes BRS-1, BRS-2, and BRS-3.  In OV-1063 cells cultured in vitro, GRP(14-27) induced the expression of mRNA for c-jun and c-fos oncogenes in a time-dependent manner.  Antagonist RC-3940-II inhibited the stimulatory effect of GRP(14-27) on c-jun and c-fos in vitro.  In vivo, the levels of c-jun and c-fos mRNA in OV-1063 tumors were decreased by 43% (P < 0.05) and 45% (P = 0.05) resp., after treatment with RC-3940-II at 20 μg per day.  Exposure of OV-1063, UCI-107 and ES-2 ovarian carcinoma cells to RC-3940-II at 1 μM concn. for 24 h in vitro, extended the latency period for the development of palpable tumors in nude mice.  Our results indicate that antagonists of bombesin/GRP inhibit the growth of OV-1063 ovarian cancers by mechanisms that probably involve the downregulation of c-jun and c-fos proto-oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP7llI0g4e3rVg90H21EOLACvtfcHk0lhpQSh9ULSuhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFGjtbw%253D&md5=ce06e2dda3053002ee109dbfd5c9cb60</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1054%2Fbjoc.2000.1374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fbjoc.2000.1374%26sid%3Dliteratum%253Aachs%26aulast%3DChatzistamou%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520growth%2520of%2520OV-1063%2520human%2520epithelial%2520ovarian%2520cancers%2520and%2520c-jun%2520and%2520c-fos%2520oncogene%2520expression%2520by%2520bombesin%2520antagonists%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2000%26volume%3D83%26spage%3D906%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Charitopoulos, K. N.; Lazaris, A. C.; Aroni, K.; Kavantzas, N.; Nikolakopoulou, E.; Davaris, P.</span><span> </span><span class="NLM_article-title">Immunodetection of gastrin-releasing peptide in malignant melanoma cells</span>.  <span class="citation_source-journal">Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span>− <span class="NLM_lpage">400</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1097%2F00008390-200008000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=10985668" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=345-400&author=K.+N.+Charitopoulos&author=A.+C.+Lazaris&author=K.+Aroni&author=N.+Kavantzas&author=E.+Nikolakopoulou&author=P.+Davaris&title=Immunodetection+of+gastrin-releasing+peptide+in+malignant+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2F00008390-200008000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008390-200008000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DCharitopoulos%26aufirst%3DK.%2BN.%26atitle%3DImmunodetection%2520of%2520gastrin-releasing%2520peptide%2520in%2520malignant%2520melanoma%2520cells%26jtitle%3DMelanoma%2520Res.%26date%3D2000%26volume%3D10%26spage%3D345%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Rider, N. M.; Guha, S.; Hines, O. J.; Reber, H. A.; Rozengurt, E.</span><span> </span><span class="NLM_article-title">G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation</span>.  <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span>− <span class="NLM_lpage">64</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1002%2F1097-4652%28200101%29186%3A1%3C53%3A%3AAID-JCP1004%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=11147814" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2001&pages=53-64&author=N.+M.+Rider&author=S.+Guha&author=O.+J.+Hines&author=H.+A.+Reber&author=E.+Rozengurt&title=G+protein-coupled+receptor+signaling+in+human+ductal+pancreatic+cancer+cells%3A+neurotensin+responsiveness+and+mitogenic+stimulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F1097-4652%28200101%29186%3A1%3C53%3A%3AAID-JCP1004%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-4652%2528200101%2529186%253A1%253C53%253A%253AAID-JCP1004%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DRider%26aufirst%3DN.%2BM.%26atitle%3DG%2520protein-coupled%2520receptor%2520signaling%2520in%2520human%2520ductal%2520pancreatic%2520cancer%2520cells%253A%2520neurotensin%2520responsiveness%2520and%2520mitogenic%2520stimulation%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2001%26volume%3D186%26spage%3D53%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Sun, B.; Schally, A. V.; Halmos, G.</span><span> </span><span class="NLM_article-title">The presence of receptors for bombesin/Grp and mRNA for three receptor subtypes in human ovarian epithelial cancers</span>.  <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span>− <span class="NLM_lpage">84</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0167-0115%2800%2900114-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=10828496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1Grtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2000&pages=77-84&author=B.+Sun&author=A.+V.+Schally&author=G.+Halmos&title=The+presence+of+receptors+for+bombesin%2FGrp+and+mRNA+for+three+receptor+subtypes+in+human+ovarian+epithelial+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers</span></div><div class="casAuthors">Sun, B.; Schally, A. V.; Halmos, G.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Bombesin-like peptides can function as autocrine or paracrine growth factors and stimulate the growth of various cancers.  The antagonists of bombesin/gastrin-releasing peptide (GRP) suppress the proliferation of diverse tumors including ovarian cancer by mechanisms likely mediated by bombesin receptors.  In this study, we used the reverse transcription-polymerase chain reaction (RT-PCR) method to evaluate the mRNA expression of three bombesin receptor subtypes: gastrin-releasing peptide receptor (GRPR), neuromedin B receptor (NMBR), and bombesin receptor subtype 3 (BRS-3), in 22 specimens of human epithelial ovarian cancer and in two human ovarian cancer lines.  Of the 22 ovarian cancer specimens analyzed, 17 tumors (∼77%) expressed mRNA for GRPR, 19 (∼86%) showed NMBR mRNA and six (∼27%) revealed BRS-3 mRNA.  Thus, 14 of 22 specimens (∼64%) expressed mRNAs for both GRPR and NMBR, and five (∼23%) expressed all three subtypes.  The expression of GRPR appeared to be greater in poorly differentiated ovarian carcinomas.  A higher incidence of BRS-3 expression was obsd. in samples with tumor Stage IV (4/4, 100%) compared with Stage III (1/17, ∼6%). mRNA for both GRPR and NMBR was also detected in OV-1063 and UCI-107 human ovarian cancer xenografts, but BRS-3 was found only in OV-1063, which originated from a metastatic tumor.  In addn., functional receptors for bombesin/GRP were found in eight of 11 ovarian cancer specimens investigated and in both ovarian cancer lines by receptor binding assay.  Our study indicates that GRPR and NMBR are widely distributed in human ovarian carcinomas with BRS-3 being found in Stage IV tumors.  Some approaches based on bombesin/GRP receptor antagonists or targeted bombesin analogs could be considered for treatment of ovarian cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUrLbCJDcCObVg90H21EOLACvtfcHk0ljnL7EsofnkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1Grtr4%253D&md5=99ab3fade717b8eee1e04f1fa10b36af</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0167-0115%2800%2900114-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-0115%252800%252900114-2%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DB.%26atitle%3DThe%2520presence%2520of%2520receptors%2520for%2520bombesin%252FGrp%2520and%2520mRNA%2520for%2520three%2520receptor%2520subtypes%2520in%2520human%2520ovarian%2520epithelial%2520cancers%26jtitle%3DRegul.%2520Pept.%26date%3D2000%26volume%3D90%26spage%3D77%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pansky, A.; de Weert, A.; Fasler, E.; Boulay, J. L.; Shulz, M.; Ketterer, S.; Selck, C.; Berlinger, C.; Von Schrenck, T.; Hildebrand, P.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma</span>.  <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1409</span>− <span class="NLM_lpage">1418</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=10906154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvVyhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=1409-1418&author=A.+Pansky&author=A.+de+Weert&author=E.+Fasler&author=J.+L.+Boulay&author=M.+Shulz&author=S.+Ketterer&author=C.+Selck&author=C.+Berlinger&author=T.+Von+Schrenck&author=P.+Hildebrand&title=Gastrin+releasing+peptide-preferring+bombesin+receptors+mediate+growth+of+human+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma</span></div><div class="casAuthors">Pansky, Andreas; De Weerth, Andreas; Fasler-Kan, Eliza Veta; Boulay, Jean-Louis; Schulz, Martina; Ketterer, Sylvia; Selck, Cristin; Beglinger, Christoph; Von Schrenck, Tammo; Hildebrand, Pius</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1409-1418</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Bombesin-like peptides typically act as neurotransmitters along the brain-gut axis and as growth factors in various human tissues.  The present study demonstrates the expression of gastrin releasing peptide (GRP)-preferring bombesin receptors in human renal cell carcinoma but not in normal kidney tissue.  The expression of GRP receptors was characterized at the mRNA level by reverse transcription-PCR, as well as at the protein level by binding of 125I-[Tyr4] bombesin to membranes prepd. from tumor tissue (Kd 0.3 nM) and healthy kidney tissue from the same four patients.  GRP receptors were also demonstrated in four human kidney carcinoma cell lines (A-498, CAKI-1, CAKI-2, and ACHN).  The effects of bombesin/GRP agonists and/or antagonists on growth were investigated in vitro on CAKI-2 cells, which expressed large amts. of GRP receptors.  Cell nos. stimulated by 10% fetal calf serum were significantly stimulated by interleukin-1β (control) and GRP-7 (10-7 M), both in the range of 136 to 148%; addn. of the GRP receptor antagonist acetyl-GRP(20-27) (10-6 M) completely reversed this effect.  Bombesin alone (10-6 M) significantly stimulated CAKI-2 cells (129%) cultured with 0.5% fetal calf serum, whereas another antagonist, D-Phe6,Leu13,(CH2NH)Leu14 bombesin(6-14) (1 μM), alone did not inhibit growth, thus excluding an autocrine mechanism.  These results indicate for the first time that malignant transformation of human kidney tissue into renal cell carcinoma is accompanied by novel expression of GRP receptors.  Bombesin-like peptides might act as mitogens in these carcinomas, and they might be useful as diagnostic or therapeutic tools such as tumor imaging or internal radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEHzuSqGBjv7Vg90H21EOLACvtfcHk0ljnL7EsofnkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvVyhtrw%253D&md5=6cfd5778f9fb064da5bcd3b3ff16c953</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPansky%26aufirst%3DA.%26atitle%3DGastrin%2520releasing%2520peptide-preferring%2520bombesin%2520receptors%2520mediate%2520growth%2520of%2520human%2520renal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2000%26volume%3D11%26spage%3D1409%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Markwalder, R.; Reubi, J. C.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide receptors in the human prostate: relation to neoplastic transformation</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span>− <span class="NLM_lpage">1159</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=1152-1159&author=R.+Markwalder&author=J.+C.+Reubi&title=Gastrin+releasing+peptide+receptors+in+the+human+prostate%3A+relation+to+neoplastic+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkwalder%26aufirst%3DR.%26atitle%3DGastrin%2520releasing%2520peptide%2520receptors%2520in%2520the%2520human%2520prostate%253A%2520relation%2520to%2520neoplastic%2520transformation%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D1152%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Halmos, G.; Wittliff, J. L.; Schally, A. V.</span><span> </span><span class="NLM_article-title">Characterization of bombesin/gastrin-releasing receptors in human breast cancer and their relationship to steroid receptor expression</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span>− <span class="NLM_lpage">287</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=280-287&author=G.+Halmos&author=J.+L.+Wittliff&author=A.+V.+Schally&title=Characterization+of+bombesin%2Fgastrin-releasing+receptors+in+human+breast+cancer+and+their+relationship+to+steroid+receptor+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalmos%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520bombesin%252Fgastrin-releasing%2520receptors%2520in%2520human%2520breast%2520cancer%2520and%2520their%2520relationship%2520to%2520steroid%2520receptor%2520expression%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D280%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Zhang, H.; Chen, J.; Waldherr, C.; Hinni, K.; Waser, B.; Reubi, J. C.; Maecke, H. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6707</span>− <span class="NLM_lpage">6715</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6707-6715&author=H.+Zhang&author=J.+Chen&author=C.+Waldherr&author=K.+Hinni&author=B.+Waser&author=J.+C.+Reubi&author=H.+R.+Maecke&title=Synthesis+and+evaluation+of+bombesin+derivatives+on+the+basis+of+pan-bombesin+peptides+labeled+with+indium-111%2C+lutetium-177%2C+and+yttrium-90+for+targeting+bombesin+receptor-expressing+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520bombesin%2520derivatives%2520on%2520the%2520basis%2520of%2520pan-bombesin%2520peptides%2520labeled%2520with%2520indium-111%252C%2520lutetium-177%252C%2520and%2520yttrium-90%2520for%2520targeting%2520bombesin%2520receptor-expressing%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6707%26epage%3D6715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lin, K. S.; Luu, A.; Baidoo, K. E.; Hashemzadeh-Gargari, H.; Chen, M. K.; Brenneman, K.; Pili, R.; Pomper, M.; Carducci, M. A.; Wagner, H. N.,  Jr.</span><span> </span><span class="NLM_article-title">A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span>− <span class="NLM_lpage">50</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc049820h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=43-50&author=K.+S.+Lin&author=A.+Luu&author=K.+E.+Baidoo&author=H.+Hashemzadeh-Gargari&author=M.+K.+Chen&author=K.+Brenneman&author=R.+Pili&author=M.+Pomper&author=M.+A.+Carducci&author=H.+N.+Wagner&title=A+new+high+affinity+technetium-99m-bombesin+analogue+with+low+abdominal+accumulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A New High Affinity Technetium-99m-Bombesin Analogue with Low Abdominal Accumulation</span></div><div class="casAuthors">Lin, Kuo-Shyan; Luu, Andrew; Baidoo, Kwamena E.; Hashemzadeh-Gargari, Hossein; Chen, Ming-Kai; Brenneman, Kenneth; Pili, Roberto; Pomper, Martin; Carducci, Michael A.; Wagner, Henry N., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-50</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">99mTc-labeled bombesin analogs have shown promise for noninvasive detection of many tumors that express bombesin (BN)/gastrin-releasing peptide (GRP) receptors.  99mTc-labeled peptides, however, have a tendency to accumulate in the liver and intestines due to hepatobiliary clearance as a result of the lipophilicity of the 99mTc chelates.  This makes the imaging of lesions in the abdominal area difficult.  In this study, we have synthesized a new high affinity 99mTc-labeled BN analog, [DTPA1, Lys3(99mTc-Pm-DADT), Tyr4]BN, having a built-in pharmacokinetic modifier, DTPA, and labeled with 99mTc using a hydrophilic diaminedithiol chelator (Pm-DADT) to effect low hepatobiliary clearance.  In vitro binding studies using human prostate cancer PC-3 cell membranes showed that the inhibition const. (Ki) for [DTPA1, Lys3(99Tc-Pm-DADT), Tyr4]BN was 4.1 ± 1.4 nM.  Biodistribution studies of [DTPA1, Lys3(99mTc-Pm-DADT), Tyr4]BN in normal mice showed very low accumulation of radioactivity in the liver and intestines (1.32 ± 0.13 and 4.58 ± 0.50% ID, 4 h postinjection, resp.).  There was significant uptake (7.71 ± 1.37% ID/g, 1 h postinjection) in the pancreas which expresses BN/GRP receptors.  The uptake in the pancreas could be blocked by BN, partially blocked by neuromedin B, but not affected by somatostatin, indicating that the in vivo binding was BN/GRP receptor specific.  Scintigraphic images showed specific, high contrast delineation of prostate cancer PC-3 xenografts in SCID mice.  Thus, the new peptide has a great potential for imaging BN/GRP receptor-pos. cancers located even in the abdomen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpafm-f8rcgALVg90H21EOLACvtfcHk0lgBjlO2UgCKzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXk&md5=dd70298a8c2edf9dc7af4b02ebbc6697</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbc049820h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc049820h%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DK.%2BS.%26atitle%3DA%2520new%2520high%2520affinity%2520technetium-99m-bombesin%2520analogue%2520with%2520low%2520abdominal%2520accumulation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2005%26volume%3D16%26spage%3D43%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nock, A. B.; Nikolopoulou, A.; Galanis, A.; Cordopatis, P.; Waser, B.; Reubi, J. C.; Maina, T.</span><span> </span><span class="NLM_article-title">Potent bombesin-like peptides for GRP receptor targeting of tumors with <sup>99m</sup>Tc: a preclinical study</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span>− <span class="NLM_lpage">110</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm049437y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=100-110&author=A.+B.+Nock&author=A.+Nikolopoulou&author=A.+Galanis&author=P.+Cordopatis&author=B.+Waser&author=J.+C.+Reubi&author=T.+Maina&title=Potent+bombesin-like+peptides+for+GRP+receptor+targeting+of+tumors+with+99mTc%3A+a+preclinical+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm049437y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049437y%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DA.%2BB.%26atitle%3DPotent%2520bombesin-like%2520peptides%2520for%2520GRP%2520receptor%2520targeting%2520of%2520tumors%2520with%252099mTc%253A%2520a%2520preclinical%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D100%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Abd-Elgaliel, W. R.; Gallazzi, F.; Garrison, J. C.; Rold, T. L.; Sieckman, G. L.; Figueroa, S. D.; Hoffman, T. J.; Lever, S. Z.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of an antagonist-bombesin analogue as targeting vector</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2040</span>− <span class="NLM_lpage">2048</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc800290c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFChtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=2040-2048&author=W.+R.+Abd-Elgaliel&author=F.+Gallazzi&author=J.+C.+Garrison&author=T.+L.+Rold&author=G.+L.+Sieckman&author=S.+D.+Figueroa&author=T.+J.+Hoffman&author=S.+Z.+Lever&title=Design%2C+synthesis+and+biological+evaluation+of+an+antagonist-bombesin+analogue+as+targeting+vector"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of an Antagonist-Bombesin Analogue as Targeting Vector</span></div><div class="casAuthors">Abd-Elgaliel, Wael R.; Gallazzi, Fabio; Garrison, Jered C.; Rold, Tammy L.; Sieckman, Gary L.; Figueroa, Said Daibes; Hoffman, Timothy J.; Lever, Susan Z.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2040-2048</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The gastrin releasing peptide receptor (GRP-R) is overexpressed on a no. of tumors and cancer cell lines including pancreas, prostate, breast, gastrointestinal, and small cell lung cancer (SCLC).  Radiolabeled bombesin (BBN) analogs have exhibited high binding affinity and specificity to the GRP-R.  A bombesin analog with an antagonist targeting vector at the C-terminus, DOTA-aminohexanoyl-[D-Phe6, Leu-NHCH2CH2CH313, des Met14] BBN[6-14] (1, "Bomproamide"), has been synthesized and displays high binding affinity (IC50 = 1.36 ± 0.09 nM) against 125I-Tyr4-BBN in in vitro competitive assays using PC-3 cells.  Maximum internalization of 111In-1 reached 14% in PC-3 cells after 45 min of incubation.  Rapid (0.25 h PI) and high (12.21 ± 3.2%ID/g) pancreatic uptake of 111In-1 was obsd. in healthy CF-1 mice, and 90% of the activity was blocked by coinjection of 100 μg of BBN.  Rapid (0.25 h PI) and high uptake (6.90 ± 1.06%ID/g) was obsd. in PC-3 prostate cancer xenografts in SCID mice, as well as visualized clearly in a SPECT/CT study.  These results support the use of a bombesin construct with an antagonist C-terminal vector as a candidate of choice for specific in vivo imaging of tumors overexpressing GRP-receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqGYSxjocUWbVg90H21EOLACvtfcHk0lgBjlO2UgCKzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFChtrrE&md5=48754d7cf7e8c73048e97cb796461fd4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbc800290c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800290c%26sid%3Dliteratum%253Aachs%26aulast%3DAbd-Elgaliel%26aufirst%3DW.%2BR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520an%2520antagonist-bombesin%2520analogue%2520as%2520targeting%2520vector%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D2040%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Anastasi, A.; Erspamer, V.; Bucci, M.</span><span> </span><span class="NLM_article-title">Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes</span>.  <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span>− <span class="NLM_lpage">167</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1971&pages=166-167&author=A.+Anastasi&author=V.+Erspamer&author=M.+Bucci&title=Isolation+and+structure+of+bombesin+and+alytesin%2C+two+analogous+active+peptides+from+the+skin+of+the+European+amphibians+Bombina+and+Alytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasi%26aufirst%3DA.%26atitle%3DIsolation%2520and%2520structure%2520of%2520bombesin%2520and%2520alytesin%252C%2520two%2520analogous%2520active%2520peptides%2520from%2520the%2520skin%2520of%2520the%2520European%2520amphibians%2520Bombina%2520and%2520Alytes%26jtitle%3DExperientia%26date%3D1971%26volume%3D27%26spage%3D166%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">McDonald, T. J.; Jörnvall, H.; Nilsson, G.</span><span> </span><span class="NLM_article-title">Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue</span>.  <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span>− <span class="NLM_lpage">233</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1979&pages=227-233&author=T.+J.+McDonald&author=H.+J%C3%B6rnvall&author=G.+Nilsson&title=Characterization+of+a+gastrin+releasing+peptide+from+porcine+non-antral+gastric+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DT.%2BJ.%26atitle%3DCharacterization%2520of%2520a%2520gastrin%2520releasing%2520peptide%2520from%2520porcine%2520non-antral%2520gastric%2520tissue%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1979%26volume%3D90%26spage%3D227%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sunday, M. E.; Kaplan, L. M.; Motoyama, E.; Chin, W. W.; Spindel, E. R.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide (mammalian bombesin) gene expression in health and disease</span>.  <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1988&pages=5-24&author=M.+E.+Sunday&author=L.+M.+Kaplan&author=E.+Motoyama&author=W.+W.+Chin&author=E.+R.+Spindel&title=Gastrin+releasing+peptide+%28mammalian+bombesin%29+gene+expression+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSunday%26aufirst%3DM.%2BE.%26atitle%3DGastrin%2520releasing%2520peptide%2520%2528mammalian%2520bombesin%2529%2520gene%2520expression%2520in%2520health%2520and%2520disease%26jtitle%3DLab.%2520Invest.%26date%3D1988%26volume%3D59%26spage%3D5%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wada, E.; Way, J.; Shapira, H.; Kusano, K.; Lebacq-Verheyden, A. M.; Coy, D.; Jensen, R.; Battey, J. F.</span><span> </span><span class="NLM_article-title">cDNA cloning, characterization and brain region-specific expression of a neuromedin-B preferring bombesin receptor</span>.  <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span>− <span class="NLM_lpage">430</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=421-430&author=E.+Wada&author=J.+Way&author=H.+Shapira&author=K.+Kusano&author=A.+M.+Lebacq-Verheyden&author=D.+Coy&author=R.+Jensen&author=J.+F.+Battey&title=cDNA+cloning%2C+characterization+and+brain+region-specific+expression+of+a+neuromedin-B+preferring+bombesin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWada%26aufirst%3DE.%26atitle%3DcDNA%2520cloning%252C%2520characterization%2520and%2520brain%2520region-specific%2520expression%2520of%2520a%2520neuromedin-B%2520preferring%2520bombesin%2520receptor%26jtitle%3DNeuron%26date%3D1991%26volume%3D6%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Van De Wiele, C.; Dumont, F.; Van Belle, S.; Slegers, G.; Peers, S. H.; Derricks, R. A.</span><span> </span><span class="NLM_article-title">Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumor imaging?</span> <span class="citation_source-journal">Nucl. Med. Com.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span>− <span class="NLM_lpage">15</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1097%2F00006231-200101000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=11233552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtl2gsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=5-15&author=C.+Van+De+Wiele&author=F.+Dumont&author=S.+Van+Belle&author=G.+Slegers&author=S.+H.+Peers&author=R.+A.+Derricks&title=Is+there+a+role+for+agonist+gastrin-releasing+peptide+receptor+radioligands+in+tumor+imaging%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?</span></div><div class="casAuthors">Van De Wiele, C.; Dumont, F.; Van Belle, S.; Slegers, G.; Peers, S. H.; Dierckx, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-15</span>CODEN:
                <span class="NLM_cas:coden">NMCODC</span>;
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 124 refs.  Gastrin-releasing peptide (GRP) has been shown to be a tumor growth stimulating agent for a no. of normal and human cancer cell lines.  The tumor growth effect is a direct result of GRP binding to membrane G-protein coupled GRP receptors (GRP-R) on the cell surface.  Available data on the role of GRP and GRP-R in human lung, prostate, breast, colorectal and gastric carcinoma are reviewed and it is suggested that radiolabeled agonists are preferable to antagonists for imaging and therapy as they appear to be internalized, yielding a higher target/background ratio.  The use of rhenium or indium radiolabels for therapy may provide a new approach to GRP/bombesin expressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ8cRDJkc0zLVg90H21EOLACvtfcHk0lgidheiXfLuLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtl2gsbc%253D&md5=cea17c167d2659db672b25bccbf0cab0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1097%2F00006231-200101000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00006231-200101000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDe%2BWiele%26aufirst%3DC.%26atitle%3DIs%2520there%2520a%2520role%2520for%2520agonist%2520gastrin-releasing%2520peptide%2520receptor%2520radioligands%2520in%2520tumor%2520imaging%253F%26jtitle%3DNucl.%2520Med.%2520Com.%26date%3D2001%26volume%3D22%26spage%3D5%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kroog, G. S.; Jian, X.; Chen, L.; Northup, J. K.; Battey, J. F.</span><span> </span><span class="NLM_article-title">Phosphorylation uncouples the gastrin-releasing-peptide receptor from G(q)</span>.  <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">36700</span>− <span class="NLM_lpage">36707</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=36700-36707&author=G.+S.+Kroog&author=X.+Jian&author=L.+Chen&author=J.+K.+Northup&author=J.+F.+Battey&title=Phosphorylation+uncouples+the+gastrin-releasing-peptide+receptor+from+G%28q%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKroog%26aufirst%3DG.%2BS.%26atitle%3DPhosphorylation%2520uncouples%2520the%2520gastrin-releasing-peptide%2520receptor%2520from%2520G%2528q%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D36700%26epage%3D36707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Spindel, E. R.; Giladi, E.; Brehm, P.; Goodman, R. H.; Segerson, T. P.</span><span> </span><span class="NLM_article-title">Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor</span>.  <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span>− <span class="NLM_lpage">1963</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1210%2Fmend-4-12-1956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=1707129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK3MXlsFaitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=1956-1963&author=E.+R.+Spindel&author=E.+Giladi&author=P.+Brehm&author=R.+H.+Goodman&author=T.+P.+Segerson&title=Cloning+and+functional+characterization+of+a+complementary+DNA+encoding+the+murine+fibroblast+bombesin%2Fgastrin-releasing+peptide+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor</span></div><div class="casAuthors">Spindel, E. R.; Giladi, E.; Brehm, P.; Goodman, R. H.; Segerson, T. P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1956-63</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    </div><div class="casAbstract">The amphibian tetradecapeptide bombesin and its mammalian homolog gastrin-releasing peptide are neurotransmitters and paracrine hormones, and are mitogenic for fibroblast and small cell lung carcinoma cell lines.  The cDNAs encoding the bombesin/gastrin-releasing peptide receptor (BR) expressed by murine Swiss 3T3 fibroblasts were isolated using electrophysiol. and luminometric Xenopus oocyte expression assays.  Oocytes microinjected with BR transcripts responded to concns. of bombesin from 1 × 10-10 to 1 × 10-6 M.  These responses showed homologous desensitization and could be specifically blocked by bombesin antagonists.  Sequence anal. showed that the BR has 7 membrane-spanning domains and 5 potential N-linked glycosylation sites.  Data base anal. showed that the BR is most homologous to the tachykinin receptors.  Although tyrosine kinase activity has been assocd. with BR function, no tyrosine kinase homologies occur within the BR sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSt7h8NdFYf7Vg90H21EOLACvtfcHk0lgidheiXfLuLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsFaitL8%253D&md5=1aca09f41d339342fe4035b78dad9b86</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1210%2Fmend-4-12-1956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend-4-12-1956%26sid%3Dliteratum%253Aachs%26aulast%3DSpindel%26aufirst%3DE.%2BR.%26atitle%3DCloning%2520and%2520functional%2520characterization%2520of%2520a%2520complementary%2520DNA%2520encoding%2520the%2520murine%2520fibroblast%2520bombesin%252Fgastrin-releasing%2520peptide%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D1990%26volume%3D4%26spage%3D1956%26epage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fathi, Z.; Corjay, M. H.; Shapira, H.; Wada, E.; Benya, R.; Jensen, R.; Viallet, J.; Sausville, E. A.; Battey, J. F.</span><span> </span><span class="NLM_article-title">BRS-3: novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells</span>.  <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span>− <span class="NLM_lpage">5984</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=5979-5984&author=Z.+Fathi&author=M.+H.+Corjay&author=H.+Shapira&author=E.+Wada&author=R.+Benya&author=R.+Jensen&author=J.+Viallet&author=E.+A.+Sausville&author=J.+F.+Battey&title=BRS-3%3A+novel+bombesin+receptor+subtype+selectively+expressed+in+testis+and+lung+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFathi%26aufirst%3DZ.%26atitle%3DBRS-3%253A%2520novel%2520bombesin%2520receptor%2520subtype%2520selectively%2520expressed%2520in%2520testis%2520and%2520lung%2520carcinoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D5979%26epage%3D5984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Smith, C. J.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span>− <span class="NLM_lpage">868</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0969-8051%2803%2900116-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=14698790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWisrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=861-868&author=C.+J.+Smith&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Gastrin+releasing+peptide+%28GRP%29+receptor+targeted+radiopharmaceuticals%3A+a+concise+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: A concise update</span></div><div class="casAuthors">Smith, C. J.; Volkert, W. A.; Hoffman, T. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">861-868</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The gastrin releasing peptide (GRP) receptor is becoming an increasingly attractive target for development of new radiolabeled peptides with diagnostic and therapeutic potential.  The attractiveness of the GRP receptor as a target is based upon the functional expression of GRP receptors in several tumors of neuroendocrine origin including prostate, breast, and small cell lung cancer.  This concise review outlines some of the efforts currently underway to develop new GRP receptor specific radiopharmaceuticals by employing a variety of radiometal chelation systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr873gXWdB4jrVg90H21EOLACvtfcHk0lhitLmberBJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWisrfE&md5=53e564422d5539ff246bbfdf0ab41a21</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2803%2900116-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252803%252900116-1%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DGastrin%2520releasing%2520peptide%2520%2528GRP%2529%2520receptor%2520targeted%2520radiopharmaceuticals%253A%2520a%2520concise%2520update%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D861%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hoffman, T. J.; Gali, H.; Smith, C. J.; Sieckman, G. L.; Hayes, D. L.; Owen, N. K.; Volkert, W. A.</span><span> </span><span class="NLM_article-title">Novel series of <sup>111</sup>In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span>− <span class="NLM_lpage">831</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12732685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Kisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=823-831&author=T.+J.+Hoffman&author=H.+Gali&author=C.+J.+Smith&author=G.+L.+Sieckman&author=D.+L.+Hayes&author=N.+K.+Owen&author=W.+A.+Volkert&title=Novel+series+of+111In-labeled+bombesin+analogs+as+potential+radiopharmaceuticals+for+specific+targeting+of+gastrin-releasing+peptide+receptors+expressed+on+human+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells</span></div><div class="casAuthors">Hoffman, Timothy J.; Gali, Hariprasad; Smith, C. Jeffrey; Sieckman, Gary L.; Hayes, Donald L.; Owen, Nellie K.; Volkert, Wynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-831</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Gastrin-releasing peptide (GRP) receptors have been shown to be expressed with high densities on several types of cancer cells including prostate, breast, small cell lung, and pancreas cancers.  Bombesin (BBN) has been known to bind to GRP receptors with high affinity and specificity.  The aim of these studies was to develop new 111In-labeled BBN analogs having high tumor uptake and optimal pharmacokinetics for specific targeting of human prostate cancers.  Methods: A novel series of dodecanetetraacetic acid (DOTA)-X-BBN[7-14]NH2 (X = 0, β-Ala, 5-Ava, 8-Aoc, or 11-Aun) conjugates and their In(III)/111In complexes exhibiting high GRP-receptor-binding affinities were synthesized and characterized.  Results: In vitro competitive binding assays, using PC-3 androgen-independent human prostate cancer cells, demonstrated values of <2.5 nmol/L for inhibitory concn. of 50% for analogs with β-Ala, 5-Ava, and 8-Aoc spacers.  In vivo biodistribution studies of the 111In-DOTA-X-BBN[7-14]NH2 conjugates performed on CF-1 mice at 1 h after injection have revealed that the uptake of radioactivity in the pancreas, a GRP-receptor-expressing tissue, increased as a function of hydrocarbon spacer length (i.e., from 0.20 ± 0.04 percentage injected dose [%ID] per g for the analog with no spacer to a max. of 26.97 ± 3.97 %ID/g for the analog with 8-Aoc spacer).  The radioactivity was cleared efficiently from the blood pool by excretion mainly through the renal/urinary pathway (e.g., 71.6.± 1.8 %ID at 1 h after injection for 8-Aoc spacer analog).  In vivo pharmacokinetic studies of the 111In-DOTA-8-Aoc-BBN[7-14]NH2 conjugate conducted on PC-3 human prostate cancer-derived xenografts in SCID mice showed a specific uptake of radioactivity in tumor, with 3.63 ± 1.11 %ID/g obsd. at 1 h after injection.  High tumor-to-blood and tumor-to-muscle ratios of approx. 6:1 and 45:1, resp., were achieved at 1 h after injection.  Relative to the radioactivity obsd. in the tumor at 1 h after injection, 43%, 19%, and 9% of the radioactivity was retained at, resp., 24, 48, and 72 h after injection.  Conclusion: These studies showed that radiometallated DOTA-X-BBN[7-14]NH2 constructs with hydrocarbon spacers ranging from 5 to 8 carbon atoms are feasible candidates for further development as diagnostic and therapeutic radiopharmaceuticals for patients with GRP-pos. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNeuC3GOWcMrVg90H21EOLACvtfcHk0lhitLmberBJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Kisbc%253D&md5=7c680df1b1a48493f38f8cda42d17aef</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26atitle%3DNovel%2520series%2520of%2520111In-labeled%2520bombesin%2520analogs%2520as%2520potential%2520radiopharmaceuticals%2520for%2520specific%2520targeting%2520of%2520gastrin-releasing%2520peptide%2520receptors%2520expressed%2520on%2520human%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D44%26spage%3D823%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Breeman, W. A. P.; De Jong, M.; Erion, J. L.; Bugaj, J. E.; Srinivasan, A.; Bernard, B. F.; Kwekkeboom, D. J.; Visser, T. J.; Krenning, E. P.</span><span> </span><span class="NLM_article-title">Preclinical comparison of <sup>111</sup>In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1650</span>− <span class="NLM_lpage">1656</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1650-1656&author=W.+A.+P.+Breeman&author=M.+De+Jong&author=J.+L.+Erion&author=J.+E.+Bugaj&author=A.+Srinivasan&author=B.+F.+Bernard&author=D.+J.+Kwekkeboom&author=T.+J.+Visser&author=E.+P.+Krenning&title=Preclinical+comparison+of+111In-labeled+DTPA-+or+DOTA-bombesin+analogs+for+receptor-targeted+scintigraphy+and+radionuclide+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26atitle%3DPreclinical%2520comparison%2520of%2520111In-labeled%2520DTPA-%2520or%2520DOTA-bombesin%2520analogs%2520for%2520receptor-targeted%2520scintigraphy%2520and%2520radionuclide%2520therapy%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2002%26volume%3D43%26spage%3D1650%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, X.; Park, R.; Hou, Y.; Tohme, M.; Shahinian, A. H.; Bading, J. R.; Conti, P.</span><span> </span><span class="NLM_article-title">MicroPET and autoradiographic imaging of GRP receptor expression with <sup>64</sup>Cu-DOTA-[Lys<sup>3</sup>]bombesin in human prostate adenocarcinoma xenografts</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1390</span>− <span class="NLM_lpage">1397</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=1390-1397&author=X.+Chen&author=R.+Park&author=Y.+Hou&author=M.+Tohme&author=A.+H.+Shahinian&author=J.+R.+Bading&author=P.+Conti&title=MicroPET+and+autoradiographic+imaging+of+GRP+receptor+expression+with+64Cu-DOTA-%5BLys3%5Dbombesin+in+human+prostate+adenocarcinoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26atitle%3DMicroPET%2520and%2520autoradiographic%2520imaging%2520of%2520GRP%2520receptor%2520expression%2520with%252064Cu-DOTA-%255BLys3%255Dbombesin%2520in%2520human%2520prostate%2520adenocarcinoma%2520xenografts%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2004%26volume%3D45%26spage%3D1390%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Meyer, G. J.; Maecke, H.; Schuhmacher, J.; Knapp, W. H.; Hoffmann, M.</span><span> </span><span class="NLM_article-title"><sup>68</sup>Ga-labeled DOTA-derivatised peptide ligands</span>.  <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span>− <span class="NLM_lpage">1104</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1007%2Fs00259-004-1486-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=1097-1104&author=G.+J.+Meyer&author=H.+Maecke&author=J.+Schuhmacher&author=W.+H.+Knapp&author=M.+Hoffmann&title=68Ga-labeled+DOTA-derivatised+peptide+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga-labelled DOTA-derivatised peptide ligands</span></div><div class="casAuthors">Meyer, G.-J.; Maecke, H.; Schuhmacher, J.; Knapp, W. H.; Hofmann, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1097-1104</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">68Ge/68Ga generators provide cyclotron-independent access to positron emission tomog. (PET) radiopharmaceuticals.  We describe a system which allows the safe and efficient handling of 68Ge/68Ga generator eluates for labeling of DOTA-derivatized peptide ligands.  The system comprises concn. and purifn. of the 68Ga eluate as well as labeling and purifn. steps for peptides, and can be used with different 68Ge/68Ga generator types.  The suitability and efficiency were tested with two different DOTA-derivatized somatostatin derivs. and a DOTA-derivatized bombesin deriv.  Amts. of 10-20 nmol of the peptides were sufficient and resulted in labeling yields of 50% for all peptides.  The built-in safety precautions have proven to be appropriate in allowing use of the method for routine clin. applications.  The system was set up and operated in a "hot lab" by personnel with no previous experience in the prepn. of PET radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWa-QTuonJwLVg90H21EOLACvtfcHk0lhitLmberBJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWks7o%253D&md5=22052184683a716f452b1b4b1bd29c39</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00259-004-1486-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-004-1486-0%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DG.%2BJ.%26atitle%3D68Ga-labeled%2520DOTA-derivatised%2520peptide%2520ligands%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2004%26volume%3D31%26spage%3D1097%26epage%3D1104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Smith, C. J.; Gali, H.; Sieckman, G. L.; Hayes, D. L.; Owen, N. K.; Mazuru, D. G.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiochemical investigations of <sup>177</sup>Lu-DOTA-8-Aoc-BBN[7-14]NH<sub>2</sub>: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span>− <span class="NLM_lpage">109</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0969-8051%2802%2900391-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12623108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Clu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=101-109&author=C.+J.+Smith&author=H.+Gali&author=G.+L.+Sieckman&author=D.+L.+Hayes&author=N.+K.+Owen&author=D.+G.+Mazuru&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Radiochemical+investigations+of+177Lu-DOTA-8-Aoc-BBN%5B7-14%5DNH2%3A+an+in+vitro%2Fin+vivo+assessment+of+the+targeting+ability+of+this+new+radiopharmaceutical+for+PC-3+human+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells</span></div><div class="casAuthors">Smith, C. Jeffrey; Gali, Hariprasad; Sieckman, Gary L.; Hayes, Donald L.; Owen, Nellie K.; Mazuru, Dana G.; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Bombesin (BBN), a 14 amino acid peptide, is an analog of human gastrin releasing peptide (GRP) that binds to GRP receptors (GRPr) with high affinity and specificity.  The GRPr is over expressed on a variety of human cancer cells including prostate, breast, lung, and pancreatic cancers.  The specific aim of this study was to identify a BBN analog that can be radiolabeled with 177Lu and maintains high specificity for GRPr pos. prostate cancer tumors in vivo.  A preselected synthetic sequence via solid phase peptide synthesis (SPPS) was designed to produce a DOTA-BBN (DOTA = 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid) conjugate with the following general structure: DOTA-X-Q-W-A-V-G-H-L-M-(NH2), where the spacer group, X = ω-NH2(CH2)7COOH (8-Aoc).  The BBN-construct was purified by reversed phase-HPLC (RP-HPLC).  Electrospray Mass Spectrometry (ES-MS) was used to characterize both metalated and non-metalated BBN-conjugates.  The new DOTA-conjugate was metalated with 177Lu(III)Cl3 or non-radioactive Lu(III)Cl3.  The 177Lu(III)- and non-radiolabeled Lu(III)-conjugates exhibit the same retention times under identical RP-HPLC conditions.  The 177Lu-DOTA-8-Aoc-BBN[7-14]NH2 conjugate was found to exhibit optimal pharmacokinetic properties in CF-1 normal mice.  In vitro and in vivo models demonstrated the ability of the 177Lu-DOTA-8-Aoc-BBN[7-14]NH2 conjugate to specifically target GRP receptors expressed on PC-3 human prostate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwuZsqyeabSbVg90H21EOLACvtfcHk0lhuOupzYiztYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Clu7w%253D&md5=044a5755f49d491be97acf61a64139a0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900391-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900391-8%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DRadiochemical%2520investigations%2520of%2520177Lu-DOTA-8-Aoc-BBN%255B7-14%255DNH2%253A%2520an%2520in%2520vitro%252Fin%2520vivo%2520assessment%2520of%2520the%2520targeting%2520ability%2520of%2520this%2520new%2520radiopharmaceutical%2520for%2520PC-3%2520human%2520prostate%2520cancer%2520cells%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Zhang, X.; Cai, W.; Cao, F.; Schreibmann, E.; Wu, Y.; Wu, J. C.; Xing, L.; Chen, X.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer</span>.  <span class="citation_source-journal">J. Nucl. Med.</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span>− <span class="NLM_lpage">501</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=492-501&author=X.+Zhang&author=W.+Cai&author=F.+Cao&author=E.+Schreibmann&author=Y.+Wu&author=J.+C.+Wu&author=L.+Xing&author=X.+Chen&title=18F-labeled+bombesin+analogs+for+targeting+GRP+receptor-expressing+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26atitle%3D18F-labeled%2520bombesin%2520analogs%2520for%2520targeting%2520GRP%2520receptor-expressing%2520prostate%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Liu, S.; Edwards, D.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-Labeled small peptides as diagnostic radiopharmaceuticals</span>.  <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2235</span>− <span class="NLM_lpage">2268</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/cr980436l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2235-2268&author=S.+Liu&author=D.+Edwards&title=99mTc-Labeled+small+peptides+as+diagnostic+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcr980436l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr980436l%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3D99mTc-Labeled%2520small%2520peptides%2520as%2520diagnostic%2520radiopharmaceuticals%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2235%26epage%3D2268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Van De Wiele, C.; Dumont, F.; Dierckx, R. A.; Peers, S. H.; Thornback, J. R.; Slegers, G.; Thierens, H.</span><span> </span><span class="NLM_article-title">Biodistribution and dosimetry of <sup>99m</sup>Tc-RP527, a gastrin-releasing peptide(GRP) agonist for the visualization of GRP receptor-expressing malignancies</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1722</span>− <span class="NLM_lpage">1727</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1722-1727&author=C.+Van+De+Wiele&author=F.+Dumont&author=R.+A.+Dierckx&author=S.+H.+Peers&author=J.+R.+Thornback&author=G.+Slegers&author=H.+Thierens&title=Biodistribution+and+dosimetry+of+99mTc-RP527%2C+a+gastrin-releasing+peptide%28GRP%29+agonist+for+the+visualization+of+GRP+receptor-expressing+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDe%2BWiele%26aufirst%3DC.%26atitle%3DBiodistribution%2520and%2520dosimetry%2520of%252099mTc-RP527%252C%2520a%2520gastrin-releasing%2520peptide%2528GRP%2529%2520agonist%2520for%2520the%2520visualization%2520of%2520GRP%2520receptor-expressing%2520malignancies%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D1722%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Varvarigou, A.; Bouziotis, P.; Zikos, C.; Scopinaro, F.; De Vincentis, G.</span><span> </span><span class="NLM_article-title">Gastrin-releasing peptide (GRP) analogues for cancer imaging</span>.  <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span>− <span class="NLM_lpage">229</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1089%2F108497804323072002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=15186603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=219-229&author=A.+Varvarigou&author=P.+Bouziotis&author=C.+Zikos&author=F.+Scopinaro&author=G.+De+Vincentis&title=Gastrin-releasing+peptide+%28GRP%29+analogues+for+cancer+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-Releasing Peptide (GRP) Analogues for Cancer Imaging</span></div><div class="casAuthors">Varvarigou, Alexandra; Bouziotis, Penelope; Zikos, Christos; Scopinaro, Francesco; De Vincentis, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-229</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Small neuropeptides, labeled with gamma- and/or beta-emitting radionuclides, are currently being investigated for their ability to bind to cell-surface receptors, overexpressed in a wide variety of malignant tissues being, thus, potentially useful for radionuclide detection and/or therapy for tumors.  Particular attention has been focused on the amphibian peptide, bombesin (BN), and the molecularly related gastrin-releasing peptide (GRP).  These peptides act as neurotransmitters and endocrine cancer cell-growth factors on normal tissues as well as on neoplastic cells of various origin.  In recent investigations, modification of the native peptide structure has been attempted in order to obtain derivs., which might easily be labeled with radionuclides.  Thus, iodinated (I-125) BN derivs., as well as Indium (In-111) labeled BN analogs are currently being investigated, presenting satisfactory tumor localization.  Also, some new BN analogs contg. a 6-carbon linker have been prepd. and labeled with Rhenium-188, resulting in pos. in vitro binding to prostate cancer cells.  More recent studies refer to the Technetium-99m labeling of BN, performed either directly, after attaching proper technetium-chelating groups onto the BN sequence, or indirectly, by coupling BN to a preformed 99mTc-tagging ligand.  Both types of conjugates were found to have a high in vitro affinity for cells with BN receptors, also presenting satisfactory in vivo uptake in exptl. tumor models.  Pilot clin. studies of a new BN-derived, 99mTc-labeled pentadecapeptide indicated significant uptake by breast cancer and invaded lymph nodes, as well as by prostate cancer, small-cell lung carcinoma, gastro-entero-pancreatic tumors, and others.  Further studies of this new GRP deriv., as well as of other new BN-like peptides, are intensively performed internationally today.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGXRRkysFoWLVg90H21EOLACvtfcHk0lhuOupzYiztYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVyjtro%253D&md5=c185ea0342651d0939ff283ce4ab3260</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1089%2F108497804323072002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F108497804323072002%26sid%3Dliteratum%253Aachs%26aulast%3DVarvarigou%26aufirst%3DA.%26atitle%3DGastrin-releasing%2520peptide%2520%2528GRP%2529%2520analogues%2520for%2520cancer%2520imaging%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2004%26volume%3D19%26spage%3D219%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Nock, B.; Nikolopoulou, A.; Chiotellis, E.; Loudos, G.; Maintas, D.; Reubi, J. C.; Maina, T.</span><span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumor imaging</span>.  <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span>− <span class="NLM_lpage">258</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1007%2Fs00259-002-1040-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1CntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=247-258&author=B.+Nock&author=A.+Nikolopoulou&author=E.+Chiotellis&author=G.+Loudos&author=D.+Maintas&author=J.+C.+Reubi&author=T.+Maina&title=%5B99mTc%5DDemobesin+1%2C+a+novel+potent+bombesin+analogue+for+GRP+receptor-targeted+tumor+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging</span></div><div class="casAuthors">Nock, Berthold; Nikolopoulou, Anastasia; Chiotellis, Efstratios; Loudos, George; Maintas, Dimitrios; Reubi, Jean Claude; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Demobesin 1 is a potent new GRP-R-selective bombesin (BN) analog contg. an open chain tetraamine chelator for stable technetium-99m binding.  Following a convenient labeling protocol, the radiopeptide, [99mTc]Demobesin 1, formed in nearly quant. yields and with high specific activities.  Both unlabeled and labeled peptide demonstrated high-affinity binding in membrane prepns. of the human androgen-independent prostate adenocarcinoma PC-3 cell line.  The IC50 values detd. for Demobesin 1 and [Tyr4]BN were 0.70±0.08 nM and 1.5±0.20 nM, resp., while the Kd defined for [99mTc/99gTc]Demobesin 1 was 0.67±0.10 nM. [99mTc]Demobesin 1 was rather stable in murine plasma, whereas it degraded rapidly in kidney and liver homogenates.  After injection in healthy Swiss albino mice, [99mTc]Demobesin 1 accumulated very efficiently in the target organs (pancreas, intestinal tract) via a GRP-R-mediated process, as shown by in vivo receptor blocking expts.  An equally high and GRP-R-mediated uptake was exhibited by [99mTc]Demobesin 1 after injection in PC-3 tumor-bearing athymic mice.  The initial high radioligand uptake of 16.2±3.1%ID/g in the PC-3 xenografts at 1 h p.i. remained at a similar level (15.61±1.19%ID/g) at 4 h p.i.  Even after 24 h p.i., when the radioactivity had cleared from all other tissues, a value of 5.24±0.67%ID/g was still obsd. in the tumor.  The high and prolonged localization of [99mTc]Demobesin 1 at the tumor site and its rapid background clearance are very promising qualities for GRP-R-targeted tumor imaging in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_PXKboVxArVg90H21EOLACvtfcHk0lhuOupzYiztYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1CntA%253D%253D&md5=19ebcbebcf11cac029412ad304113f77</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-1040-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-1040-x%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%26atitle%3D%255B99mTc%255DDemobesin%25201%252C%2520a%2520novel%2520potent%2520bombesin%2520analogue%2520for%2520GRP%2520receptor-targeted%2520tumor%2520imaging%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D30%26spage%3D247%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Karra, S. R.; Schibli, R.; Gali, H.; Katti, K. V.; Hoffman, T. J.; Higginbotham-Sieckman, G. L.; Volkert, W. A.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labeling and in vivo studies of a bombesin analogue with novel water-soluble dithiadiphosphine-based bifunctional chelating agent</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span>− <span class="NLM_lpage">260</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc980096a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK1MXosV2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=254-260&author=S.+R.+Karra&author=R.+Schibli&author=H.+Gali&author=K.+V.+Katti&author=T.+J.+Hoffman&author=G.+L.+Higginbotham-Sieckman&author=W.+A.+Volkert&title=99mTc-labeling+and+in+vivo+studies+of+a+bombesin+analogue+with+novel+water-soluble+dithiadiphosphine-based+bifunctional+chelating+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-Labeling and in Vivo Studies of a Bombesin Analog with a Novel Water-Soluble Dithiadiphosphine-Based Bifunctional Chelating Agent</span></div><div class="casAuthors">Karra, Srinivasa R.; Schibli, Roger; Gali, Hariprasad; Katti, Kattesh V.; Hoffman, Timothy J.; Higginbotham, Chris; Sieckman, Gary L.; Volkert, Wynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">254-260</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent progress in the synthesis of water-sol. phosphine ligand systems and their corresponding 99mTc complexes prompted the development of a new bifunctional chelating agent (BFCA) based on a tetradentate dithiadiphosphine framework (P2S2-COOH).  The detailed synthesis of this new BFCA is described.  The corresponding 99mTc complex, 99mTc-P2S2-COOH, can be formed in >95% yield.  To demonstrate the potential of this chelate to efficiently label peptides, 99mTc-P2S2-COOH was coupled to the N-terminal region of the truncated nine-amino acid bombesin analog, 5-Ava-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [BBN(7-14)], to form 99mTc-P2S2-BBN(7-14).  Conjugation to the peptide was performed in borate buffer (pH 8.5) by applying the prelabeling approach in yields of >60%.  In competitive binding assays, using Swiss 3T3 mouse fibroblast cells against [125I-Tyr4]bombesin, Re-P2S2-BBN(7-14) exhibited an IC50 value of 0.8 ± 0.4 nM.  The pharmacokinetic studies of 99mTc-P2S2-BBN(7-14) and its ability to target tissue expressing gastrin-releasing peptide (GRP) receptors were performed in normal mice.  The 99mTc-P2S2-BBN(7-14) exhibited fast and efficient clearance from the blood pool (0.6 ± 0.1% ID, 4 h postinjection) and excretion through the renal and hepatobiliary pathways (56.4 ± 8.2 and 28.1 ± 7.9% ID, 4 h postinjection, resp.).  Significant uptake in the pancreas was obsd. (pancreatic acini cells express bombesin/GRP receptors), producing pancreas:blood and pancreas:muscle ratios of ca. 22 and 80, resp., at 4 h postinjection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB8mO29gA6hLVg90H21EOLACvtfcHk0ljtkkzPQ5tzYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXosV2rtQ%253D%253D&md5=24f274794d9b531e42f90dc28436dea7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbc980096a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc980096a%26sid%3Dliteratum%253Aachs%26aulast%3DKarra%26aufirst%3DS.%2BR.%26atitle%3D99mTc-labeling%2520and%2520in%2520vivo%2520studies%2520of%2520a%2520bombesin%2520analogue%2520with%2520novel%2520water-soluble%2520dithiadiphosphine-based%2520bifunctional%2520chelating%2520agent%26jtitle%3DBioconjugate%2520Chem.%26date%3D1999%26volume%3D10%26spage%3D254%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Gourni, E.; Paravatou, M.; Bouziotis, P.; Zikos, C.; Fani, M.; Xanthopoulos, S.; Archimandritis, S. C.; Livaniou, E.; Varvarigou, A. D.</span><span> </span><span class="NLM_article-title">Evaluation of a series of new <sup>99m</sup>Tc-labeled bombesin-like peptides for early cancer detection</span>.  <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span>− <span class="NLM_lpage">438</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=16475730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ahtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=435-438&author=E.+Gourni&author=M.+Paravatou&author=P.+Bouziotis&author=C.+Zikos&author=M.+Fani&author=S.+Xanthopoulos&author=S.+C.+Archimandritis&author=E.+Livaniou&author=A.+D.+Varvarigou&title=Evaluation+of+a+series+of+new+99mTc-labeled+bombesin-like+peptides+for+early+cancer+detection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a series of new 99mTc-labeled bombesin-like peptides for early cancer detection</span></div><div class="casAuthors">Gourni, Eleni; Paravatou, Maria; Bouziotis, Penelope; Zikos, Christos; Fani, Melpomeni; Xanthopoulos, Stavros; Archimandritis, Spyridon C.; Livaniou, Evagelia; Varvarigou, Alexandra D.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1A</span>),
    <span class="NLM_cas:pages">435-438</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Bombesin (BN) is a peptide exhibiting a high affinity for the gastrin-releasing peptide (GRP) receptor, which is overexpressed by a variety of tumors, including breast or prostate cancer.  The aim of the present study was the investigation of the complexes formed between a series of BN-like peptides and the nuclides 185/187Re and 99mTc.  The 185/187Re complexes were formed via the precursor Re-gluconate.  The radiolabeling of the derivs. with 99mTc was performed using either 99mTc-gluconate or 99mTc-MDP as the intermediate complex.  For the in vitro evaluation of the new peptides, the cancer cell line PC3 was used.  The in vivo behavior of the 99mTc-labeled BN-like peptides was evaluated in normal mice.  All the derivs. showed specific uptake in the pancreas, an organ rich in BN receptors and high affinity for the cancer cell line PC3.  The above preliminary results indicated that the new BN derivs. are promising for human cancer studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ccIBqm2XobVg90H21EOLACvtfcHk0ljtkkzPQ5tzYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ahtbY%253D&md5=793db8f68b6c314365377535b6fae674</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGourni%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520a%2520series%2520of%2520new%252099mTc-labeled%2520bombesin-like%2520peptides%2520for%2520early%2520cancer%2520detection%26jtitle%3DAnticancer%2520Res.%26date%3D2006%26volume%3D26%26spage%3D435%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Varvarigou, A. D.; Scopinaro, F.; Leondiadis, L.; Corleto, V.; Schillaci, O.; De Vicentis, G.; Sourlingas, T. G.; Sekeri-Pataryas, K. E.; Evangelatos, G. P.; Leonti, A.; Xanthopoulos, S.; Delle Fave, G.; Archimandritis, S. C.</span><span> </span><span class="NLM_article-title">Synthesis, chemical, radiochemical and radiobiological evaluation of a new <sup>99m</sup>Tc-labeled bombesin-like peptide</span>.  <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1089%2F10849780260179288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12136524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1agsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=317-326&author=A.+D.+Varvarigou&author=F.+Scopinaro&author=L.+Leondiadis&author=V.+Corleto&author=O.+Schillaci&author=G.+De+Vicentis&author=T.+G.+Sourlingas&author=K.+E.+Sekeri-Pataryas&author=G.+P.+Evangelatos&author=A.+Leonti&author=S.+Xanthopoulos&author=G.+Delle+Fave&author=S.+C.+Archimandritis&title=Synthesis%2C+chemical%2C+radiochemical+and+radiobiological+evaluation+of+a+new+99mTc-labeled+bombesin-like+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide</span></div><div class="casAuthors">Varvarigou, A. D.; Scopinaro, F.; Leondiadis, L.; Corleto, V.; Schillaci, O.; De Vincentis, G.; Sourlingas, T. G.; Sekeri-Pataryas, K. E.; Evangelatos, G. P.; Leonti, A.; Xanthopoulos, S.; Delle Fave, G.; Archimandritis, S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-326</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A new pentadecapeptide bombesin analog was prepd. by Fmoc synthesis, purified by HPLC and identified by electron ionization mass spectrometry.  The biol. activity of the new peptide was tested on isolated human colonic muscle cells and compared to native bombesin.  Labeling of the new biomol. with Tc-99m yielded a single radioactive species which remained stable at room temp. for eight hours.  In a binding assay, the radiolabeled peptide showed high affinity for oat-cell carcinoma (Kd = 9.8 nM) and colorectal adenocarcinoma (Kd = 27.2 nM).  Biodistribution studies, performed in normal rodents, indicated uptake by organs that normally express bombesin receptors, such as liver, intestines and kidneys.  Scintigraphic studies, performed in nude mice transplanted with small cell lung carcinoma and colon cancer cells, showed significant tumor uptake two hours p.i.  The new synthetic pentadecapeptide appears to have promise for several malignancies, including oat-cell lung carcinoma, colorectal cancer and gastroenteropancreatic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtuzQGym0SOLVg90H21EOLACvtfcHk0ljtkkzPQ5tzYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1agsbY%253D&md5=52978e226ffdba565b5613c9137f74b7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1089%2F10849780260179288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F10849780260179288%26sid%3Dliteratum%253Aachs%26aulast%3DVarvarigou%26aufirst%3DA.%2BD.%26atitle%3DSynthesis%252C%2520chemical%252C%2520radiochemical%2520and%2520radiobiological%2520evaluation%2520of%2520a%2520new%252099mTc-labeled%2520bombesin-like%2520peptide%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2002%26volume%3D17%26spage%3D317%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Okarvi, S. M.; Jammaz, I.</span><span> </span><span class="NLM_article-title">Synthesis, radiolabeling, and biological characteristics of a bombesin peptide analog as a tumor imaging agent</span>.  <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2745</span>− <span class="NLM_lpage">2750</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12894569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFyqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=2745-2750&author=S.+M.+Okarvi&author=I.+Jammaz&title=Synthesis%2C+radiolabeling%2C+and+biological+characteristics+of+a+bombesin+peptide+analog+as+a+tumor+imaging+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent</span></div><div class="casAuthors">Okarvi, S. M.; Al-Jammaz, I.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3B</span>),
    <span class="NLM_cas:pages">2745-2750</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Several human cancers, including small cell lung, prostate, breast, gastric, colon and pancreatic cancers, express receptors for bombesin-like peptides.  Bombesin (BN) peptides that bind specifically to these receptors are useful for detection of bombesin receptor-expressing cancers in vivo.  A new 99mTc-labeled-BN peptide for targeting bombesin receptor-expressing cancers was prepd. and characterized.  Materials and Methods: MAG3-coupled BN peptide (MAG3-BN) was prepd. by solid-phase synthesis and radiolabeled with 99mTc by an exchange method.  In vitro cell binding assays were conducted on human breast cancer cell lines, MDA-MB-231 and MCF-7.  In vivo biodistribution studies were performed in normal and nude mice bearing bombesin receptor-pos. tumors.  Results: Radiolabelling of MAG3-BN with 99mTc produces a single radioactive species (>95%).  In vitro cell-binding indicated the affinity and specificity of 99mTc-MAG3-BN towards bombesin receptors.  In vivo biodistribution in mice demonstrated that 99mTc-MAG3-BN cleared rapidly from the blood and most non-targeted tissues and was excreted mainly via the kidneys.  Uptake in bombesin receptor-pos. tissues and in the tumor was low to moderate.  Conclusion: 99mTc-MAG3-BN displays good radiolabelling together with certain favorable biol. characteristics and might be a useful peptide radiopharmaceutical in the detection of bombesin receptor-expressing cancers in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0Pz-r5A4ALVg90H21EOLACvtfcHk0liY4yPcEkKCIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFyqsrs%253D&md5=7976942bfb5dbc4872900eb286597f3e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkarvi%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%252C%2520radiolabeling%252C%2520and%2520biological%2520characteristics%2520of%2520a%2520bombesin%2520peptide%2520analog%2520as%2520a%2520tumor%2520imaging%2520agent%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D2745%26epage%3D2750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Smith, C. J.; Gali, H.; Sieckman, G. L.; Higginbotham, C.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiochemical investigations of <sup>99m</sup>Tc-N<sub>3</sub>S-X-BBN[7-14]NH<sub>2</sub>: An in vivo/in vitro structure−activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span>− <span class="NLM_lpage">102</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc020034r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFWmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=93-102&author=C.+J.+Smith&author=H.+Gali&author=G.+L.+Sieckman&author=C.+Higginbotham&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Radiochemical+investigations+of+99mTc-N3S-X-BBN%5B7-14%5DNH2%3A+An+in+vivo%2Fin+vitro+structure%E2%88%92activity+relationship+study+where+X+%3D+0-%2C+3-%2C+5-%2C+8-%2C+and+11-carbon+tethering+moieties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Radiochemical Investigations of 99mTc-N3S-X-BBN[7-14]NH2: An in Vitro/in Vivo Structure-Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties</span></div><div class="casAuthors">Smith, C. Jeffrey; Gali, Hariprasad; Sieckman, Gary L.; Higginbotham, Chris; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bombesin (BBN), a 14 amino acid peptide, is an analog of human gastrin releasing peptide (GRP) that binds to GRP receptors (GRPr) with high affinity and specificity.  The GRPr is overexpressed on a variety of human cancer cells, including prostate, breast, lung, and pancreatic cancers.  The specific aim of this study was to develop 99mTc-radiolabeled BBN analogs that maintain high specificity for the GRPr in vivo.  A preselected synthetic sequence via solid-phase peptide synthesis (SPPS) was designed to produce N3S-BBN (N3S = dimethylglycyl-L-seryl-L-cysteinylglycinamide) conjugates with the following general structure: DMG-S-C-G-X-Q-W-A-V-G-H-L-M-(NH2), where the spacer group, X = 0 (no spacer), ω-NH2(CH2)2COOH, ω-NH2(CH2)4COOH, ω-NH2(CH2)7COOH, or ω-NH2-(CH2)10COOH.  The new BBN constructs were purified by reversed phase-HPLC (RP-HPLC).  Electrospray mass spectrometry (ES-MS) was used to characterize the nonmetalated BBN conjugates.  Re(V)-BBN conjugates were prepd. by the reaction of Re(V)gluconate with N3S-X-BBN[7-14]NH2 (X = 0 carbons, β-Ala (β-alanine), 5-Ava (5-aminovaleric acid), 8-Aoc (8-aminooctanoic acid), and 11-Aun (11-aminoundecanoic acid)) with gentle heating. Re-N3S-5-Ava-BBN[7-14]NH2 was also prepd. by the reaction of [Re(V)dimethylglycyl-L-seryl-L-cysteinylglycinamide] with 5-Ava-BBN[7-14]NH2. ES-MS was used to det. the mol. constitution of the new Re(V) conjugates.  The 99mTc conjugates were prepd. at the tracer level by each the prelabeling, post-conjugation and pre-conjugation, postlabeling approaches from the reaction of Na[99mTcO4] with excess SnCl2, sodium gluconate, and corresponding ligand.  The 99mTc and Re(V) conjugates behaved similarly under identical RP-HPLC conditions.  In vitro and in vivo models demonstrated biol. integrity of the new conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3hpJybG-Tg7Vg90H21EOLACvtfcHk0liY4yPcEkKCIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFWmtrY%253D&md5=18c07e13b6fbb5a2c20d4fe0a4ca724b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbc020034r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc020034r%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DRadiochemical%2520investigations%2520of%252099mTc-N3S-X-BBN%255B7-14%255DNH2%253A%2520An%2520in%2520vivo%252Fin%2520vitro%2520structure%25E2%2588%2592activity%2520relationship%2520study%2520where%2520X%2520%253D%25200-%252C%25203-%252C%25205-%252C%25208-%252C%2520and%252011-carbon%2520tethering%2520moieties%26jtitle%3DBioconjugate%2520Chem.%26date%3D2003%26volume%3D14%26spage%3D93%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Veerendra, B.; Sieckman, G. L.; Hoffman, T. J.; Rold, T.; Retzloff, L.; McCrate, J.; Prasanphanich, A.; Smith, C. J.</span><span> </span><span class="NLM_article-title">Synthesis, radiolabeling and in vitro GRP receptor targeting of <sup>99m</sup>Tc-triaza-X-BN[7-14]NH<sub>2</sub> (X = seylserylserine, glycylglycylglycine, glycylserylglycine, or beta alanine)</span>.  <span class="citation_source-journal">Synth. React. Inorg. Met.-Org., Nano-Met. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span>− <span class="NLM_lpage">491</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1080%2F15533170600778075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVentrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=481-491&author=B.+Veerendra&author=G.+L.+Sieckman&author=T.+J.+Hoffman&author=T.+Rold&author=L.+Retzloff&author=J.+McCrate&author=A.+Prasanphanich&author=C.+J.+Smith&title=Synthesis%2C+radiolabeling+and+in+vitro+GRP+receptor+targeting+of+99mTc-triaza-X-BN%5B7-14%5DNH2+%28X+%3D+seylserylserine%2C+glycylglycylglycine%2C+glycylserylglycine%2C+or+beta+alanine%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, radiolabeling and in vitro GRP receptor targeting studies of 99mTc-Triaza-X-BBN[7-14]NH2 (X = Serylserylserine, Glycylglycylglycine, Glycylserylglycine, or beta alanine)</span></div><div class="casAuthors">Veerendra, Bhadrasetty; Sieckman, Gary L.; Hoffman, Timothy J.; Rold, Tammy; Retzloff, Lauren; McCrate, Joseph; Prasanphanich, Adam; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">481-491</span>CODEN:
                <span class="NLM_cas:coden">SRIMDO</span>;
        ISSN:<span class="NLM_cas:issn">1553-3174</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Gastrin-releasing peptide (GRP) receptors are over-expressed on several types of human cancer cells including prostate, breast, small cell lung and pancreatic cancers.  Bombesin (BBN) is a 14 amino acid peptide that is an analog of human gastrin-releasing peptide, binding to GRP receptors (GRPr) with high affinity and specificity.  The aim of these studies was to develop new 99mTc-labeled BBN analogs having high tumor uptake and optimal pharmacokinetics for specific targeting of human prostate cancers.  A new tridentate bifunctional chelating agent, 2-(4,7-bis(tert-butoxycarbonyl)-1,4,7-triazanonan-1-yl)acetic acid, was synthesized by first reacting 2 equiv of BOC-ON with 1,4,7-triazacyclononane (Triaza) in CHCl3 at room temp.  The product, N, N'-bis-(tert-butoxycarbonyl)-1,4,7-triazacyclononane, was alkylated using BrCH2COOH in acetonitrile.  This new ligand framework was characterized by 1H and 13C NMR and electrospray ionization mass spectrometry (ESI-MS).  Solid-phase peptide synthesis (SPPS) was used to produce Triaza-X-BBN[7-14]NH2 conjugates with the following structure: Triaza-X-Q-W-A-V-G-H-L-M-(NH2), where the spacer group X = SSS, GGG, GSG and β-Alanine (SSS = Serylserylserine, GGG = Glycylglycylglycine, and GSG = Glycylserylglycine).  These conjugates were purified by reversed phase-HPLC (RP-HPLC) and characterized by ESI-MS.  In vitro competitive binding assays, using 125I-Tyr4-BBN as the radiolabelling gold std., demonstrated IC50 values in the nanomolar range for all the new nonmetalated conjugates.  For example, IC50s were 1.8 ± 0.4, 3.9. ± 0.4, 1.9 ± 0.3, and 1.3 ± 0.2 nM for X = SSS, GGG, GSG and β-Alanine, resp.  The new BBN conjugates were radiolabeled with 99mTc in moderate yield via the Isolink radiolabeling kit available from Tyco Healthcare, St. Louis, MO.  In vitro internalization and externalization analyses indicated receptor binding to be receptor specific in human, PC-3, prostate cancer cells.  Future in vivo studies in tumor-bearing mouse models are justified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHYXfVl45B3LVg90H21EOLACvtfcHk0liY4yPcEkKCIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVentrw%253D&md5=f4b141f2140e19d788a969b657e2a728</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F15533170600778075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15533170600778075%26sid%3Dliteratum%253Aachs%26aulast%3DVeerendra%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520radiolabeling%2520and%2520in%2520vitro%2520GRP%2520receptor%2520targeting%2520of%252099mTc-triaza-X-BN%255B7-14%255DNH2%2520%2528X%2520%253D%2520seylserylserine%252C%2520glycylglycylglycine%252C%2520glycylserylglycine%252C%2520or%2520beta%2520alanine%2529%26jtitle%3DSynth.%2520React.%2520Inorg.%2520Met.-Org.%252C%2520Nano-Met.%2520Chem.%26date%3D2006%26volume%3D36%26spage%3D481%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">La Bella, R.; Garcia-Garayoa, E.; Langer, M.; Blauenstein, P.; Beck-Sickinger, A. G.; Schubiger, P. A.</span><span> </span><span class="NLM_article-title">In vitro and in vivo evaluation of a <sup>99m</sup>Tc(I)-labeled bombesin analogue for imaging gastrin releasing peptide receptor-positive tumors</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span>− <span class="NLM_lpage">560</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0969-8051%2802%2900314-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12088725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslKhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=553-560&author=R.+La+Bella&author=E.+Garcia-Garayoa&author=M.+Langer&author=P.+Blauenstein&author=A.+G.+Beck-Sickinger&author=P.+A.+Schubiger&title=In+vitro+and+in+vivo+evaluation+of+a+99mTc%28I%29-labeled+bombesin+analogue+for+imaging+gastrin+releasing+peptide+receptor-positive+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors</span></div><div class="casAuthors">La Bella, Roberto; Garcia-Garayoa, Elisa; Langer, Michael; Blauenstein, Peter; Beck-Sickinger, Annette G.; August Schubiger, P.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">553-560</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A new radiolabeled bombesin analog, [99mTc(I)-PADA-AVA]bombesin (7-14), was synthesized and in vitro and in vivo characterized.  High affinity and rapid internalization were obtained in binding assays.  A specific binding towards gastrin releasing peptide receptors-pos. tissues, pancreas and tumor, was obsd. in CD-1 nu/nu mice bearing PC-3 prostate adenocarcinoma xenografts.  We therefore conclude that [99mTc(I)-PADA-AVA]bombesin (7-14) might have promising characteristics for applications in nuclear medicine, namely for diagnosis of GRP receptor overexpressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqOSXZ_EGTJbVg90H21EOLACvtfcHk0liHReKm7bOR3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslKhs7g%253D&md5=75f26a1abdf1d00788f8160f1d742804</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900314-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900314-1%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BBella%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520a%252099mTc%2528I%2529-labeled%2520bombesin%2520analogue%2520for%2520imaging%2520gastrin%2520releasing%2520peptide%2520receptor-positive%2520tumors%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2002%26volume%3D29%26spage%3D553%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Garcia-Garayoa, E.; Rüegg, D.; Bläuenstein, P.; Zwimpfer, M.; Khan, I. U.; Maes, V.; Blanc, A.; Beck-Sickinger, A. G.; Tourwé, D. A.; Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Chemical and biological characterization of new Re(CO)<sub>3</sub>/[<sup>99m</sup>Tc](CO)<sub>3</sub> bombesin analogues</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span>− <span class="NLM_lpage">28</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2006.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=17210458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVWqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=17-28&author=E.+Garcia-Garayoa&author=D.+R%C3%BCegg&author=P.+Bl%C3%A4uenstein&author=M.+Zwimpfer&author=I.+U.+Khan&author=V.+Maes&author=A.+Blanc&author=A.+G.+Beck-Sickinger&author=D.+A.+Tourw%C3%A9&author=P.+A.+Schubiger&title=Chemical+and+biological+characterization+of+new+Re%28CO%293%2F%5B99mTc%5D%28CO%293+bombesin+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues</span></div><div class="casAuthors">Garcia Garayoa, Elisa; Ruegg, Dominique; Blauenstein, Peter; Zwimpfer, Martin; Khan, Irfan Ullah; Maes, Veronique; Blanc, Alain; Beck-Sickinger, Annette G.; Tourwe, Dirk A.; Schubiger, P. August</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-28</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Bombesin, a neuropeptide with potential for breast and prostate tumor targeting, is rapidly metabolized in vivo, and as a result, uptake in tumor xenografts in mice is poor.  An improvement can be expected from the introduction of nonnatural amino acids and spacers.  Leu13 was replaced by cyclohexylalanine and Met14 by norleucine.  Two spacers, -βAla-βAla- and 3,6-dioxa-8-aminooctanoic acid, were inserted between the receptor-binding amino acid sequence (7-14) of bombesin (BBS) and the retroNα-carboxymethyl histidine chelator used for labeling with the [99mTc](CO)3 core and the rhenium (Re) congener.  Methods: The biol. characterization of the new compds. was performed both in vitro on prostate carcinoma PC-3 cells (binding affinity, internalization/externalization) and in vivo (biodistribution in nude mice with tumor xenografts).  The stability was also investigated in human plasma.  The Re analogs were prepd. for chem. characterization.  Results: The nonnatural amino acids led to markedly slower degrdn. in human plasma and PC-3 cell cultures.  The receptor affinity of the new technetium 99m ([99mTc])-labeled BBS analogs was similar to the unmodified compd. with Kd<1 nM.  Uptake in the pancreas and in PC-3 tumor xenografts in nude mice was blocked by unlabeled BBS.  The best target-to-nontarget uptake ratio was clearly due to the presence of the more polar spacer, -βAla-βAla-.  Conclusions: The different spacers did not have a significant effect on stability or receptor affinity but had a clear influence on the uptake in healthy organs and tumors.  Uptake in the kidneys was lower than in the liver, which is likely to be due to the lipophilicity of the compds.  A specific, high uptake was also obsd. in the gastrin-releasing peptide receptor-rich pancreas.  Thus, with the introduction of spacers the in vivo properties of the compds. can be improved while leaving the affinity unaffected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb0lSgIEjZTLVg90H21EOLACvtfcHk0liHReKm7bOR3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVWqug%253D%253D&md5=35b5f5439f495e056e19be138af185b6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Garayoa%26aufirst%3DE.%26atitle%3DChemical%2520and%2520biological%2520characterization%2520of%2520new%2520Re%2528CO%25293%252F%255B99mTc%255D%2528CO%25293%2520bombesin%2520analogues%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2007%26volume%3D34%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Smith, C. J.; Sieckman, G. L.; Owen, N. K.; Hayes, D. L.; Mazuru, D. G.; Kannan, R.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiochemical investigations of gastrin-releasing peptide receptor-specific [<sup>99m</sup>Tc(X)(CO)<sub>3</sub>-Dpr-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH<sub>2</sub>)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H<sub>2</sub>O or P(CH<sub>2</sub>OH)<sub>3</sub><sup>1</sup></span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4082</span>− <span class="NLM_lpage">4088</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=4082-4088&author=C.+J.+Smith&author=G.+L.+Sieckman&author=N.+K.+Owen&author=D.+L.+Hayes&author=D.+G.+Mazuru&author=R.+Kannan&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Radiochemical+investigations+of+gastrin-releasing+peptide+receptor-specific+%5B99mTc%28X%29%28CO%293-Dpr-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-%28NH2%29%5D+in+PC-3%2C+tumor-bearing%2C+rodent+models%3A+syntheses%2C+radiolabeling%2C+and+in+vitro%2Fin+vivo+studies+where+Dpr+%3D+2%2C3-diaminopropionic+acid+and+X+%3D+H2O+or+P%28CH2OH%2931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DRadiochemical%2520investigations%2520of%2520gastrin-releasing%2520peptide%2520receptor-specific%2520%255B99mTc%2528X%2529%2528CO%25293-Dpr-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-%2528NH2%2529%255D%2520in%2520PC-3%252C%2520tumor-bearing%252C%2520rodent%2520models%253A%2520syntheses%252C%2520radiolabeling%252C%2520and%2520in%2520vitro%252Fin%2520vivo%2520studies%2520where%2520Dpr%2520%253D%25202%252C3-diaminopropionic%2520acid%2520and%2520X%2520%253D%2520H2O%2520or%2520P%2528CH2OH%252931%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D15%26spage%3D4082%26epage%3D4088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Alves, S.; Correia, J. D. G.; Santos, I.; Veerendra, B.; Sieckman, G. L.; Hoffman, T. J.; Rold, T.; Figueroa, S. D.; Retzloff, L.; McCrate, J.; Prasanphanich, A.; Smith, C. J.</span><span> </span><span class="NLM_article-title">Pyrazolyl conjugates of bombesin: a new tridentate ligand framework for stabilization of fac-[M(CO)<sub>3</sub>]<sup>+</sup> moiety</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span>− <span class="NLM_lpage">634</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2006.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=16843837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFWrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=625-634&author=S.+Alves&author=J.+D.+G.+Correia&author=I.+Santos&author=B.+Veerendra&author=G.+L.+Sieckman&author=T.+J.+Hoffman&author=T.+Rold&author=S.+D.+Figueroa&author=L.+Retzloff&author=J.+McCrate&author=A.+Prasanphanich&author=C.+J.+Smith&title=Pyrazolyl+conjugates+of+bombesin%3A+a+new+tridentate+ligand+framework+for+stabilization+of+fac-%5BM%28CO%293%5D%2B+moiety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazolyl conjugates of bombesin: A new tridentate ligand framework for the stabilization of fac-[M(CO)3]+ moiety</span></div><div class="casAuthors">Alves, Susana; Correia, Joao D. G.; Santos, Isabel; Veerendra, Bhadrasetty; Sieckman, Gary L.; Hoffman, Timothy J.; Rold, Tammy L.; Figueroa, Said Daibes; Retzloff, Lauren; McCrate, Joseph; Prasanphanich, Adam; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We have described the synthesis of tridentate pyrazolyl ligand frameworks for coordination to the fac-[*M(CO)3]+ metal fragment (*M = 186/188Re or 99mTc).  These ligands impart a degree of kinetic inertness on the metal center, warranting their study in biol. systems.  We herein report in vitro/in vivo radiolabeling investigations of a new series of pyrazolyl bombesin (BBN) conjugates radiolabeled via the Isolink kit.  These new conjugates are based on the general structure [99mTc-pyrazolyl-X-BBN[7-14]NH2], where X = β-alanine, serylserylserine or glycylglycylglycine.  The pyrazolyl ligand is a tridentate ligand framework that coordinates the metal center through nitrogen donor atoms.  The results of these investigations demonstrate the ability of these new conjugates to specifically target the gastrin-releasing peptide receptor subtype 2, which is overexpressed on human prostate PC-3 cancerous tissues.  Therefore, these studies suggest the tridentate pyrazolyl ligand framework to be an ideal candidate for the design and development of low-valent 99mTc-based diagnostic radiopharmaceuticals based on BBN or other targeting vectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjIoH7usgZFLVg90H21EOLACvtfcHk0ljEFLltyA-t0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFWrtrg%253D&md5=036ff65a33b173f9f6294379a16dabed</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DAlves%26aufirst%3DS.%26atitle%3DPyrazolyl%2520conjugates%2520of%2520bombesin%253A%2520a%2520new%2520tridentate%2520ligand%2520framework%2520for%2520stabilization%2520of%2520fac-%255BM%2528CO%25293%255D%252B%2520moiety%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D625%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Maina, T.; Nock, B.; Mather, S.</span><span> </span><span class="NLM_article-title">Targeting prostate cancer with radiolabelled bombesins</span>.  <span class="citation_source-journal">Cancer Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span>− <span class="NLM_lpage">157</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=153-157&author=T.+Maina&author=B.+Nock&author=S.+Mather&title=Targeting+prostate+cancer+with+radiolabelled+bombesins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DTargeting%2520prostate%2520cancer%2520with%2520radiolabelled%2520bombesins%26jtitle%3DCancer%2520Imaging%26date%3D2006%26volume%3D6%26spage%3D153%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Seo, Y.; Kurhanewicz, J.; Franc, B. L.; Hawkins, R. A.; Hasegawa, B. H.</span><span> </span><span class="NLM_article-title">Improved prostate cancer imaging with SPECT/CT and MRI/MRSI</span>.  <span class="citation_source-journal">IEEE Trans. Nucl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span>),  <span class="NLM_fpage">1316</span>− <span class="NLM_lpage">1320</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1109%2FTNS.2005.858241" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=1316-1320&issue=5&author=Y.+Seo&author=J.+Kurhanewicz&author=B.+L.+Franc&author=R.+A.+Hawkins&author=B.+H.+Hasegawa&title=Improved+prostate+cancer+imaging+with+SPECT%2FCT+and+MRI%2FMRSI"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1109%2FTNS.2005.858241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1109%252FTNS.2005.858241%26sid%3Dliteratum%253Aachs%26aulast%3DSeo%26aufirst%3DY.%26atitle%3DImproved%2520prostate%2520cancer%2520imaging%2520with%2520SPECT%252FCT%2520and%2520MRI%252FMRSI%26jtitle%3DIEEE%2520Trans.%2520Nucl.%2520Sci.%26date%3D2005%26volume%3D52%26issue%3D5%26spage%3D1316%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Swanson, M. G.; Vigneron, D. B.; Tran, T. K.; Kurhanewicz, J.</span><span> </span><span class="NLM_article-title">Magnetic resonance imaging and spectroscopic imaging of prostate cancer</span>.  <span class="citation_source-journal">Cancer Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span>− <span class="NLM_lpage">523</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=510-523&author=M.+G.+Swanson&author=D.+B.+Vigneron&author=T.+K.+Tran&author=J.+Kurhanewicz&title=Magnetic+resonance+imaging+and+spectroscopic+imaging+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DM.%2BG.%26atitle%3DMagnetic%2520resonance%2520imaging%2520and%2520spectroscopic%2520imaging%2520of%2520prostate%2520cancer%26jtitle%3DCancer%2520Invest.%26date%3D2001%26volume%3D19%26spage%3D510%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Jadvar, H.; Pinski, J. K.; Conti, P. S.</span><span> </span><span class="NLM_article-title">FDG PET in suspected recurrent and metastatic prostate cancer</span>.  <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span>− <span class="NLM_lpage">1488</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12883728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A280%3ADC%252BD3szltFGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1485-1488&author=H.+Jadvar&author=J.+K.+Pinski&author=P.+S.+Conti&title=FDG+PET+in+suspected+recurrent+and+metastatic+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">FDG PET in suspected recurrent and metastatic prostate cancer</span></div><div class="casAuthors">Jadvar Hossein; Pinski Jacek K; Conti Peter S</div><div class="citationInfo"><span class="NLM_cas:title">Oncology reports</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1485-8</span>
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    </div><div class="casAbstract">Development of an accurate non-invasive imaging technique to detect recurrent and metastatic prostate cancer is critical for the effective management of these patients.  The purpose of our study was to determine the diagnostic utility of positron emission tomography with [F-18]fluorodeoxyglucose (FDG PET) in patients with suspected or known metastatic and recurrent prostate cancer.  We performed 12 FDG PET scans in 12 men (age 65-81 years) with history of prostate cancer who had previously undergone radical prostatectomy (n=3) or prostate radiotherapy (n=9).  Serum prostate specific antigen (PSA) level was elevated in all patients (5-206 ng/ml).  Available correlative imaging studies included contrast-enhanced chest, abdomen and pelvis CT (n=8), bone scintigraphy (n=5), and radiography (n=2).  PET findings were compared to the findings of the other imaging studies on a lesion-by-lesion basis in individual patients.  Validation was by clinical or imaging follow-up for up to 1 year.  PET findings were concordant with the findings of the other imaging studies in 7 patients.  PET was discordant with the other imaging studies in 5 patients.  PET demonstrated suspicious hypermetabolic pelvic lymph nodes in one patient with negative pelvis CT.  PET underestimated the extent of osseous metastatic disease in the remaining 4 patients.  FDG PET is limited in the detection of osseous metastatic lesions but may be useful in the detection of metastatic nodal and soft tissue disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIzh94Sim3sexsqfvU0ziafW6udTcc2eYe-D5fOWcHMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szltFGhtQ%253D%253D&md5=02619ddceff00e62762bc0b374532dcc</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJadvar%26aufirst%3DH.%26atitle%3DFDG%2520PET%2520in%2520suspected%2520recurrent%2520and%2520metastatic%2520prostate%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2003%26volume%3D10%26spage%3D1485%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Picchio, M.; Messa, C.; Landoni, C.; Gianolli, L.; Sironi, S.; Brioschi, M.; Matarrese, M.; Matei, D. V.; De Cobelli, F.; Del Maschio, A.; Rocco, F.; Rigatti, P.; Fazio, F.</span><span> </span><span class="NLM_article-title">Value of [<sup>11</sup>C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [<sup>1</sup>8F]fluorodeoxyglucose-positron emission tomography</span>.  <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span>− <span class="NLM_lpage">1340</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1097%2F01.ju.0000056901.95996.43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12629355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFahs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2003&pages=1337-1340&author=M.+Picchio&author=C.+Messa&author=C.+Landoni&author=L.+Gianolli&author=S.+Sironi&author=M.+Brioschi&author=M.+Matarrese&author=D.+V.+Matei&author=F.+De+Cobelli&author=A.+Del+Maschio&author=F.+Rocco&author=P.+Rigatti&author=F.+Fazio&title=Value+of+%5B11C%5Dcholine-positron+emission+tomography+for+re-staging+prostate+cancer%3A+a+comparison+with+%5B18F%5Dfluorodeoxyglucose-positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Value of [11C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [18F]fluorodeoxyglucose-Positron Emission Tomography</span></div><div class="casAuthors">Picchio, M.; Messa, C.; Landoni, C.; Gianolli, L.; Sironi, S.; Brioschi, M.; Matarrese, M.; Matei, D. V.; De Cobelli, F.; Del Maschio, A.; Rocco, F.; Rigatti, P.; Fazio, F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1337-1340</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">PURPOSE We compared [11C]choline-positron emission tomog. (PET) with [18F]fluorodeoxyglucose-PET for re-staging prostate cancer in a group of 100 patients.  MATERIALS AND METHODS A total of 100 consecutive patients referred for whole body [18F]fluorodeoxyglucose-PET for clin. prostate re-staging after radical treatment for prostate cancer were retrospectively included in the study.  Mean prostate specific antigen (PSA) was 6.57 ng./mL.  In all cases [11C]choline-PET was also performed.  PET studies were done with a multiring device 5 min after i.v. injection of approx. 370 MBq. [11C]choline and 60 min after injection of approx. 370 MBq. [18F]fluorodeoxyglucose.  PET findings were compared with those obtained with different conventional imaging and with PSA assessed at the time of PET and 1 yr later.  RESULTS Areas of abnormal focal increases were noted in 47% of patients on [11C]choline-PET and in 27% on [18F]fluorodeoxyglucose-PET.  Of the 100 patients 49 had pos. conventional imaging findings.  All except 14 [11C]choline-PET findings were concordant with conventional imaging, including 6 neg. and 8 pos. conventional imaging results.  All except 1 [11C]choline-PET neg. cases also had neg. conventional imaging after 1 yr.  PSA at 1 yr remained stable or decreased in 80% and 62% of [11C]choline-PET neg. and pos. cases, resp.  CONCLUSIONS [11C]choline-PET seems to be useful for re-staging prostatectomy cases with increasing serum PSA levels.  It is superior to [18F]fluorodeoxyglucose-PET and complementary to conventional imaging but with the advantage of staging disease at a single step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpAkqx-bhrArVg90H21EOLACvtfcHk0ljEFLltyA-t0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFahs7o%253D&md5=d29b617ddde72c33dc9f3e58454ecaa5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1097%2F01.ju.0000056901.95996.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.ju.0000056901.95996.43%26sid%3Dliteratum%253Aachs%26aulast%3DPicchio%26aufirst%3DM.%26atitle%3DValue%2520of%2520%255B11C%255Dcholine-positron%2520emission%2520tomography%2520for%2520re-staging%2520prostate%2520cancer%253A%2520a%2520comparison%2520with%2520%255B18F%255Dfluorodeoxyglucose-positron%2520emission%2520tomography%26jtitle%3DJ.%2520Urol.%26date%3D2003%26volume%3D169%26spage%3D1337%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Hara, T.; Kosaka, N.; Kishi, H.</span><span> </span><span class="NLM_article-title">Development of (18)F-fluoroethyl-choline for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span>− <span class="NLM_lpage">199</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=187-199&author=T.+Hara&author=N.+Kosaka&author=H.+Kishi&title=Development+of+%2818%29F-fluoroethyl-choline+for+cancer+imaging+with+PET%3A+synthesis%2C+biochemistry%2C+and+prostate+cancer+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520%252818%2529F-fluoroethyl-choline%2520for%2520cancer%2520imaging%2520with%2520PET%253A%2520synthesis%252C%2520biochemistry%252C%2520and%2520prostate%2520cancer%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2002%26volume%3D43%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Jankowsky, R.; Kirsch, S.; Reich, T.; Spies, H.; Johannsen, B.</span><span> </span><span class="NLM_article-title">Solution structure of rhenium(V) oxo peptide complexes of glycylglycylcysteine and cysteinylglycine as studied by capillary electrophoresis and X-ray absorption spectroscopy</span>.  <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span>− <span class="NLM_lpage">106</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=99-106&author=R.+Jankowsky&author=S.+Kirsch&author=T.+Reich&author=H.+Spies&author=B.+Johannsen&title=Solution+structure+of+rhenium%28V%29+oxo+peptide+complexes+of+glycylglycylcysteine+and+cysteinylglycine+as+studied+by+capillary+electrophoresis+and+X-ray+absorption+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJankowsky%26aufirst%3DR.%26atitle%3DSolution%2520structure%2520of%2520rhenium%2528V%2529%2520oxo%2520peptide%2520complexes%2520of%2520glycylglycylcysteine%2520and%2520cysteinylglycine%2520as%2520studied%2520by%2520capillary%2520electrophoresis%2520and%2520X-ray%2520absorption%2520spectroscopy%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1998%26volume%3D70%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Gourni, E.; Bouziotis, P.; Zikos, C.; Loudos, G.; Xanthopoulos, S.; Fani, M.; Archimandritis, S. C.; Varvarigou, A. D.</span><span> </span><span class="NLM_article-title">Comparative in vivo evaluation of two novel Tc-99m labeled bombesin derivatives</span>.  <span class="citation_source-journal">Nucl. Instrum. Methods A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">569</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span>− <span class="NLM_lpage">521</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nima.2006.08.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KgtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=569&publication_year=2006&pages=518-521&author=E.+Gourni&author=P.+Bouziotis&author=C.+Zikos&author=G.+Loudos&author=S.+Xanthopoulos&author=M.+Fani&author=S.+C.+Archimandritis&author=A.+D.+Varvarigou&title=Comparative+in+vivo+evaluation+of+two+novel+Tc-99m+labeled+bombesin+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative in vivo evaluation of two novel 99mTc labelled bombesin derivatives</span></div><div class="casAuthors">Gourni, Eleni; Bouziotis, Penelope; Zikos, Christos; Loudos, George; Xanthopoulos, Stavros; Fani, Melpomeni; Archimandritis, Spyridon C.; Varvarigou, Alexandra D.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Instruments & Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors, and Associated Equipment</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">569</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">518-521</span>CODEN:
                <span class="NLM_cas:coden">NIMAER</span>;
        ISSN:<span class="NLM_cas:issn">0168-9002</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bombesin (BN), a 14 amino acid peptide, is an analog of human gastrin-releasing-peptide (GRP) that binds to GRP receptors (GRP-R) with high affinity and specificity.  In addn. to this physiol. role, GRP, through its interaction with GRP-R, promotes tumor growth in a no. of human cancer cell lines.  The GRP receptors are over-expressed on a variety of human cancer cells.  Aim of the present work is the study of two novels BN-like peptides, by investigating the radiochem. and radiopharmacol. behavior of their complexes with metals.  The derivs. under study are: Gly-Gly-Cys-Aca-BN [2-14] where Aca: 6-amino-hexanoic acid.  Pyroglutamic acid in the bombesin mol. has been replaced by the chem. group Gly-Gly-Cys-Aca, which bears an amino-acid combination capable of complexing a variety of radiometals.  The other deriv. under study is: Gly-Gly-Cys-Aca-BN [7-14].  This moiety of the peptide has been chosen because it has been proven to be a potent GRP agonist.  The peptide derivs. were synthesized by SPPS, according to the Fmoc strategy and were identified by reverse phase high performance liq. chromatog. (RP-HPLC).  Radiolabelling with 99mTc was performed via the precursor 99mTc-gluconate.  The stability of the radiolabeled species was examd. with time.  In vivo studies of the two 99mTc-labeled derivs. were performed, comparatively, in normal mice, attention being focused on GRP receptor-bearing organs, and in exptl. induced prostate cancer models.  Exptl. tumors were imaged in a small field-of-view animal gamma camera.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDZ8ZZouotUbVg90H21EOLACvtfcHk0lgh71r9EI62ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KgtL7O&md5=a0008b48682d2aedc0c08acebb9898da</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.nima.2006.08.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nima.2006.08.141%26sid%3Dliteratum%253Aachs%26aulast%3DGourni%26aufirst%3DE.%26atitle%3DComparative%2520in%2520vivo%2520evaluation%2520of%2520two%2520novel%2520Tc-99m%2520labeled%2520bombesin%2520derivatives%26jtitle%3DNucl.%2520Instrum.%2520Methods%2520A%26date%3D2006%26volume%3D569%26spage%3D518%26epage%3D521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Deutsch, E.; Libson, K.; Vanderheyden, J.-L.; Ketring, A. R.; Maxon, H. R.</span><span> </span><span class="NLM_article-title">The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span>− <span class="NLM_lpage">477</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaL2sXks1Grtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1986&pages=465-477&author=E.+Deutsch&author=K.+Libson&author=J.-L.+Vanderheyden&author=A.+R.+Ketring&author=H.+R.+Maxon&title=The+chemistry+of+rhenium+and+technetium+as+related+to+the+use+of+isotopes+of+these+elements+in+therapeutic+and+diagnostic+nuclear+medicine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine</span></div><div class="casAuthors">Deutsch, Edward; Libson, Karen; Vanderheyden, Jean Luc; Ketring, Alan R.; Maxon, Harry R.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-77</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    </div><div class="casAbstract">The β-emitting isotopes 186Re and 188Re are logical choices on which to base therapeutic radiopharmaceuticals that might be expected to be analogous to diagnostic radiopharmaceuticals based on 99mTc.  However, the chem. of Re is sufficiently different from that of Tc so that the development of Re radiopharmaceuticals often cannot be predicated on the known chem. and biol. behavior of 99mTc radiopharmaceuticals.  The relevant chem. differences involve the greater stability of the higher oxidn. states of Re (and thus the greater tendency of reduced Re radiopharmaceuticals to undergo reoxidn. to perrhenate), and the greater substitution inertness of reduced Re complexes.  These differences are illustrated (1) in the prepn. and use of 186Re (Sn)-HEDP and 99mTc(Sn)-HEDP diphosphonate radiopharmaceuticals designed, resp., for palliative therapy and diagnosis of metastatic cancer to bone and (2) in the prepn. and biodistribution of tr-[186Re(DMPE)2Cl2]+ and [186Re(DMPE)3]+ (where DMPE = 1,2-bis(dimethylphosphino)ethane]), analogs to the potential myocardial perfusion imaging agents tr-[99mTc(DMPE)2Cl2]+ and [99mTc(DMPE)3]+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT5RYYRmjFFbVg90H21EOLACvtfcHk0lgh71r9EI62ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXks1Grtg%253D%253D&md5=42810b36423c1ba759885c3bcc371869</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DE.%26atitle%3DThe%2520chemistry%2520of%2520rhenium%2520and%2520technetium%2520as%2520related%2520to%2520the%2520use%2520of%2520isotopes%2520of%2520these%2520elements%2520in%2520therapeutic%2520and%2520diagnostic%2520nuclear%2520medicine%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1986%26volume%3D13%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Wüthrich, K.</span> <span class="citation_source-book">NMR of Proteins and Nucleic Acids</span>; <span class="NLM_publisher-name">Wiley-Interscience Publication</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">130</span>− <span class="NLM_lpage">161</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=130-161&author=K.+W%C3%BCthrich&title=NMR+of+Proteins+and+Nucleic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26btitle%3DNMR%2520of%2520Proteins%2520and%2520Nucleic%2520Acids%26pub%3DWiley-Interscience%2520Publication%26date%3D1986%26spage%3D130%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Lever, S. Z.; Baidoo, K. E.; Mahmood, A.</span><span> </span><span class="NLM_article-title">Structure proof of <i>syn/anti</i> isomerism in N-alkylated diaminedithiol (DADT) complexes of technetium</span>.  <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span>− <span class="NLM_lpage">184</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0020-1693%2800%2984842-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFGqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=1990&pages=183-184&author=S.+Z.+Lever&author=K.+E.+Baidoo&author=A.+Mahmood&title=Structure+proof+of+syn%2Fanti+isomerism+in+N-alkylated+diaminedithiol+%28DADT%29+complexes+of+technetium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structure proof of syn/anti isomerism in N-alkylated diaminedithiol (DADT) complexes of technetium</span></div><div class="casAuthors">Lever, Susan Z.; Baidoo, Kwamena E.; Mahmood, Ashfaq</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-4</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    </div><div class="casAbstract">The redn. of NH499TeO4 by NaS2O4 in aq. NaOH in the presence of 2,4,9-trimethyl-4,7-diaza-2,9-decanedithiol (H3L) gave syn- and anti-99TcOL (I).  syn-I is monoclinic, space group P21/n, Z = 8, R = 0.035, Rw = 0.074.  anti-I is orthorhombic, space group Fddd2, Z = 16, R = 0.023, Rw = 0.029.  The Me group on the N atom is syn or anti to the O on Tc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqssa5Fs9_hz7Vg90H21EOLACvtfcHk0lhbk5G0Ccd_0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFGqsLY%253D&md5=0b40f835bfbb5b31f75b885c0704d134</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0020-1693%2800%2984842-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-1693%252800%252984842-2%26sid%3Dliteratum%253Aachs%26aulast%3DLever%26aufirst%3DS.%2BZ.%26atitle%3DStructure%2520proof%2520of%2520syn%252Fanti%2520isomerism%2520in%2520N-alkylated%2520diaminedithiol%2520%2528DADT%2529%2520complexes%2520of%2520technetium%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D1990%26volume%3D176%26spage%3D183%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Francesconi, L. C.; Graczyk, G.; Wehrli, S.; Shaikh, S. N.; McClinton, D.; Liu, S.; Zubieta, J.; Kung, H. F.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of neutral MVO (M = technetium, rhenium) amine−thiol complexes containing a pendant phenylpiperidine group</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3114</span>− <span class="NLM_lpage">3124</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic00066a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=3114-3124&author=L.+C.+Francesconi&author=G.+Graczyk&author=S.+Wehrli&author=S.+N.+Shaikh&author=D.+McClinton&author=S.+Liu&author=J.+Zubieta&author=H.+F.+Kung&title=Synthesis+and+characterization+of+neutral+MVO+%28M+%3D+technetium%2C+rhenium%29+amine%E2%88%92thiol+complexes+containing+a+pendant+phenylpiperidine+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fic00066a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00066a025%26sid%3Dliteratum%253Aachs%26aulast%3DFrancesconi%26aufirst%3DL.%2BC.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520neutral%2520MVO%2520%2528M%2520%253D%2520technetium%252C%2520rhenium%2529%2520amine%25E2%2588%2592thiol%2520complexes%2520containing%2520a%2520pendant%2520phenylpiperidine%2520group%26jtitle%3DInorg.%2520Chem.%26date%3D1993%26volume%3D32%26spage%3D3114%26epage%3D3124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Pelecanou, M.; Chryssou, K.; Stassinopoulou, C. I.</span><span> </span><span class="NLM_article-title">Trends in NMR chemical shifts and ligand mobility of TcO(V) and ReO(V) complexes with aminothiols</span>.  <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span>− <span class="NLM_lpage">351</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2000&pages=347-351&author=M.+Pelecanou&author=K.+Chryssou&author=C.+I.+Stassinopoulou&title=Trends+in+NMR+chemical+shifts+and+ligand+mobility+of+TcO%28V%29+and+ReO%28V%29+complexes+with+aminothiols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPelecanou%26aufirst%3DM.%26atitle%3DTrends%2520in%2520NMR%2520chemical%2520shifts%2520and%2520ligand%2520mobility%2520of%2520TcO%2528V%2529%2520and%2520ReO%2528V%2529%2520complexes%2520with%2520aminothiols%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2000%26volume%3D79%26spage%3D347%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Liu, S.; Edwards, S.; Barrett, J.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc labeling of highly potent small peptides</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span>− <span class="NLM_lpage">636</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc970058b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK2sXlslGmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=621-636&author=S.+Liu&author=S.+Edwards&author=J.+Barrett&title=99mTc+labeling+of+highly+potent+small+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc Labeling of Highly Potent Small Peptides</span></div><div class="casAuthors">Liu, Shuang; Edwards, D. Scott; Barrett, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">621-636</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 211 refs. on clin. requirements for new 99mTC radiopharmaceuticals, various radiolabeling approaches, different chelating systems and their 99mTc-labeling kinetics, and examples of 99mTc-labeled peptides as radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPhZW5ileFrVg90H21EOLACvtfcHk0lhbk5G0Ccd_0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlslGmsrc%253D&md5=5f0320e9b77dfbe58e105b31c80289f6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbc970058b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc970058b%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3D99mTc%2520labeling%2520of%2520highly%2520potent%2520small%2520peptides%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D621%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Banerjee, S. R.; Maresca, K. P.; Francesconi, L.; Valliant, J.; Babich, J. W.; Zubieta, J.</span><span> </span><span class="NLM_article-title">New directions in the coordination chemistry of <sup>99m</sup>Tc: a reflection on technetium core structures and a strategy for new chelate design</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span>− <span class="NLM_lpage">20</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2004.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=15691657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=1-20&author=S.+R.+Banerjee&author=K.+P.+Maresca&author=L.+Francesconi&author=J.+Valliant&author=J.+W.+Babich&author=J.+Zubieta&title=New+directions+in+the+coordination+chemistry+of+99mTc%3A+a+reflection+on+technetium+core+structures+and+a+strategy+for+new+chelate+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design</span></div><div class="casAuthors">Banerjee, Sangeeta Ray; Maresca, Kevin P.; Francesconi, Lynn; Valliant, John; Babich, John W.; Zubieta, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-20</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Bifunctional chelates offer a general approach for the linking of radioactive metal cations to macromols.  In the specific case of 99mTc, a variety of technologies were developed for assembling a metal-chelate-biomol. complex.  An evaluation of these methodologies requires an appreciation of the coordination characteristics and preferences of the Tc core structures and oxidn. states, which serve as platforms for the development of the imaging agent.  Three technologies, namely, the MAG3-based bifunctional chelates, the N-oxysuccinimidylhydrazino-nicotinamide system and the recently described single amino acid chelates for the {Tc(CO)3}1+ core, are discussed in terms of the fundamental coordination chem. of the Tc core structures.  In assessing the advantages and disadvantages of these technologies, the single amino acid analog chelates (SAAC), which are readily conjugated to small peptides by solid-phase synthesis methods and which form robust complexes with the {Tc(CO)3}1+ core, offer an effective alternative to the previously described methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfLLF_PjeDlrVg90H21EOLACvtfcHk0lhbk5G0Ccd_0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyisbs%253D&md5=995097fc00e6bb258cc9178cba1f49bf</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2004.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2004.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%2BR.%26atitle%3DNew%2520directions%2520in%2520the%2520coordination%2520chemistry%2520of%252099mTc%253A%2520a%2520reflection%2520on%2520technetium%2520core%2520structures%2520and%2520a%2520strategy%2520for%2520new%2520chelate%2520design%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Lister-James, J.; Knight, L. C.; Mauer, A. H.; Bush, L. R.; Mayer, B. R.; Dean, R. T.</span><span> </span><span class="NLM_article-title">Thrombus imaging with a technetium-99m-labeled, activated platelet receptor-binding peptide</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span>− <span class="NLM_lpage">781</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=775-781&author=J.+Lister-James&author=L.+C.+Knight&author=A.+H.+Mauer&author=L.+R.+Bush&author=B.+R.+Mayer&author=R.+T.+Dean&title=Thrombus+imaging+with+a+technetium-99m-labeled%2C+activated+platelet+receptor-binding+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLister-James%26aufirst%3DJ.%26atitle%3DThrombus%2520imaging%2520with%2520a%2520technetium-99m-labeled%252C%2520activated%2520platelet%2520receptor-binding%2520peptide%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1996%26volume%3D37%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Pearson, D. A.; Lister-James, J.; McBride, W. J.; Wilson, D. M.; Martel, L. J.; Civitello, E. R.; Taylor, J. E.; Moyer, B. R.; Dean, R. T.</span><span> </span><span class="NLM_article-title">Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span>− <span class="NLM_lpage">1371</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm950111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1361-1371&author=D.+A.+Pearson&author=J.+Lister-James&author=W.+J.+McBride&author=D.+M.+Wilson&author=L.+J.+Martel&author=E.+R.+Civitello&author=J.+E.+Taylor&author=B.+R.+Moyer&author=R.+T.+Dean&title=Somatostatin+receptor-binding+peptides+labeled+with+technetium-99m%3A+chemistry+and+initial+biological+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm950111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950111m%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DD.%2BA.%26atitle%3DSomatostatin%2520receptor-binding%2520peptides%2520labeled%2520with%2520technetium-99m%253A%2520chemistry%2520and%2520initial%2520biological%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1361%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Lister-James, J.; Moyer, B. R.; Dean, T.</span><span> </span><span class="NLM_article-title">Small peptides radiolabeled with <sup>99m</sup>Tc</span>.  <span class="citation_source-journal">Q. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span>− <span class="NLM_lpage">233</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=8961801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A280%3ADyaK2s7itFWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=221-233&author=J.+Lister-James&author=B.+R.+Moyer&author=T.+Dean&title=Small+peptides+radiolabeled+with+99mTc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Small peptides radiolabeled with 99mTc</span></div><div class="casAuthors">Lister-James J; Moyer B R; Dean T</div><div class="citationInfo"><span class="NLM_cas:title">The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-33</span>
        ISSN:<span class="NLM_cas:issn">1125-0135</span>.
    </div><div class="casAbstract">UNLABELLED:  The pharmacokinetic characteristics of small peptides radiolabeled with technetium-99m, their physico-chemical properties and radiolabeling techniques are reviewed.  METHODS:  Physical and chemical characteristics which affect pharmacokinetics are discussed with particular reference to lipophilicity, charge and resistance to peptidases.  General biodistribution, pharmacokinetics, metabolism and excretion characteristics, as well as tissue uptake kinetics are described.  Methods of radiolabeling small peptides with 99mTc are reviewed, including discussion of chelating groups for technetium.  Specific examples drawn either from the literature or from the 99mTc labeled peptides under development by Diatide are presented.  RESULT:  Although lipophilicity and charge have an impact, the degree of resistance to peptidases is a key determinant of pharmacokinetic behavior.  In general, pharmacokinetics and rate of tissue uptake are fast and metabolism occurs mainly via peptidase activity in the liver and kidneys.  Although the route depends on a number of factors, excretion also usually is rapid.  Chelating groups for 99mTc in the (+5) oxidation state are preferred.  Site specific incorporation of the chelating groups during peptide synthesis is also preferred.  Examples of renal imaging agents (MAG3), thrombus imaging peptides (P280 and P748), tumor imaging peptides (P587 and P829) and infection/inflammation imaging peptides (fMLF-type and P483H) are presented and discussed.  CONCLUSIONS:  99mTc labeled small peptides are characterized by rapid pharmacokinetics and tissue penetration.  Furthermore, small peptides are readily synthesized and the desired pharmacokinetic behavior may be engineered into the molecule.  They are well suited for development as radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDV5lQiqZLqYqdXsLcGTEUfW6udTcc2ebfHiAI-_C5erntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7itFWgtg%253D%253D&md5=110033e7aef1b659f380b85ade31a52a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLister-James%26aufirst%3DJ.%26atitle%3DSmall%2520peptides%2520radiolabeled%2520with%252099mTc%26jtitle%3DQ.%2520J.%2520Nucl.%2520Med.%26date%3D1996%26volume%3D40%26spage%3D221%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Jankowsky, R.; Kirsch, S.; Reich, T.; Spies, H.; Johannsen, B.</span><span> </span><span class="NLM_article-title">Solution structures of rhenium(V) oxo peptide complexes of glycylglycylcysteine and cysteinylglycine as studied by capillary electrophoresis and X-ray absorption spectroscopy</span>.  <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span>− <span class="NLM_lpage">106</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=99-106&author=R.+Jankowsky&author=S.+Kirsch&author=T.+Reich&author=H.+Spies&author=B.+Johannsen&title=Solution+structures+of+rhenium%28V%29+oxo+peptide+complexes+of+glycylglycylcysteine+and+cysteinylglycine+as+studied+by+capillary+electrophoresis+and+X-ray+absorption+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJankowsky%26aufirst%3DR.%26atitle%3DSolution%2520structures%2520of%2520rhenium%2528V%2529%2520oxo%2520peptide%2520complexes%2520of%2520glycylglycylcysteine%2520and%2520cysteinylglycine%2520as%2520studied%2520by%2520capillary%2520electrophoresis%2520and%2520X-ray%2520absorption%2520spectroscopy%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1998%26volume%3D70%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Wong, E.; Fauconnier, T.; Bennett, S.; Valliant, J.; Nguyen, T.; Lau, F.; Lu, L. F. L.; Pollak, A.; Bell, R. A.; Thornback, J. R.</span><span> </span><span class="NLM_article-title">Rhenium(V) and technetium(V) oxo complexes of an N<sub>2</sub>N′S peptidic chelator: evidence of interconversion between the <i>syn</i> and <i>anti</i> conformations</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5799</span>− <span class="NLM_lpage">5808</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic9706562" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=5799-5808&author=E.+Wong&author=T.+Fauconnier&author=S.+Bennett&author=J.+Valliant&author=T.+Nguyen&author=F.+Lau&author=L.+F.+L.+Lu&author=A.+Pollak&author=R.+A.+Bell&author=J.+R.+Thornback&title=Rhenium%28V%29+and+technetium%28V%29+oxo+complexes+of+an+N2N%E2%80%B2S+peptidic+chelator%3A+evidence+of+interconversion+between+the+syn+and+anti+conformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fic9706562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic9706562%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%26atitle%3DRhenium%2528V%2529%2520and%2520technetium%2528V%2529%2520oxo%2520complexes%2520of%2520an%2520N2N%25E2%2580%25B2S%2520peptidic%2520chelator%253A%2520evidence%2520of%2520interconversion%2520between%2520the%2520syn%2520and%2520anti%2520conformations%26jtitle%3DInorg.%2520Chem.%26date%3D1997%26volume%3D36%26spage%3D5799%26epage%3D5808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Takayama, T.; Suzuki, K.; Sekine, T.; Kudo, H.</span><span> </span><span class="NLM_article-title">Syntheses and structures of technetium(V) and rhenium(V) oxo complexes of peptide having KYC-sequence</span>.  <span class="citation_source-journal">Radiochim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span>− <span class="NLM_lpage">251</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1524%2Fract.2000.88.3-4.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslaqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2000&pages=247-251&author=T.+Takayama&author=K.+Suzuki&author=T.+Sekine&author=H.+Kudo&title=Syntheses+and+structures+of+technetium%28V%29+and+rhenium%28V%29+oxo+complexes+of+peptide+having+KYC-sequence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and structures of technetium(V) and rhenium(V) oxo complexes of peptide having KYC-sequence</span></div><div class="casAuthors">Takayama, Tsutomu; Suzuki, Keisuke; Sekine, Tsutomu; Kudo, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Radiochimica Acta</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">247-251</span>CODEN:
                <span class="NLM_cas:coden">RAACAP</span>;
        ISSN:<span class="NLM_cas:issn">0033-8230</span>.
    
            (<span class="NLM_cas:orgname">R. Oldenbourg Verlag</span>)
        </div><div class="casAbstract">Tc(V) and Re(V) oxo complexes of a peptide having a KYC-sequence such as KYCAR (H3L5) and KYCAREPPTRTNAYWGQG-NH2 (H3L18) were synthesized, and structures of the complexes were characterized by spectroscopic techniques.  All of the complexes were synthesized by the ligand exchange reaction of [Bu4N][MOCl4] (M = 99Tc, Re) with peptide in MeOH or DMF soln.  These complexes have a square pyramidal structure with an oxo ligand at the apical position.  The peptide is coordinated to a metal atom through Namine of lysine, Sthiol of cysteine, and Namide of tyrosine and cysteine in the equatorial plane.  A lysine (CH2)4NH2 group of the L5 ligand has the syn conformation with respect to metal-oxo bonding in the complex.  The syn isomer was selectively formed in the ligand exchange reaction.  The conversion of the syn isomer to the anti isomer was obsd. only for syn-[ReO(L5)], in which the coordination of H2O to the trans position of the oxo ligand was involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqibm5mxhJRzrVg90H21EOLACvtfcHk0lj7sZW4MnEY2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslaqurY%253D&md5=97840f719387eeba527afb3727afecd3</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1524%2Fract.2000.88.3-4.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1524%252Fract.2000.88.3-4.247%26sid%3Dliteratum%253Aachs%26aulast%3DTakayama%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520structures%2520of%2520technetium%2528V%2529%2520and%2520rhenium%2528V%2529%2520oxo%2520complexes%2520of%2520peptide%2520having%2520KYC-sequence%26jtitle%3DRadiochim.%2520Acta%26date%3D2000%26volume%3D88%26spage%3D247%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Wong, E.; Bennett, S.; Lawrence, B.; Fauconnier, T.; Lu, L. F. L.; Bell, R. A.; Thornback, J. R.; Eshima, D.</span><span> </span><span class="NLM_article-title">Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">5695</span>− <span class="NLM_lpage">5700</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic010462t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=5695-5700&author=E.+Wong&author=S.+Bennett&author=B.+Lawrence&author=T.+Fauconnier&author=L.+F.+L.+Lu&author=R.+A.+Bell&author=J.+R.+Thornback&author=D.+Eshima&title=Tuftsin+receptor-binding+peptide+labeled+with+technetium%3A+chemistry+and+preliminary+in+vitro+receptor-binding+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fic010462t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic010462t%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%26atitle%3DTuftsin%2520receptor-binding%2520peptide%2520labeled%2520with%2520technetium%253A%2520chemistry%2520and%2520preliminary%2520in%2520vitro%2520receptor-binding%2520study%26jtitle%3DInorg.%2520Chem.%26date%3D2001%26volume%3D40%26spage%3D5695%26epage%3D5700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Valliant, J. F.; Ridoch, R. W.; Hughes, D. W.; Roe, D. G.; Fauconnier, T. K.; Thornback, J. R.</span><span> </span><span class="NLM_article-title">The solid phase synthesis and NMR spectroscopy of a <sup>99</sup>Tc chelate-bombesin derived peptide conjugate</span>.  <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span>− <span class="NLM_lpage">163</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0020-1693%2801%2900637-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFGgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2001&pages=155-163&author=J.+F.+Valliant&author=R.+W.+Ridoch&author=D.+W.+Hughes&author=D.+G.+Roe&author=T.+K.+Fauconnier&author=J.+R.+Thornback&title=The+solid+phase+synthesis+and+NMR+spectroscopy+of+a+99Tc+chelate-bombesin+derived+peptide+conjugate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The solid phase synthesis and NMR spectroscopy of a 99Tc chelate-bombesin derived peptide conjugate</span></div><div class="casAuthors">Valliant, John F.; Riddoch, R. William; Hughes, Donald W.; Roe, David G.; Fauconnier, Theresa K.; Thornback, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A bombesin derived peptide-99Tc chelate conjugate was prepd. using a solid phase synthetic methodol.  The reported approach involved linking a prefabricated bifunctional N2N'S technetium chelate complex to a resin bound peptide sequence derived from bombesin, which has been shown to bind to the gastrin-releasing peptide (GRP) receptor.  The technetium chelate-peptide conjugate was subsequently isolated from the solid support and characterized by electrospray mass spectrometry, HPLC and NMR spectroscopy.  The goal of the approach was to develop a versatile solid phase synthetic procedure that would facilitate the future application of modern drug discovery techniques for the development of receptor selective technetium radiopharmaceuticals.  Furthermore, the NMR studies of the reported radiometal-peptide conjugate provide an important ref. for the characterization of future bombesin-based radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Mzx7KiMSu7Vg90H21EOLACvtfcHk0lgdVHJMxPhlPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFGgs7g%253D&md5=94ecbf5dab38f4b2a413437e59f6588d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0020-1693%2801%2900637-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-1693%252801%252900637-5%26sid%3Dliteratum%253Aachs%26aulast%3DValliant%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520solid%2520phase%2520synthesis%2520and%2520NMR%2520spectroscopy%2520of%2520a%252099Tc%2520chelate-bombesin%2520derived%2520peptide%2520conjugate%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2001%26volume%3D325%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Cantorias, M. V.; Howell, R. C.; Todaro, L.; Cyr, J. E.; Berndorff, D.; Rogers, R. D.; Francesconi, L. C.</span><span> </span><span class="NLM_article-title">MO tripeptide diastereomers (M = <sup>99/99m</sup>Tc, Re): models to identify the structure of <sup>99m</sup>Tc peptide targeted radiopharmaceuticals</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">7326</span>− <span class="NLM_lpage">7340</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic070077p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=7326-7340&author=M.+V.+Cantorias&author=R.+C.+Howell&author=L.+Todaro&author=J.+E.+Cyr&author=D.+Berndorff&author=R.+D.+Rogers&author=L.+C.+Francesconi&title=MO+tripeptide+diastereomers+%28M+%3D+99%2F99mTc%2C+Re%29%3A+models+to+identify+the+structure+of+99mTc+peptide+targeted+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fic070077p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic070077p%26sid%3Dliteratum%253Aachs%26aulast%3DCantorias%26aufirst%3DM.%2BV.%26atitle%3DMO%2520tripeptide%2520diastereomers%2520%2528M%2520%253D%252099%252F99mTc%252C%2520Re%2529%253A%2520models%2520to%2520identify%2520the%2520structure%2520of%252099mTc%2520peptide%2520targeted%2520radiopharmaceuticals%26jtitle%3DInorg.%2520Chem.%26date%3D2007%26volume%3D46%26spage%3D7326%26epage%3D7340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Francesconi, L. C.; Zheng, Y.; Bartis, J.; Blumenstein, M.; Costello, C.; De Rosch, M. A.</span><span> </span><span class="NLM_article-title">Preparation and characterization of [<sup>99</sup>TcO] apcitide: a technetium labeled peptide</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2867</span>− <span class="NLM_lpage">2875</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic035473w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=2867-2875&author=L.+C.+Francesconi&author=Y.+Zheng&author=J.+Bartis&author=M.+Blumenstein&author=C.+Costello&author=M.+A.+De+Rosch&title=Preparation+and+characterization+of+%5B99TcO%5D+apcitide%3A+a+technetium+labeled+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fic035473w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic035473w%26sid%3Dliteratum%253Aachs%26aulast%3DFrancesconi%26aufirst%3DL.%2BC.%26atitle%3DPreparation%2520and%2520characterization%2520of%2520%255B99TcO%255D%2520apcitide%253A%2520a%2520technetium%2520labeled%2520peptide%26jtitle%3DInorg.%2520Chem.%26date%3D2004%26volume%3D43%26spage%3D2867%26epage%3D2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Cyr, J. E.; Pearson, D. A.; Nelson, C. A.; Lyons, B. A.; Zheng, Y.; Bartis, J.; He, J.; Cantorias, M. V.; Howell, R. C.; Francesconi, L. C.</span><span> </span><span class="NLM_article-title">Isolation, characterization, and biological evaluation of <i>syn</i> and <i>anti</i> diasteromers of [<sup>99m</sup>Tc]technetium depreotide: a somatostatin receptor binding tumor imaging</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4295</span>− <span class="NLM_lpage">4303</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm060887v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4295-4303&author=J.+E.+Cyr&author=D.+A.+Pearson&author=C.+A.+Nelson&author=B.+A.+Lyons&author=Y.+Zheng&author=J.+Bartis&author=J.+He&author=M.+V.+Cantorias&author=R.+C.+Howell&author=L.+C.+Francesconi&title=Isolation%2C+characterization%2C+and+biological+evaluation+of+syn+and+anti+diasteromers+of+%5B99mTc%5Dtechnetium+depreotide%3A+a+somatostatin+receptor+binding+tumor+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm060887v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060887v%26sid%3Dliteratum%253Aachs%26aulast%3DCyr%26aufirst%3DJ.%2BE.%26atitle%3DIsolation%252C%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%2520syn%2520and%2520anti%2520diasteromers%2520of%2520%255B99mTc%255Dtechnetium%2520depreotide%253A%2520a%2520somatostatin%2520receptor%2520binding%2520tumor%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4295%26epage%3D4303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Carver, J. A.</span><span> </span><span class="NLM_article-title">The conformation of bombesin in solution as determined by two-dimensional <sup>1</sup>H-NMR techniques</span>.  <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span>− <span class="NLM_lpage">199</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1111%2Fj.1432-1033.1987.tb13404.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=3665915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaL1cXhs1Cjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=1987&pages=193-199&author=J.+A.+Carver&title=The+conformation+of+bombesin+in+solution+as+determined+by+two-dimensional+1H-NMR+techniques"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">The conformation of bombesin in solution as determined by two-dimensional proton NMR techniques</span></div><div class="casAuthors">Carver, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-9</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The 1H NMR spectrum of the tetradecapeptide, bombesin, has been assigned in [2H6]DMSO soln. and aq. soln. by using 2-dimensional techniques.  The chem. shifts in both solvents indicate that the mol. has little secondary structure and adopts a random coil conformation.  A comparison is made between the spectra of various smaller bombesin fragments and the intact polypeptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomMAhfbmOUpLVg90H21EOLACvtfcHk0lgdVHJMxPhlPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhs1Cjuw%253D%253D&md5=3a8507a0f527ec6ca9189337f35c9863</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1987.tb13404.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1987.tb13404.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarver%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520conformation%2520of%2520bombesin%2520in%2520solution%2520as%2520determined%2520by%2520two-dimensional%25201H-NMR%2520techniques%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1987%26volume%3D168%26spage%3D193%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Cavatorta, P.; Spisni, A.; Szabo, A. G.; Farruggia, G.; Franzoni, L.; Masotti, L.</span><span> </span><span class="NLM_article-title">Conformation of bombesin in buffer and in the presence of lysolecithin micelles: NMR, CD, and fluorescence studies</span>.  <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span>− <span class="NLM_lpage">463</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=441-463&author=P.+Cavatorta&author=A.+Spisni&author=A.+G.+Szabo&author=G.+Farruggia&author=L.+Franzoni&author=L.+Masotti&title=Conformation+of+bombesin+in+buffer+and+in+the+presence+of+lysolecithin+micelles%3A+NMR%2C+CD%2C+and+fluorescence+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCavatorta%26aufirst%3DP.%26atitle%3DConformation%2520of%2520bombesin%2520in%2520buffer%2520and%2520in%2520the%2520presence%2520of%2520lysolecithin%2520micelles%253A%2520NMR%252C%2520CD%252C%2520and%2520fluorescence%2520studies%26jtitle%3DBiopolymers%26date%3D1989%26volume%3D28%26spage%3D441%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Johnson, C. V.; Shelton, T.; Smith, C. J.; Ma, L.; Perry, M. C.; Volkert, W .A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Evaluation of combined <sup>177</sup>Lu-DOTA-8-AOC-BBN[7-14]NH<sub>2</sub> GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice</span>.  <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span>− <span class="NLM_lpage">166</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1089%2Fcbr.2006.21.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=16706636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1ajtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=155-166&author=C.+V.+Johnson&author=T.+Shelton&author=C.+J.+Smith&author=L.+Ma&author=M.+C.+Perry&author=W+.A.+Volkert&author=T.+J.+Hoffman&title=Evaluation+of+combined+177Lu-DOTA-8-AOC-BBN%5B7-14%5DNH2+GRP+receptor-targeted+radiotherapy+and+chemotherapy+in+PC-3+human+prostate+tumor+cell+xenografted+SCID+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Combined 177Lu-DOTA-8-AOC-BBN (7-14)NH2 GRP Receptor-Targeted Radiotherapy and Chemotherapy in PC-3 Human Prostate Tumor Cell Xenografted SCID Mice</span></div><div class="casAuthors">Johnson, Christopher V.; Shelton, Tiffani; Smith, Charles J.; Ma, Lixin; Perry, Michael C.; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-166</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The focus of this study was to evaluate the therapeutic benefit of combined gastrin-releasing peptide (GRP) receptor-targeted radiotherapy (TRT) with chemotherapy, using the PC-3 xenograft severe combined immunodeficiency (SCID) mouse model.  177Lu-DOTA-8-AOC-BBN(7-14)NH2 is a radiotherapeutic peptide that specifically targets the gastrin-releasing peptide receptor overexpressed on primary and metastatic prostate cancer.  The chemotherapeutic agents, docetaxel and estramustine, were administered as single agents or in combination with the receptor-targeted radiotherapeutic agent.  Combination receptor TRT/chemotherapy studies were begun 21 days postxenografting and were conducted as multiple-dose trials.  The GRP receptor TRT agent was administered every 14 days, and single and combination chemotherapy dose regimens were given weekly.  Tumor size, body wt., and body condition score were evaluated twice-weekly and a hematol. profile once-weekly.  Therapy study tumor vols. were evaluated by way of a repeated measures anal. of variance (ANOVA).  Tumor vol. measurements at 12 days postdose administration demonstrated a statistically significant (two-tailed P-value <0.05) tumor growth suppression in all exptl. groups receiving GRP receptor-targeted radiotherapy, when compared to the control group.  The two combined GRP receptor TRT/chemotherapy treatment groups demonstrated the greatest tumor growth suppression of all treatment groups.  In comparing the two combined GRP receptor TRT/chemotherapy groups to the GRP receptor TRT alone group, a statistically significant difference was demonstrated for the combined groups by day 30, postdose administration.  These data demonstrate that GRP receptor-targeted radiation therapy, using 177Lu-DOTA-8-AOC-BBN(7-14)NH2, used either alone or in combination with conventional chemotherapy, can suppress the growth of androgen- independent prostate cancer (AIPC).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Y9H_Ev0hVbVg90H21EOLACvtfcHk0lg2rww3v1ZX2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1ajtrw%253D&md5=5dee59638944916b5c13f4c507fcba4e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2006.21.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2006.21.155%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BV.%26atitle%3DEvaluation%2520of%2520combined%2520177Lu-DOTA-8-AOC-BBN%255B7-14%255DNH2%2520GRP%2520receptor-targeted%2520radiotherapy%2520and%2520chemotherapy%2520in%2520PC-3%2520human%2520prostate%2520tumor%2520cell%2520xenografted%2520SCID%2520mice%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2006%26volume%3D21%26spage%3D155%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Bläuenstein, P.; Garcia-Garayoa, E.; Rüegg, D.; Blanc, A.; Tourwé, D.; Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Improving the tumour uptake of <sup>99m</sup>Tc-labeled neuropeptides using stabilised peptide analogues</span>.  <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span>− <span class="NLM_lpage">188</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1089%2F108497804323071959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=15186598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A280%3ADC%252BD2c3os1Chug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=181-188&author=P.+Bl%C3%A4uenstein&author=E.+Garcia-Garayoa&author=D.+R%C3%BCegg&author=A.+Blanc&author=D.+Tourw%C3%A9&author=P.+A.+Schubiger&title=Improving+the+tumour+uptake+of+99mTc-labeled+neuropeptides+using+stabilised+peptide+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analogues</span></div><div class="casAuthors">Blauenstein Peter; Garayoa Elisa Garcia; Ruegg Dominique; Blanc Alain; Tourwe Dirk; Beck-Sickinger Annette; Schubiger P August</div><div class="citationInfo"><span class="NLM_cas:title">Cancer biotherapy & radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-8</span>
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    </div><div class="casAbstract">Two neuropeptides, bombesin (BBS) and neurotensin (NT) and their radiolabeled analogues, have great potential for tumour targeting, either for diagnosis (e.g., with 99mTc) or therapy (e.g., with 90Y or 188Re).  In this study, we investigated NT(8-13) and BBS(7-14) analogues with Nalpha-histidinyl acetate linked to the N-terminus of the peptide.  This His-derivative forms a stable and inert tridentate complex with the 99mTc(CO)3 and the 188Re(CO)3 moieties.  The stability of 99mTc-labeled neurotensin and bombesin analogues was tested in human plasma samples and in tumour cell cultures in the presence and absence of specific enzyme inhibitors.  The inhibitor of ACE (angiotensin converting enzyme) was the most effective in inhibiting the peptide cleavage of both NT(8-13) and BBS(7-14).  In agreement with this finding, the replacement of Ile12 by tert-leucine (NT) and Leu13 by cyclohexylalanin (BBS) brought about a better stability.  With NT(8-13) analogues, higher tumour to nontarget (t/nt) ratios and the same affinity to the receptor was observed, but with BBS(7-14) derivatives the affinity was lower and the t/nt ratio was not significantly improved.  Toxicity tests showed no effect in mice of up to a five-hundred-fold higher dose than planned for patient application, which started successfully with NT(8-13) analogues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRrRWEFiTEIbFU0A1HOshhfW6udTcc2eYjQEib8sYdOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3os1Chug%253D%253D&md5=04552c3003388e876be5f9410c99e947</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1089%2F108497804323071959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F108497804323071959%26sid%3Dliteratum%253Aachs%26aulast%3DBl%25C3%25A4uenstein%26aufirst%3DP.%26atitle%3DImproving%2520the%2520tumour%2520uptake%2520of%252099mTc-labeled%2520neuropeptides%2520using%2520stabilised%2520peptide%2520analogues%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2004%26volume%3D19%26spage%3D181%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Preston, E.; Miller, G. V.; Primrose, J. N.</span><span> </span><span class="NLM_article-title">Bombesin-like peptides and cancer</span>.  <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span>− <span class="NLM_lpage">238</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2F1040-8428%2896%2900204-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=8842591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A280%3ADyaK28vktVarsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=225-238&author=E.+Preston&author=G.+V.+Miller&author=J.+N.+Primrose&title=Bombesin-like+peptides+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin-like peptides and cancer</span></div><div class="casAuthors">Preston S R; Miller G V; Primrose J N</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-38</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTerUms1UqVm-WhZTslLrfffW6udTcc2eYjQEib8sYdOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vktVarsg%253D%253D&md5=3cb8a8b8a90530266ae715b377b32266</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2F1040-8428%2896%2900204-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1040-8428%252896%252900204-1%26sid%3Dliteratum%253Aachs%26aulast%3DPreston%26aufirst%3DE.%26atitle%3DBombesin-like%2520peptides%2520and%2520cancer%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D1996%26volume%3D23%26spage%3D225%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Faintuch, B. L.; Teorodo, R.; Duatti, A.; Muramoto, E.; Faintuch, S.; Smith, C. J.</span><span> </span><span class="NLM_article-title">Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span>− <span class="NLM_lpage">411</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2008.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=18482677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvF2qt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=401-411&author=B.+L.+Faintuch&author=R.+Teorodo&author=A.+Duatti&author=E.+Muramoto&author=S.+Faintuch&author=C.+J.+Smith&title=Radiolabeled+bombesin+analogs+for+prostate+cancer+diagnosis%3A+preclinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies</span></div><div class="casAuthors">Faintuch, Bluma Linkowski; Teodoro, Rodrigo; Duatti, Adriano; Muramoto, Emiko; Faintuch, Salomao; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">401-411</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Radionuclide imaging can be a useful tool for the diagnosis of prostate cancer.  Bombesin (BBN) is a mol. with high affinity for gastrin releasing peptide (GRP) receptors which are over-expressed in that tumor.  This report compares 99mTc-HYNIC-βAla-BBN(7-14)NH2 [99mTc-HYNIC-BBN] and 99mTc N(PNP6)-Cys-βAla-BBN(7-14)NH2 [99mTcN(PNP6)-Cys-BBN] with regard to labeling procedures as well as in vitro and in vivo evaluation (biodistribution and scintigraphic imaging).  Methods: Peptide synthesis was performed in an automated peptide synthesizer.  HYNIC-BBN was radiolabeled with pertechnetate using tricine and ethylenediamine diacetic acid (EDDA) as coligands.  Cys- BBN was radiolabeled in a two-step procedure with the prepn. of the precursor 99mTc-Nitrido first and then introducing diphosphine (PNP6).  Radiochem. evaluation of conjugates, as well as studies of stability, transchelation toward cysteine, and partition coeff. were done.  Biol. studies included internalization, biodistribution in healthy animals and in animals bearing PC3 cancer cells with acquisition of images from the tumor-bearing animals.  Results: Both complexes showed a high radiochem. yield along with good stability.  Biodistribution studies pointed out strong renal excretion for the former complex due to its hydrophilic profile and marked hepatobiliary excretion for the latter, corresponding to obsd. lipophilicity.  Tumor uptake was higher for 99mTc-HYNIC-BBN and the same occurred with internalization findings, which exceeded those of 99mTcN(PNP6)-BBN.  Blocking studies in mice bearing PC-3 tumor cells revealed significantly reduced pancreas and tumor uptake, demonstrating receptor specificity of the conjugates.  Conclusion: The best radiotracer was 99mTc-HYNIC-BBN on the basis of high radiochem. yield, fast radiolabeling procedure without need for a purifn. step, and more consistent tumor uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWqYt6BroQTbVg90H21EOLACvtfcHk0lhivVApq0cNNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvF2qt7o%253D&md5=e422310f10fa2285b8856e651fca147c</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DFaintuch%26aufirst%3DB.%2BL.%26atitle%3DRadiolabeled%2520bombesin%2520analogs%2520for%2520prostate%2520cancer%2520diagnosis%253A%2520preclinical%2520studies%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D401%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Smith, C. J.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span>− <span class="NLM_lpage">740</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2005.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=16243649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=733-740&author=C.+J.+Smith&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Radiolabeled+peptide+conjugates+for+targeting+of+the+bombesin+receptor+superfamily+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes</span></div><div class="casAuthors">Smith, Charles J.; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">733-740</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Research labs. around the world are currently focusing their efforts toward the development of radiometallated, site-directed, diagnostic/therapeutic agents based upon small peptides such as octreotide, neurotensin, α-MSH, vasointestinal peptide and others.  Bombesin (BBN) or derivs. of bombesin are also of significant interest.  Bombesin is a 14-amino-acid peptide with very high affinity for the BB2 or gastrin-releasing peptide receptor (GRPr).  Over-expression of the GRPr on a variety of human cancers (i.e., breast, prostate, pancreatic, small cell lung, etc.) provides potential efficacy toward development of radiometallated BBN derivs. for targeting and, hence, diagnosis/treatment of these specific diseases.  New derivs. are being developed that are also capable of targeting the BB1 and BB3 receptor subtypes that are over-expressed on cancer cells.  This review highlights some of the more recent developments toward design of BBN receptor-specific radiopharmaceuticals that have taken place over the past 2 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiAuROohyHhrVg90H21EOLACvtfcHk0lhivVApq0cNNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb7I&md5=36e8e01e6e3e1e90439a7f66732ce217</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DRadiolabeled%2520peptide%2520conjugates%2520for%2520targeting%2520of%2520the%2520bombesin%2520receptor%2520superfamily%2520subtypes%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D733%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Reile, H.; Armatis, P. E.; Schally, A. V.</span><span> </span><span class="NLM_article-title">Characterization of high affinity receptors for bombesin/gastrin-releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: Internalization of receptor bound <sup>125</sup>I-[Tyr4]bombesin by tumor cells</span>.  <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span>− <span class="NLM_lpage">38</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=29-38&author=H.+Reile&author=P.+E.+Armatis&author=A.+V.+Schally&title=Characterization+of+high+affinity+receptors+for+bombesin%2Fgastrin-releasing+peptide+on+the+human+prostate+cancer+cell+lines+PC-3+and+DU-145%3A+Internalization+of+receptor+bound+125I-%5BTyr4%5Dbombesin+by+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReile%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520high%2520affinity%2520receptors%2520for%2520bombesin%252Fgastrin-releasing%2520peptide%2520on%2520the%2520human%2520prostate%2520cancer%2520cell%2520lines%2520PC-3%2520and%2520DU-145%253A%2520Internalization%2520of%2520receptor%2520bound%2520125I-%255BTyr4%255Dbombesin%2520by%2520tumor%2520cells%26jtitle%3DProstate%26date%3D1994%26volume%3D25%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Moran, T. H.; Moody, T. W.; Hostetler, A. M.; Robinson, P. H.; Goldrich, M.; McHugh, P. R.</span><span> </span><span class="NLM_article-title">Distribution of bombesin binding sites in the rat gastrointestinal tract</span>.  <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span>− <span class="NLM_lpage">649</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1988&pages=643-649&author=T.+H.+Moran&author=T.+W.+Moody&author=A.+M.+Hostetler&author=P.+H.+Robinson&author=M.+Goldrich&author=P.+R.+McHugh&title=Distribution+of+bombesin+binding+sites+in+the+rat+gastrointestinal+tract"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoran%26aufirst%3DT.%2BH.%26atitle%3DDistribution%2520of%2520bombesin%2520binding%2520sites%2520in%2520the%2520rat%2520gastrointestinal%2520tract%26jtitle%3DPeptides%26date%3D1988%26volume%3D9%26spage%3D643%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Cescato, R.; Maina, T.; Nock, B.; Nikolopoulou, A.; Charalabidis, D.; Piccand, V.; Reudi, J. C.</span><span> </span><span class="NLM_article-title">Bombesin receptor antagonists may be preferable to agonists for tumor imaging</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=318-326&author=R.+Cescato&author=T.+Maina&author=B.+Nock&author=A.+Nikolopoulou&author=D.+Charalabidis&author=V.+Piccand&author=J.+C.+Reudi&title=Bombesin+receptor+antagonists+may+be+preferable+to+agonists+for+tumor+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCescato%26aufirst%3DR.%26atitle%3DBombesin%2520receptor%2520antagonists%2520may%2520be%2520preferable%2520to%2520agonists%2520for%2520tumor%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26spage%3D318%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Shi, J.; Jia, B.; Liu, Z.; Yu, Z.; Chen, K.; Chen, X.; Liu, S.; Wang, F.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labeled bombesin(7-14)NH<sub>2</sub> with favorable properties for SPECT imaging of colon cancer</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span>− <span class="NLM_lpage">1178</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc700471z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtFWhu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1170-1178&author=J.+Shi&author=B.+Jia&author=Z.+Liu&author=Z.+Yu&author=K.+Chen&author=X.+Chen&author=S.+Liu&author=F.+Wang&title=99mTc-labeled+bombesin%287-14%29NH2+with+favorable+properties+for+SPECT+imaging+of+colon+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-Labeled Bombesin(7-14)NH2 with Favorable Properties for SPECT Imaging of Colon Cancer</span></div><div class="casAuthors">Shi, Jiyun; Jia, Bing; Liu, Zhaofei; Yang, Zhi; Yu, Zilin; Chen, Kai; Chen, Xiaoyuan; Liu, Shuang; Wang, Fan</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1170-1178</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this report, we present the synthesis and evaluation of the 99mTc-labeled β-Ala-BN(7-14)NH2 (ABN = β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2) as a new radiotracer for tumor imaging in the BALB/c nude mice bearing HT-29 human colon cancer xenografts.  The gastrin releasing peptide receptor binding affinity of ABN and HYNIC-ABN (6-hydrazinonicotinamide) was assessed via a competitive displacement of 125I-[Tyr4]BBN bound to the PC-3 human prostate carcinoma cells.  The IC50 values were calcd. to be 24 ± 2 nM and 38 ± 1 nM for ABN and HYNIC-ABN, resp.  HYNIC is the bifunctional coupling agent for 99mTc-labeling, while tricine and TPPTS (trisodium triphenylphosphine-3,3',3''-trisulfonate) are used as coligands to prep. the ternary ligand complex [99mTc(HYNIC-ABN)(tricine)(TPPTS)] in very high yield and high specific activity.  Because of its high hydrophilicity (log P = -2.39 ± 0.06), [99mTc(HYNIC-ABN)(tricine)(TPPS)] was excreted mainly through the renal route with little radioactivity accumulation in the liver, lungs, stomach, and gastrointestinal tract.  The tumor uptake at 30 min postinjection (p.i.) was 1.59 ± 0.23%ID/g with a steady tumor washout over the 4 h study period.  As a result, it had the best T/B ratios in the blood (2.37 ± 0.68), liver (1.69 ± 0.41), and muscle (11.17 ± 3.32) at 1 h p.i.  Most of the injected radioactivity was found in the urine sample at 1 h p.i., and there was no intact [99mTc(HYNIC-ABN)(tricine)(TPPTS)] detectable in the urine, kidney, and liver samples.  Its metabolic instability may contribute to its rapid clearance from the liver, lungs, and stomach.  Despite the steady radioactivity washout, the tumors could be clearly visualized in planar images of the BALB/c nude mice bearing the HT-29 human colon xenografts at 1 and 4 h p.i.  The favorable excretion kinetics from the liver, lungs, stomach, and gastrointestinal tract makes [99mTc(HYNIC-ABN)(tricine)(TPPTS)] a promising SPECT radiotracer for imaging colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxaPPRVAfeo7Vg90H21EOLACvtfcHk0ljo4Hl9cBY58Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtFWhu70%253D&md5=8a9109ec5b85cef7215255c4840af15a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fbc700471z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700471z%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26atitle%3D99mTc-labeled%2520bombesin%25287-14%2529NH2%2520with%2520favorable%2520properties%2520for%2520SPECT%2520imaging%2520of%2520colon%2520cancer%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D1170%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Lane, S. R.; Veerendra, B.; Rold, T. L.; Sieckman, G. L.; Hoffman, T. J.; Jurisson, S. S.; Smith, C. J.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc(CO)<sub>3</sub>-DTMA bombesin conjugates having high affinity for the GRP receptor</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span>− <span class="NLM_lpage">272</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2007.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=18355681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Kit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=263-272&author=S.+R.+Lane&author=B.+Veerendra&author=T.+L.+Rold&author=G.+L.+Sieckman&author=T.+J.+Hoffman&author=S.+S.+Jurisson&author=C.+J.+Smith&title=99mTc%28CO%293-DTMA+bombesin+conjugates+having+high+affinity+for+the+GRP+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor</span></div><div class="casAuthors">Lane, Stephanie R.; Veerendra, Bhadrasetty; Rold, Tammy L.; Sieckman, Gary L.; Hoffman, Timothy J.; Jurisson, Silvia S.; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Targeted diagnosis of specific human cancer types continues to be of significant interest in nuclear medicine. 99mTc is ideally suited as a diagnostic radiometal for in vivo tumor targeting due to its ideal phys. characteristics and diverse labeling chemistries in numerous oxidn. states.  In this study, we report a synthetic approach toward design of a new tridentate amine ligand for the organometallic aqua-ion [99mTc(H2O)3(CO)3]+.  The new chelating ligand framework, 2-(N,N'-Bis(tert-butoxycarbonyl)diethylenetriamine) acetic acid (DTMA), was synthesized from a diethylenetriamine precursor and fully characterized by mass spectrometry and NMR spectroscopy (1H and 13C).  DTMA was conjugated to H2N-(X)-BBN(7-14)NH2, where X = an amino acid or aliph. pharmacokinetic modifier and BBN=bombesin peptide, by means of solid phase peptide synthesis.  DTMA-(X)-BBN(7-14)NH2 conjugates were purified by reversed-phase high-performance chromatog. and characterized by electrospray-ionization mass spectrometry.  The new conjugates were radiolabeled with [99mTc(H2O)3(CO)3]+ produced via Isolink radiolabeling kits to produce [99mTc(CO)3-DTMA-(X)-BBN(7-14)NH2].  Radiolabeled conjugates were purified by reversed-phase high-performance chromatog.  Effective receptor binding behavior was evaluated in vitro and in vivo.  [99mTc(CO)3-DTMA-(X)-BBN(7-14)NH2] conjugates displayed very high affinity for the gastrin releasing peptide receptor in vitro and in vivo.  Therefore, these conjugates hold some propensity to be investigated as mol. imaging agents that specifically target human cancers uniquely expressing the gastrin releasing peptide receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4FukM8pF_bLVg90H21EOLACvtfcHk0ljo4Hl9cBY58Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Kit7s%253D&md5=05de34ad950f030113759e43fa30790e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DS.%2BR.%26atitle%3D99mTc%2528CO%25293-DTMA%2520bombesin%2520conjugates%2520having%2520high%2520affinity%2520for%2520the%2520GRP%2520receptor%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D263%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Maina, T.; Nock, B. A.; Zhang, H.; Nikolopoulou, A.; Waser, B.; Reudi, J. C.</span><span> </span><span class="NLM_article-title">Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span>− <span class="NLM_lpage">830</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=823-830&author=T.+Maina&author=B.+A.+Nock&author=H.+Zhang&author=A.+Nikolopoulou&author=B.+Waser&author=J.+C.+Reudi&title=Species+differences+of+bombesin+analog+interactions+with+GRP-R+define+the+choice+of+animal+models+in+the+development+of+GRP-R-targeting+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DSpecies%2520differences%2520of%2520bombesin%2520analog%2520interactions%2520with%2520GRP-R%2520define%2520the%2520choice%2520of%2520animal%2520models%2520in%2520the%2520development%2520of%2520GRP-R-targeting%2520drugs%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D823%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Noll, B.; Kniess, M.; Friebe, M.; Spies, H.; Johannsen, B.</span><span> </span><span class="NLM_article-title">Rhenium(V) gluconate, a suitable precursor for the preparation of rhenium(V) complexes</span>.  <span class="citation_source-journal">Isot. Environ. Health Stud.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span>− <span class="NLM_lpage">29</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1080%2F10256019608036290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK1cXisFKmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1996&pages=21-29&author=B.+Noll&author=M.+Kniess&author=M.+Friebe&author=H.+Spies&author=B.+Johannsen&title=Rhenium%28V%29+gluconate%2C+a+suitable+precursor+for+the+preparation+of+rhenium%28V%29+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Rhenium(V) gluconate, a suitable precursor for the preparation of rhenium(V) complexes</span></div><div class="casAuthors">Noll, B.; Kniess, T.; Friebe, M.; Spies, Hartmut; Johannsen, B.</div><div class="citationInfo"><span class="NLM_cas:title">Isotopes in Environmental and Health Studies</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">IEHSF8</span>;
        ISSN:<span class="NLM_cas:issn">1025-6016</span>.
    
            (<span class="NLM_cas:orgname">Gordon & Breach Science Publishers</span>)
        </div><div class="casAbstract">Redn. of perrhenate with SnCl2 at an excess of Na gluconate in aq. soln. results in formation of Re(V) gluconate.  The reaction proceeds slowly compared to that of pertechnetate.  Aq. solns. of Re(V) gluconate can be prepd. down to a concn. level of at least 10-4 mol·1-1 within 2 h.  The usefulness of Re(V) gluconate to serve as a precursor for prepn. of oxorhenium(V) complexes as potential radiotherapeutic agents is revealed by subsequent ligand exchange reactions carried out with mercaptoacetyldiglycine, 3-thiapentane-dithiol-1,5/butanethiol and with 2-aminobenzenethiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqusqlYJWwv1bVg90H21EOLACvtfcHk0ljo4Hl9cBY58Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFKmsLc%253D&md5=39af0768a37d435bf5de0e8499823885</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1080%2F10256019608036290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10256019608036290%26sid%3Dliteratum%253Aachs%26aulast%3DNoll%26aufirst%3DB.%26atitle%3DRhenium%2528V%2529%2520gluconate%252C%2520a%2520suitable%2520precursor%2520for%2520the%2520preparation%2520of%2520rhenium%2528V%2529%2520complexes%26jtitle%3DIsot.%2520Environ.%2520Health%2520Stud.%26date%3D1996%26volume%3D32%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Loudos, G.; Majewski, S.; Wojcik, R.; Weisenberger, A.; Sakellios, N.; Nikita, K.; Uzunoglu, N.; Bouziotis, P.; Xanthopoulos, S.; Varvarigou, A.</span><span> </span><span class="NLM_article-title">Performance evaluation of a dedicated camera suitable for dynamic radiopharmaceuticals evaluation in small animals</span>.  <span class="citation_source-journal">IEEE Trans. Nucl. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span>− <span class="NLM_lpage">59</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=54-59&author=G.+Loudos&author=S.+Majewski&author=R.+Wojcik&author=A.+Weisenberger&author=N.+Sakellios&author=K.+Nikita&author=N.+Uzunoglu&author=P.+Bouziotis&author=S.+Xanthopoulos&author=A.+Varvarigou&title=Performance+evaluation+of+a+dedicated+camera+suitable+for+dynamic+radiopharmaceuticals+evaluation+in+small+animals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoudos%26aufirst%3DG.%26atitle%3DPerformance%2520evaluation%2520of%2520a%2520dedicated%2520camera%2520suitable%2520for%2520dynamic%2520radiopharmaceuticals%2520evaluation%2520in%2520small%2520animals%26jtitle%3DIEEE%2520Trans.%2520Nucl.%2520Soc.%26date%3D2007%26spage%3D54%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Efthymios  Paronis</span>, <span class="hlFld-ContribAuthor ">Michalis  Katsimpoulas</span>, <span class="hlFld-ContribAuthor ">Nikolaos P. E.  Kadoglou</span>, <span class="hlFld-ContribAuthor ">Claire  Provost</span>, <span class="hlFld-ContribAuthor ">Marianna  Stasinopoulou</span>, <span class="hlFld-ContribAuthor ">Christos  Spyropoulos</span>, <span class="hlFld-ContribAuthor ">Elpida  Poulaki</span>, <span class="hlFld-ContribAuthor ">Aurelie  Prignon</span>, <span class="hlFld-ContribAuthor ">Ioannis  Kakisis</span>, <span class="hlFld-ContribAuthor ">Nikolaos G.  Kostomitsopoulos</span>, <span class="hlFld-ContribAuthor ">Penelope  Bouziotis</span>, <span class="hlFld-ContribAuthor ">Ioannis V.  Kostopoulos</span>, <span class="hlFld-ContribAuthor ">Ourania  Tsitsilonis</span>, <span class="hlFld-ContribAuthor ">Andreas  Lazaris</span>. </span><span class="cited-content_cbyCitation_article-title">Cilostazol Mediates Immune Responses and Affects Angiogenesis During the Acute Phase of Hind Limb Ischemia in a Mouse Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Pharmacology and Therapeutics</span><span> <strong>2020,</strong> <em>25 </em>
                                    (3)
                                     , 273-285. <a href="https://doi.org/10.1177/1074248419897852" title="DOI URL">https://doi.org/10.1177/1074248419897852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1074248419897852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1074248419897852%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Pharmacology%2520and%2520Therapeutics%26atitle%3DCilostazol%252BMediates%252BImmune%252BResponses%252Band%252BAffects%252BAngiogenesis%252BDuring%252Bthe%252BAcute%252BPhase%252Bof%252BHind%252BLimb%252BIschemia%252Bin%252Ba%252BMouse%252BModel%26aulast%3DParonis%26aufirst%3DEfthymios%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D3%26spage%3D273%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamideh  Sabahnoo</span>, <span class="hlFld-ContribAuthor ">Zohreh  Noaparast</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad  Abedi</span>, <span class="hlFld-ContribAuthor ">Seyed Jalal  Hosseinimehr</span>. </span><span class="cited-content_cbyCitation_article-title">New small 99mTc-labeled peptides for HER2 receptor imaging. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 1012-1024. <a href="https://doi.org/10.1016/j.ejmech.2016.11.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bsmall%252B99mTc-labeled%252Bpeptides%252Bfor%252BHER2%252Breceptor%252Bimaging%26aulast%3DSabahnoo%26aufirst%3DHamideh%26date%3D2017%26volume%3D127%26spage%3D1012%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myrta  Kostomoiri</span>, <span class="hlFld-ContribAuthor ">Christos  Zikos</span>, <span class="hlFld-ContribAuthor ">Dimitra  Benaki</span>, <span class="hlFld-ContribAuthor ">Charalampos  Triantis</span>, <span class="hlFld-ContribAuthor ">Marina  Sagnou</span>, <span class="hlFld-ContribAuthor ">Maria  Paravatou-Petsotas</span>, <span class="hlFld-ContribAuthor ">Amalia  Papadaki</span>, <span class="hlFld-ContribAuthor ">Haralabia  Boleti</span>, <span class="hlFld-ContribAuthor ">Minas  Papadopoulos</span>, <span class="hlFld-ContribAuthor ">Ioannis  Pirmettis</span>, <span class="hlFld-ContribAuthor ">Maria  Pelecanou</span>, <span class="hlFld-ContribAuthor ">Evangelia  Livaniou</span>. </span><span class="cited-content_cbyCitation_article-title">New labeled derivatives of the neuroprotective peptide colivelin: Synthesis, characterization, and first in vitro and in vivo applications. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2015,</strong> <em>567 </em>, 83-93. <a href="https://doi.org/10.1016/j.abb.2014.12.027" title="DOI URL">https://doi.org/10.1016/j.abb.2014.12.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2014.12.027%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DNew%252Blabeled%252Bderivatives%252Bof%252Bthe%252Bneuroprotective%252Bpeptide%252Bcolivelin%25253A%252BSynthesis%25252C%252Bcharacterization%25252C%252Band%252Bfirst%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bapplications%26aulast%3DKostomoiri%26aufirst%3DMyrta%26date%3D2015%26volume%3D567%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamila J.  Stott Reynolds</span>, <span class="hlFld-ContribAuthor ">Rebecca  Schehr</span>, <span class="hlFld-ContribAuthor ">Dijie  Liu</span>, <span class="hlFld-ContribAuthor ">Jingli  Xu</span>, <span class="hlFld-ContribAuthor ">Yubin  Miao</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Tammy L.  Rold</span>, <span class="hlFld-ContribAuthor ">Michael R.  Lewis</span>, <span class="hlFld-ContribAuthor ">Charles J.  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2015,</strong> <em>42 </em>
                                    (2)
                                     , 99-108. <a href="https://doi.org/10.1016/j.nucmedbio.2014.10.002" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2014.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2014.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DCharacterization%252Band%252Bevaluation%252Bof%252BDOTA-conjugated%252BBombesin%25252FRGD-antagonists%252Bfor%252Bprostate%252Bcancer%252Btumor%252Bimaging%252Band%252Btherapy%26aulast%3DStott%2BReynolds%26aufirst%3DTamila%2BJ.%26date%3D2015%26volume%3D42%26issue%3D2%26spage%3D99%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Tsiapa</span>, <span class="hlFld-ContribAuthor ">George  Loudos</span>, <span class="hlFld-ContribAuthor ">Eirini A.  Fragogeorgi</span>, <span class="hlFld-ContribAuthor ">Penelope  Bouziotis</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Psimadas</span>, <span class="hlFld-ContribAuthor ">Stavros  Xanthopoulos</span>, <span class="hlFld-ContribAuthor ">Maria  Paravatou-Petsotas</span>, <span class="hlFld-ContribAuthor ">Lazaros  Palamaris</span>, <span class="hlFld-ContribAuthor ">Alexandra D.  Varvarigou</span>, <span class="hlFld-ContribAuthor ">Dimitris  Karnabatidis</span>, <span class="hlFld-ContribAuthor ">George C.  Kagadis</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of α
              ν
              β
              3
              -Mediated Tumor Expression with a
              99m
              Tc-Labeled Ornithine-Modified RGD Derivative During Glioblastoma Growth
              In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biotherapy and Radiopharmaceuticals</span><span> <strong>2014,</strong> <em>29 </em>
                                    (10)
                                     , 444-450. <a href="https://doi.org/10.1089/cbr.2014.1672" title="DOI URL">https://doi.org/10.1089/cbr.2014.1672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/cbr.2014.1672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fcbr.2014.1672%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biotherapy%2520and%2520Radiopharmaceuticals%26atitle%3DEvaluation%252Bof%252B%2525CE%2525B1%252B%2525CE%2525BD%252B%2525CE%2525B2%252B3%252B-Mediated%252BTumor%252BExpression%252Bwith%252Ba%252B99m%252BTc-Labeled%252BOrnithine-Modified%252BRGD%252BDerivative%252BDuring%252BGlioblastoma%252BGrowth%252BIn%252BVivo%26aulast%3DTsiapa%26aufirst%3DIrene%26date%3D2014%26volume%3D29%26issue%3D10%26spage%3D444%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kubra  Durkan</span>, <span class="hlFld-ContribAuthor ">Zongrun  Jiang</span>, <span class="hlFld-ContribAuthor ">Tammy L.  Rold</span>, <span class="hlFld-ContribAuthor ">Gary L.  Sieckman</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Rajendra Prasad  Bandari</span>, <span class="hlFld-ContribAuthor ">Ashley F.  Szczodroski</span>, <span class="hlFld-ContribAuthor ">Liqin  Liu</span>, <span class="hlFld-ContribAuthor ">Yubin  Miao</span>, <span class="hlFld-ContribAuthor ">Tamila Stott  Reynolds</span>, <span class="hlFld-ContribAuthor ">Charles J.  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">A heterodimeric [RGD-Glu-[64Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2014,</strong> <em>41 </em>
                                    (2)
                                     , 133-139. <a href="https://doi.org/10.1016/j.nucmedbio.2013.11.006" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2013.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2013.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2013.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DA%252Bheterodimeric%252B%25255BRGD-Glu-%25255B64Cu-NO2A%25255D-6-Ahx-RM2%25255D%252B%2525CE%2525B1v%2525CE%2525B23%25252FGRPr-targeting%252Bantagonist%252Bradiotracer%252Bfor%252BPET%252Bimaging%252Bof%252Bprostate%252Btumors%26aulast%3DDurkan%26aufirst%3DKubra%26date%3D2014%26volume%3D41%26issue%3D2%26spage%3D133%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Penelope  Bouziotis</span>, <span class="hlFld-ContribAuthor ">Eleni  Gourni</span>, <span class="hlFld-ContribAuthor ">George  Patsis</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Psimadas</span>, <span class="hlFld-ContribAuthor ">Christos  Zikos</span>, <span class="hlFld-ContribAuthor ">Melpomeni  Fani</span>, <span class="hlFld-ContribAuthor ">Stavros  Xanthopoulos</span>, <span class="hlFld-ContribAuthor ">George  Loudos</span>, <span class="hlFld-ContribAuthor ">Maria  Paravatou-Petsotas</span>, <span class="hlFld-ContribAuthor ">Evangelia  Livaniou</span>, <span class="hlFld-ContribAuthor ">Alexandra D.  Varvarigou</span>, <span class="hlFld-ContribAuthor ">Ioannis  Pirmettis</span>, <span class="hlFld-ContribAuthor ">Minas  Papadopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the 99mTc core. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (21)
                                     , 6699-6707. <a href="https://doi.org/10.1016/j.bmc.2013.08.010" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.08.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.08.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRadiochemical%252Band%252Bradiobiological%252Bassessment%252Bof%252Ba%252Bpyridyl-S-cysteine%252Bfunctionalized%252Bbombesin%252Bderivative%252Blabeled%252Bwith%252Bthe%252B99mTc%252Bcore%26aulast%3DBouziotis%26aufirst%3DPenelope%26date%3D2013%26volume%3D21%26issue%3D21%26spage%3D6699%26epage%3D6707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Igor A.  Schepetkin</span>, <span class="hlFld-ContribAuthor ">Liliya N.  Kirpotina</span>, <span class="hlFld-ContribAuthor ">Andrei I.  Khlebnikov</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Ermelinda  Lucente</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Paola  De Giorgio</span>, <span class="hlFld-ContribAuthor ">Mark T.  Quinn</span>. </span><span class="cited-content_cbyCitation_article-title">3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: Molecular modeling of chiral recognition by FPR2. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2013,</strong> <em>85 </em>
                                    (3)
                                     , 404-416. <a href="https://doi.org/10.1016/j.bcp.2012.11.015" title="DOI URL">https://doi.org/10.1016/j.bcp.2012.11.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2012.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2012.11.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3D3-%2525281H-indol-3-yl%252529-2-%25255B3-%2525284-nitrophenyl%252529ureido%25255Dpropanamide%252Benantiomers%252Bwith%252Bhuman%252Bformyl-peptide%252Breceptor%252Bagonist%252Bactivity%25253A%252BMolecular%252Bmodeling%252Bof%252Bchiral%252Brecognition%252Bby%252BFPR2%26aulast%3DSchepetkin%26aufirst%3DIgor%2BA.%26date%3D2013%26volume%3D85%26issue%3D3%26spage%3D404%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Tsiapa</span>, <span class="hlFld-ContribAuthor ">George  Loudos</span>, <span class="hlFld-ContribAuthor ">Alexandra  Varvarigou</span>, <span class="hlFld-ContribAuthor ">Eirini  Fragogeorgi</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Psimadas</span>, <span class="hlFld-ContribAuthor ">Theodoros  Tsotakos</span>, <span class="hlFld-ContribAuthor ">Stavros  Xanthopoulos</span>, <span class="hlFld-ContribAuthor ">Dimitris  Mihailidis</span>, <span class="hlFld-ContribAuthor ">Penelope  Bouziotis</span>, <span class="hlFld-ContribAuthor ">George C.  Nikiforidis</span>, <span class="hlFld-ContribAuthor ">George C.  Kagadis</span>. </span><span class="cited-content_cbyCitation_article-title">Biological evaluation of an ornithine-modified 99mTc-labeled RGD peptide as an angiogenesis imaging agent. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2013,</strong> <em>40 </em>
                                    (2)
                                     , 262-272. <a href="https://doi.org/10.1016/j.nucmedbio.2012.10.015" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2012.10.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2012.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2012.10.015%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DBiological%252Bevaluation%252Bof%252Ban%252Bornithine-modified%252B99mTc-labeled%252BRGD%252Bpeptide%252Bas%252Ban%252Bangiogenesis%252Bimaging%252Bagent%26aulast%3DTsiapa%26aufirst%3DIrene%26date%3D2013%26volume%3D40%26issue%3D2%26spage%3D262%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raunak  Varshney</span>, <span class="hlFld-ContribAuthor ">Puja P.  Hazari</span>, <span class="hlFld-ContribAuthor ">P.  Fernandez</span>, <span class="hlFld-ContribAuthor ">J.  Schulz</span>, <span class="hlFld-ContribAuthor ">M.  Allard</span>, <span class="hlFld-ContribAuthor ">Anil K.  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">68Ga-Labeled Bombesin Analogs for Receptor-Mediated Imaging. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 221-256. <a href="https://doi.org/10.1007/978-3-642-27994-2_12" title="DOI URL">https://doi.org/10.1007/978-3-642-27994-2_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-27994-2_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-27994-2_12%26sid%3Dliteratum%253Aachs%26atitle%3D68Ga-Labeled%252BBombesin%252BAnalogs%252Bfor%252BReceptor-Mediated%252BImaging%26aulast%3DVarshney%26aufirst%3DRaunak%26date%3D2013%26date%3D2012%26spage%3D221%26epage%3D256%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTheranostics%25252C%252BGallium-68%25252C%252Band%252BOther%252BRadionuclides%26aulast%3DBaum%26aufirst%3DRichard%2BP.%26date%3D2013%26volume%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Alberto</span>, <span class="hlFld-ContribAuthor ">H.  Braband</span>. </span><span class="cited-content_cbyCitation_article-title">SPECT/PET Imaging with Technetium, Gallium, Copper, and Other Metallic Radionuclides. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 785-817. <a href="https://doi.org/10.1016/B978-0-08-097774-4.00331-4" title="DOI URL">https://doi.org/10.1016/B978-0-08-097774-4.00331-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-097774-4.00331-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-097774-4.00331-4%26sid%3Dliteratum%253Aachs%26atitle%3DSPECT%25252FPET%252BImaging%252Bwith%252BTechnetium%25252C%252BGallium%25252C%252BCopper%25252C%252Band%252BOther%252BMetallic%252BRadionuclides%26aulast%3DAlberto%26aufirst%3DR.%26date%3D2013%26spage%3D785%26epage%3D817%26pub%3DElsevier%26atitle%3DComprehensive%252BInorganic%252BChemistry%252BII%26date%3D2013%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dimitra  Benaki</span>, <span class="hlFld-ContribAuthor ">Christos  Zikos</span>, <span class="hlFld-ContribAuthor ">Chrysoula-Evangelia  Karachaliou</span>, <span class="hlFld-ContribAuthor ">Ourania  Tsitsilonis</span>, <span class="hlFld-ContribAuthor ">Leondios  Leondiadis</span>, <span class="hlFld-ContribAuthor ">Hubert  Kalbacher</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Voelter</span>, <span class="hlFld-ContribAuthor ">Minas  Papadopoulos</span>, <span class="hlFld-ContribAuthor ">Ioannis  Pirmettis</span>, <span class="hlFld-ContribAuthor ">Maria  Pelecanou</span>, <span class="hlFld-ContribAuthor ">Evangelia  Livaniou</span>. </span><span class="cited-content_cbyCitation_article-title">Complexes of an Alpha Thymosin Derivative with
              185/187
              Re and
              99m
              Tc: Structural Analysis and Initial Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2012,</strong> <em>80 </em>
                                    (4)
                                     , 545-553. <a href="https://doi.org/10.1111/j.1747-0285.2012.01425.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2012.01425.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2012.01425.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2012.01425.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DComplexes%252Bof%252Ban%252BAlpha%252BThymosin%252BDerivative%252Bwith%252B185%25252F187%252BRe%252Band%252B99m%252BTc%25253A%252BStructural%252BAnalysis%252Band%252BInitial%252BBiological%252BEvaluation%26aulast%3DBenaki%26aufirst%3DDimitra%26date%3D2012%26date%3D2012%26volume%3D80%26issue%3D4%26spage%3D545%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christos C.  Liolios</span>, <span class="hlFld-ContribAuthor ">Eirini A.  Fragogeorgi</span>, <span class="hlFld-ContribAuthor ">Christos  Zikos</span>, <span class="hlFld-ContribAuthor ">George  Loudos</span>, <span class="hlFld-ContribAuthor ">Stavros  Xanthopoulos</span>, <span class="hlFld-ContribAuthor ">Penelope  Bouziotis</span>, <span class="hlFld-ContribAuthor ">Maria  Paravatou-Petsotas</span>, <span class="hlFld-ContribAuthor ">Evangelia  Livaniou</span>, <span class="hlFld-ContribAuthor ">Alexandra D.  Varvarigou</span>, <span class="hlFld-ContribAuthor ">Gregory B.  Sivolapenko</span>. </span><span class="cited-content_cbyCitation_article-title">Structural modifications of 99mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmaceutics</span><span> <strong>2012,</strong> <em>430 </em>
                                    (1-2)
                                     , 1-17. <a href="https://doi.org/10.1016/j.ijpharm.2012.02.049" title="DOI URL">https://doi.org/10.1016/j.ijpharm.2012.02.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpharm.2012.02.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpharm.2012.02.049%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmaceutics%26atitle%3DStructural%252Bmodifications%252Bof%252B99mTc-labelled%252Bbombesin-like%252Bpeptides%252Bfor%252Boptimizing%252Bpharmacokinetics%252Bin%252Bprostate%252Btumor%252Btargeting%26aulast%3DLiolios%26aufirst%3DChristos%2BC.%26date%3D2012%26volume%3D430%26issue%3D1-2%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christos C.  Liolios</span>, <span class="hlFld-ContribAuthor ">Christos  Zikos</span>, <span class="hlFld-ContribAuthor ">Eirini  Fragogeorgi</span>, <span class="hlFld-ContribAuthor ">Dimitra  Benaki</span>, <span class="hlFld-ContribAuthor ">Maria  Pelecanou</span>, <span class="hlFld-ContribAuthor ">Ioannis  Pirmettis</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Ioannidis</span>, <span class="hlFld-ContribAuthor ">Yiannis  Sanakis</span>, <span class="hlFld-ContribAuthor ">Catherine P.  Raptopoulou</span>, <span class="hlFld-ContribAuthor ">Vassilis  Psycharis</span>, <span class="hlFld-ContribAuthor ">Aris  Terzis</span>, <span class="hlFld-ContribAuthor ">Frédéric  Boschetti</span>, <span class="hlFld-ContribAuthor ">Minas S.  Papadopoulos</span>, <span class="hlFld-ContribAuthor ">Gregory  Sivolapenko</span>, <span class="hlFld-ContribAuthor ">Alexandra D.  Varvarigou</span>. </span><span class="cited-content_cbyCitation_article-title">A Bombesin Copper Complex Based on a Bifunctional Cyclam Derivative. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Inorganic Chemistry</span><span> <strong>2012,</strong> <em>2012 </em>
                                    (17)
                                     , 2877-2888. <a href="https://doi.org/10.1002/ejic.201200049" title="DOI URL">https://doi.org/10.1002/ejic.201200049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejic.201200049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejic.201200049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Inorganic%2520Chemistry%26atitle%3DA%252BBombesin%252BCopper%252BComplex%252BBased%252Bon%252Ba%252BBifunctional%252BCyclam%252BDerivative%26aulast%3DLiolios%26aufirst%3DChristos%2BC.%26date%3D2012%26date%3D2012%26volume%3D2012%26issue%3D17%26spage%3D2877%26epage%3D2888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David S.  Urch</span>. </span><span class="cited-content_cbyCitation_article-title">Radiochemistry. </span><span class="cited-content_cbyCitation_journal-name">Annual Reports Section "A" (Inorganic Chemistry)</span><span> <strong>2010,</strong> <em>106 </em>, 458. <a href="https://doi.org/10.1039/b920669h" title="DOI URL">https://doi.org/10.1039/b920669h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b920669h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb920669h%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Reports%2520Section%2520%2522A%2522%2520%2528Inorganic%2520Chemistry%2529%26atitle%3DRadiochemistry%26aulast%3DUrch%26aufirst%3DDavid%2BS.%26date%3D2010%26volume%3D106%26spage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0009.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0010.jpeg" id="rightTab-_i4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of BN-1.1, BN-1.1p (A) and <sup>185/187</sup>Re-BN-1.1, <sup>185/187</sup>Re-BN-1.1p (B)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. <sup>1</sup>H NMR spectra (5.5−2.8 ppm region) of the aqueous solution of (A) the BN-1.1 peptide and (B) the <sup>185/187</sup>Re-BN-1.1 complex presented in comparison. Lines indicate the changes in the chemical shifts of the α and β protons of the Gly1′-Gly2′-Cys3′ ligand moiety after coordination of the BN-1.1 peptide to the metal core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Displacement curves of [<sup>125</sup>I-Tyr4]-BN bound to the BB2-Rs of PC-3 cells by [Tyr4]-BN, BN-1.1, <sup>185/187</sup>Re-BN-1.1, BN-1.1p, <sup>185/187</sup>Re-BN-1.1p, and the T-epitope of cholera.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time course internalization of <sup>99m</sup>Tc-BN-1.1 (◆) and <sup>99m</sup>Tc-BN-1.1p (◼) in PC-3 cells at 37 °C. Nonspecific internalization (▲) was performed in the presence of 1 μM [Tyr4]-BN. Data are percentage of internalized radioactivity into the cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Efflux determination of <sup>99m</sup>Tc-BN-1.1 (◆) and <sup>99m</sup>Tc-BN-1.1p (◼) in PC-3 cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Enzymatic degradation of <sup>99m</sup>Tc-labeled peptides after incubation with plasma and kidney−liver homogenates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. A 2 h dynamic study of <sup>99m</sup>Tc-BN-1.1 in PC-3 bearing-tumor SCID mice (A) and ROI analysis (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/medium/jm-2009-00360d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. A 2 h dynamic study of <sup>99m</sup>Tc-BN-1.1p in PC-3 bearing-tumor SCID mice (A) and ROI analysis (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900360d/production/images/large/jm-2009-00360d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900360d&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45743" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45743" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 85 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Reubi, C. R.</span><span> </span><span class="NLM_article-title">Peptide receptors as molecular targets for cancer diagnosis and therapy</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1210%2Fer.2002-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12920149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=389-427&issue=4&author=C.+R.+Reubi&title=Peptide+receptors+as+molecular+targets+for+cancer+diagnosis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide receptors as molecular targets for cancer diagnosis and therapy</span></div><div class="casAuthors">Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-427</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  During the past decade, proof of the principle that peptide receptors can be used successfully for in vivo targeting of human cancers has been provided.  A review.  The mol. basis for targeting rests on the in vitro observation that peptide receptors can be expressed in large quantities in certain tumors.  The clin. impact is at the diagnostic level: in vivo receptor scintigraphy uses radiolabeled peptides for the localization of tumors and their metastases.  It is also at the therapeutic level: peptide receptor radiotherapy of tumors emerges as a serious treatment option.  Peptides linked to cytotoxic agents are also considered for therapeutic applications.  The use of nonradiolabeled, noncytotoxic peptide analogs for long-term antiproliferative treatment of tumors appears promising for only a few tumor types, whereas the symptomatic treatment of neuroendocrine tumors by somatostatin analogs is clearly successful.  The present review summarizes and critically evaluates the in vitro data on peptide and peptide receptor expression in human cancers.  These data are considered to be the mol. basis for peptide receptor targeting of tumors.  The paradigmatic peptide somatostatin and its receptors are extensively reviewed in the light of in vivo targeting of neuroendocrine tumors.  The role of the more recently described targeting peptides vasoactive intestinal peptide, gastrin-releasing peptide, and cholecystokinin/gastrin is discussed.  Other emerging and promising peptides and their resp. receptors, including neurotensin, substance P, and neuropeptide Y, are introduced.  This information relates to established and potential clin. applications in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpImMX7eTxXDbVg90H21EOLACvtfcHk0lhok-5QcIsEcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlKjtbs%253D&md5=2203d38ced1a18b3998f9e284b7f2348</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fer.2002-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2002-0007%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DC.%2BR.%26atitle%3DPeptide%2520receptors%2520as%2520molecular%2520targets%2520for%2520cancer%2520diagnosis%2520and%2520therapy%26jtitle%3DEndocr.%2520Rev.%26date%3D2003%26volume%3D24%26issue%3D4%26spage%3D389%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Glunde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhujwalla, Z. M.</span><span> </span><span class="NLM_article-title">Molecular-functional imaging of cancer: to image and imagine</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=287-303&issue=7&author=K.+Glundeauthor=A.+P.+Pathakauthor=Z.+M.+Bhujwalla&title=Molecular-functional+imaging+of+cancer%3A+to+image+and+imagine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlunde%26aufirst%3DK.%26aulast%3DPathak%26aufirst%3DA.%2BP.%26aulast%3DBhujwalla%26aufirst%3DZ.%2BM.%26atitle%3DMolecular-functional%2520imaging%2520of%2520cancer%253A%2520to%2520image%2520and%2520imagine%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2007%26volume%3D13%26issue%3D7%26spage%3D287%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kiaris, H.; Schally, A. V.; Sun, B.; Armatis, P.; Groot, K.</span><span> </span><span class="NLM_article-title">Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin releasing peptide</span>.  <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7168</span>− <span class="NLM_lpage">7173</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=7168-7173&author=H.+Kiaris&author=A.+V.+Schally&author=B.+Sun&author=P.+Armatis&author=K.+Groot&title=Inhibition+of+growth+of+human+malignant+glioblastoma+in+nude+mice+by+antagonists+of+bombesin%2Fgastrin+releasing+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiaris%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520growth%2520of%2520human%2520malignant%2520glioblastoma%2520in%2520nude%2520mice%2520by%2520antagonists%2520of%2520bombesin%252Fgastrin%2520releasing%2520peptide%26jtitle%3DOncogene%26date%3D1999%26volume%3D18%26spage%3D7168%26epage%3D7173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Moody, T. W.; Desmond, N. C.; Cutitta, F.; Quattrocchi, K.; Minna, J. D.</span><span> </span><span class="NLM_article-title">High affinity receptors for bombesin GRP-like peptides for human small cell lung carcinoma</span>.  <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span>− <span class="NLM_lpage">113</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1985&pages=105-113&author=T.+W.+Moody&author=N.+C.+Desmond&author=F.+Cutitta&author=K.+Quattrocchi&author=J.+D.+Minna&title=High+affinity+receptors+for+bombesin+GRP-like+peptides+for+human+small+cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoody%26aufirst%3DT.%2BW.%26atitle%3DHigh%2520affinity%2520receptors%2520for%2520bombesin%2520GRP-like%2520peptides%2520for%2520human%2520small%2520cell%2520lung%2520carcinoma%26jtitle%3DLife%2520Sci.%26date%3D1985%26volume%3D37%26spage%3D105%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chatzistamou, I.; Schally, A. V.; Sun, B.; Armatis, P.; Szepeshazi, K.</span><span> </span><span class="NLM_article-title">Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists</span>.  <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span>− <span class="NLM_lpage">913</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1054%2Fbjoc.2000.1374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=10970693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2000&pages=906-913&author=I.+Chatzistamou&author=A.+V.+Schally&author=B.+Sun&author=P.+Armatis&author=K.+Szepeshazi&title=Inhibition+of+growth+of+OV-1063+human+epithelial+ovarian+cancers+and+c-jun+and+c-fos+oncogene+expression+by+bombesin+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists</span></div><div class="casAuthors">Chatzistamou, I.; Schally, A. V.; Sun, B.; Armatis, P.; Szepeshazi, K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">906-913</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Harcourt Publishers Ltd.</span>)
        </div><div class="casAbstract">Receptors for bombesin are present on human ovarian cancers and bombesin-like peptides could function as growth factors in this carcinoma.  Therefore, we investigated the effects of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095 on the growth of human ovarian carcinoma cell line OV-1063, xenografted into nude mice.  Treatment with RC-3940-II at doses of 10 μg and 20 μg per day s.c. decreased tumor vol. by 60.9% (P < 0.05) and 73.5% (P < 0.05) resp., after 25 days, compared to controls.  RC-3095 at a dose of 20 μg per day reduced the vol. of OV-1063 tumors by 47.7% (P = 0.15).  In comparison, LH-releasing hormone (LH-RH) antagonist Cetrorelix at a dose of 100 μg per day caused a 64.2% inhibition (P < 0.05).  RT-PCR anal. showed that OV-1063 tumors expressed mRNA for bombesin receptor subtypes BRS-1, BRS-2, and BRS-3.  In OV-1063 cells cultured in vitro, GRP(14-27) induced the expression of mRNA for c-jun and c-fos oncogenes in a time-dependent manner.  Antagonist RC-3940-II inhibited the stimulatory effect of GRP(14-27) on c-jun and c-fos in vitro.  In vivo, the levels of c-jun and c-fos mRNA in OV-1063 tumors were decreased by 43% (P < 0.05) and 45% (P = 0.05) resp., after treatment with RC-3940-II at 20 μg per day.  Exposure of OV-1063, UCI-107 and ES-2 ovarian carcinoma cells to RC-3940-II at 1 μM concn. for 24 h in vitro, extended the latency period for the development of palpable tumors in nude mice.  Our results indicate that antagonists of bombesin/GRP inhibit the growth of OV-1063 ovarian cancers by mechanisms that probably involve the downregulation of c-jun and c-fos proto-oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP7llI0g4e3rVg90H21EOLACvtfcHk0lhwo5QbI3aCEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFGjtbw%253D&md5=ce06e2dda3053002ee109dbfd5c9cb60</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1054%2Fbjoc.2000.1374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fbjoc.2000.1374%26sid%3Dliteratum%253Aachs%26aulast%3DChatzistamou%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520growth%2520of%2520OV-1063%2520human%2520epithelial%2520ovarian%2520cancers%2520and%2520c-jun%2520and%2520c-fos%2520oncogene%2520expression%2520by%2520bombesin%2520antagonists%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2000%26volume%3D83%26spage%3D906%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Charitopoulos, K. N.; Lazaris, A. C.; Aroni, K.; Kavantzas, N.; Nikolakopoulou, E.; Davaris, P.</span><span> </span><span class="NLM_article-title">Immunodetection of gastrin-releasing peptide in malignant melanoma cells</span>.  <span class="citation_source-journal">Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span>− <span class="NLM_lpage">400</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1097%2F00008390-200008000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=10985668" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=345-400&author=K.+N.+Charitopoulos&author=A.+C.+Lazaris&author=K.+Aroni&author=N.+Kavantzas&author=E.+Nikolakopoulou&author=P.+Davaris&title=Immunodetection+of+gastrin-releasing+peptide+in+malignant+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2F00008390-200008000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008390-200008000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DCharitopoulos%26aufirst%3DK.%2BN.%26atitle%3DImmunodetection%2520of%2520gastrin-releasing%2520peptide%2520in%2520malignant%2520melanoma%2520cells%26jtitle%3DMelanoma%2520Res.%26date%3D2000%26volume%3D10%26spage%3D345%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Rider, N. M.; Guha, S.; Hines, O. J.; Reber, H. A.; Rozengurt, E.</span><span> </span><span class="NLM_article-title">G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation</span>.  <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span>− <span class="NLM_lpage">64</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1002%2F1097-4652%28200101%29186%3A1%3C53%3A%3AAID-JCP1004%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=11147814" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2001&pages=53-64&author=N.+M.+Rider&author=S.+Guha&author=O.+J.+Hines&author=H.+A.+Reber&author=E.+Rozengurt&title=G+protein-coupled+receptor+signaling+in+human+ductal+pancreatic+cancer+cells%3A+neurotensin+responsiveness+and+mitogenic+stimulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F1097-4652%28200101%29186%3A1%3C53%3A%3AAID-JCP1004%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-4652%2528200101%2529186%253A1%253C53%253A%253AAID-JCP1004%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DRider%26aufirst%3DN.%2BM.%26atitle%3DG%2520protein-coupled%2520receptor%2520signaling%2520in%2520human%2520ductal%2520pancreatic%2520cancer%2520cells%253A%2520neurotensin%2520responsiveness%2520and%2520mitogenic%2520stimulation%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2001%26volume%3D186%26spage%3D53%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Sun, B.; Schally, A. V.; Halmos, G.</span><span> </span><span class="NLM_article-title">The presence of receptors for bombesin/Grp and mRNA for three receptor subtypes in human ovarian epithelial cancers</span>.  <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span>− <span class="NLM_lpage">84</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0167-0115%2800%2900114-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=10828496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1Grtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2000&pages=77-84&author=B.+Sun&author=A.+V.+Schally&author=G.+Halmos&title=The+presence+of+receptors+for+bombesin%2FGrp+and+mRNA+for+three+receptor+subtypes+in+human+ovarian+epithelial+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers</span></div><div class="casAuthors">Sun, B.; Schally, A. V.; Halmos, G.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Bombesin-like peptides can function as autocrine or paracrine growth factors and stimulate the growth of various cancers.  The antagonists of bombesin/gastrin-releasing peptide (GRP) suppress the proliferation of diverse tumors including ovarian cancer by mechanisms likely mediated by bombesin receptors.  In this study, we used the reverse transcription-polymerase chain reaction (RT-PCR) method to evaluate the mRNA expression of three bombesin receptor subtypes: gastrin-releasing peptide receptor (GRPR), neuromedin B receptor (NMBR), and bombesin receptor subtype 3 (BRS-3), in 22 specimens of human epithelial ovarian cancer and in two human ovarian cancer lines.  Of the 22 ovarian cancer specimens analyzed, 17 tumors (∼77%) expressed mRNA for GRPR, 19 (∼86%) showed NMBR mRNA and six (∼27%) revealed BRS-3 mRNA.  Thus, 14 of 22 specimens (∼64%) expressed mRNAs for both GRPR and NMBR, and five (∼23%) expressed all three subtypes.  The expression of GRPR appeared to be greater in poorly differentiated ovarian carcinomas.  A higher incidence of BRS-3 expression was obsd. in samples with tumor Stage IV (4/4, 100%) compared with Stage III (1/17, ∼6%). mRNA for both GRPR and NMBR was also detected in OV-1063 and UCI-107 human ovarian cancer xenografts, but BRS-3 was found only in OV-1063, which originated from a metastatic tumor.  In addn., functional receptors for bombesin/GRP were found in eight of 11 ovarian cancer specimens investigated and in both ovarian cancer lines by receptor binding assay.  Our study indicates that GRPR and NMBR are widely distributed in human ovarian carcinomas with BRS-3 being found in Stage IV tumors.  Some approaches based on bombesin/GRP receptor antagonists or targeted bombesin analogs could be considered for treatment of ovarian cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUrLbCJDcCObVg90H21EOLACvtfcHk0lhpEQNaHyfYAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1Grtr4%253D&md5=99ab3fade717b8eee1e04f1fa10b36af</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0167-0115%2800%2900114-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-0115%252800%252900114-2%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DB.%26atitle%3DThe%2520presence%2520of%2520receptors%2520for%2520bombesin%252FGrp%2520and%2520mRNA%2520for%2520three%2520receptor%2520subtypes%2520in%2520human%2520ovarian%2520epithelial%2520cancers%26jtitle%3DRegul.%2520Pept.%26date%3D2000%26volume%3D90%26spage%3D77%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pansky, A.; de Weert, A.; Fasler, E.; Boulay, J. L.; Shulz, M.; Ketterer, S.; Selck, C.; Berlinger, C.; Von Schrenck, T.; Hildebrand, P.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma</span>.  <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1409</span>− <span class="NLM_lpage">1418</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=10906154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvVyhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=1409-1418&author=A.+Pansky&author=A.+de+Weert&author=E.+Fasler&author=J.+L.+Boulay&author=M.+Shulz&author=S.+Ketterer&author=C.+Selck&author=C.+Berlinger&author=T.+Von+Schrenck&author=P.+Hildebrand&title=Gastrin+releasing+peptide-preferring+bombesin+receptors+mediate+growth+of+human+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma</span></div><div class="casAuthors">Pansky, Andreas; De Weerth, Andreas; Fasler-Kan, Eliza Veta; Boulay, Jean-Louis; Schulz, Martina; Ketterer, Sylvia; Selck, Cristin; Beglinger, Christoph; Von Schrenck, Tammo; Hildebrand, Pius</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1409-1418</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Bombesin-like peptides typically act as neurotransmitters along the brain-gut axis and as growth factors in various human tissues.  The present study demonstrates the expression of gastrin releasing peptide (GRP)-preferring bombesin receptors in human renal cell carcinoma but not in normal kidney tissue.  The expression of GRP receptors was characterized at the mRNA level by reverse transcription-PCR, as well as at the protein level by binding of 125I-[Tyr4] bombesin to membranes prepd. from tumor tissue (Kd 0.3 nM) and healthy kidney tissue from the same four patients.  GRP receptors were also demonstrated in four human kidney carcinoma cell lines (A-498, CAKI-1, CAKI-2, and ACHN).  The effects of bombesin/GRP agonists and/or antagonists on growth were investigated in vitro on CAKI-2 cells, which expressed large amts. of GRP receptors.  Cell nos. stimulated by 10% fetal calf serum were significantly stimulated by interleukin-1β (control) and GRP-7 (10-7 M), both in the range of 136 to 148%; addn. of the GRP receptor antagonist acetyl-GRP(20-27) (10-6 M) completely reversed this effect.  Bombesin alone (10-6 M) significantly stimulated CAKI-2 cells (129%) cultured with 0.5% fetal calf serum, whereas another antagonist, D-Phe6,Leu13,(CH2NH)Leu14 bombesin(6-14) (1 μM), alone did not inhibit growth, thus excluding an autocrine mechanism.  These results indicate for the first time that malignant transformation of human kidney tissue into renal cell carcinoma is accompanied by novel expression of GRP receptors.  Bombesin-like peptides might act as mitogens in these carcinomas, and they might be useful as diagnostic or therapeutic tools such as tumor imaging or internal radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEHzuSqGBjv7Vg90H21EOLACvtfcHk0lhpEQNaHyfYAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvVyhtrw%253D&md5=6cfd5778f9fb064da5bcd3b3ff16c953</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPansky%26aufirst%3DA.%26atitle%3DGastrin%2520releasing%2520peptide-preferring%2520bombesin%2520receptors%2520mediate%2520growth%2520of%2520human%2520renal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2000%26volume%3D11%26spage%3D1409%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Markwalder, R.; Reubi, J. C.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide receptors in the human prostate: relation to neoplastic transformation</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span>− <span class="NLM_lpage">1159</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=1152-1159&author=R.+Markwalder&author=J.+C.+Reubi&title=Gastrin+releasing+peptide+receptors+in+the+human+prostate%3A+relation+to+neoplastic+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkwalder%26aufirst%3DR.%26atitle%3DGastrin%2520releasing%2520peptide%2520receptors%2520in%2520the%2520human%2520prostate%253A%2520relation%2520to%2520neoplastic%2520transformation%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D1152%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Halmos, G.; Wittliff, J. L.; Schally, A. V.</span><span> </span><span class="NLM_article-title">Characterization of bombesin/gastrin-releasing receptors in human breast cancer and their relationship to steroid receptor expression</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span>− <span class="NLM_lpage">287</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=280-287&author=G.+Halmos&author=J.+L.+Wittliff&author=A.+V.+Schally&title=Characterization+of+bombesin%2Fgastrin-releasing+receptors+in+human+breast+cancer+and+their+relationship+to+steroid+receptor+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalmos%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520bombesin%252Fgastrin-releasing%2520receptors%2520in%2520human%2520breast%2520cancer%2520and%2520their%2520relationship%2520to%2520steroid%2520receptor%2520expression%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D280%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Zhang, H.; Chen, J.; Waldherr, C.; Hinni, K.; Waser, B.; Reubi, J. C.; Maecke, H. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6707</span>− <span class="NLM_lpage">6715</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6707-6715&author=H.+Zhang&author=J.+Chen&author=C.+Waldherr&author=K.+Hinni&author=B.+Waser&author=J.+C.+Reubi&author=H.+R.+Maecke&title=Synthesis+and+evaluation+of+bombesin+derivatives+on+the+basis+of+pan-bombesin+peptides+labeled+with+indium-111%2C+lutetium-177%2C+and+yttrium-90+for+targeting+bombesin+receptor-expressing+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520bombesin%2520derivatives%2520on%2520the%2520basis%2520of%2520pan-bombesin%2520peptides%2520labeled%2520with%2520indium-111%252C%2520lutetium-177%252C%2520and%2520yttrium-90%2520for%2520targeting%2520bombesin%2520receptor-expressing%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6707%26epage%3D6715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lin, K. S.; Luu, A.; Baidoo, K. E.; Hashemzadeh-Gargari, H.; Chen, M. K.; Brenneman, K.; Pili, R.; Pomper, M.; Carducci, M. A.; Wagner, H. N.,  Jr.</span><span> </span><span class="NLM_article-title">A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span>− <span class="NLM_lpage">50</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc049820h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=43-50&author=K.+S.+Lin&author=A.+Luu&author=K.+E.+Baidoo&author=H.+Hashemzadeh-Gargari&author=M.+K.+Chen&author=K.+Brenneman&author=R.+Pili&author=M.+Pomper&author=M.+A.+Carducci&author=H.+N.+Wagner&title=A+new+high+affinity+technetium-99m-bombesin+analogue+with+low+abdominal+accumulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A New High Affinity Technetium-99m-Bombesin Analogue with Low Abdominal Accumulation</span></div><div class="casAuthors">Lin, Kuo-Shyan; Luu, Andrew; Baidoo, Kwamena E.; Hashemzadeh-Gargari, Hossein; Chen, Ming-Kai; Brenneman, Kenneth; Pili, Roberto; Pomper, Martin; Carducci, Michael A.; Wagner, Henry N., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-50</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">99mTc-labeled bombesin analogs have shown promise for noninvasive detection of many tumors that express bombesin (BN)/gastrin-releasing peptide (GRP) receptors.  99mTc-labeled peptides, however, have a tendency to accumulate in the liver and intestines due to hepatobiliary clearance as a result of the lipophilicity of the 99mTc chelates.  This makes the imaging of lesions in the abdominal area difficult.  In this study, we have synthesized a new high affinity 99mTc-labeled BN analog, [DTPA1, Lys3(99mTc-Pm-DADT), Tyr4]BN, having a built-in pharmacokinetic modifier, DTPA, and labeled with 99mTc using a hydrophilic diaminedithiol chelator (Pm-DADT) to effect low hepatobiliary clearance.  In vitro binding studies using human prostate cancer PC-3 cell membranes showed that the inhibition const. (Ki) for [DTPA1, Lys3(99Tc-Pm-DADT), Tyr4]BN was 4.1 ± 1.4 nM.  Biodistribution studies of [DTPA1, Lys3(99mTc-Pm-DADT), Tyr4]BN in normal mice showed very low accumulation of radioactivity in the liver and intestines (1.32 ± 0.13 and 4.58 ± 0.50% ID, 4 h postinjection, resp.).  There was significant uptake (7.71 ± 1.37% ID/g, 1 h postinjection) in the pancreas which expresses BN/GRP receptors.  The uptake in the pancreas could be blocked by BN, partially blocked by neuromedin B, but not affected by somatostatin, indicating that the in vivo binding was BN/GRP receptor specific.  Scintigraphic images showed specific, high contrast delineation of prostate cancer PC-3 xenografts in SCID mice.  Thus, the new peptide has a great potential for imaging BN/GRP receptor-pos. cancers located even in the abdomen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpafm-f8rcgALVg90H21EOLACvtfcHk0lglFBnQA4gmcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXk&md5=dd70298a8c2edf9dc7af4b02ebbc6697</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbc049820h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc049820h%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DK.%2BS.%26atitle%3DA%2520new%2520high%2520affinity%2520technetium-99m-bombesin%2520analogue%2520with%2520low%2520abdominal%2520accumulation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2005%26volume%3D16%26spage%3D43%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nock, A. B.; Nikolopoulou, A.; Galanis, A.; Cordopatis, P.; Waser, B.; Reubi, J. C.; Maina, T.</span><span> </span><span class="NLM_article-title">Potent bombesin-like peptides for GRP receptor targeting of tumors with <sup>99m</sup>Tc: a preclinical study</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span>− <span class="NLM_lpage">110</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm049437y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=100-110&author=A.+B.+Nock&author=A.+Nikolopoulou&author=A.+Galanis&author=P.+Cordopatis&author=B.+Waser&author=J.+C.+Reubi&author=T.+Maina&title=Potent+bombesin-like+peptides+for+GRP+receptor+targeting+of+tumors+with+99mTc%3A+a+preclinical+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm049437y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049437y%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DA.%2BB.%26atitle%3DPotent%2520bombesin-like%2520peptides%2520for%2520GRP%2520receptor%2520targeting%2520of%2520tumors%2520with%252099mTc%253A%2520a%2520preclinical%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D100%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Abd-Elgaliel, W. R.; Gallazzi, F.; Garrison, J. C.; Rold, T. L.; Sieckman, G. L.; Figueroa, S. D.; Hoffman, T. J.; Lever, S. Z.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of an antagonist-bombesin analogue as targeting vector</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2040</span>− <span class="NLM_lpage">2048</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc800290c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFChtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=2040-2048&author=W.+R.+Abd-Elgaliel&author=F.+Gallazzi&author=J.+C.+Garrison&author=T.+L.+Rold&author=G.+L.+Sieckman&author=S.+D.+Figueroa&author=T.+J.+Hoffman&author=S.+Z.+Lever&title=Design%2C+synthesis+and+biological+evaluation+of+an+antagonist-bombesin+analogue+as+targeting+vector"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of an Antagonist-Bombesin Analogue as Targeting Vector</span></div><div class="casAuthors">Abd-Elgaliel, Wael R.; Gallazzi, Fabio; Garrison, Jered C.; Rold, Tammy L.; Sieckman, Gary L.; Figueroa, Said Daibes; Hoffman, Timothy J.; Lever, Susan Z.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2040-2048</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The gastrin releasing peptide receptor (GRP-R) is overexpressed on a no. of tumors and cancer cell lines including pancreas, prostate, breast, gastrointestinal, and small cell lung cancer (SCLC).  Radiolabeled bombesin (BBN) analogs have exhibited high binding affinity and specificity to the GRP-R.  A bombesin analog with an antagonist targeting vector at the C-terminus, DOTA-aminohexanoyl-[D-Phe6, Leu-NHCH2CH2CH313, des Met14] BBN[6-14] (1, "Bomproamide"), has been synthesized and displays high binding affinity (IC50 = 1.36 ± 0.09 nM) against 125I-Tyr4-BBN in in vitro competitive assays using PC-3 cells.  Maximum internalization of 111In-1 reached 14% in PC-3 cells after 45 min of incubation.  Rapid (0.25 h PI) and high (12.21 ± 3.2%ID/g) pancreatic uptake of 111In-1 was obsd. in healthy CF-1 mice, and 90% of the activity was blocked by coinjection of 100 μg of BBN.  Rapid (0.25 h PI) and high uptake (6.90 ± 1.06%ID/g) was obsd. in PC-3 prostate cancer xenografts in SCID mice, as well as visualized clearly in a SPECT/CT study.  These results support the use of a bombesin construct with an antagonist C-terminal vector as a candidate of choice for specific in vivo imaging of tumors overexpressing GRP-receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqGYSxjocUWbVg90H21EOLACvtfcHk0ljc6Lbr1VH11g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFChtrrE&md5=48754d7cf7e8c73048e97cb796461fd4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbc800290c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800290c%26sid%3Dliteratum%253Aachs%26aulast%3DAbd-Elgaliel%26aufirst%3DW.%2BR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520an%2520antagonist-bombesin%2520analogue%2520as%2520targeting%2520vector%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D2040%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Anastasi, A.; Erspamer, V.; Bucci, M.</span><span> </span><span class="NLM_article-title">Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes</span>.  <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span>− <span class="NLM_lpage">167</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1971&pages=166-167&author=A.+Anastasi&author=V.+Erspamer&author=M.+Bucci&title=Isolation+and+structure+of+bombesin+and+alytesin%2C+two+analogous+active+peptides+from+the+skin+of+the+European+amphibians+Bombina+and+Alytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasi%26aufirst%3DA.%26atitle%3DIsolation%2520and%2520structure%2520of%2520bombesin%2520and%2520alytesin%252C%2520two%2520analogous%2520active%2520peptides%2520from%2520the%2520skin%2520of%2520the%2520European%2520amphibians%2520Bombina%2520and%2520Alytes%26jtitle%3DExperientia%26date%3D1971%26volume%3D27%26spage%3D166%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">McDonald, T. J.; Jörnvall, H.; Nilsson, G.</span><span> </span><span class="NLM_article-title">Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue</span>.  <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span>− <span class="NLM_lpage">233</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1979&pages=227-233&author=T.+J.+McDonald&author=H.+J%C3%B6rnvall&author=G.+Nilsson&title=Characterization+of+a+gastrin+releasing+peptide+from+porcine+non-antral+gastric+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DT.%2BJ.%26atitle%3DCharacterization%2520of%2520a%2520gastrin%2520releasing%2520peptide%2520from%2520porcine%2520non-antral%2520gastric%2520tissue%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1979%26volume%3D90%26spage%3D227%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sunday, M. E.; Kaplan, L. M.; Motoyama, E.; Chin, W. W.; Spindel, E. R.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide (mammalian bombesin) gene expression in health and disease</span>.  <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1988&pages=5-24&author=M.+E.+Sunday&author=L.+M.+Kaplan&author=E.+Motoyama&author=W.+W.+Chin&author=E.+R.+Spindel&title=Gastrin+releasing+peptide+%28mammalian+bombesin%29+gene+expression+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSunday%26aufirst%3DM.%2BE.%26atitle%3DGastrin%2520releasing%2520peptide%2520%2528mammalian%2520bombesin%2529%2520gene%2520expression%2520in%2520health%2520and%2520disease%26jtitle%3DLab.%2520Invest.%26date%3D1988%26volume%3D59%26spage%3D5%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wada, E.; Way, J.; Shapira, H.; Kusano, K.; Lebacq-Verheyden, A. M.; Coy, D.; Jensen, R.; Battey, J. F.</span><span> </span><span class="NLM_article-title">cDNA cloning, characterization and brain region-specific expression of a neuromedin-B preferring bombesin receptor</span>.  <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span>− <span class="NLM_lpage">430</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=421-430&author=E.+Wada&author=J.+Way&author=H.+Shapira&author=K.+Kusano&author=A.+M.+Lebacq-Verheyden&author=D.+Coy&author=R.+Jensen&author=J.+F.+Battey&title=cDNA+cloning%2C+characterization+and+brain+region-specific+expression+of+a+neuromedin-B+preferring+bombesin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWada%26aufirst%3DE.%26atitle%3DcDNA%2520cloning%252C%2520characterization%2520and%2520brain%2520region-specific%2520expression%2520of%2520a%2520neuromedin-B%2520preferring%2520bombesin%2520receptor%26jtitle%3DNeuron%26date%3D1991%26volume%3D6%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Van De Wiele, C.; Dumont, F.; Van Belle, S.; Slegers, G.; Peers, S. H.; Derricks, R. A.</span><span> </span><span class="NLM_article-title">Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumor imaging?</span> <span class="citation_source-journal">Nucl. Med. Com.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span>− <span class="NLM_lpage">15</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1097%2F00006231-200101000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=11233552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtl2gsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=5-15&author=C.+Van+De+Wiele&author=F.+Dumont&author=S.+Van+Belle&author=G.+Slegers&author=S.+H.+Peers&author=R.+A.+Derricks&title=Is+there+a+role+for+agonist+gastrin-releasing+peptide+receptor+radioligands+in+tumor+imaging%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?</span></div><div class="casAuthors">Van De Wiele, C.; Dumont, F.; Van Belle, S.; Slegers, G.; Peers, S. H.; Dierckx, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-15</span>CODEN:
                <span class="NLM_cas:coden">NMCODC</span>;
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 124 refs.  Gastrin-releasing peptide (GRP) has been shown to be a tumor growth stimulating agent for a no. of normal and human cancer cell lines.  The tumor growth effect is a direct result of GRP binding to membrane G-protein coupled GRP receptors (GRP-R) on the cell surface.  Available data on the role of GRP and GRP-R in human lung, prostate, breast, colorectal and gastric carcinoma are reviewed and it is suggested that radiolabeled agonists are preferable to antagonists for imaging and therapy as they appear to be internalized, yielding a higher target/background ratio.  The use of rhenium or indium radiolabels for therapy may provide a new approach to GRP/bombesin expressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ8cRDJkc0zLVg90H21EOLACvtfcHk0lgBpG1CIylHWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtl2gsbc%253D&md5=cea17c167d2659db672b25bccbf0cab0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1097%2F00006231-200101000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00006231-200101000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDe%2BWiele%26aufirst%3DC.%26atitle%3DIs%2520there%2520a%2520role%2520for%2520agonist%2520gastrin-releasing%2520peptide%2520receptor%2520radioligands%2520in%2520tumor%2520imaging%253F%26jtitle%3DNucl.%2520Med.%2520Com.%26date%3D2001%26volume%3D22%26spage%3D5%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kroog, G. S.; Jian, X.; Chen, L.; Northup, J. K.; Battey, J. F.</span><span> </span><span class="NLM_article-title">Phosphorylation uncouples the gastrin-releasing-peptide receptor from G(q)</span>.  <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">36700</span>− <span class="NLM_lpage">36707</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=36700-36707&author=G.+S.+Kroog&author=X.+Jian&author=L.+Chen&author=J.+K.+Northup&author=J.+F.+Battey&title=Phosphorylation+uncouples+the+gastrin-releasing-peptide+receptor+from+G%28q%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKroog%26aufirst%3DG.%2BS.%26atitle%3DPhosphorylation%2520uncouples%2520the%2520gastrin-releasing-peptide%2520receptor%2520from%2520G%2528q%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D36700%26epage%3D36707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Spindel, E. R.; Giladi, E.; Brehm, P.; Goodman, R. H.; Segerson, T. P.</span><span> </span><span class="NLM_article-title">Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor</span>.  <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span>− <span class="NLM_lpage">1963</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1210%2Fmend-4-12-1956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=1707129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK3MXlsFaitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=1956-1963&author=E.+R.+Spindel&author=E.+Giladi&author=P.+Brehm&author=R.+H.+Goodman&author=T.+P.+Segerson&title=Cloning+and+functional+characterization+of+a+complementary+DNA+encoding+the+murine+fibroblast+bombesin%2Fgastrin-releasing+peptide+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor</span></div><div class="casAuthors">Spindel, E. R.; Giladi, E.; Brehm, P.; Goodman, R. H.; Segerson, T. P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1956-63</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    </div><div class="casAbstract">The amphibian tetradecapeptide bombesin and its mammalian homolog gastrin-releasing peptide are neurotransmitters and paracrine hormones, and are mitogenic for fibroblast and small cell lung carcinoma cell lines.  The cDNAs encoding the bombesin/gastrin-releasing peptide receptor (BR) expressed by murine Swiss 3T3 fibroblasts were isolated using electrophysiol. and luminometric Xenopus oocyte expression assays.  Oocytes microinjected with BR transcripts responded to concns. of bombesin from 1 × 10-10 to 1 × 10-6 M.  These responses showed homologous desensitization and could be specifically blocked by bombesin antagonists.  Sequence anal. showed that the BR has 7 membrane-spanning domains and 5 potential N-linked glycosylation sites.  Data base anal. showed that the BR is most homologous to the tachykinin receptors.  Although tyrosine kinase activity has been assocd. with BR function, no tyrosine kinase homologies occur within the BR sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSt7h8NdFYf7Vg90H21EOLACvtfcHk0lgBpG1CIylHWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsFaitL8%253D&md5=1aca09f41d339342fe4035b78dad9b86</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1210%2Fmend-4-12-1956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend-4-12-1956%26sid%3Dliteratum%253Aachs%26aulast%3DSpindel%26aufirst%3DE.%2BR.%26atitle%3DCloning%2520and%2520functional%2520characterization%2520of%2520a%2520complementary%2520DNA%2520encoding%2520the%2520murine%2520fibroblast%2520bombesin%252Fgastrin-releasing%2520peptide%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D1990%26volume%3D4%26spage%3D1956%26epage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fathi, Z.; Corjay, M. H.; Shapira, H.; Wada, E.; Benya, R.; Jensen, R.; Viallet, J.; Sausville, E. A.; Battey, J. F.</span><span> </span><span class="NLM_article-title">BRS-3: novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells</span>.  <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span>− <span class="NLM_lpage">5984</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=5979-5984&author=Z.+Fathi&author=M.+H.+Corjay&author=H.+Shapira&author=E.+Wada&author=R.+Benya&author=R.+Jensen&author=J.+Viallet&author=E.+A.+Sausville&author=J.+F.+Battey&title=BRS-3%3A+novel+bombesin+receptor+subtype+selectively+expressed+in+testis+and+lung+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFathi%26aufirst%3DZ.%26atitle%3DBRS-3%253A%2520novel%2520bombesin%2520receptor%2520subtype%2520selectively%2520expressed%2520in%2520testis%2520and%2520lung%2520carcinoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D5979%26epage%3D5984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Smith, C. J.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span>− <span class="NLM_lpage">868</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0969-8051%2803%2900116-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=14698790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWisrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=861-868&author=C.+J.+Smith&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Gastrin+releasing+peptide+%28GRP%29+receptor+targeted+radiopharmaceuticals%3A+a+concise+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: A concise update</span></div><div class="casAuthors">Smith, C. J.; Volkert, W. A.; Hoffman, T. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">861-868</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The gastrin releasing peptide (GRP) receptor is becoming an increasingly attractive target for development of new radiolabeled peptides with diagnostic and therapeutic potential.  The attractiveness of the GRP receptor as a target is based upon the functional expression of GRP receptors in several tumors of neuroendocrine origin including prostate, breast, and small cell lung cancer.  This concise review outlines some of the efforts currently underway to develop new GRP receptor specific radiopharmaceuticals by employing a variety of radiometal chelation systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr873gXWdB4jrVg90H21EOLACvtfcHk0liLsm14MRa6KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWisrfE&md5=53e564422d5539ff246bbfdf0ab41a21</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2803%2900116-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252803%252900116-1%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DGastrin%2520releasing%2520peptide%2520%2528GRP%2529%2520receptor%2520targeted%2520radiopharmaceuticals%253A%2520a%2520concise%2520update%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D861%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hoffman, T. J.; Gali, H.; Smith, C. J.; Sieckman, G. L.; Hayes, D. L.; Owen, N. K.; Volkert, W. A.</span><span> </span><span class="NLM_article-title">Novel series of <sup>111</sup>In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span>− <span class="NLM_lpage">831</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12732685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Kisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=823-831&author=T.+J.+Hoffman&author=H.+Gali&author=C.+J.+Smith&author=G.+L.+Sieckman&author=D.+L.+Hayes&author=N.+K.+Owen&author=W.+A.+Volkert&title=Novel+series+of+111In-labeled+bombesin+analogs+as+potential+radiopharmaceuticals+for+specific+targeting+of+gastrin-releasing+peptide+receptors+expressed+on+human+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells</span></div><div class="casAuthors">Hoffman, Timothy J.; Gali, Hariprasad; Smith, C. Jeffrey; Sieckman, Gary L.; Hayes, Donald L.; Owen, Nellie K.; Volkert, Wynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-831</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Gastrin-releasing peptide (GRP) receptors have been shown to be expressed with high densities on several types of cancer cells including prostate, breast, small cell lung, and pancreas cancers.  Bombesin (BBN) has been known to bind to GRP receptors with high affinity and specificity.  The aim of these studies was to develop new 111In-labeled BBN analogs having high tumor uptake and optimal pharmacokinetics for specific targeting of human prostate cancers.  Methods: A novel series of dodecanetetraacetic acid (DOTA)-X-BBN[7-14]NH2 (X = 0, β-Ala, 5-Ava, 8-Aoc, or 11-Aun) conjugates and their In(III)/111In complexes exhibiting high GRP-receptor-binding affinities were synthesized and characterized.  Results: In vitro competitive binding assays, using PC-3 androgen-independent human prostate cancer cells, demonstrated values of <2.5 nmol/L for inhibitory concn. of 50% for analogs with β-Ala, 5-Ava, and 8-Aoc spacers.  In vivo biodistribution studies of the 111In-DOTA-X-BBN[7-14]NH2 conjugates performed on CF-1 mice at 1 h after injection have revealed that the uptake of radioactivity in the pancreas, a GRP-receptor-expressing tissue, increased as a function of hydrocarbon spacer length (i.e., from 0.20 ± 0.04 percentage injected dose [%ID] per g for the analog with no spacer to a max. of 26.97 ± 3.97 %ID/g for the analog with 8-Aoc spacer).  The radioactivity was cleared efficiently from the blood pool by excretion mainly through the renal/urinary pathway (e.g., 71.6.± 1.8 %ID at 1 h after injection for 8-Aoc spacer analog).  In vivo pharmacokinetic studies of the 111In-DOTA-8-Aoc-BBN[7-14]NH2 conjugate conducted on PC-3 human prostate cancer-derived xenografts in SCID mice showed a specific uptake of radioactivity in tumor, with 3.63 ± 1.11 %ID/g obsd. at 1 h after injection.  High tumor-to-blood and tumor-to-muscle ratios of approx. 6:1 and 45:1, resp., were achieved at 1 h after injection.  Relative to the radioactivity obsd. in the tumor at 1 h after injection, 43%, 19%, and 9% of the radioactivity was retained at, resp., 24, 48, and 72 h after injection.  Conclusion: These studies showed that radiometallated DOTA-X-BBN[7-14]NH2 constructs with hydrocarbon spacers ranging from 5 to 8 carbon atoms are feasible candidates for further development as diagnostic and therapeutic radiopharmaceuticals for patients with GRP-pos. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNeuC3GOWcMrVg90H21EOLACvtfcHk0liLsm14MRa6KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Kisbc%253D&md5=7c680df1b1a48493f38f8cda42d17aef</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26atitle%3DNovel%2520series%2520of%2520111In-labeled%2520bombesin%2520analogs%2520as%2520potential%2520radiopharmaceuticals%2520for%2520specific%2520targeting%2520of%2520gastrin-releasing%2520peptide%2520receptors%2520expressed%2520on%2520human%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D44%26spage%3D823%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Breeman, W. A. P.; De Jong, M.; Erion, J. L.; Bugaj, J. E.; Srinivasan, A.; Bernard, B. F.; Kwekkeboom, D. J.; Visser, T. J.; Krenning, E. P.</span><span> </span><span class="NLM_article-title">Preclinical comparison of <sup>111</sup>In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1650</span>− <span class="NLM_lpage">1656</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1650-1656&author=W.+A.+P.+Breeman&author=M.+De+Jong&author=J.+L.+Erion&author=J.+E.+Bugaj&author=A.+Srinivasan&author=B.+F.+Bernard&author=D.+J.+Kwekkeboom&author=T.+J.+Visser&author=E.+P.+Krenning&title=Preclinical+comparison+of+111In-labeled+DTPA-+or+DOTA-bombesin+analogs+for+receptor-targeted+scintigraphy+and+radionuclide+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26atitle%3DPreclinical%2520comparison%2520of%2520111In-labeled%2520DTPA-%2520or%2520DOTA-bombesin%2520analogs%2520for%2520receptor-targeted%2520scintigraphy%2520and%2520radionuclide%2520therapy%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2002%26volume%3D43%26spage%3D1650%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, X.; Park, R.; Hou, Y.; Tohme, M.; Shahinian, A. H.; Bading, J. R.; Conti, P.</span><span> </span><span class="NLM_article-title">MicroPET and autoradiographic imaging of GRP receptor expression with <sup>64</sup>Cu-DOTA-[Lys<sup>3</sup>]bombesin in human prostate adenocarcinoma xenografts</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1390</span>− <span class="NLM_lpage">1397</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=1390-1397&author=X.+Chen&author=R.+Park&author=Y.+Hou&author=M.+Tohme&author=A.+H.+Shahinian&author=J.+R.+Bading&author=P.+Conti&title=MicroPET+and+autoradiographic+imaging+of+GRP+receptor+expression+with+64Cu-DOTA-%5BLys3%5Dbombesin+in+human+prostate+adenocarcinoma+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26atitle%3DMicroPET%2520and%2520autoradiographic%2520imaging%2520of%2520GRP%2520receptor%2520expression%2520with%252064Cu-DOTA-%255BLys3%255Dbombesin%2520in%2520human%2520prostate%2520adenocarcinoma%2520xenografts%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2004%26volume%3D45%26spage%3D1390%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Meyer, G. J.; Maecke, H.; Schuhmacher, J.; Knapp, W. H.; Hoffmann, M.</span><span> </span><span class="NLM_article-title"><sup>68</sup>Ga-labeled DOTA-derivatised peptide ligands</span>.  <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span>− <span class="NLM_lpage">1104</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1007%2Fs00259-004-1486-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=1097-1104&author=G.+J.+Meyer&author=H.+Maecke&author=J.+Schuhmacher&author=W.+H.+Knapp&author=M.+Hoffmann&title=68Ga-labeled+DOTA-derivatised+peptide+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga-labelled DOTA-derivatised peptide ligands</span></div><div class="casAuthors">Meyer, G.-J.; Maecke, H.; Schuhmacher, J.; Knapp, W. H.; Hofmann, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1097-1104</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">68Ge/68Ga generators provide cyclotron-independent access to positron emission tomog. (PET) radiopharmaceuticals.  We describe a system which allows the safe and efficient handling of 68Ge/68Ga generator eluates for labeling of DOTA-derivatized peptide ligands.  The system comprises concn. and purifn. of the 68Ga eluate as well as labeling and purifn. steps for peptides, and can be used with different 68Ge/68Ga generator types.  The suitability and efficiency were tested with two different DOTA-derivatized somatostatin derivs. and a DOTA-derivatized bombesin deriv.  Amts. of 10-20 nmol of the peptides were sufficient and resulted in labeling yields of 50% for all peptides.  The built-in safety precautions have proven to be appropriate in allowing use of the method for routine clin. applications.  The system was set up and operated in a "hot lab" by personnel with no previous experience in the prepn. of PET radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWa-QTuonJwLVg90H21EOLACvtfcHk0ljICLi-eiLU2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWks7o%253D&md5=22052184683a716f452b1b4b1bd29c39</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00259-004-1486-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-004-1486-0%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DG.%2BJ.%26atitle%3D68Ga-labeled%2520DOTA-derivatised%2520peptide%2520ligands%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2004%26volume%3D31%26spage%3D1097%26epage%3D1104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Smith, C. J.; Gali, H.; Sieckman, G. L.; Hayes, D. L.; Owen, N. K.; Mazuru, D. G.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiochemical investigations of <sup>177</sup>Lu-DOTA-8-Aoc-BBN[7-14]NH<sub>2</sub>: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span>− <span class="NLM_lpage">109</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0969-8051%2802%2900391-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12623108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Clu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=101-109&author=C.+J.+Smith&author=H.+Gali&author=G.+L.+Sieckman&author=D.+L.+Hayes&author=N.+K.+Owen&author=D.+G.+Mazuru&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Radiochemical+investigations+of+177Lu-DOTA-8-Aoc-BBN%5B7-14%5DNH2%3A+an+in+vitro%2Fin+vivo+assessment+of+the+targeting+ability+of+this+new+radiopharmaceutical+for+PC-3+human+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells</span></div><div class="casAuthors">Smith, C. Jeffrey; Gali, Hariprasad; Sieckman, Gary L.; Hayes, Donald L.; Owen, Nellie K.; Mazuru, Dana G.; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Bombesin (BBN), a 14 amino acid peptide, is an analog of human gastrin releasing peptide (GRP) that binds to GRP receptors (GRPr) with high affinity and specificity.  The GRPr is over expressed on a variety of human cancer cells including prostate, breast, lung, and pancreatic cancers.  The specific aim of this study was to identify a BBN analog that can be radiolabeled with 177Lu and maintains high specificity for GRPr pos. prostate cancer tumors in vivo.  A preselected synthetic sequence via solid phase peptide synthesis (SPPS) was designed to produce a DOTA-BBN (DOTA = 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid) conjugate with the following general structure: DOTA-X-Q-W-A-V-G-H-L-M-(NH2), where the spacer group, X = ω-NH2(CH2)7COOH (8-Aoc).  The BBN-construct was purified by reversed phase-HPLC (RP-HPLC).  Electrospray Mass Spectrometry (ES-MS) was used to characterize both metalated and non-metalated BBN-conjugates.  The new DOTA-conjugate was metalated with 177Lu(III)Cl3 or non-radioactive Lu(III)Cl3.  The 177Lu(III)- and non-radiolabeled Lu(III)-conjugates exhibit the same retention times under identical RP-HPLC conditions.  The 177Lu-DOTA-8-Aoc-BBN[7-14]NH2 conjugate was found to exhibit optimal pharmacokinetic properties in CF-1 normal mice.  In vitro and in vivo models demonstrated the ability of the 177Lu-DOTA-8-Aoc-BBN[7-14]NH2 conjugate to specifically target GRP receptors expressed on PC-3 human prostate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwuZsqyeabSbVg90H21EOLACvtfcHk0lgly1IMMZ4xLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Clu7w%253D&md5=044a5755f49d491be97acf61a64139a0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900391-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900391-8%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DRadiochemical%2520investigations%2520of%2520177Lu-DOTA-8-Aoc-BBN%255B7-14%255DNH2%253A%2520an%2520in%2520vitro%252Fin%2520vivo%2520assessment%2520of%2520the%2520targeting%2520ability%2520of%2520this%2520new%2520radiopharmaceutical%2520for%2520PC-3%2520human%2520prostate%2520cancer%2520cells%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Zhang, X.; Cai, W.; Cao, F.; Schreibmann, E.; Wu, Y.; Wu, J. C.; Xing, L.; Chen, X.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer</span>.  <span class="citation_source-journal">J. Nucl. Med.</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span>− <span class="NLM_lpage">501</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=492-501&author=X.+Zhang&author=W.+Cai&author=F.+Cao&author=E.+Schreibmann&author=Y.+Wu&author=J.+C.+Wu&author=L.+Xing&author=X.+Chen&title=18F-labeled+bombesin+analogs+for+targeting+GRP+receptor-expressing+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26atitle%3D18F-labeled%2520bombesin%2520analogs%2520for%2520targeting%2520GRP%2520receptor-expressing%2520prostate%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Liu, S.; Edwards, D.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-Labeled small peptides as diagnostic radiopharmaceuticals</span>.  <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2235</span>− <span class="NLM_lpage">2268</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/cr980436l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2235-2268&author=S.+Liu&author=D.+Edwards&title=99mTc-Labeled+small+peptides+as+diagnostic+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcr980436l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr980436l%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3D99mTc-Labeled%2520small%2520peptides%2520as%2520diagnostic%2520radiopharmaceuticals%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2235%26epage%3D2268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Van De Wiele, C.; Dumont, F.; Dierckx, R. A.; Peers, S. H.; Thornback, J. R.; Slegers, G.; Thierens, H.</span><span> </span><span class="NLM_article-title">Biodistribution and dosimetry of <sup>99m</sup>Tc-RP527, a gastrin-releasing peptide(GRP) agonist for the visualization of GRP receptor-expressing malignancies</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1722</span>− <span class="NLM_lpage">1727</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1722-1727&author=C.+Van+De+Wiele&author=F.+Dumont&author=R.+A.+Dierckx&author=S.+H.+Peers&author=J.+R.+Thornback&author=G.+Slegers&author=H.+Thierens&title=Biodistribution+and+dosimetry+of+99mTc-RP527%2C+a+gastrin-releasing+peptide%28GRP%29+agonist+for+the+visualization+of+GRP+receptor-expressing+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDe%2BWiele%26aufirst%3DC.%26atitle%3DBiodistribution%2520and%2520dosimetry%2520of%252099mTc-RP527%252C%2520a%2520gastrin-releasing%2520peptide%2528GRP%2529%2520agonist%2520for%2520the%2520visualization%2520of%2520GRP%2520receptor-expressing%2520malignancies%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D1722%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Varvarigou, A.; Bouziotis, P.; Zikos, C.; Scopinaro, F.; De Vincentis, G.</span><span> </span><span class="NLM_article-title">Gastrin-releasing peptide (GRP) analogues for cancer imaging</span>.  <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span>− <span class="NLM_lpage">229</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1089%2F108497804323072002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=15186603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=219-229&author=A.+Varvarigou&author=P.+Bouziotis&author=C.+Zikos&author=F.+Scopinaro&author=G.+De+Vincentis&title=Gastrin-releasing+peptide+%28GRP%29+analogues+for+cancer+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-Releasing Peptide (GRP) Analogues for Cancer Imaging</span></div><div class="casAuthors">Varvarigou, Alexandra; Bouziotis, Penelope; Zikos, Christos; Scopinaro, Francesco; De Vincentis, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-229</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Small neuropeptides, labeled with gamma- and/or beta-emitting radionuclides, are currently being investigated for their ability to bind to cell-surface receptors, overexpressed in a wide variety of malignant tissues being, thus, potentially useful for radionuclide detection and/or therapy for tumors.  Particular attention has been focused on the amphibian peptide, bombesin (BN), and the molecularly related gastrin-releasing peptide (GRP).  These peptides act as neurotransmitters and endocrine cancer cell-growth factors on normal tissues as well as on neoplastic cells of various origin.  In recent investigations, modification of the native peptide structure has been attempted in order to obtain derivs., which might easily be labeled with radionuclides.  Thus, iodinated (I-125) BN derivs., as well as Indium (In-111) labeled BN analogs are currently being investigated, presenting satisfactory tumor localization.  Also, some new BN analogs contg. a 6-carbon linker have been prepd. and labeled with Rhenium-188, resulting in pos. in vitro binding to prostate cancer cells.  More recent studies refer to the Technetium-99m labeling of BN, performed either directly, after attaching proper technetium-chelating groups onto the BN sequence, or indirectly, by coupling BN to a preformed 99mTc-tagging ligand.  Both types of conjugates were found to have a high in vitro affinity for cells with BN receptors, also presenting satisfactory in vivo uptake in exptl. tumor models.  Pilot clin. studies of a new BN-derived, 99mTc-labeled pentadecapeptide indicated significant uptake by breast cancer and invaded lymph nodes, as well as by prostate cancer, small-cell lung carcinoma, gastro-entero-pancreatic tumors, and others.  Further studies of this new GRP deriv., as well as of other new BN-like peptides, are intensively performed internationally today.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGXRRkysFoWLVg90H21EOLACvtfcHk0lgly1IMMZ4xLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVyjtro%253D&md5=c185ea0342651d0939ff283ce4ab3260</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1089%2F108497804323072002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F108497804323072002%26sid%3Dliteratum%253Aachs%26aulast%3DVarvarigou%26aufirst%3DA.%26atitle%3DGastrin-releasing%2520peptide%2520%2528GRP%2529%2520analogues%2520for%2520cancer%2520imaging%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2004%26volume%3D19%26spage%3D219%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Nock, B.; Nikolopoulou, A.; Chiotellis, E.; Loudos, G.; Maintas, D.; Reubi, J. C.; Maina, T.</span><span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumor imaging</span>.  <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span>− <span class="NLM_lpage">258</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1007%2Fs00259-002-1040-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1CntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=247-258&author=B.+Nock&author=A.+Nikolopoulou&author=E.+Chiotellis&author=G.+Loudos&author=D.+Maintas&author=J.+C.+Reubi&author=T.+Maina&title=%5B99mTc%5DDemobesin+1%2C+a+novel+potent+bombesin+analogue+for+GRP+receptor-targeted+tumor+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging</span></div><div class="casAuthors">Nock, Berthold; Nikolopoulou, Anastasia; Chiotellis, Efstratios; Loudos, George; Maintas, Dimitrios; Reubi, Jean Claude; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Demobesin 1 is a potent new GRP-R-selective bombesin (BN) analog contg. an open chain tetraamine chelator for stable technetium-99m binding.  Following a convenient labeling protocol, the radiopeptide, [99mTc]Demobesin 1, formed in nearly quant. yields and with high specific activities.  Both unlabeled and labeled peptide demonstrated high-affinity binding in membrane prepns. of the human androgen-independent prostate adenocarcinoma PC-3 cell line.  The IC50 values detd. for Demobesin 1 and [Tyr4]BN were 0.70±0.08 nM and 1.5±0.20 nM, resp., while the Kd defined for [99mTc/99gTc]Demobesin 1 was 0.67±0.10 nM. [99mTc]Demobesin 1 was rather stable in murine plasma, whereas it degraded rapidly in kidney and liver homogenates.  After injection in healthy Swiss albino mice, [99mTc]Demobesin 1 accumulated very efficiently in the target organs (pancreas, intestinal tract) via a GRP-R-mediated process, as shown by in vivo receptor blocking expts.  An equally high and GRP-R-mediated uptake was exhibited by [99mTc]Demobesin 1 after injection in PC-3 tumor-bearing athymic mice.  The initial high radioligand uptake of 16.2±3.1%ID/g in the PC-3 xenografts at 1 h p.i. remained at a similar level (15.61±1.19%ID/g) at 4 h p.i.  Even after 24 h p.i., when the radioactivity had cleared from all other tissues, a value of 5.24±0.67%ID/g was still obsd. in the tumor.  The high and prolonged localization of [99mTc]Demobesin 1 at the tumor site and its rapid background clearance are very promising qualities for GRP-R-targeted tumor imaging in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_PXKboVxArVg90H21EOLACvtfcHk0ljlESNssQU_ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1CntA%253D%253D&md5=19ebcbebcf11cac029412ad304113f77</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-1040-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-1040-x%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%26atitle%3D%255B99mTc%255DDemobesin%25201%252C%2520a%2520novel%2520potent%2520bombesin%2520analogue%2520for%2520GRP%2520receptor-targeted%2520tumor%2520imaging%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D30%26spage%3D247%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Karra, S. R.; Schibli, R.; Gali, H.; Katti, K. V.; Hoffman, T. J.; Higginbotham-Sieckman, G. L.; Volkert, W. A.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labeling and in vivo studies of a bombesin analogue with novel water-soluble dithiadiphosphine-based bifunctional chelating agent</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span>− <span class="NLM_lpage">260</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc980096a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK1MXosV2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=254-260&author=S.+R.+Karra&author=R.+Schibli&author=H.+Gali&author=K.+V.+Katti&author=T.+J.+Hoffman&author=G.+L.+Higginbotham-Sieckman&author=W.+A.+Volkert&title=99mTc-labeling+and+in+vivo+studies+of+a+bombesin+analogue+with+novel+water-soluble+dithiadiphosphine-based+bifunctional+chelating+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-Labeling and in Vivo Studies of a Bombesin Analog with a Novel Water-Soluble Dithiadiphosphine-Based Bifunctional Chelating Agent</span></div><div class="casAuthors">Karra, Srinivasa R.; Schibli, Roger; Gali, Hariprasad; Katti, Kattesh V.; Hoffman, Timothy J.; Higginbotham, Chris; Sieckman, Gary L.; Volkert, Wynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">254-260</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent progress in the synthesis of water-sol. phosphine ligand systems and their corresponding 99mTc complexes prompted the development of a new bifunctional chelating agent (BFCA) based on a tetradentate dithiadiphosphine framework (P2S2-COOH).  The detailed synthesis of this new BFCA is described.  The corresponding 99mTc complex, 99mTc-P2S2-COOH, can be formed in >95% yield.  To demonstrate the potential of this chelate to efficiently label peptides, 99mTc-P2S2-COOH was coupled to the N-terminal region of the truncated nine-amino acid bombesin analog, 5-Ava-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [BBN(7-14)], to form 99mTc-P2S2-BBN(7-14).  Conjugation to the peptide was performed in borate buffer (pH 8.5) by applying the prelabeling approach in yields of >60%.  In competitive binding assays, using Swiss 3T3 mouse fibroblast cells against [125I-Tyr4]bombesin, Re-P2S2-BBN(7-14) exhibited an IC50 value of 0.8 ± 0.4 nM.  The pharmacokinetic studies of 99mTc-P2S2-BBN(7-14) and its ability to target tissue expressing gastrin-releasing peptide (GRP) receptors were performed in normal mice.  The 99mTc-P2S2-BBN(7-14) exhibited fast and efficient clearance from the blood pool (0.6 ± 0.1% ID, 4 h postinjection) and excretion through the renal and hepatobiliary pathways (56.4 ± 8.2 and 28.1 ± 7.9% ID, 4 h postinjection, resp.).  Significant uptake in the pancreas was obsd. (pancreatic acini cells express bombesin/GRP receptors), producing pancreas:blood and pancreas:muscle ratios of ca. 22 and 80, resp., at 4 h postinjection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB8mO29gA6hLVg90H21EOLACvtfcHk0ljlESNssQU_ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXosV2rtQ%253D%253D&md5=24f274794d9b531e42f90dc28436dea7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbc980096a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc980096a%26sid%3Dliteratum%253Aachs%26aulast%3DKarra%26aufirst%3DS.%2BR.%26atitle%3D99mTc-labeling%2520and%2520in%2520vivo%2520studies%2520of%2520a%2520bombesin%2520analogue%2520with%2520novel%2520water-soluble%2520dithiadiphosphine-based%2520bifunctional%2520chelating%2520agent%26jtitle%3DBioconjugate%2520Chem.%26date%3D1999%26volume%3D10%26spage%3D254%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Gourni, E.; Paravatou, M.; Bouziotis, P.; Zikos, C.; Fani, M.; Xanthopoulos, S.; Archimandritis, S. C.; Livaniou, E.; Varvarigou, A. D.</span><span> </span><span class="NLM_article-title">Evaluation of a series of new <sup>99m</sup>Tc-labeled bombesin-like peptides for early cancer detection</span>.  <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span>− <span class="NLM_lpage">438</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=16475730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ahtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=435-438&author=E.+Gourni&author=M.+Paravatou&author=P.+Bouziotis&author=C.+Zikos&author=M.+Fani&author=S.+Xanthopoulos&author=S.+C.+Archimandritis&author=E.+Livaniou&author=A.+D.+Varvarigou&title=Evaluation+of+a+series+of+new+99mTc-labeled+bombesin-like+peptides+for+early+cancer+detection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a series of new 99mTc-labeled bombesin-like peptides for early cancer detection</span></div><div class="casAuthors">Gourni, Eleni; Paravatou, Maria; Bouziotis, Penelope; Zikos, Christos; Fani, Melpomeni; Xanthopoulos, Stavros; Archimandritis, Spyridon C.; Livaniou, Evagelia; Varvarigou, Alexandra D.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1A</span>),
    <span class="NLM_cas:pages">435-438</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Bombesin (BN) is a peptide exhibiting a high affinity for the gastrin-releasing peptide (GRP) receptor, which is overexpressed by a variety of tumors, including breast or prostate cancer.  The aim of the present study was the investigation of the complexes formed between a series of BN-like peptides and the nuclides 185/187Re and 99mTc.  The 185/187Re complexes were formed via the precursor Re-gluconate.  The radiolabeling of the derivs. with 99mTc was performed using either 99mTc-gluconate or 99mTc-MDP as the intermediate complex.  For the in vitro evaluation of the new peptides, the cancer cell line PC3 was used.  The in vivo behavior of the 99mTc-labeled BN-like peptides was evaluated in normal mice.  All the derivs. showed specific uptake in the pancreas, an organ rich in BN receptors and high affinity for the cancer cell line PC3.  The above preliminary results indicated that the new BN derivs. are promising for human cancer studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ccIBqm2XobVg90H21EOLACvtfcHk0ljlESNssQU_ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ahtbY%253D&md5=793db8f68b6c314365377535b6fae674</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGourni%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520a%2520series%2520of%2520new%252099mTc-labeled%2520bombesin-like%2520peptides%2520for%2520early%2520cancer%2520detection%26jtitle%3DAnticancer%2520Res.%26date%3D2006%26volume%3D26%26spage%3D435%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Varvarigou, A. D.; Scopinaro, F.; Leondiadis, L.; Corleto, V.; Schillaci, O.; De Vicentis, G.; Sourlingas, T. G.; Sekeri-Pataryas, K. E.; Evangelatos, G. P.; Leonti, A.; Xanthopoulos, S.; Delle Fave, G.; Archimandritis, S. C.</span><span> </span><span class="NLM_article-title">Synthesis, chemical, radiochemical and radiobiological evaluation of a new <sup>99m</sup>Tc-labeled bombesin-like peptide</span>.  <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1089%2F10849780260179288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12136524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1agsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=317-326&author=A.+D.+Varvarigou&author=F.+Scopinaro&author=L.+Leondiadis&author=V.+Corleto&author=O.+Schillaci&author=G.+De+Vicentis&author=T.+G.+Sourlingas&author=K.+E.+Sekeri-Pataryas&author=G.+P.+Evangelatos&author=A.+Leonti&author=S.+Xanthopoulos&author=G.+Delle+Fave&author=S.+C.+Archimandritis&title=Synthesis%2C+chemical%2C+radiochemical+and+radiobiological+evaluation+of+a+new+99mTc-labeled+bombesin-like+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide</span></div><div class="casAuthors">Varvarigou, A. D.; Scopinaro, F.; Leondiadis, L.; Corleto, V.; Schillaci, O.; De Vincentis, G.; Sourlingas, T. G.; Sekeri-Pataryas, K. E.; Evangelatos, G. P.; Leonti, A.; Xanthopoulos, S.; Delle Fave, G.; Archimandritis, S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-326</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A new pentadecapeptide bombesin analog was prepd. by Fmoc synthesis, purified by HPLC and identified by electron ionization mass spectrometry.  The biol. activity of the new peptide was tested on isolated human colonic muscle cells and compared to native bombesin.  Labeling of the new biomol. with Tc-99m yielded a single radioactive species which remained stable at room temp. for eight hours.  In a binding assay, the radiolabeled peptide showed high affinity for oat-cell carcinoma (Kd = 9.8 nM) and colorectal adenocarcinoma (Kd = 27.2 nM).  Biodistribution studies, performed in normal rodents, indicated uptake by organs that normally express bombesin receptors, such as liver, intestines and kidneys.  Scintigraphic studies, performed in nude mice transplanted with small cell lung carcinoma and colon cancer cells, showed significant tumor uptake two hours p.i.  The new synthetic pentadecapeptide appears to have promise for several malignancies, including oat-cell lung carcinoma, colorectal cancer and gastroenteropancreatic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtuzQGym0SOLVg90H21EOLACvtfcHk0lhx3vwEElHH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1agsbY%253D&md5=52978e226ffdba565b5613c9137f74b7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1089%2F10849780260179288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F10849780260179288%26sid%3Dliteratum%253Aachs%26aulast%3DVarvarigou%26aufirst%3DA.%2BD.%26atitle%3DSynthesis%252C%2520chemical%252C%2520radiochemical%2520and%2520radiobiological%2520evaluation%2520of%2520a%2520new%252099mTc-labeled%2520bombesin-like%2520peptide%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2002%26volume%3D17%26spage%3D317%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Okarvi, S. M.; Jammaz, I.</span><span> </span><span class="NLM_article-title">Synthesis, radiolabeling, and biological characteristics of a bombesin peptide analog as a tumor imaging agent</span>.  <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2745</span>− <span class="NLM_lpage">2750</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12894569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFyqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=2745-2750&author=S.+M.+Okarvi&author=I.+Jammaz&title=Synthesis%2C+radiolabeling%2C+and+biological+characteristics+of+a+bombesin+peptide+analog+as+a+tumor+imaging+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent</span></div><div class="casAuthors">Okarvi, S. M.; Al-Jammaz, I.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3B</span>),
    <span class="NLM_cas:pages">2745-2750</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Several human cancers, including small cell lung, prostate, breast, gastric, colon and pancreatic cancers, express receptors for bombesin-like peptides.  Bombesin (BN) peptides that bind specifically to these receptors are useful for detection of bombesin receptor-expressing cancers in vivo.  A new 99mTc-labeled-BN peptide for targeting bombesin receptor-expressing cancers was prepd. and characterized.  Materials and Methods: MAG3-coupled BN peptide (MAG3-BN) was prepd. by solid-phase synthesis and radiolabeled with 99mTc by an exchange method.  In vitro cell binding assays were conducted on human breast cancer cell lines, MDA-MB-231 and MCF-7.  In vivo biodistribution studies were performed in normal and nude mice bearing bombesin receptor-pos. tumors.  Results: Radiolabelling of MAG3-BN with 99mTc produces a single radioactive species (>95%).  In vitro cell-binding indicated the affinity and specificity of 99mTc-MAG3-BN towards bombesin receptors.  In vivo biodistribution in mice demonstrated that 99mTc-MAG3-BN cleared rapidly from the blood and most non-targeted tissues and was excreted mainly via the kidneys.  Uptake in bombesin receptor-pos. tissues and in the tumor was low to moderate.  Conclusion: 99mTc-MAG3-BN displays good radiolabelling together with certain favorable biol. characteristics and might be a useful peptide radiopharmaceutical in the detection of bombesin receptor-expressing cancers in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0Pz-r5A4ALVg90H21EOLACvtfcHk0lhx3vwEElHH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFyqsrs%253D&md5=7976942bfb5dbc4872900eb286597f3e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkarvi%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%252C%2520radiolabeling%252C%2520and%2520biological%2520characteristics%2520of%2520a%2520bombesin%2520peptide%2520analog%2520as%2520a%2520tumor%2520imaging%2520agent%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D2745%26epage%3D2750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Smith, C. J.; Gali, H.; Sieckman, G. L.; Higginbotham, C.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiochemical investigations of <sup>99m</sup>Tc-N<sub>3</sub>S-X-BBN[7-14]NH<sub>2</sub>: An in vivo/in vitro structure−activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span>− <span class="NLM_lpage">102</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc020034r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFWmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=93-102&author=C.+J.+Smith&author=H.+Gali&author=G.+L.+Sieckman&author=C.+Higginbotham&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Radiochemical+investigations+of+99mTc-N3S-X-BBN%5B7-14%5DNH2%3A+An+in+vivo%2Fin+vitro+structure%E2%88%92activity+relationship+study+where+X+%3D+0-%2C+3-%2C+5-%2C+8-%2C+and+11-carbon+tethering+moieties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Radiochemical Investigations of 99mTc-N3S-X-BBN[7-14]NH2: An in Vitro/in Vivo Structure-Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties</span></div><div class="casAuthors">Smith, C. Jeffrey; Gali, Hariprasad; Sieckman, Gary L.; Higginbotham, Chris; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bombesin (BBN), a 14 amino acid peptide, is an analog of human gastrin releasing peptide (GRP) that binds to GRP receptors (GRPr) with high affinity and specificity.  The GRPr is overexpressed on a variety of human cancer cells, including prostate, breast, lung, and pancreatic cancers.  The specific aim of this study was to develop 99mTc-radiolabeled BBN analogs that maintain high specificity for the GRPr in vivo.  A preselected synthetic sequence via solid-phase peptide synthesis (SPPS) was designed to produce N3S-BBN (N3S = dimethylglycyl-L-seryl-L-cysteinylglycinamide) conjugates with the following general structure: DMG-S-C-G-X-Q-W-A-V-G-H-L-M-(NH2), where the spacer group, X = 0 (no spacer), ω-NH2(CH2)2COOH, ω-NH2(CH2)4COOH, ω-NH2(CH2)7COOH, or ω-NH2-(CH2)10COOH.  The new BBN constructs were purified by reversed phase-HPLC (RP-HPLC).  Electrospray mass spectrometry (ES-MS) was used to characterize the nonmetalated BBN conjugates.  Re(V)-BBN conjugates were prepd. by the reaction of Re(V)gluconate with N3S-X-BBN[7-14]NH2 (X = 0 carbons, β-Ala (β-alanine), 5-Ava (5-aminovaleric acid), 8-Aoc (8-aminooctanoic acid), and 11-Aun (11-aminoundecanoic acid)) with gentle heating. Re-N3S-5-Ava-BBN[7-14]NH2 was also prepd. by the reaction of [Re(V)dimethylglycyl-L-seryl-L-cysteinylglycinamide] with 5-Ava-BBN[7-14]NH2. ES-MS was used to det. the mol. constitution of the new Re(V) conjugates.  The 99mTc conjugates were prepd. at the tracer level by each the prelabeling, post-conjugation and pre-conjugation, postlabeling approaches from the reaction of Na[99mTcO4] with excess SnCl2, sodium gluconate, and corresponding ligand.  The 99mTc and Re(V) conjugates behaved similarly under identical RP-HPLC conditions.  In vitro and in vivo models demonstrated biol. integrity of the new conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3hpJybG-Tg7Vg90H21EOLACvtfcHk0lhx3vwEElHH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFWmtrY%253D&md5=18c07e13b6fbb5a2c20d4fe0a4ca724b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbc020034r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc020034r%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DRadiochemical%2520investigations%2520of%252099mTc-N3S-X-BBN%255B7-14%255DNH2%253A%2520An%2520in%2520vivo%252Fin%2520vitro%2520structure%25E2%2588%2592activity%2520relationship%2520study%2520where%2520X%2520%253D%25200-%252C%25203-%252C%25205-%252C%25208-%252C%2520and%252011-carbon%2520tethering%2520moieties%26jtitle%3DBioconjugate%2520Chem.%26date%3D2003%26volume%3D14%26spage%3D93%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Veerendra, B.; Sieckman, G. L.; Hoffman, T. J.; Rold, T.; Retzloff, L.; McCrate, J.; Prasanphanich, A.; Smith, C. J.</span><span> </span><span class="NLM_article-title">Synthesis, radiolabeling and in vitro GRP receptor targeting of <sup>99m</sup>Tc-triaza-X-BN[7-14]NH<sub>2</sub> (X = seylserylserine, glycylglycylglycine, glycylserylglycine, or beta alanine)</span>.  <span class="citation_source-journal">Synth. React. Inorg. Met.-Org., Nano-Met. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span>− <span class="NLM_lpage">491</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1080%2F15533170600778075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVentrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=481-491&author=B.+Veerendra&author=G.+L.+Sieckman&author=T.+J.+Hoffman&author=T.+Rold&author=L.+Retzloff&author=J.+McCrate&author=A.+Prasanphanich&author=C.+J.+Smith&title=Synthesis%2C+radiolabeling+and+in+vitro+GRP+receptor+targeting+of+99mTc-triaza-X-BN%5B7-14%5DNH2+%28X+%3D+seylserylserine%2C+glycylglycylglycine%2C+glycylserylglycine%2C+or+beta+alanine%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, radiolabeling and in vitro GRP receptor targeting studies of 99mTc-Triaza-X-BBN[7-14]NH2 (X = Serylserylserine, Glycylglycylglycine, Glycylserylglycine, or beta alanine)</span></div><div class="casAuthors">Veerendra, Bhadrasetty; Sieckman, Gary L.; Hoffman, Timothy J.; Rold, Tammy; Retzloff, Lauren; McCrate, Joseph; Prasanphanich, Adam; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">481-491</span>CODEN:
                <span class="NLM_cas:coden">SRIMDO</span>;
        ISSN:<span class="NLM_cas:issn">1553-3174</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Gastrin-releasing peptide (GRP) receptors are over-expressed on several types of human cancer cells including prostate, breast, small cell lung and pancreatic cancers.  Bombesin (BBN) is a 14 amino acid peptide that is an analog of human gastrin-releasing peptide, binding to GRP receptors (GRPr) with high affinity and specificity.  The aim of these studies was to develop new 99mTc-labeled BBN analogs having high tumor uptake and optimal pharmacokinetics for specific targeting of human prostate cancers.  A new tridentate bifunctional chelating agent, 2-(4,7-bis(tert-butoxycarbonyl)-1,4,7-triazanonan-1-yl)acetic acid, was synthesized by first reacting 2 equiv of BOC-ON with 1,4,7-triazacyclononane (Triaza) in CHCl3 at room temp.  The product, N, N'-bis-(tert-butoxycarbonyl)-1,4,7-triazacyclononane, was alkylated using BrCH2COOH in acetonitrile.  This new ligand framework was characterized by 1H and 13C NMR and electrospray ionization mass spectrometry (ESI-MS).  Solid-phase peptide synthesis (SPPS) was used to produce Triaza-X-BBN[7-14]NH2 conjugates with the following structure: Triaza-X-Q-W-A-V-G-H-L-M-(NH2), where the spacer group X = SSS, GGG, GSG and β-Alanine (SSS = Serylserylserine, GGG = Glycylglycylglycine, and GSG = Glycylserylglycine).  These conjugates were purified by reversed phase-HPLC (RP-HPLC) and characterized by ESI-MS.  In vitro competitive binding assays, using 125I-Tyr4-BBN as the radiolabelling gold std., demonstrated IC50 values in the nanomolar range for all the new nonmetalated conjugates.  For example, IC50s were 1.8 ± 0.4, 3.9. ± 0.4, 1.9 ± 0.3, and 1.3 ± 0.2 nM for X = SSS, GGG, GSG and β-Alanine, resp.  The new BBN conjugates were radiolabeled with 99mTc in moderate yield via the Isolink radiolabeling kit available from Tyco Healthcare, St. Louis, MO.  In vitro internalization and externalization analyses indicated receptor binding to be receptor specific in human, PC-3, prostate cancer cells.  Future in vivo studies in tumor-bearing mouse models are justified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHYXfVl45B3LVg90H21EOLACvtfcHk0lhx3vwEElHH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVentrw%253D&md5=f4b141f2140e19d788a969b657e2a728</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F15533170600778075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15533170600778075%26sid%3Dliteratum%253Aachs%26aulast%3DVeerendra%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520radiolabeling%2520and%2520in%2520vitro%2520GRP%2520receptor%2520targeting%2520of%252099mTc-triaza-X-BN%255B7-14%255DNH2%2520%2528X%2520%253D%2520seylserylserine%252C%2520glycylglycylglycine%252C%2520glycylserylglycine%252C%2520or%2520beta%2520alanine%2529%26jtitle%3DSynth.%2520React.%2520Inorg.%2520Met.-Org.%252C%2520Nano-Met.%2520Chem.%26date%3D2006%26volume%3D36%26spage%3D481%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">La Bella, R.; Garcia-Garayoa, E.; Langer, M.; Blauenstein, P.; Beck-Sickinger, A. G.; Schubiger, P. A.</span><span> </span><span class="NLM_article-title">In vitro and in vivo evaluation of a <sup>99m</sup>Tc(I)-labeled bombesin analogue for imaging gastrin releasing peptide receptor-positive tumors</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span>− <span class="NLM_lpage">560</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0969-8051%2802%2900314-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12088725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslKhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=553-560&author=R.+La+Bella&author=E.+Garcia-Garayoa&author=M.+Langer&author=P.+Blauenstein&author=A.+G.+Beck-Sickinger&author=P.+A.+Schubiger&title=In+vitro+and+in+vivo+evaluation+of+a+99mTc%28I%29-labeled+bombesin+analogue+for+imaging+gastrin+releasing+peptide+receptor-positive+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors</span></div><div class="casAuthors">La Bella, Roberto; Garcia-Garayoa, Elisa; Langer, Michael; Blauenstein, Peter; Beck-Sickinger, Annette G.; August Schubiger, P.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">553-560</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A new radiolabeled bombesin analog, [99mTc(I)-PADA-AVA]bombesin (7-14), was synthesized and in vitro and in vivo characterized.  High affinity and rapid internalization were obtained in binding assays.  A specific binding towards gastrin releasing peptide receptors-pos. tissues, pancreas and tumor, was obsd. in CD-1 nu/nu mice bearing PC-3 prostate adenocarcinoma xenografts.  We therefore conclude that [99mTc(I)-PADA-AVA]bombesin (7-14) might have promising characteristics for applications in nuclear medicine, namely for diagnosis of GRP receptor overexpressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqOSXZ_EGTJbVg90H21EOLACvtfcHk0lhZBt9bfgM8Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslKhs7g%253D&md5=75f26a1abdf1d00788f8160f1d742804</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900314-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900314-1%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BBella%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520a%252099mTc%2528I%2529-labeled%2520bombesin%2520analogue%2520for%2520imaging%2520gastrin%2520releasing%2520peptide%2520receptor-positive%2520tumors%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2002%26volume%3D29%26spage%3D553%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Garcia-Garayoa, E.; Rüegg, D.; Bläuenstein, P.; Zwimpfer, M.; Khan, I. U.; Maes, V.; Blanc, A.; Beck-Sickinger, A. G.; Tourwé, D. A.; Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Chemical and biological characterization of new Re(CO)<sub>3</sub>/[<sup>99m</sup>Tc](CO)<sub>3</sub> bombesin analogues</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span>− <span class="NLM_lpage">28</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2006.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=17210458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVWqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=17-28&author=E.+Garcia-Garayoa&author=D.+R%C3%BCegg&author=P.+Bl%C3%A4uenstein&author=M.+Zwimpfer&author=I.+U.+Khan&author=V.+Maes&author=A.+Blanc&author=A.+G.+Beck-Sickinger&author=D.+A.+Tourw%C3%A9&author=P.+A.+Schubiger&title=Chemical+and+biological+characterization+of+new+Re%28CO%293%2F%5B99mTc%5D%28CO%293+bombesin+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues</span></div><div class="casAuthors">Garcia Garayoa, Elisa; Ruegg, Dominique; Blauenstein, Peter; Zwimpfer, Martin; Khan, Irfan Ullah; Maes, Veronique; Blanc, Alain; Beck-Sickinger, Annette G.; Tourwe, Dirk A.; Schubiger, P. August</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-28</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Bombesin, a neuropeptide with potential for breast and prostate tumor targeting, is rapidly metabolized in vivo, and as a result, uptake in tumor xenografts in mice is poor.  An improvement can be expected from the introduction of nonnatural amino acids and spacers.  Leu13 was replaced by cyclohexylalanine and Met14 by norleucine.  Two spacers, -βAla-βAla- and 3,6-dioxa-8-aminooctanoic acid, were inserted between the receptor-binding amino acid sequence (7-14) of bombesin (BBS) and the retroNα-carboxymethyl histidine chelator used for labeling with the [99mTc](CO)3 core and the rhenium (Re) congener.  Methods: The biol. characterization of the new compds. was performed both in vitro on prostate carcinoma PC-3 cells (binding affinity, internalization/externalization) and in vivo (biodistribution in nude mice with tumor xenografts).  The stability was also investigated in human plasma.  The Re analogs were prepd. for chem. characterization.  Results: The nonnatural amino acids led to markedly slower degrdn. in human plasma and PC-3 cell cultures.  The receptor affinity of the new technetium 99m ([99mTc])-labeled BBS analogs was similar to the unmodified compd. with Kd<1 nM.  Uptake in the pancreas and in PC-3 tumor xenografts in nude mice was blocked by unlabeled BBS.  The best target-to-nontarget uptake ratio was clearly due to the presence of the more polar spacer, -βAla-βAla-.  Conclusions: The different spacers did not have a significant effect on stability or receptor affinity but had a clear influence on the uptake in healthy organs and tumors.  Uptake in the kidneys was lower than in the liver, which is likely to be due to the lipophilicity of the compds.  A specific, high uptake was also obsd. in the gastrin-releasing peptide receptor-rich pancreas.  Thus, with the introduction of spacers the in vivo properties of the compds. can be improved while leaving the affinity unaffected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb0lSgIEjZTLVg90H21EOLACvtfcHk0lhZBt9bfgM8Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVWqug%253D%253D&md5=35b5f5439f495e056e19be138af185b6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Garayoa%26aufirst%3DE.%26atitle%3DChemical%2520and%2520biological%2520characterization%2520of%2520new%2520Re%2528CO%25293%252F%255B99mTc%255D%2528CO%25293%2520bombesin%2520analogues%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2007%26volume%3D34%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Smith, C. J.; Sieckman, G. L.; Owen, N. K.; Hayes, D. L.; Mazuru, D. G.; Kannan, R.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiochemical investigations of gastrin-releasing peptide receptor-specific [<sup>99m</sup>Tc(X)(CO)<sub>3</sub>-Dpr-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH<sub>2</sub>)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H<sub>2</sub>O or P(CH<sub>2</sub>OH)<sub>3</sub><sup>1</sup></span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4082</span>− <span class="NLM_lpage">4088</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=4082-4088&author=C.+J.+Smith&author=G.+L.+Sieckman&author=N.+K.+Owen&author=D.+L.+Hayes&author=D.+G.+Mazuru&author=R.+Kannan&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Radiochemical+investigations+of+gastrin-releasing+peptide+receptor-specific+%5B99mTc%28X%29%28CO%293-Dpr-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-%28NH2%29%5D+in+PC-3%2C+tumor-bearing%2C+rodent+models%3A+syntheses%2C+radiolabeling%2C+and+in+vitro%2Fin+vivo+studies+where+Dpr+%3D+2%2C3-diaminopropionic+acid+and+X+%3D+H2O+or+P%28CH2OH%2931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DRadiochemical%2520investigations%2520of%2520gastrin-releasing%2520peptide%2520receptor-specific%2520%255B99mTc%2528X%2529%2528CO%25293-Dpr-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-%2528NH2%2529%255D%2520in%2520PC-3%252C%2520tumor-bearing%252C%2520rodent%2520models%253A%2520syntheses%252C%2520radiolabeling%252C%2520and%2520in%2520vitro%252Fin%2520vivo%2520studies%2520where%2520Dpr%2520%253D%25202%252C3-diaminopropionic%2520acid%2520and%2520X%2520%253D%2520H2O%2520or%2520P%2528CH2OH%252931%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D15%26spage%3D4082%26epage%3D4088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Alves, S.; Correia, J. D. G.; Santos, I.; Veerendra, B.; Sieckman, G. L.; Hoffman, T. J.; Rold, T.; Figueroa, S. D.; Retzloff, L.; McCrate, J.; Prasanphanich, A.; Smith, C. J.</span><span> </span><span class="NLM_article-title">Pyrazolyl conjugates of bombesin: a new tridentate ligand framework for stabilization of fac-[M(CO)<sub>3</sub>]<sup>+</sup> moiety</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span>− <span class="NLM_lpage">634</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2006.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=16843837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFWrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=625-634&author=S.+Alves&author=J.+D.+G.+Correia&author=I.+Santos&author=B.+Veerendra&author=G.+L.+Sieckman&author=T.+J.+Hoffman&author=T.+Rold&author=S.+D.+Figueroa&author=L.+Retzloff&author=J.+McCrate&author=A.+Prasanphanich&author=C.+J.+Smith&title=Pyrazolyl+conjugates+of+bombesin%3A+a+new+tridentate+ligand+framework+for+stabilization+of+fac-%5BM%28CO%293%5D%2B+moiety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazolyl conjugates of bombesin: A new tridentate ligand framework for the stabilization of fac-[M(CO)3]+ moiety</span></div><div class="casAuthors">Alves, Susana; Correia, Joao D. G.; Santos, Isabel; Veerendra, Bhadrasetty; Sieckman, Gary L.; Hoffman, Timothy J.; Rold, Tammy L.; Figueroa, Said Daibes; Retzloff, Lauren; McCrate, Joseph; Prasanphanich, Adam; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We have described the synthesis of tridentate pyrazolyl ligand frameworks for coordination to the fac-[*M(CO)3]+ metal fragment (*M = 186/188Re or 99mTc).  These ligands impart a degree of kinetic inertness on the metal center, warranting their study in biol. systems.  We herein report in vitro/in vivo radiolabeling investigations of a new series of pyrazolyl bombesin (BBN) conjugates radiolabeled via the Isolink kit.  These new conjugates are based on the general structure [99mTc-pyrazolyl-X-BBN[7-14]NH2], where X = β-alanine, serylserylserine or glycylglycylglycine.  The pyrazolyl ligand is a tridentate ligand framework that coordinates the metal center through nitrogen donor atoms.  The results of these investigations demonstrate the ability of these new conjugates to specifically target the gastrin-releasing peptide receptor subtype 2, which is overexpressed on human prostate PC-3 cancerous tissues.  Therefore, these studies suggest the tridentate pyrazolyl ligand framework to be an ideal candidate for the design and development of low-valent 99mTc-based diagnostic radiopharmaceuticals based on BBN or other targeting vectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjIoH7usgZFLVg90H21EOLACvtfcHk0lhZBt9bfgM8Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFWrtrg%253D&md5=036ff65a33b173f9f6294379a16dabed</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DAlves%26aufirst%3DS.%26atitle%3DPyrazolyl%2520conjugates%2520of%2520bombesin%253A%2520a%2520new%2520tridentate%2520ligand%2520framework%2520for%2520stabilization%2520of%2520fac-%255BM%2528CO%25293%255D%252B%2520moiety%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D625%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Maina, T.; Nock, B.; Mather, S.</span><span> </span><span class="NLM_article-title">Targeting prostate cancer with radiolabelled bombesins</span>.  <span class="citation_source-journal">Cancer Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span>− <span class="NLM_lpage">157</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=153-157&author=T.+Maina&author=B.+Nock&author=S.+Mather&title=Targeting+prostate+cancer+with+radiolabelled+bombesins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DTargeting%2520prostate%2520cancer%2520with%2520radiolabelled%2520bombesins%26jtitle%3DCancer%2520Imaging%26date%3D2006%26volume%3D6%26spage%3D153%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Seo, Y.; Kurhanewicz, J.; Franc, B. L.; Hawkins, R. A.; Hasegawa, B. H.</span><span> </span><span class="NLM_article-title">Improved prostate cancer imaging with SPECT/CT and MRI/MRSI</span>.  <span class="citation_source-journal">IEEE Trans. Nucl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span>),  <span class="NLM_fpage">1316</span>− <span class="NLM_lpage">1320</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1109%2FTNS.2005.858241" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=1316-1320&issue=5&author=Y.+Seo&author=J.+Kurhanewicz&author=B.+L.+Franc&author=R.+A.+Hawkins&author=B.+H.+Hasegawa&title=Improved+prostate+cancer+imaging+with+SPECT%2FCT+and+MRI%2FMRSI"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1109%2FTNS.2005.858241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1109%252FTNS.2005.858241%26sid%3Dliteratum%253Aachs%26aulast%3DSeo%26aufirst%3DY.%26atitle%3DImproved%2520prostate%2520cancer%2520imaging%2520with%2520SPECT%252FCT%2520and%2520MRI%252FMRSI%26jtitle%3DIEEE%2520Trans.%2520Nucl.%2520Sci.%26date%3D2005%26volume%3D52%26issue%3D5%26spage%3D1316%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Swanson, M. G.; Vigneron, D. B.; Tran, T. K.; Kurhanewicz, J.</span><span> </span><span class="NLM_article-title">Magnetic resonance imaging and spectroscopic imaging of prostate cancer</span>.  <span class="citation_source-journal">Cancer Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span>− <span class="NLM_lpage">523</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=510-523&author=M.+G.+Swanson&author=D.+B.+Vigneron&author=T.+K.+Tran&author=J.+Kurhanewicz&title=Magnetic+resonance+imaging+and+spectroscopic+imaging+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DM.%2BG.%26atitle%3DMagnetic%2520resonance%2520imaging%2520and%2520spectroscopic%2520imaging%2520of%2520prostate%2520cancer%26jtitle%3DCancer%2520Invest.%26date%3D2001%26volume%3D19%26spage%3D510%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Jadvar, H.; Pinski, J. K.; Conti, P. S.</span><span> </span><span class="NLM_article-title">FDG PET in suspected recurrent and metastatic prostate cancer</span>.  <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span>− <span class="NLM_lpage">1488</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12883728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A280%3ADC%252BD3szltFGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1485-1488&author=H.+Jadvar&author=J.+K.+Pinski&author=P.+S.+Conti&title=FDG+PET+in+suspected+recurrent+and+metastatic+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">FDG PET in suspected recurrent and metastatic prostate cancer</span></div><div class="casAuthors">Jadvar Hossein; Pinski Jacek K; Conti Peter S</div><div class="citationInfo"><span class="NLM_cas:title">Oncology reports</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1485-8</span>
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    </div><div class="casAbstract">Development of an accurate non-invasive imaging technique to detect recurrent and metastatic prostate cancer is critical for the effective management of these patients.  The purpose of our study was to determine the diagnostic utility of positron emission tomography with [F-18]fluorodeoxyglucose (FDG PET) in patients with suspected or known metastatic and recurrent prostate cancer.  We performed 12 FDG PET scans in 12 men (age 65-81 years) with history of prostate cancer who had previously undergone radical prostatectomy (n=3) or prostate radiotherapy (n=9).  Serum prostate specific antigen (PSA) level was elevated in all patients (5-206 ng/ml).  Available correlative imaging studies included contrast-enhanced chest, abdomen and pelvis CT (n=8), bone scintigraphy (n=5), and radiography (n=2).  PET findings were compared to the findings of the other imaging studies on a lesion-by-lesion basis in individual patients.  Validation was by clinical or imaging follow-up for up to 1 year.  PET findings were concordant with the findings of the other imaging studies in 7 patients.  PET was discordant with the other imaging studies in 5 patients.  PET demonstrated suspicious hypermetabolic pelvic lymph nodes in one patient with negative pelvis CT.  PET underestimated the extent of osseous metastatic disease in the remaining 4 patients.  FDG PET is limited in the detection of osseous metastatic lesions but may be useful in the detection of metastatic nodal and soft tissue disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIzh94Sim3sexsqfvU0ziafW6udTcc2ebvTQHHUqrkybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szltFGhtQ%253D%253D&md5=02619ddceff00e62762bc0b374532dcc</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJadvar%26aufirst%3DH.%26atitle%3DFDG%2520PET%2520in%2520suspected%2520recurrent%2520and%2520metastatic%2520prostate%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2003%26volume%3D10%26spage%3D1485%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Picchio, M.; Messa, C.; Landoni, C.; Gianolli, L.; Sironi, S.; Brioschi, M.; Matarrese, M.; Matei, D. V.; De Cobelli, F.; Del Maschio, A.; Rocco, F.; Rigatti, P.; Fazio, F.</span><span> </span><span class="NLM_article-title">Value of [<sup>11</sup>C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [<sup>1</sup>8F]fluorodeoxyglucose-positron emission tomography</span>.  <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span>− <span class="NLM_lpage">1340</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1097%2F01.ju.0000056901.95996.43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=12629355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFahs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2003&pages=1337-1340&author=M.+Picchio&author=C.+Messa&author=C.+Landoni&author=L.+Gianolli&author=S.+Sironi&author=M.+Brioschi&author=M.+Matarrese&author=D.+V.+Matei&author=F.+De+Cobelli&author=A.+Del+Maschio&author=F.+Rocco&author=P.+Rigatti&author=F.+Fazio&title=Value+of+%5B11C%5Dcholine-positron+emission+tomography+for+re-staging+prostate+cancer%3A+a+comparison+with+%5B18F%5Dfluorodeoxyglucose-positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Value of [11C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [18F]fluorodeoxyglucose-Positron Emission Tomography</span></div><div class="casAuthors">Picchio, M.; Messa, C.; Landoni, C.; Gianolli, L.; Sironi, S.; Brioschi, M.; Matarrese, M.; Matei, D. V.; De Cobelli, F.; Del Maschio, A.; Rocco, F.; Rigatti, P.; Fazio, F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1337-1340</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">PURPOSE We compared [11C]choline-positron emission tomog. (PET) with [18F]fluorodeoxyglucose-PET for re-staging prostate cancer in a group of 100 patients.  MATERIALS AND METHODS A total of 100 consecutive patients referred for whole body [18F]fluorodeoxyglucose-PET for clin. prostate re-staging after radical treatment for prostate cancer were retrospectively included in the study.  Mean prostate specific antigen (PSA) was 6.57 ng./mL.  In all cases [11C]choline-PET was also performed.  PET studies were done with a multiring device 5 min after i.v. injection of approx. 370 MBq. [11C]choline and 60 min after injection of approx. 370 MBq. [18F]fluorodeoxyglucose.  PET findings were compared with those obtained with different conventional imaging and with PSA assessed at the time of PET and 1 yr later.  RESULTS Areas of abnormal focal increases were noted in 47% of patients on [11C]choline-PET and in 27% on [18F]fluorodeoxyglucose-PET.  Of the 100 patients 49 had pos. conventional imaging findings.  All except 14 [11C]choline-PET findings were concordant with conventional imaging, including 6 neg. and 8 pos. conventional imaging results.  All except 1 [11C]choline-PET neg. cases also had neg. conventional imaging after 1 yr.  PSA at 1 yr remained stable or decreased in 80% and 62% of [11C]choline-PET neg. and pos. cases, resp.  CONCLUSIONS [11C]choline-PET seems to be useful for re-staging prostatectomy cases with increasing serum PSA levels.  It is superior to [18F]fluorodeoxyglucose-PET and complementary to conventional imaging but with the advantage of staging disease at a single step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpAkqx-bhrArVg90H21EOLACvtfcHk0lgogwRm1gbBSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFahs7o%253D&md5=d29b617ddde72c33dc9f3e58454ecaa5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1097%2F01.ju.0000056901.95996.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.ju.0000056901.95996.43%26sid%3Dliteratum%253Aachs%26aulast%3DPicchio%26aufirst%3DM.%26atitle%3DValue%2520of%2520%255B11C%255Dcholine-positron%2520emission%2520tomography%2520for%2520re-staging%2520prostate%2520cancer%253A%2520a%2520comparison%2520with%2520%255B18F%255Dfluorodeoxyglucose-positron%2520emission%2520tomography%26jtitle%3DJ.%2520Urol.%26date%3D2003%26volume%3D169%26spage%3D1337%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Hara, T.; Kosaka, N.; Kishi, H.</span><span> </span><span class="NLM_article-title">Development of (18)F-fluoroethyl-choline for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span>− <span class="NLM_lpage">199</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=187-199&author=T.+Hara&author=N.+Kosaka&author=H.+Kishi&title=Development+of+%2818%29F-fluoroethyl-choline+for+cancer+imaging+with+PET%3A+synthesis%2C+biochemistry%2C+and+prostate+cancer+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520%252818%2529F-fluoroethyl-choline%2520for%2520cancer%2520imaging%2520with%2520PET%253A%2520synthesis%252C%2520biochemistry%252C%2520and%2520prostate%2520cancer%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2002%26volume%3D43%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Jankowsky, R.; Kirsch, S.; Reich, T.; Spies, H.; Johannsen, B.</span><span> </span><span class="NLM_article-title">Solution structure of rhenium(V) oxo peptide complexes of glycylglycylcysteine and cysteinylglycine as studied by capillary electrophoresis and X-ray absorption spectroscopy</span>.  <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span>− <span class="NLM_lpage">106</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=99-106&author=R.+Jankowsky&author=S.+Kirsch&author=T.+Reich&author=H.+Spies&author=B.+Johannsen&title=Solution+structure+of+rhenium%28V%29+oxo+peptide+complexes+of+glycylglycylcysteine+and+cysteinylglycine+as+studied+by+capillary+electrophoresis+and+X-ray+absorption+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJankowsky%26aufirst%3DR.%26atitle%3DSolution%2520structure%2520of%2520rhenium%2528V%2529%2520oxo%2520peptide%2520complexes%2520of%2520glycylglycylcysteine%2520and%2520cysteinylglycine%2520as%2520studied%2520by%2520capillary%2520electrophoresis%2520and%2520X-ray%2520absorption%2520spectroscopy%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1998%26volume%3D70%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Gourni, E.; Bouziotis, P.; Zikos, C.; Loudos, G.; Xanthopoulos, S.; Fani, M.; Archimandritis, S. C.; Varvarigou, A. D.</span><span> </span><span class="NLM_article-title">Comparative in vivo evaluation of two novel Tc-99m labeled bombesin derivatives</span>.  <span class="citation_source-journal">Nucl. Instrum. Methods A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">569</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span>− <span class="NLM_lpage">521</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nima.2006.08.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KgtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=569&publication_year=2006&pages=518-521&author=E.+Gourni&author=P.+Bouziotis&author=C.+Zikos&author=G.+Loudos&author=S.+Xanthopoulos&author=M.+Fani&author=S.+C.+Archimandritis&author=A.+D.+Varvarigou&title=Comparative+in+vivo+evaluation+of+two+novel+Tc-99m+labeled+bombesin+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative in vivo evaluation of two novel 99mTc labelled bombesin derivatives</span></div><div class="casAuthors">Gourni, Eleni; Bouziotis, Penelope; Zikos, Christos; Loudos, George; Xanthopoulos, Stavros; Fani, Melpomeni; Archimandritis, Spyridon C.; Varvarigou, Alexandra D.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Instruments & Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors, and Associated Equipment</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">569</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">518-521</span>CODEN:
                <span class="NLM_cas:coden">NIMAER</span>;
        ISSN:<span class="NLM_cas:issn">0168-9002</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bombesin (BN), a 14 amino acid peptide, is an analog of human gastrin-releasing-peptide (GRP) that binds to GRP receptors (GRP-R) with high affinity and specificity.  In addn. to this physiol. role, GRP, through its interaction with GRP-R, promotes tumor growth in a no. of human cancer cell lines.  The GRP receptors are over-expressed on a variety of human cancer cells.  Aim of the present work is the study of two novels BN-like peptides, by investigating the radiochem. and radiopharmacol. behavior of their complexes with metals.  The derivs. under study are: Gly-Gly-Cys-Aca-BN [2-14] where Aca: 6-amino-hexanoic acid.  Pyroglutamic acid in the bombesin mol. has been replaced by the chem. group Gly-Gly-Cys-Aca, which bears an amino-acid combination capable of complexing a variety of radiometals.  The other deriv. under study is: Gly-Gly-Cys-Aca-BN [7-14].  This moiety of the peptide has been chosen because it has been proven to be a potent GRP agonist.  The peptide derivs. were synthesized by SPPS, according to the Fmoc strategy and were identified by reverse phase high performance liq. chromatog. (RP-HPLC).  Radiolabelling with 99mTc was performed via the precursor 99mTc-gluconate.  The stability of the radiolabeled species was examd. with time.  In vivo studies of the two 99mTc-labeled derivs. were performed, comparatively, in normal mice, attention being focused on GRP receptor-bearing organs, and in exptl. induced prostate cancer models.  Exptl. tumors were imaged in a small field-of-view animal gamma camera.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDZ8ZZouotUbVg90H21EOLACvtfcHk0li1g14fp0_U2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KgtL7O&md5=a0008b48682d2aedc0c08acebb9898da</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.nima.2006.08.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nima.2006.08.141%26sid%3Dliteratum%253Aachs%26aulast%3DGourni%26aufirst%3DE.%26atitle%3DComparative%2520in%2520vivo%2520evaluation%2520of%2520two%2520novel%2520Tc-99m%2520labeled%2520bombesin%2520derivatives%26jtitle%3DNucl.%2520Instrum.%2520Methods%2520A%26date%3D2006%26volume%3D569%26spage%3D518%26epage%3D521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Deutsch, E.; Libson, K.; Vanderheyden, J.-L.; Ketring, A. R.; Maxon, H. R.</span><span> </span><span class="NLM_article-title">The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span>− <span class="NLM_lpage">477</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaL2sXks1Grtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1986&pages=465-477&author=E.+Deutsch&author=K.+Libson&author=J.-L.+Vanderheyden&author=A.+R.+Ketring&author=H.+R.+Maxon&title=The+chemistry+of+rhenium+and+technetium+as+related+to+the+use+of+isotopes+of+these+elements+in+therapeutic+and+diagnostic+nuclear+medicine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine</span></div><div class="casAuthors">Deutsch, Edward; Libson, Karen; Vanderheyden, Jean Luc; Ketring, Alan R.; Maxon, Harry R.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-77</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    </div><div class="casAbstract">The β-emitting isotopes 186Re and 188Re are logical choices on which to base therapeutic radiopharmaceuticals that might be expected to be analogous to diagnostic radiopharmaceuticals based on 99mTc.  However, the chem. of Re is sufficiently different from that of Tc so that the development of Re radiopharmaceuticals often cannot be predicated on the known chem. and biol. behavior of 99mTc radiopharmaceuticals.  The relevant chem. differences involve the greater stability of the higher oxidn. states of Re (and thus the greater tendency of reduced Re radiopharmaceuticals to undergo reoxidn. to perrhenate), and the greater substitution inertness of reduced Re complexes.  These differences are illustrated (1) in the prepn. and use of 186Re (Sn)-HEDP and 99mTc(Sn)-HEDP diphosphonate radiopharmaceuticals designed, resp., for palliative therapy and diagnosis of metastatic cancer to bone and (2) in the prepn. and biodistribution of tr-[186Re(DMPE)2Cl2]+ and [186Re(DMPE)3]+ (where DMPE = 1,2-bis(dimethylphosphino)ethane]), analogs to the potential myocardial perfusion imaging agents tr-[99mTc(DMPE)2Cl2]+ and [99mTc(DMPE)3]+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT5RYYRmjFFbVg90H21EOLACvtfcHk0li1g14fp0_U2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXks1Grtg%253D%253D&md5=42810b36423c1ba759885c3bcc371869</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DE.%26atitle%3DThe%2520chemistry%2520of%2520rhenium%2520and%2520technetium%2520as%2520related%2520to%2520the%2520use%2520of%2520isotopes%2520of%2520these%2520elements%2520in%2520therapeutic%2520and%2520diagnostic%2520nuclear%2520medicine%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1986%26volume%3D13%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Wüthrich, K.</span> <span class="citation_source-book">NMR of Proteins and Nucleic Acids</span>; <span class="NLM_publisher-name">Wiley-Interscience Publication</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">130</span>− <span class="NLM_lpage">161</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=130-161&author=K.+W%C3%BCthrich&title=NMR+of+Proteins+and+Nucleic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26btitle%3DNMR%2520of%2520Proteins%2520and%2520Nucleic%2520Acids%26pub%3DWiley-Interscience%2520Publication%26date%3D1986%26spage%3D130%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Lever, S. Z.; Baidoo, K. E.; Mahmood, A.</span><span> </span><span class="NLM_article-title">Structure proof of <i>syn/anti</i> isomerism in N-alkylated diaminedithiol (DADT) complexes of technetium</span>.  <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span>− <span class="NLM_lpage">184</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0020-1693%2800%2984842-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFGqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=1990&pages=183-184&author=S.+Z.+Lever&author=K.+E.+Baidoo&author=A.+Mahmood&title=Structure+proof+of+syn%2Fanti+isomerism+in+N-alkylated+diaminedithiol+%28DADT%29+complexes+of+technetium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structure proof of syn/anti isomerism in N-alkylated diaminedithiol (DADT) complexes of technetium</span></div><div class="casAuthors">Lever, Susan Z.; Baidoo, Kwamena E.; Mahmood, Ashfaq</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-4</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    </div><div class="casAbstract">The redn. of NH499TeO4 by NaS2O4 in aq. NaOH in the presence of 2,4,9-trimethyl-4,7-diaza-2,9-decanedithiol (H3L) gave syn- and anti-99TcOL (I).  syn-I is monoclinic, space group P21/n, Z = 8, R = 0.035, Rw = 0.074.  anti-I is orthorhombic, space group Fddd2, Z = 16, R = 0.023, Rw = 0.029.  The Me group on the N atom is syn or anti to the O on Tc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqssa5Fs9_hz7Vg90H21EOLACvtfcHk0li1g14fp0_U2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFGqsLY%253D&md5=0b40f835bfbb5b31f75b885c0704d134</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0020-1693%2800%2984842-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-1693%252800%252984842-2%26sid%3Dliteratum%253Aachs%26aulast%3DLever%26aufirst%3DS.%2BZ.%26atitle%3DStructure%2520proof%2520of%2520syn%252Fanti%2520isomerism%2520in%2520N-alkylated%2520diaminedithiol%2520%2528DADT%2529%2520complexes%2520of%2520technetium%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D1990%26volume%3D176%26spage%3D183%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Francesconi, L. C.; Graczyk, G.; Wehrli, S.; Shaikh, S. N.; McClinton, D.; Liu, S.; Zubieta, J.; Kung, H. F.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of neutral MVO (M = technetium, rhenium) amine−thiol complexes containing a pendant phenylpiperidine group</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3114</span>− <span class="NLM_lpage">3124</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic00066a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=3114-3124&author=L.+C.+Francesconi&author=G.+Graczyk&author=S.+Wehrli&author=S.+N.+Shaikh&author=D.+McClinton&author=S.+Liu&author=J.+Zubieta&author=H.+F.+Kung&title=Synthesis+and+characterization+of+neutral+MVO+%28M+%3D+technetium%2C+rhenium%29+amine%E2%88%92thiol+complexes+containing+a+pendant+phenylpiperidine+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fic00066a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00066a025%26sid%3Dliteratum%253Aachs%26aulast%3DFrancesconi%26aufirst%3DL.%2BC.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520neutral%2520MVO%2520%2528M%2520%253D%2520technetium%252C%2520rhenium%2529%2520amine%25E2%2588%2592thiol%2520complexes%2520containing%2520a%2520pendant%2520phenylpiperidine%2520group%26jtitle%3DInorg.%2520Chem.%26date%3D1993%26volume%3D32%26spage%3D3114%26epage%3D3124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Pelecanou, M.; Chryssou, K.; Stassinopoulou, C. I.</span><span> </span><span class="NLM_article-title">Trends in NMR chemical shifts and ligand mobility of TcO(V) and ReO(V) complexes with aminothiols</span>.  <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span>− <span class="NLM_lpage">351</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2000&pages=347-351&author=M.+Pelecanou&author=K.+Chryssou&author=C.+I.+Stassinopoulou&title=Trends+in+NMR+chemical+shifts+and+ligand+mobility+of+TcO%28V%29+and+ReO%28V%29+complexes+with+aminothiols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPelecanou%26aufirst%3DM.%26atitle%3DTrends%2520in%2520NMR%2520chemical%2520shifts%2520and%2520ligand%2520mobility%2520of%2520TcO%2528V%2529%2520and%2520ReO%2528V%2529%2520complexes%2520with%2520aminothiols%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2000%26volume%3D79%26spage%3D347%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Liu, S.; Edwards, S.; Barrett, J.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc labeling of highly potent small peptides</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span>− <span class="NLM_lpage">636</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc970058b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK2sXlslGmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=621-636&author=S.+Liu&author=S.+Edwards&author=J.+Barrett&title=99mTc+labeling+of+highly+potent+small+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc Labeling of Highly Potent Small Peptides</span></div><div class="casAuthors">Liu, Shuang; Edwards, D. Scott; Barrett, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">621-636</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 211 refs. on clin. requirements for new 99mTC radiopharmaceuticals, various radiolabeling approaches, different chelating systems and their 99mTc-labeling kinetics, and examples of 99mTc-labeled peptides as radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPhZW5ileFrVg90H21EOLACvtfcHk0liI8UjvVf0lzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlslGmsrc%253D&md5=5f0320e9b77dfbe58e105b31c80289f6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbc970058b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc970058b%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3D99mTc%2520labeling%2520of%2520highly%2520potent%2520small%2520peptides%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D621%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Banerjee, S. R.; Maresca, K. P.; Francesconi, L.; Valliant, J.; Babich, J. W.; Zubieta, J.</span><span> </span><span class="NLM_article-title">New directions in the coordination chemistry of <sup>99m</sup>Tc: a reflection on technetium core structures and a strategy for new chelate design</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span>− <span class="NLM_lpage">20</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2004.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=15691657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=1-20&author=S.+R.+Banerjee&author=K.+P.+Maresca&author=L.+Francesconi&author=J.+Valliant&author=J.+W.+Babich&author=J.+Zubieta&title=New+directions+in+the+coordination+chemistry+of+99mTc%3A+a+reflection+on+technetium+core+structures+and+a+strategy+for+new+chelate+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design</span></div><div class="casAuthors">Banerjee, Sangeeta Ray; Maresca, Kevin P.; Francesconi, Lynn; Valliant, John; Babich, John W.; Zubieta, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-20</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Bifunctional chelates offer a general approach for the linking of radioactive metal cations to macromols.  In the specific case of 99mTc, a variety of technologies were developed for assembling a metal-chelate-biomol. complex.  An evaluation of these methodologies requires an appreciation of the coordination characteristics and preferences of the Tc core structures and oxidn. states, which serve as platforms for the development of the imaging agent.  Three technologies, namely, the MAG3-based bifunctional chelates, the N-oxysuccinimidylhydrazino-nicotinamide system and the recently described single amino acid chelates for the {Tc(CO)3}1+ core, are discussed in terms of the fundamental coordination chem. of the Tc core structures.  In assessing the advantages and disadvantages of these technologies, the single amino acid analog chelates (SAAC), which are readily conjugated to small peptides by solid-phase synthesis methods and which form robust complexes with the {Tc(CO)3}1+ core, offer an effective alternative to the previously described methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfLLF_PjeDlrVg90H21EOLACvtfcHk0liI8UjvVf0lzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyisbs%253D&md5=995097fc00e6bb258cc9178cba1f49bf</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2004.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2004.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%2BR.%26atitle%3DNew%2520directions%2520in%2520the%2520coordination%2520chemistry%2520of%252099mTc%253A%2520a%2520reflection%2520on%2520technetium%2520core%2520structures%2520and%2520a%2520strategy%2520for%2520new%2520chelate%2520design%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Lister-James, J.; Knight, L. C.; Mauer, A. H.; Bush, L. R.; Mayer, B. R.; Dean, R. T.</span><span> </span><span class="NLM_article-title">Thrombus imaging with a technetium-99m-labeled, activated platelet receptor-binding peptide</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span>− <span class="NLM_lpage">781</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=775-781&author=J.+Lister-James&author=L.+C.+Knight&author=A.+H.+Mauer&author=L.+R.+Bush&author=B.+R.+Mayer&author=R.+T.+Dean&title=Thrombus+imaging+with+a+technetium-99m-labeled%2C+activated+platelet+receptor-binding+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLister-James%26aufirst%3DJ.%26atitle%3DThrombus%2520imaging%2520with%2520a%2520technetium-99m-labeled%252C%2520activated%2520platelet%2520receptor-binding%2520peptide%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1996%26volume%3D37%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Pearson, D. A.; Lister-James, J.; McBride, W. J.; Wilson, D. M.; Martel, L. J.; Civitello, E. R.; Taylor, J. E.; Moyer, B. R.; Dean, R. T.</span><span> </span><span class="NLM_article-title">Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span>− <span class="NLM_lpage">1371</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm950111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1361-1371&author=D.+A.+Pearson&author=J.+Lister-James&author=W.+J.+McBride&author=D.+M.+Wilson&author=L.+J.+Martel&author=E.+R.+Civitello&author=J.+E.+Taylor&author=B.+R.+Moyer&author=R.+T.+Dean&title=Somatostatin+receptor-binding+peptides+labeled+with+technetium-99m%3A+chemistry+and+initial+biological+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm950111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950111m%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DD.%2BA.%26atitle%3DSomatostatin%2520receptor-binding%2520peptides%2520labeled%2520with%2520technetium-99m%253A%2520chemistry%2520and%2520initial%2520biological%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1361%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Lister-James, J.; Moyer, B. R.; Dean, T.</span><span> </span><span class="NLM_article-title">Small peptides radiolabeled with <sup>99m</sup>Tc</span>.  <span class="citation_source-journal">Q. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span>− <span class="NLM_lpage">233</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=8961801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A280%3ADyaK2s7itFWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=221-233&author=J.+Lister-James&author=B.+R.+Moyer&author=T.+Dean&title=Small+peptides+radiolabeled+with+99mTc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Small peptides radiolabeled with 99mTc</span></div><div class="casAuthors">Lister-James J; Moyer B R; Dean T</div><div class="citationInfo"><span class="NLM_cas:title">The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-33</span>
        ISSN:<span class="NLM_cas:issn">1125-0135</span>.
    </div><div class="casAbstract">UNLABELLED:  The pharmacokinetic characteristics of small peptides radiolabeled with technetium-99m, their physico-chemical properties and radiolabeling techniques are reviewed.  METHODS:  Physical and chemical characteristics which affect pharmacokinetics are discussed with particular reference to lipophilicity, charge and resistance to peptidases.  General biodistribution, pharmacokinetics, metabolism and excretion characteristics, as well as tissue uptake kinetics are described.  Methods of radiolabeling small peptides with 99mTc are reviewed, including discussion of chelating groups for technetium.  Specific examples drawn either from the literature or from the 99mTc labeled peptides under development by Diatide are presented.  RESULT:  Although lipophilicity and charge have an impact, the degree of resistance to peptidases is a key determinant of pharmacokinetic behavior.  In general, pharmacokinetics and rate of tissue uptake are fast and metabolism occurs mainly via peptidase activity in the liver and kidneys.  Although the route depends on a number of factors, excretion also usually is rapid.  Chelating groups for 99mTc in the (+5) oxidation state are preferred.  Site specific incorporation of the chelating groups during peptide synthesis is also preferred.  Examples of renal imaging agents (MAG3), thrombus imaging peptides (P280 and P748), tumor imaging peptides (P587 and P829) and infection/inflammation imaging peptides (fMLF-type and P483H) are presented and discussed.  CONCLUSIONS:  99mTc labeled small peptides are characterized by rapid pharmacokinetics and tissue penetration.  Furthermore, small peptides are readily synthesized and the desired pharmacokinetic behavior may be engineered into the molecule.  They are well suited for development as radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDV5lQiqZLqYqdXsLcGTEUfW6udTcc2eb0eZbHcb_c17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7itFWgtg%253D%253D&md5=110033e7aef1b659f380b85ade31a52a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLister-James%26aufirst%3DJ.%26atitle%3DSmall%2520peptides%2520radiolabeled%2520with%252099mTc%26jtitle%3DQ.%2520J.%2520Nucl.%2520Med.%26date%3D1996%26volume%3D40%26spage%3D221%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Jankowsky, R.; Kirsch, S.; Reich, T.; Spies, H.; Johannsen, B.</span><span> </span><span class="NLM_article-title">Solution structures of rhenium(V) oxo peptide complexes of glycylglycylcysteine and cysteinylglycine as studied by capillary electrophoresis and X-ray absorption spectroscopy</span>.  <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span>− <span class="NLM_lpage">106</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=99-106&author=R.+Jankowsky&author=S.+Kirsch&author=T.+Reich&author=H.+Spies&author=B.+Johannsen&title=Solution+structures+of+rhenium%28V%29+oxo+peptide+complexes+of+glycylglycylcysteine+and+cysteinylglycine+as+studied+by+capillary+electrophoresis+and+X-ray+absorption+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJankowsky%26aufirst%3DR.%26atitle%3DSolution%2520structures%2520of%2520rhenium%2528V%2529%2520oxo%2520peptide%2520complexes%2520of%2520glycylglycylcysteine%2520and%2520cysteinylglycine%2520as%2520studied%2520by%2520capillary%2520electrophoresis%2520and%2520X-ray%2520absorption%2520spectroscopy%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1998%26volume%3D70%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Wong, E.; Fauconnier, T.; Bennett, S.; Valliant, J.; Nguyen, T.; Lau, F.; Lu, L. F. L.; Pollak, A.; Bell, R. A.; Thornback, J. R.</span><span> </span><span class="NLM_article-title">Rhenium(V) and technetium(V) oxo complexes of an N<sub>2</sub>N′S peptidic chelator: evidence of interconversion between the <i>syn</i> and <i>anti</i> conformations</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5799</span>− <span class="NLM_lpage">5808</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic9706562" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=5799-5808&author=E.+Wong&author=T.+Fauconnier&author=S.+Bennett&author=J.+Valliant&author=T.+Nguyen&author=F.+Lau&author=L.+F.+L.+Lu&author=A.+Pollak&author=R.+A.+Bell&author=J.+R.+Thornback&title=Rhenium%28V%29+and+technetium%28V%29+oxo+complexes+of+an+N2N%E2%80%B2S+peptidic+chelator%3A+evidence+of+interconversion+between+the+syn+and+anti+conformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fic9706562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic9706562%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%26atitle%3DRhenium%2528V%2529%2520and%2520technetium%2528V%2529%2520oxo%2520complexes%2520of%2520an%2520N2N%25E2%2580%25B2S%2520peptidic%2520chelator%253A%2520evidence%2520of%2520interconversion%2520between%2520the%2520syn%2520and%2520anti%2520conformations%26jtitle%3DInorg.%2520Chem.%26date%3D1997%26volume%3D36%26spage%3D5799%26epage%3D5808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Takayama, T.; Suzuki, K.; Sekine, T.; Kudo, H.</span><span> </span><span class="NLM_article-title">Syntheses and structures of technetium(V) and rhenium(V) oxo complexes of peptide having KYC-sequence</span>.  <span class="citation_source-journal">Radiochim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span>− <span class="NLM_lpage">251</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1524%2Fract.2000.88.3-4.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslaqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2000&pages=247-251&author=T.+Takayama&author=K.+Suzuki&author=T.+Sekine&author=H.+Kudo&title=Syntheses+and+structures+of+technetium%28V%29+and+rhenium%28V%29+oxo+complexes+of+peptide+having+KYC-sequence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and structures of technetium(V) and rhenium(V) oxo complexes of peptide having KYC-sequence</span></div><div class="casAuthors">Takayama, Tsutomu; Suzuki, Keisuke; Sekine, Tsutomu; Kudo, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Radiochimica Acta</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">247-251</span>CODEN:
                <span class="NLM_cas:coden">RAACAP</span>;
        ISSN:<span class="NLM_cas:issn">0033-8230</span>.
    
            (<span class="NLM_cas:orgname">R. Oldenbourg Verlag</span>)
        </div><div class="casAbstract">Tc(V) and Re(V) oxo complexes of a peptide having a KYC-sequence such as KYCAR (H3L5) and KYCAREPPTRTNAYWGQG-NH2 (H3L18) were synthesized, and structures of the complexes were characterized by spectroscopic techniques.  All of the complexes were synthesized by the ligand exchange reaction of [Bu4N][MOCl4] (M = 99Tc, Re) with peptide in MeOH or DMF soln.  These complexes have a square pyramidal structure with an oxo ligand at the apical position.  The peptide is coordinated to a metal atom through Namine of lysine, Sthiol of cysteine, and Namide of tyrosine and cysteine in the equatorial plane.  A lysine (CH2)4NH2 group of the L5 ligand has the syn conformation with respect to metal-oxo bonding in the complex.  The syn isomer was selectively formed in the ligand exchange reaction.  The conversion of the syn isomer to the anti isomer was obsd. only for syn-[ReO(L5)], in which the coordination of H2O to the trans position of the oxo ligand was involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqibm5mxhJRzrVg90H21EOLACvtfcHk0liflsgloEjX0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslaqurY%253D&md5=97840f719387eeba527afb3727afecd3</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1524%2Fract.2000.88.3-4.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1524%252Fract.2000.88.3-4.247%26sid%3Dliteratum%253Aachs%26aulast%3DTakayama%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520structures%2520of%2520technetium%2528V%2529%2520and%2520rhenium%2528V%2529%2520oxo%2520complexes%2520of%2520peptide%2520having%2520KYC-sequence%26jtitle%3DRadiochim.%2520Acta%26date%3D2000%26volume%3D88%26spage%3D247%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Wong, E.; Bennett, S.; Lawrence, B.; Fauconnier, T.; Lu, L. F. L.; Bell, R. A.; Thornback, J. R.; Eshima, D.</span><span> </span><span class="NLM_article-title">Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">5695</span>− <span class="NLM_lpage">5700</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic010462t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=5695-5700&author=E.+Wong&author=S.+Bennett&author=B.+Lawrence&author=T.+Fauconnier&author=L.+F.+L.+Lu&author=R.+A.+Bell&author=J.+R.+Thornback&author=D.+Eshima&title=Tuftsin+receptor-binding+peptide+labeled+with+technetium%3A+chemistry+and+preliminary+in+vitro+receptor-binding+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fic010462t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic010462t%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DE.%26atitle%3DTuftsin%2520receptor-binding%2520peptide%2520labeled%2520with%2520technetium%253A%2520chemistry%2520and%2520preliminary%2520in%2520vitro%2520receptor-binding%2520study%26jtitle%3DInorg.%2520Chem.%26date%3D2001%26volume%3D40%26spage%3D5695%26epage%3D5700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Valliant, J. F.; Ridoch, R. W.; Hughes, D. W.; Roe, D. G.; Fauconnier, T. K.; Thornback, J. R.</span><span> </span><span class="NLM_article-title">The solid phase synthesis and NMR spectroscopy of a <sup>99</sup>Tc chelate-bombesin derived peptide conjugate</span>.  <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span>− <span class="NLM_lpage">163</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2FS0020-1693%2801%2900637-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFGgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2001&pages=155-163&author=J.+F.+Valliant&author=R.+W.+Ridoch&author=D.+W.+Hughes&author=D.+G.+Roe&author=T.+K.+Fauconnier&author=J.+R.+Thornback&title=The+solid+phase+synthesis+and+NMR+spectroscopy+of+a+99Tc+chelate-bombesin+derived+peptide+conjugate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The solid phase synthesis and NMR spectroscopy of a 99Tc chelate-bombesin derived peptide conjugate</span></div><div class="casAuthors">Valliant, John F.; Riddoch, R. William; Hughes, Donald W.; Roe, David G.; Fauconnier, Theresa K.; Thornback, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A bombesin derived peptide-99Tc chelate conjugate was prepd. using a solid phase synthetic methodol.  The reported approach involved linking a prefabricated bifunctional N2N'S technetium chelate complex to a resin bound peptide sequence derived from bombesin, which has been shown to bind to the gastrin-releasing peptide (GRP) receptor.  The technetium chelate-peptide conjugate was subsequently isolated from the solid support and characterized by electrospray mass spectrometry, HPLC and NMR spectroscopy.  The goal of the approach was to develop a versatile solid phase synthetic procedure that would facilitate the future application of modern drug discovery techniques for the development of receptor selective technetium radiopharmaceuticals.  Furthermore, the NMR studies of the reported radiometal-peptide conjugate provide an important ref. for the characterization of future bombesin-based radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Mzx7KiMSu7Vg90H21EOLACvtfcHk0lhn35wjVYqzsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFGgs7g%253D&md5=94ecbf5dab38f4b2a413437e59f6588d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0020-1693%2801%2900637-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-1693%252801%252900637-5%26sid%3Dliteratum%253Aachs%26aulast%3DValliant%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520solid%2520phase%2520synthesis%2520and%2520NMR%2520spectroscopy%2520of%2520a%252099Tc%2520chelate-bombesin%2520derived%2520peptide%2520conjugate%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2001%26volume%3D325%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Cantorias, M. V.; Howell, R. C.; Todaro, L.; Cyr, J. E.; Berndorff, D.; Rogers, R. D.; Francesconi, L. C.</span><span> </span><span class="NLM_article-title">MO tripeptide diastereomers (M = <sup>99/99m</sup>Tc, Re): models to identify the structure of <sup>99m</sup>Tc peptide targeted radiopharmaceuticals</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">7326</span>− <span class="NLM_lpage">7340</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic070077p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=7326-7340&author=M.+V.+Cantorias&author=R.+C.+Howell&author=L.+Todaro&author=J.+E.+Cyr&author=D.+Berndorff&author=R.+D.+Rogers&author=L.+C.+Francesconi&title=MO+tripeptide+diastereomers+%28M+%3D+99%2F99mTc%2C+Re%29%3A+models+to+identify+the+structure+of+99mTc+peptide+targeted+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fic070077p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic070077p%26sid%3Dliteratum%253Aachs%26aulast%3DCantorias%26aufirst%3DM.%2BV.%26atitle%3DMO%2520tripeptide%2520diastereomers%2520%2528M%2520%253D%252099%252F99mTc%252C%2520Re%2529%253A%2520models%2520to%2520identify%2520the%2520structure%2520of%252099mTc%2520peptide%2520targeted%2520radiopharmaceuticals%26jtitle%3DInorg.%2520Chem.%26date%3D2007%26volume%3D46%26spage%3D7326%26epage%3D7340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Francesconi, L. C.; Zheng, Y.; Bartis, J.; Blumenstein, M.; Costello, C.; De Rosch, M. A.</span><span> </span><span class="NLM_article-title">Preparation and characterization of [<sup>99</sup>TcO] apcitide: a technetium labeled peptide</span>.  <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2867</span>− <span class="NLM_lpage">2875</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/ic035473w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=2867-2875&author=L.+C.+Francesconi&author=Y.+Zheng&author=J.+Bartis&author=M.+Blumenstein&author=C.+Costello&author=M.+A.+De+Rosch&title=Preparation+and+characterization+of+%5B99TcO%5D+apcitide%3A+a+technetium+labeled+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fic035473w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic035473w%26sid%3Dliteratum%253Aachs%26aulast%3DFrancesconi%26aufirst%3DL.%2BC.%26atitle%3DPreparation%2520and%2520characterization%2520of%2520%255B99TcO%255D%2520apcitide%253A%2520a%2520technetium%2520labeled%2520peptide%26jtitle%3DInorg.%2520Chem.%26date%3D2004%26volume%3D43%26spage%3D2867%26epage%3D2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Cyr, J. E.; Pearson, D. A.; Nelson, C. A.; Lyons, B. A.; Zheng, Y.; Bartis, J.; He, J.; Cantorias, M. V.; Howell, R. C.; Francesconi, L. C.</span><span> </span><span class="NLM_article-title">Isolation, characterization, and biological evaluation of <i>syn</i> and <i>anti</i> diasteromers of [<sup>99m</sup>Tc]technetium depreotide: a somatostatin receptor binding tumor imaging</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4295</span>− <span class="NLM_lpage">4303</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm060887v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4295-4303&author=J.+E.+Cyr&author=D.+A.+Pearson&author=C.+A.+Nelson&author=B.+A.+Lyons&author=Y.+Zheng&author=J.+Bartis&author=J.+He&author=M.+V.+Cantorias&author=R.+C.+Howell&author=L.+C.+Francesconi&title=Isolation%2C+characterization%2C+and+biological+evaluation+of+syn+and+anti+diasteromers+of+%5B99mTc%5Dtechnetium+depreotide%3A+a+somatostatin+receptor+binding+tumor+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm060887v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060887v%26sid%3Dliteratum%253Aachs%26aulast%3DCyr%26aufirst%3DJ.%2BE.%26atitle%3DIsolation%252C%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%2520syn%2520and%2520anti%2520diasteromers%2520of%2520%255B99mTc%255Dtechnetium%2520depreotide%253A%2520a%2520somatostatin%2520receptor%2520binding%2520tumor%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4295%26epage%3D4303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Carver, J. A.</span><span> </span><span class="NLM_article-title">The conformation of bombesin in solution as determined by two-dimensional <sup>1</sup>H-NMR techniques</span>.  <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span>− <span class="NLM_lpage">199</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1111%2Fj.1432-1033.1987.tb13404.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=3665915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaL1cXhs1Cjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=1987&pages=193-199&author=J.+A.+Carver&title=The+conformation+of+bombesin+in+solution+as+determined+by+two-dimensional+1H-NMR+techniques"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">The conformation of bombesin in solution as determined by two-dimensional proton NMR techniques</span></div><div class="casAuthors">Carver, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-9</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The 1H NMR spectrum of the tetradecapeptide, bombesin, has been assigned in [2H6]DMSO soln. and aq. soln. by using 2-dimensional techniques.  The chem. shifts in both solvents indicate that the mol. has little secondary structure and adopts a random coil conformation.  A comparison is made between the spectra of various smaller bombesin fragments and the intact polypeptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomMAhfbmOUpLVg90H21EOLACvtfcHk0lgt_ywhM0LLjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhs1Cjuw%253D%253D&md5=3a8507a0f527ec6ca9189337f35c9863</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1987.tb13404.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1987.tb13404.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarver%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520conformation%2520of%2520bombesin%2520in%2520solution%2520as%2520determined%2520by%2520two-dimensional%25201H-NMR%2520techniques%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1987%26volume%3D168%26spage%3D193%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Cavatorta, P.; Spisni, A.; Szabo, A. G.; Farruggia, G.; Franzoni, L.; Masotti, L.</span><span> </span><span class="NLM_article-title">Conformation of bombesin in buffer and in the presence of lysolecithin micelles: NMR, CD, and fluorescence studies</span>.  <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span>− <span class="NLM_lpage">463</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=441-463&author=P.+Cavatorta&author=A.+Spisni&author=A.+G.+Szabo&author=G.+Farruggia&author=L.+Franzoni&author=L.+Masotti&title=Conformation+of+bombesin+in+buffer+and+in+the+presence+of+lysolecithin+micelles%3A+NMR%2C+CD%2C+and+fluorescence+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCavatorta%26aufirst%3DP.%26atitle%3DConformation%2520of%2520bombesin%2520in%2520buffer%2520and%2520in%2520the%2520presence%2520of%2520lysolecithin%2520micelles%253A%2520NMR%252C%2520CD%252C%2520and%2520fluorescence%2520studies%26jtitle%3DBiopolymers%26date%3D1989%26volume%3D28%26spage%3D441%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Johnson, C. V.; Shelton, T.; Smith, C. J.; Ma, L.; Perry, M. C.; Volkert, W .A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Evaluation of combined <sup>177</sup>Lu-DOTA-8-AOC-BBN[7-14]NH<sub>2</sub> GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice</span>.  <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span>− <span class="NLM_lpage">166</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1089%2Fcbr.2006.21.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=16706636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1ajtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=155-166&author=C.+V.+Johnson&author=T.+Shelton&author=C.+J.+Smith&author=L.+Ma&author=M.+C.+Perry&author=W+.A.+Volkert&author=T.+J.+Hoffman&title=Evaluation+of+combined+177Lu-DOTA-8-AOC-BBN%5B7-14%5DNH2+GRP+receptor-targeted+radiotherapy+and+chemotherapy+in+PC-3+human+prostate+tumor+cell+xenografted+SCID+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Combined 177Lu-DOTA-8-AOC-BBN (7-14)NH2 GRP Receptor-Targeted Radiotherapy and Chemotherapy in PC-3 Human Prostate Tumor Cell Xenografted SCID Mice</span></div><div class="casAuthors">Johnson, Christopher V.; Shelton, Tiffani; Smith, Charles J.; Ma, Lixin; Perry, Michael C.; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-166</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The focus of this study was to evaluate the therapeutic benefit of combined gastrin-releasing peptide (GRP) receptor-targeted radiotherapy (TRT) with chemotherapy, using the PC-3 xenograft severe combined immunodeficiency (SCID) mouse model.  177Lu-DOTA-8-AOC-BBN(7-14)NH2 is a radiotherapeutic peptide that specifically targets the gastrin-releasing peptide receptor overexpressed on primary and metastatic prostate cancer.  The chemotherapeutic agents, docetaxel and estramustine, were administered as single agents or in combination with the receptor-targeted radiotherapeutic agent.  Combination receptor TRT/chemotherapy studies were begun 21 days postxenografting and were conducted as multiple-dose trials.  The GRP receptor TRT agent was administered every 14 days, and single and combination chemotherapy dose regimens were given weekly.  Tumor size, body wt., and body condition score were evaluated twice-weekly and a hematol. profile once-weekly.  Therapy study tumor vols. were evaluated by way of a repeated measures anal. of variance (ANOVA).  Tumor vol. measurements at 12 days postdose administration demonstrated a statistically significant (two-tailed P-value <0.05) tumor growth suppression in all exptl. groups receiving GRP receptor-targeted radiotherapy, when compared to the control group.  The two combined GRP receptor TRT/chemotherapy treatment groups demonstrated the greatest tumor growth suppression of all treatment groups.  In comparing the two combined GRP receptor TRT/chemotherapy groups to the GRP receptor TRT alone group, a statistically significant difference was demonstrated for the combined groups by day 30, postdose administration.  These data demonstrate that GRP receptor-targeted radiation therapy, using 177Lu-DOTA-8-AOC-BBN(7-14)NH2, used either alone or in combination with conventional chemotherapy, can suppress the growth of androgen- independent prostate cancer (AIPC).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Y9H_Ev0hVbVg90H21EOLACvtfcHk0lgt_ywhM0LLjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1ajtrw%253D&md5=5dee59638944916b5c13f4c507fcba4e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2006.21.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2006.21.155%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BV.%26atitle%3DEvaluation%2520of%2520combined%2520177Lu-DOTA-8-AOC-BBN%255B7-14%255DNH2%2520GRP%2520receptor-targeted%2520radiotherapy%2520and%2520chemotherapy%2520in%2520PC-3%2520human%2520prostate%2520tumor%2520cell%2520xenografted%2520SCID%2520mice%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2006%26volume%3D21%26spage%3D155%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Bläuenstein, P.; Garcia-Garayoa, E.; Rüegg, D.; Blanc, A.; Tourwé, D.; Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Improving the tumour uptake of <sup>99m</sup>Tc-labeled neuropeptides using stabilised peptide analogues</span>.  <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span>− <span class="NLM_lpage">188</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1089%2F108497804323071959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=15186598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A280%3ADC%252BD2c3os1Chug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=181-188&author=P.+Bl%C3%A4uenstein&author=E.+Garcia-Garayoa&author=D.+R%C3%BCegg&author=A.+Blanc&author=D.+Tourw%C3%A9&author=P.+A.+Schubiger&title=Improving+the+tumour+uptake+of+99mTc-labeled+neuropeptides+using+stabilised+peptide+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analogues</span></div><div class="casAuthors">Blauenstein Peter; Garayoa Elisa Garcia; Ruegg Dominique; Blanc Alain; Tourwe Dirk; Beck-Sickinger Annette; Schubiger P August</div><div class="citationInfo"><span class="NLM_cas:title">Cancer biotherapy & radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-8</span>
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    </div><div class="casAbstract">Two neuropeptides, bombesin (BBS) and neurotensin (NT) and their radiolabeled analogues, have great potential for tumour targeting, either for diagnosis (e.g., with 99mTc) or therapy (e.g., with 90Y or 188Re).  In this study, we investigated NT(8-13) and BBS(7-14) analogues with Nalpha-histidinyl acetate linked to the N-terminus of the peptide.  This His-derivative forms a stable and inert tridentate complex with the 99mTc(CO)3 and the 188Re(CO)3 moieties.  The stability of 99mTc-labeled neurotensin and bombesin analogues was tested in human plasma samples and in tumour cell cultures in the presence and absence of specific enzyme inhibitors.  The inhibitor of ACE (angiotensin converting enzyme) was the most effective in inhibiting the peptide cleavage of both NT(8-13) and BBS(7-14).  In agreement with this finding, the replacement of Ile12 by tert-leucine (NT) and Leu13 by cyclohexylalanin (BBS) brought about a better stability.  With NT(8-13) analogues, higher tumour to nontarget (t/nt) ratios and the same affinity to the receptor was observed, but with BBS(7-14) derivatives the affinity was lower and the t/nt ratio was not significantly improved.  Toxicity tests showed no effect in mice of up to a five-hundred-fold higher dose than planned for patient application, which started successfully with NT(8-13) analogues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRrRWEFiTEIbFU0A1HOshhfW6udTcc2ebAfI68pt6a1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3os1Chug%253D%253D&md5=04552c3003388e876be5f9410c99e947</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1089%2F108497804323071959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F108497804323071959%26sid%3Dliteratum%253Aachs%26aulast%3DBl%25C3%25A4uenstein%26aufirst%3DP.%26atitle%3DImproving%2520the%2520tumour%2520uptake%2520of%252099mTc-labeled%2520neuropeptides%2520using%2520stabilised%2520peptide%2520analogues%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2004%26volume%3D19%26spage%3D181%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Preston, E.; Miller, G. V.; Primrose, J. N.</span><span> </span><span class="NLM_article-title">Bombesin-like peptides and cancer</span>.  <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span>− <span class="NLM_lpage">238</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2F1040-8428%2896%2900204-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=8842591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A280%3ADyaK28vktVarsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=225-238&author=E.+Preston&author=G.+V.+Miller&author=J.+N.+Primrose&title=Bombesin-like+peptides+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin-like peptides and cancer</span></div><div class="casAuthors">Preston S R; Miller G V; Primrose J N</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-38</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTerUms1UqVm-WhZTslLrfffW6udTcc2ebAfI68pt6a1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vktVarsg%253D%253D&md5=3cb8a8b8a90530266ae715b377b32266</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2F1040-8428%2896%2900204-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1040-8428%252896%252900204-1%26sid%3Dliteratum%253Aachs%26aulast%3DPreston%26aufirst%3DE.%26atitle%3DBombesin-like%2520peptides%2520and%2520cancer%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D1996%26volume%3D23%26spage%3D225%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Faintuch, B. L.; Teorodo, R.; Duatti, A.; Muramoto, E.; Faintuch, S.; Smith, C. J.</span><span> </span><span class="NLM_article-title">Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span>− <span class="NLM_lpage">411</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2008.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=18482677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvF2qt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=401-411&author=B.+L.+Faintuch&author=R.+Teorodo&author=A.+Duatti&author=E.+Muramoto&author=S.+Faintuch&author=C.+J.+Smith&title=Radiolabeled+bombesin+analogs+for+prostate+cancer+diagnosis%3A+preclinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies</span></div><div class="casAuthors">Faintuch, Bluma Linkowski; Teodoro, Rodrigo; Duatti, Adriano; Muramoto, Emiko; Faintuch, Salomao; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">401-411</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Radionuclide imaging can be a useful tool for the diagnosis of prostate cancer.  Bombesin (BBN) is a mol. with high affinity for gastrin releasing peptide (GRP) receptors which are over-expressed in that tumor.  This report compares 99mTc-HYNIC-βAla-BBN(7-14)NH2 [99mTc-HYNIC-BBN] and 99mTc N(PNP6)-Cys-βAla-BBN(7-14)NH2 [99mTcN(PNP6)-Cys-BBN] with regard to labeling procedures as well as in vitro and in vivo evaluation (biodistribution and scintigraphic imaging).  Methods: Peptide synthesis was performed in an automated peptide synthesizer.  HYNIC-BBN was radiolabeled with pertechnetate using tricine and ethylenediamine diacetic acid (EDDA) as coligands.  Cys- BBN was radiolabeled in a two-step procedure with the prepn. of the precursor 99mTc-Nitrido first and then introducing diphosphine (PNP6).  Radiochem. evaluation of conjugates, as well as studies of stability, transchelation toward cysteine, and partition coeff. were done.  Biol. studies included internalization, biodistribution in healthy animals and in animals bearing PC3 cancer cells with acquisition of images from the tumor-bearing animals.  Results: Both complexes showed a high radiochem. yield along with good stability.  Biodistribution studies pointed out strong renal excretion for the former complex due to its hydrophilic profile and marked hepatobiliary excretion for the latter, corresponding to obsd. lipophilicity.  Tumor uptake was higher for 99mTc-HYNIC-BBN and the same occurred with internalization findings, which exceeded those of 99mTcN(PNP6)-BBN.  Blocking studies in mice bearing PC-3 tumor cells revealed significantly reduced pancreas and tumor uptake, demonstrating receptor specificity of the conjugates.  Conclusion: The best radiotracer was 99mTc-HYNIC-BBN on the basis of high radiochem. yield, fast radiolabeling procedure without need for a purifn. step, and more consistent tumor uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWqYt6BroQTbVg90H21EOLACvtfcHk0lhX9_4QUZWK-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvF2qt7o%253D&md5=e422310f10fa2285b8856e651fca147c</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DFaintuch%26aufirst%3DB.%2BL.%26atitle%3DRadiolabeled%2520bombesin%2520analogs%2520for%2520prostate%2520cancer%2520diagnosis%253A%2520preclinical%2520studies%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D401%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Smith, C. J.; Volkert, W. A.; Hoffman, T. J.</span><span> </span><span class="NLM_article-title">Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span>− <span class="NLM_lpage">740</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2005.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=16243649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=733-740&author=C.+J.+Smith&author=W.+A.+Volkert&author=T.+J.+Hoffman&title=Radiolabeled+peptide+conjugates+for+targeting+of+the+bombesin+receptor+superfamily+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes</span></div><div class="casAuthors">Smith, Charles J.; Volkert, Wynn A.; Hoffman, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">733-740</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Research labs. around the world are currently focusing their efforts toward the development of radiometallated, site-directed, diagnostic/therapeutic agents based upon small peptides such as octreotide, neurotensin, α-MSH, vasointestinal peptide and others.  Bombesin (BBN) or derivs. of bombesin are also of significant interest.  Bombesin is a 14-amino-acid peptide with very high affinity for the BB2 or gastrin-releasing peptide receptor (GRPr).  Over-expression of the GRPr on a variety of human cancers (i.e., breast, prostate, pancreatic, small cell lung, etc.) provides potential efficacy toward development of radiometallated BBN derivs. for targeting and, hence, diagnosis/treatment of these specific diseases.  New derivs. are being developed that are also capable of targeting the BB1 and BB3 receptor subtypes that are over-expressed on cancer cells.  This review highlights some of the more recent developments toward design of BBN receptor-specific radiopharmaceuticals that have taken place over the past 2 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiAuROohyHhrVg90H21EOLACvtfcHk0lgW1eA9wf_ChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb7I&md5=36e8e01e6e3e1e90439a7f66732ce217</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DRadiolabeled%2520peptide%2520conjugates%2520for%2520targeting%2520of%2520the%2520bombesin%2520receptor%2520superfamily%2520subtypes%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D733%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Reile, H.; Armatis, P. E.; Schally, A. V.</span><span> </span><span class="NLM_article-title">Characterization of high affinity receptors for bombesin/gastrin-releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: Internalization of receptor bound <sup>125</sup>I-[Tyr4]bombesin by tumor cells</span>.  <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span>− <span class="NLM_lpage">38</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=29-38&author=H.+Reile&author=P.+E.+Armatis&author=A.+V.+Schally&title=Characterization+of+high+affinity+receptors+for+bombesin%2Fgastrin-releasing+peptide+on+the+human+prostate+cancer+cell+lines+PC-3+and+DU-145%3A+Internalization+of+receptor+bound+125I-%5BTyr4%5Dbombesin+by+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReile%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520high%2520affinity%2520receptors%2520for%2520bombesin%252Fgastrin-releasing%2520peptide%2520on%2520the%2520human%2520prostate%2520cancer%2520cell%2520lines%2520PC-3%2520and%2520DU-145%253A%2520Internalization%2520of%2520receptor%2520bound%2520125I-%255BTyr4%255Dbombesin%2520by%2520tumor%2520cells%26jtitle%3DProstate%26date%3D1994%26volume%3D25%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Moran, T. H.; Moody, T. W.; Hostetler, A. M.; Robinson, P. H.; Goldrich, M.; McHugh, P. R.</span><span> </span><span class="NLM_article-title">Distribution of bombesin binding sites in the rat gastrointestinal tract</span>.  <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span>− <span class="NLM_lpage">649</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1988&pages=643-649&author=T.+H.+Moran&author=T.+W.+Moody&author=A.+M.+Hostetler&author=P.+H.+Robinson&author=M.+Goldrich&author=P.+R.+McHugh&title=Distribution+of+bombesin+binding+sites+in+the+rat+gastrointestinal+tract"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoran%26aufirst%3DT.%2BH.%26atitle%3DDistribution%2520of%2520bombesin%2520binding%2520sites%2520in%2520the%2520rat%2520gastrointestinal%2520tract%26jtitle%3DPeptides%26date%3D1988%26volume%3D9%26spage%3D643%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Cescato, R.; Maina, T.; Nock, B.; Nikolopoulou, A.; Charalabidis, D.; Piccand, V.; Reudi, J. C.</span><span> </span><span class="NLM_article-title">Bombesin receptor antagonists may be preferable to agonists for tumor imaging</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=318-326&author=R.+Cescato&author=T.+Maina&author=B.+Nock&author=A.+Nikolopoulou&author=D.+Charalabidis&author=V.+Piccand&author=J.+C.+Reudi&title=Bombesin+receptor+antagonists+may+be+preferable+to+agonists+for+tumor+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCescato%26aufirst%3DR.%26atitle%3DBombesin%2520receptor%2520antagonists%2520may%2520be%2520preferable%2520to%2520agonists%2520for%2520tumor%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26spage%3D318%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Shi, J.; Jia, B.; Liu, Z.; Yu, Z.; Chen, K.; Chen, X.; Liu, S.; Wang, F.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labeled bombesin(7-14)NH<sub>2</sub> with favorable properties for SPECT imaging of colon cancer</span>.  <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span>− <span class="NLM_lpage">1178</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bc700471z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtFWhu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1170-1178&author=J.+Shi&author=B.+Jia&author=Z.+Liu&author=Z.+Yu&author=K.+Chen&author=X.+Chen&author=S.+Liu&author=F.+Wang&title=99mTc-labeled+bombesin%287-14%29NH2+with+favorable+properties+for+SPECT+imaging+of+colon+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-Labeled Bombesin(7-14)NH2 with Favorable Properties for SPECT Imaging of Colon Cancer</span></div><div class="casAuthors">Shi, Jiyun; Jia, Bing; Liu, Zhaofei; Yang, Zhi; Yu, Zilin; Chen, Kai; Chen, Xiaoyuan; Liu, Shuang; Wang, Fan</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1170-1178</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this report, we present the synthesis and evaluation of the 99mTc-labeled β-Ala-BN(7-14)NH2 (ABN = β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2) as a new radiotracer for tumor imaging in the BALB/c nude mice bearing HT-29 human colon cancer xenografts.  The gastrin releasing peptide receptor binding affinity of ABN and HYNIC-ABN (6-hydrazinonicotinamide) was assessed via a competitive displacement of 125I-[Tyr4]BBN bound to the PC-3 human prostate carcinoma cells.  The IC50 values were calcd. to be 24 ± 2 nM and 38 ± 1 nM for ABN and HYNIC-ABN, resp.  HYNIC is the bifunctional coupling agent for 99mTc-labeling, while tricine and TPPTS (trisodium triphenylphosphine-3,3',3''-trisulfonate) are used as coligands to prep. the ternary ligand complex [99mTc(HYNIC-ABN)(tricine)(TPPTS)] in very high yield and high specific activity.  Because of its high hydrophilicity (log P = -2.39 ± 0.06), [99mTc(HYNIC-ABN)(tricine)(TPPS)] was excreted mainly through the renal route with little radioactivity accumulation in the liver, lungs, stomach, and gastrointestinal tract.  The tumor uptake at 30 min postinjection (p.i.) was 1.59 ± 0.23%ID/g with a steady tumor washout over the 4 h study period.  As a result, it had the best T/B ratios in the blood (2.37 ± 0.68), liver (1.69 ± 0.41), and muscle (11.17 ± 3.32) at 1 h p.i.  Most of the injected radioactivity was found in the urine sample at 1 h p.i., and there was no intact [99mTc(HYNIC-ABN)(tricine)(TPPTS)] detectable in the urine, kidney, and liver samples.  Its metabolic instability may contribute to its rapid clearance from the liver, lungs, and stomach.  Despite the steady radioactivity washout, the tumors could be clearly visualized in planar images of the BALB/c nude mice bearing the HT-29 human colon xenografts at 1 and 4 h p.i.  The favorable excretion kinetics from the liver, lungs, stomach, and gastrointestinal tract makes [99mTc(HYNIC-ABN)(tricine)(TPPTS)] a promising SPECT radiotracer for imaging colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxaPPRVAfeo7Vg90H21EOLACvtfcHk0lgW1eA9wf_ChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtFWhu70%253D&md5=8a9109ec5b85cef7215255c4840af15a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fbc700471z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700471z%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26atitle%3D99mTc-labeled%2520bombesin%25287-14%2529NH2%2520with%2520favorable%2520properties%2520for%2520SPECT%2520imaging%2520of%2520colon%2520cancer%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D1170%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Lane, S. R.; Veerendra, B.; Rold, T. L.; Sieckman, G. L.; Hoffman, T. J.; Jurisson, S. S.; Smith, C. J.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc(CO)<sub>3</sub>-DTMA bombesin conjugates having high affinity for the GRP receptor</span>.  <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span>− <span class="NLM_lpage">272</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1016%2Fj.nucmedbio.2007.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm900360d&amp;key=18355681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Kit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=263-272&author=S.+R.+Lane&author=B.+Veerendra&author=T.+L.+Rold&author=G.+L.+Sieckman&author=T.+J.+Hoffman&author=S.+S.+Jurisson&author=C.+J.+Smith&title=99mTc%28CO%293-DTMA+bombesin+conjugates+having+high+affinity+for+the+GRP+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor</span></div><div class="casAuthors">Lane, Stephanie R.; Veerendra, Bhadrasetty; Rold, Tammy L.; Sieckman, Gary L.; Hoffman, Timothy J.; Jurisson, Silvia S.; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Targeted diagnosis of specific human cancer types continues to be of significant interest in nuclear medicine. 99mTc is ideally suited as a diagnostic radiometal for in vivo tumor targeting due to its ideal phys. characteristics and diverse labeling chemistries in numerous oxidn. states.  In this study, we report a synthetic approach toward design of a new tridentate amine ligand for the organometallic aqua-ion [99mTc(H2O)3(CO)3]+.  The new chelating ligand framework, 2-(N,N'-Bis(tert-butoxycarbonyl)diethylenetriamine) acetic acid (DTMA), was synthesized from a diethylenetriamine precursor and fully characterized by mass spectrometry and NMR spectroscopy (1H and 13C).  DTMA was conjugated to H2N-(X)-BBN(7-14)NH2, where X = an amino acid or aliph. pharmacokinetic modifier and BBN=bombesin peptide, by means of solid phase peptide synthesis.  DTMA-(X)-BBN(7-14)NH2 conjugates were purified by reversed-phase high-performance chromatog. and characterized by electrospray-ionization mass spectrometry.  The new conjugates were radiolabeled with [99mTc(H2O)3(CO)3]+ produced via Isolink radiolabeling kits to produce [99mTc(CO)3-DTMA-(X)-BBN(7-14)NH2].  Radiolabeled conjugates were purified by reversed-phase high-performance chromatog.  Effective receptor binding behavior was evaluated in vitro and in vivo.  [99mTc(CO)3-DTMA-(X)-BBN(7-14)NH2] conjugates displayed very high affinity for the gastrin releasing peptide receptor in vitro and in vivo.  Therefore, these conjugates hold some propensity to be investigated as mol. imaging agents that specifically target human cancers uniquely expressing the gastrin releasing peptide receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4FukM8pF_bLVg90H21EOLACvtfcHk0ljlPLFAuHlYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Kit7s%253D&md5=05de34ad950f030113759e43fa30790e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DS.%2BR.%26atitle%3D99mTc%2528CO%25293-DTMA%2520bombesin%2520conjugates%2520having%2520high%2520affinity%2520for%2520the%2520GRP%2520receptor%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D263%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Maina, T.; Nock, B. A.; Zhang, H.; Nikolopoulou, A.; Waser, B.; Reudi, J. C.</span><span> </span><span class="NLM_article-title">Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs</span>.  <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span>− <span class="NLM_lpage">830</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=823-830&author=T.+Maina&author=B.+A.+Nock&author=H.+Zhang&author=A.+Nikolopoulou&author=B.+Waser&author=J.+C.+Reudi&title=Species+differences+of+bombesin+analog+interactions+with+GRP-R+define+the+choice+of+animal+models+in+the+development+of+GRP-R-targeting+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DSpecies%2520differences%2520of%2520bombesin%2520analog%2520interactions%2520with%2520GRP-R%2520define%2520the%2520choice%2520of%2520animal%2520models%2520in%2520the%2520development%2520of%2520GRP-R-targeting%2520drugs%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D823%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Noll, B.; Kniess, M.; Friebe, M.; Spies, H.; Johannsen, B.</span><span> </span><span class="NLM_article-title">Rhenium(V) gluconate, a suitable precursor for the preparation of rhenium(V) complexes</span>.  <span class="citation_source-journal">Isot. Environ. Health Stud.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span>− <span class="NLM_lpage">29</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm900360d&amp;key=10.1080%2F10256019608036290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm900360d&amp;key=1%3ACAS%3A528%3ADyaK1cXisFKmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1996&pages=21-29&author=B.+Noll&author=M.+Kniess&author=M.+Friebe&author=H.+Spies&author=B.+Johannsen&title=Rhenium%28V%29+gluconate%2C+a+suitable+precursor+for+the+preparation+of+rhenium%28V%29+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Rhenium(V) gluconate, a suitable precursor for the preparation of rhenium(V) complexes</span></div><div class="casAuthors">Noll, B.; Kniess, T.; Friebe, M.; Spies, Hartmut; Johannsen, B.</div><div class="citationInfo"><span class="NLM_cas:title">Isotopes in Environmental and Health Studies</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">IEHSF8</span>;
        ISSN:<span class="NLM_cas:issn">1025-6016</span>.
    
            (<span class="NLM_cas:orgname">Gordon & Breach Science Publishers</span>)
        </div><div class="casAbstract">Redn. of perrhenate with SnCl2 at an excess of Na gluconate in aq. soln. results in formation of Re(V) gluconate.  The reaction proceeds slowly compared to that of pertechnetate.  Aq. solns. of Re(V) gluconate can be prepd. down to a concn. level of at least 10-4 mol·1-1 within 2 h.  The usefulness of Re(V) gluconate to serve as a precursor for prepn. of oxorhenium(V) complexes as potential radiotherapeutic agents is revealed by subsequent ligand exchange reactions carried out with mercaptoacetyldiglycine, 3-thiapentane-dithiol-1,5/butanethiol and with 2-aminobenzenethiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqusqlYJWwv1bVg90H21EOLACvtfcHk0ljlPLFAuHlYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFKmsLc%253D&md5=39af0768a37d435bf5de0e8499823885</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1080%2F10256019608036290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10256019608036290%26sid%3Dliteratum%253Aachs%26aulast%3DNoll%26aufirst%3DB.%26atitle%3DRhenium%2528V%2529%2520gluconate%252C%2520a%2520suitable%2520precursor%2520for%2520the%2520preparation%2520of%2520rhenium%2528V%2529%2520complexes%26jtitle%3DIsot.%2520Environ.%2520Health%2520Stud.%26date%3D1996%26volume%3D32%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Loudos, G.; Majewski, S.; Wojcik, R.; Weisenberger, A.; Sakellios, N.; Nikita, K.; Uzunoglu, N.; Bouziotis, P.; Xanthopoulos, S.; Varvarigou, A.</span><span> </span><span class="NLM_article-title">Performance evaluation of a dedicated camera suitable for dynamic radiopharmaceuticals evaluation in small animals</span>.  <span class="citation_source-journal">IEEE Trans. Nucl. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span>− <span class="NLM_lpage">59</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=54-59&author=G.+Loudos&author=S.+Majewski&author=R.+Wojcik&author=A.+Weisenberger&author=N.+Sakellios&author=K.+Nikita&author=N.+Uzunoglu&author=P.+Bouziotis&author=S.+Xanthopoulos&author=A.+Varvarigou&title=Performance+evaluation+of+a+dedicated+camera+suitable+for+dynamic+radiopharmaceuticals+evaluation+in+small+animals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoudos%26aufirst%3DG.%26atitle%3DPerformance%2520evaluation%2520of%2520a%2520dedicated%2520camera%2520suitable%2520for%2520dynamic%2520radiopharmaceuticals%2520evaluation%2520in%2520small%2520animals%26jtitle%3DIEEE%2520Trans.%2520Nucl.%2520Soc.%26date%3D2007%26spage%3D54%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a href="/doi/suppl/10.1021/jm900360d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_41360"></div></div></div></div></div><hr /></hr><p class="last">Tables of <sup>1</sup>H and <sup>13</sup>C NMR chemical shifts for BN-1.1 (Table S1), <sup>185/187</sup>Re-BN-1.1 (Table S2), BN-1.1p (Table S3), and <sup>185/187</sup>Re-BN-1.1p (Table S4) in aqueous solution H<sub>2</sub>O/D<sub>2</sub>O (9:1) at 25 °C; Figure S1 showing the CD spectra of <sup>185/187</sup>Re-BN1.1p (A) in a 5.4 mM aqueous solution in the region 190−600 nm and (B) far-UV 190−260 nm region of a 15-fold dilution of the same sample. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900360d/suppl_file/jm900360d_si_001.pdf">jm900360d_si_001.pdf (75.9 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900360d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm900360d%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-14" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900360d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998efef8c02332","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
